{
  "meta": {
    "title": "60_Inicet_Mock_Test-2_-_03-05-2025",
    "url": "https://brainandscalpel.vercel.app/60-inicet-mock-test-2-03-05-2025-33c8dc3e.html",
    "scrapedAt": "2025-11-29T17:24:01.950Z"
  },
  "questions": [
    {
      "id": 79043,
      "choices": [
        {
          "id": 314933,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer PPI or H₂ blocker</span></p>"
        },
        {
          "id": 314934,
          "text": "<p><span style=\"font-size:14.0pt;\">Start sucralfate regardless of risk</span></p>"
        },
        {
          "id": 314935,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer H₂ blocker in all ventilated ICU patients</span></p>"
        },
        {
          "id": 314936,
          "text": "<p><span style=\"font-size:14.0pt;\">Avoid prophylaxis unless GI bleed occurs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 66-year-old man in the ICU with septic shock is on mechanical ventilation for 3 days and receiving vasopressors for hemodynamic support. He has no history of gastrointestinal bleeding. Current labs show platelets 48,000/μL, INR 1.7, and creatinine 2.1 mg/dL. He is being fed via a nasogastric tube but is unable to tolerate oral medications. A junior resident suggests continuing only fluids and lactulose due to infection concerns with acid-suppressive agents. What is the most appropriate approach for stress ulcer prophylaxis?</span></p>",
      "unique_key": "Q7347876",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Administer PPI or H₂ blocker</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient meets <strong>multiple high-risk criteria</strong> for clinically significant upper GI bleeding:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Mechanical ventilation &gt;48 hours</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bleeding diathesis</strong> (platelets &lt;50,000/µL, INR &gt;1.5),</span></li><li><span style=\"font-size:14.0pt;\"><strong>Shock requiring vasopressors</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">For <strong>critically ill high-risk patients</strong>, guidelines <strong>strongly recommend SUP</strong> with a <strong>proton pump inhibitor (PPI)</strong> or <strong>histamine-2 receptor blocker (H₂ blocker)</strong> (Grade 1B).</span></li><li><span style=\"font-size:14.0pt;\"><strong>PPI is preferred</strong> due to superior acid suppression and evidence from meta-analyses supporting its efficacy in preventing UGIB, especially in those at highest risk.</span></li><li><span style=\"font-size:14.0pt;\">In patients <strong>unable to take enteral medications</strong>, an <strong>IV PPI</strong> is preferred; IV H₂ blockers are an acceptable alternative if cost or availability is an issue.</span></li><li><span style=\"font-size:14.0pt;\">Though acid suppression is associated with increased VAP and Clostridioides difficile risk, these risks are outweighed by the benefits in <strong>high-risk ICU patients</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sucralfate</strong> is no longer considered effective as monotherapy for SUP in high-risk patients.</span></li><li><span style=\"font-size:14.0pt;\">Avoiding prophylaxis until bleeding occurs contradicts the <strong>preventive intent</strong> of SUP.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Indications for Stress Ulcer Prophylaxis in ICU:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_HiY10Hj.png\" width=\"1348\" height=\"537\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start sucralfate regardless of risk</strong>: Not evidence-based for high-risk ICU patients and less effective than PPIs or H₂ blockers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Administer&nbsp;H₂ blocker in all ventilated patients</strong>: Blanket approach is outdated. SUP is recommended <strong>only in those with bleeding risk</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Avoid prophylaxis unless GI bleed occurs</strong>: SUP is <strong>preventive</strong>, not therapeutic — waiting for bleeding defeats its purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In critically ill ICU patients with bleeding diathesis or mechanical ventilation &gt;48 hours, stress ulcer prophylaxis with PPI (preferred) or H₂ blocker is recommended. The benefits of prophylaxis outweigh infection risks in high-risk patients.</span></p>",
      "correct_choice_id": 314933,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79043/Dr._Dilip_Mock_Test_2_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79043/Dr._Dilip_Mock_Test_2_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78837,
      "choices": [
        {
          "id": 314121,
          "text": "<p><span style=\"font-size:14.0pt;\">Indirect inguinal hernia</span></p>"
        },
        {
          "id": 314122,
          "text": "<p><span style=\"font-size:14.0pt;\">Infertility</span></p>"
        },
        {
          "id": 314123,
          "text": "<p><span style=\"font-size:14.0pt;\">Testicular torsion</span></p>"
        },
        {
          "id": 314124,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal hydrocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-month-old male infant is brought to the paediatrician for a routine examination. On physical examination, the right side of the scrotum is empty, and the testis is palpated in the inguinal canal. The parents are concerned and ask about possible complications their child may face in the future if this condition is left untreated. Which of the following is the least likely complication associated with this condition?&nbsp;</span></p>",
      "unique_key": "Q3004736",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Vaginal hydrocele</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>vaginal hydrocele</strong> occurs when there is <strong>fluid accumulation around the testis</strong> only in the scrotum (tunica vaginalis).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, in the case of an <strong>undescended testis</strong>, a patent processus vaginalis will lead to a “congenital” hydrocele which will extend from the scrotum up to the deep ring.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Indirect inguinal hernia:&nbsp;</strong>Highly likely. About <strong>90%</strong> of undescended testes are associated with a <strong>patent processus vaginalis</strong>, predisposing to indirect inguinal hernias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Infertility: </strong>Common in undescended testes due to <strong>impaired spermatogenesis</strong> from higher intra-abdominal temperature. Even after orchidopexy, fertility may still be affected, particularly in bilateral cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Testicular torsion:&nbsp;</strong>More likely to occur in undescended testes due to <strong>inadequate fixation</strong> and <strong>abnormal mesentery</strong>, making them prone to rotation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Undescended testis (cryptorchidism)</strong> is associated with several complications if not surgically corrected early, including <strong>infertility, malignancy risk (seminoma), inguinal hernia, congenital hydrocele, and testicular torsion</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, a <strong>vaginal hydrocele</strong> is <strong>less likely</strong> in this condition since it typically involves the <strong>scrotal testis</strong>.</span></li></ul>",
      "correct_choice_id": 314124,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78837/Surgery_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78837/Surgery_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78930,
      "choices": [
        {
          "id": 314485,
          "text": "<p><span style=\"font-size:14.0pt;\">Zona occludens</span></p>"
        },
        {
          "id": 314486,
          "text": "<p><span style=\"font-size:14.0pt;\">Gap junction</span></p>"
        },
        {
          "id": 314487,
          "text": "<p><span style=\"font-size:14.0pt;\">Adherent junction</span></p>"
        },
        {
          "id": 314488,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemidesmosomes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male presents with acute onset of profuse watery diarrhea described as resembling “rice water” or rice gruel. He recently returned from a coastal region in South Asia. He appears dehydrated, and stool cultures are pending. The physician suspects a bacterial toxin that increases intestinal permeability. Which of the following cellular structures is most likely impaired, leading to the patient's symptoms?&nbsp;</span></p>",
      "unique_key": "Q2831297",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Zona occludens</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Zona occludens</strong>, also known as <strong>tight junctions</strong>, are crucial components of the intestinal epithelial barrier. They are located at the apical portion of epithelial cells and regulate paracellular permeability. In infections such as <strong>cholera</strong>, bacterial enterotoxins (like cholera toxin) disrupt these tight junctions, leading to massive water and electrolyte secretion into the intestinal lumen, producing <strong>watery diarrhea that resembles rice water</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Gap junction:</strong> Allow for intercellular communication via ions and small molecules but do not regulate epithelial barrier function.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Adherent junction:</strong> Provide mechanical adhesion between adjacent cells but do not primarily regulate permeability.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Hemidesmosomes:</strong> Anchor epithelial cells to the basement membrane and are not involved in regulating intestinal lumen permeability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Damage to <strong>tight junctions (zona occludens)</strong> increases paracellular permeability in the gut, leading to leakage of fluids and electrolytes, a mechanism often exploited by pathogens causing secretory diarrhea.</span></p>",
      "correct_choice_id": 314485,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78930/Physiology_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78930/Physiology_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78949,
      "choices": [
        {
          "id": 314561,
          "text": "<p><span style=\"font-size:14.0pt;\">Day 5 to Day 9</span></p>"
        },
        {
          "id": 314562,
          "text": "<p><span style=\"font-size:14.0pt;\">Day 2 to Day 6</span></p>"
        },
        {
          "id": 314563,
          "text": "<p><span style=\"font-size:14.0pt;\">Day 10 to Day 14</span></p>"
        },
        {
          "id": 314564,
          "text": "<p><span style=\"font-size:14.0pt;\">Day 12 to Day 16</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman with secondary infertility visits the clinic with complaints of irregular menstrual cycles and inability to conceive for 2 years. After ruling out anatomical and endocrinological causes, you decide to start ovulation induction with Clomiphene citrate 50 mg/day for 5 days. On which days of her menstrual cycle should she begin the medication for optimal follicular recruitment and ovulation?&nbsp;</span></p>",
      "unique_key": "Q2676473",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Day 2 to Day 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clomiphene citrate is used for <strong>ovulation induction</strong> in women with anovulatory infertility. It is typically initiated at a dose of <strong>50 mg/day for 5 days</strong>, starting <strong>from Day 2 to Day 6</strong> of the menstrual cycle. This timing ensures adequate <strong>FSH stimulation</strong> for <strong>follicular development</strong>, leading to ovulation around <strong>Day 14</strong> in a regular 28-day cycle.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If ovulation does not occur, the dose can be increased up to <strong>100 mg/day</strong>.</span></li><li><span style=\"font-size:14.0pt;\">If ovulation induction fails after 6–8 cycles, <strong>gonadotropin therapy</strong> may be considered.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clomiphene citrate is started from <strong>Day 2 to Day 6</strong> of the menstrual cycle for ovulation induction in anovulatory infertility. It acts by increasing FSH secretion and promoting follicular maturation.</span></p>",
      "correct_choice_id": 314562,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78949/Obg_Q_13_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78949/Obg_Q_13_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78899,
      "choices": [
        {
          "id": 314361,
          "text": "<p><span style=\"font-size:14.0pt;\">Patch test</span></p>"
        },
        {
          "id": 314362,
          "text": "<p><span style=\"font-size:14.0pt;\">Prick test</span></p>"
        },
        {
          "id": 314363,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum IgE levels</span></p>"
        },
        {
          "id": 314364,
          "text": "<p><span style=\"font-size:14.0pt;\">Skin biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man presents with multiple pruritic, erythematous papules distributed over his forehead, neck, and the V-area of his chest. He reports that the rash has recurred every summer for the past four years and tends to resolve spontaneously during the winter. He denies any systemic symptoms. He works outdoors and frequently uses various sunscreen and cosmetic products. Examination reveals discrete lichenified papules with mild scaling in the affected areas. What is the most appropriate diagnostic test to identify the underlying cause?</span></p>",
      "unique_key": "Q8644009",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Patch test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is suggestive of <strong>chronic photoallergic contact dermatitis</strong>, often caused by a delayed-type (Type IV) hypersensitivity to photo-exposed allergens such as cosmetic ingredients or sunscreens.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>patch test</strong> is the gold standard for diagnosing allergic contact dermatitis due to delayed-type hypersensitivity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves applying allergens under occlusion for 48 hours and interpreting results at 48 and 96 hours. 48 hours is reading 1 and 96 hours is reading 2.</span></li><li><span style=\"font-size:14.0pt;\">Reading 2 is best for patch test.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_q5ElZWO.png\" width=\"579\" height=\"434\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Prick test:&nbsp;</strong>Used to evaluate immediate-type (Type I) hypersensitivity, typically for urticaria or food/drug allergies—not for delayed hypersensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum IgE levels:&nbsp;</strong>Elevated in atopic dermatitis or systemic allergic conditions but not helpful in diagnosing contact dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Skin biopsy:&nbsp;</strong>May help exclude other dermatologic conditions but is not diagnostic for allergic contact dermatitis or its allergen.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Patch testing is the investigation of choice for diagnosing <strong>allergic contact dermatitis</strong> caused by delayed-type hypersensitivity. It is particularly useful in chronic, relapsing, photo-distributed rashes exacerbated by topical exposures.</span></p>",
      "correct_choice_id": 314361,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78899/Dermatology_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78899/Dermatology_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78824,
      "choices": [
        {
          "id": 314069,
          "text": "<p><span style=\"font-size:14.0pt;\">Menkes disease</span></p>"
        },
        {
          "id": 314070,
          "text": "<p><span style=\"font-size:14.0pt;\">Down syndrome</span></p>"
        },
        {
          "id": 314071,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 314072,
          "text": "<p><span style=\"font-size:14.0pt;\">Lesch-Nyhan syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A child presents with anemia, seizures, intellectual disability, and hair texture as shown in the image below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_m9C6vbh.png\" width=\"940\" height=\"219\"></strong></span></p>",
      "unique_key": "Q1030123",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Menkes disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Menkes disease is an <strong>X-linked recessive disorder</strong> of copper metabolism caused by mutations in the <strong>ATP7A gene</strong>, leading to defective copper transport. This results in <strong>copper deficiency</strong> in various tissues.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Key clinical features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Kinky, sparse, brittle hair</strong> (pili torti)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Neurodegeneration</strong> (seizures, hypotonia, developmental delay)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anemia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Failure to thrive</strong></span></li><li><span style=\"font-size:14.0pt;\">Skeletal abnormalities</span></li><li><span style=\"font-size:14.0pt;\">Death typically occurs in early childhood if untreated.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:14.0pt;\">The characteristic hair abnormalities (seen in the image) are a hallmark of Menkes disease and help in clinical diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Down syndrome</strong>: Characterized by hypotonia, intellectual disability, flat facies, and congenital anomalies — not associated with kinky hair.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Iron deficiency anemia</strong>: Can cause pallor, pica, and hair thinning but not the kinky hair pattern seen here.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Lesch-Nyhan syndrome</strong>: Presents with self-mutilation, hyperuricemia, and neurologic features — hair changes are not typical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Menkes disease</strong> is a copper transport disorder marked by <strong>kinky hair (pili torti)</strong>, neurodevelopmental delay, seizures, and failure to thrive. It is confirmed by low serum copper and ceruloplasmin levels and characteristic hair microscopy findings.</span></p>",
      "correct_choice_id": 314069,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78824/Pediatrics_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78824/Pediatrics_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78818,
      "choices": [
        {
          "id": 314045,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, and 4</span></p>"
        },
        {
          "id": 314046,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 5</span></p>"
        },
        {
          "id": 314047,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 5</span></p>"
        },
        {
          "id": 314048,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4, and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the nutritional composition of human milk is/are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Human milk contains higher concentrations of whey and lactalbumin compared to casein.</span></li><li><span style=\"font-size:14.0pt;\">The calcium to phosphorus ratio in human milk is less than 1.</span></li><li><span style=\"font-size:14.0pt;\">Human milk is richer in polyunsaturated fatty acids (PUFAs) and has lower protein content than cow’s milk.</span></li><li><span style=\"font-size:14.0pt;\">The osmolality of human milk is approximately 290 mOsm/L.</span></li><li><span style=\"font-size:14.0pt;\">Iron content in human milk ranges between 1.5–2.0 mg/100 mL.</span></li></ol>",
      "unique_key": "Q2130312",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 3, and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Human milk contains higher concentrations of whey and lactalbumin compared to casein:&nbsp;</strong>Correct<strong>,&nbsp;</strong>Human milk contains <strong>high levels of lactalbumin and whey protein</strong>, with <strong>whey: casein ratio of 60:40</strong>, making it easier to digest.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Human milk is richer in polyunsaturated fatty acids (PUFAs) and has lower protein content than cow’s milk:&nbsp;</strong>Correct<strong>,</strong> Human milk is <strong>richer in PUFAs</strong> (important for brain and retinal development) and contains <strong>lower protein content</strong> (1.1 g/100 mL) compared to cow’s milk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The osmolality of human milk is approximately 290 mOsm/L:&nbsp;</strong>Correct, the <strong>osmolality</strong> of human milk is <strong>approximately 280-300 mOsm/L</strong>, which is ideal for infant kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2</strong>. <strong>The calcium to phosphorus ratio in human milk is less than 1:&nbsp;</strong>Incorrect, the <strong>calcium to phosphorus ratio</strong> in human milk is <strong>2:1</strong>, which enhances calcium absorption—unlike cow's milk, where the ratio is lower.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>Iron content in human milk ranges between 1.5–2.0 mg/100 mL:&nbsp;</strong>Incorrect<strong>,</strong> <strong>Iron content</strong> in human milk is <strong>0.29–0.45 mg/100 mL</strong>, <strong>not 1.5–2.0 mg</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Human milk provides optimal nutrition tailored to infants, with a high whey-to-casein ratio, low protein content, essential fatty acids, ideal osmolality, and enhanced mineral bioavailability despite low absolute concentrations.</span></p>",
      "correct_choice_id": 314045,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78818/Pediatrics_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78818/Pediatrics_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78885,
      "choices": [
        {
          "id": 314305,
          "text": "<p><span style=\"font-size:14.0pt;\">Marcus Gunn pupil</span></p>"
        },
        {
          "id": 314306,
          "text": "<p><span style=\"font-size:14.0pt;\">Tonic pupil (Adie’s pupil)</span></p>"
        },
        {
          "id": 314307,
          "text": "<p><span style=\"font-size:14.0pt;\">Oculomotor nerve (CN III) paralysis</span></p>"
        },
        {
          "id": 314308,
          "text": "<p><span style=\"font-size:14.0pt;\">Argyll Robertson pupil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 61-year-old man with a history of neurosyphilis presents with difficulty in vision, especially in dim light. On examination, his pupils are small, irregular, and do not constrict in response to light, but do constrict during accommodation. What is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q2251281",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Argyll Robertson pupil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Argyll Robertson pupil</strong> is classically associated with <strong>neurosyphilis</strong>. These pupils:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Are <strong>small and irregular</strong></span></li><li><span style=\"font-size:14.0pt;\">Exhibit <strong>light-near dissociation</strong> (they <strong>do not constrict to light</strong>, but <strong>do constrict during accommodation</strong>)</span></li><li><span style=\"font-size:14.0pt;\">Are often <strong>bilateral</strong></span></li><li><span style=\"font-size:14.0pt;\">Known as \"<strong>prostitute’s pupils</strong>\" — they <strong>accommodate but do not react</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6FKZsQ9.png\" width=\"462\" height=\"517\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This presentation is highly specific to <strong>tertiary syphilis</strong> (neurosyphilis).</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Marcus Gunn pupil:&nbsp;</strong>&nbsp;Seen in <strong>optic nerve disease</strong>, typically <strong>unilateral</strong>, presenting as a <strong>relative afferent pupillary defect (RAPD)</strong>. Light response is affected <strong>in both direct and consensual pathways</strong>, unlike the light-near dissociation in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tonic pupil (Adie’s pupil):&nbsp;</strong>&nbsp;Usually <strong>unilateral</strong>, with a <strong>dilated pupil</strong> that reacts poorly to light and slowly to accommodation. It is typically seen in <strong>young women</strong>, not linked to neurosyphilis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oculomotor nerve (CN III) paralysis:&nbsp; </strong>Results in a <strong>dilated pupil</strong>, often with <strong>ptosis</strong> and <strong>extraocular muscle involvement</strong>. The pupil may not respond to light or near stimulus depending on parasympathetic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Argyll Robertson pupils are classically seen in neurosyphilis and are characterized by small, irregular pupils that accommodate but do not react to light — a key example of light-near dissociation.</span></p>",
      "correct_choice_id": 314308,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78885/Ophthalmology_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78885/Ophthalmology_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78820,
      "choices": [
        {
          "id": 314053,
          "text": "<p><span style=\"font-size:14.0pt;\">Insulin-dependent diabetes mellitus</span></p>"
        },
        {
          "id": 314054,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic renal failure</span></p>"
        },
        {
          "id": 314055,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal tubular acidosis</span></p>"
        },
        {
          "id": 314056,
          "text": "<p><span style=\"font-size:14.0pt;\">Inborn errors of metabolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 11-year-old child presents with failure to thrive and laboratory findings reveal metabolic acidosis with an elevated anion gap. Which of the following conditions is not<strong>&nbsp;</strong>typically associated with high anion gap metabolic acidosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4942342",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Renal tubular acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">High anion gap metabolic acidosis (HAGMA) occurs when there is an accumulation of unmeasured anions (such as lactate, ketones, or organic acids). Common causes include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Diabetic ketoacidosis (A)</strong> → ↑ ketone bodies</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chronic renal failure (B)</strong> → retention of acids like sulfates and phosphates</span></li><li><span style=\"font-size:14.0pt;\"><strong>Inborn errors of metabolism (D)</strong> → organic acidemias (e.g., methylmalonic acidemia)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Renal Tubular Acidosis (RTA)</strong>, on the other hand, is a cause of <strong>normal (non-anion gap) metabolic acidosis</strong>. It results from defects in acid excretion or bicarbonate reabsorption without accumulation of unmeasured anions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Renal tubular acidosis</strong> presents with <strong>normal anion gap metabolic acidosis</strong>, unlike conditions such as Methanol exposure, Uremia, DKA, Propylene glycol exposure, Infection/Isoniazid, Lactic acidosis, Ethylene glycol exposure, Salicylates (<strong>Mnemonic - MUDPILES</strong>) which present with a <strong>high anion gap</strong>.</span></p>",
      "correct_choice_id": 314055,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78820/Pediatrics_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78820/Pediatrics_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79069,
      "choices": [
        {
          "id": 315037,
          "text": "<p><span style=\"font-size:14.0pt;\">Balamuthia mandrillaris</span></p>"
        },
        {
          "id": 315038,
          "text": "<p><span style=\"font-size:14.0pt;\">Naegleria fowleri</span></p>"
        },
        {
          "id": 315039,
          "text": "<p><span style=\"font-size:14.0pt;\">Dientamoeba fragilis</span></p>"
        },
        {
          "id": 315040,
          "text": "<p><span style=\"font-size:14.0pt;\">Acanthamoeba species</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following amoebae is least likely to be associated with neuropathogenesis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6584901",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Dientamoeba fragilis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Dientamoeba fragilis</strong> is a protozoan parasite primarily associated with <strong>gastrointestinal symptoms</strong>, including abdominal discomfort, diarrhea, and flatulence. It has <strong>no established neuropathogenic potential</strong> and is not known to invade the central nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Balamuthia mandrillaris:</strong> This free-living amoeba causes <strong>granulomatous amoebic encephalitis (GAE)</strong>, a rare but often fatal CNS infection. It typically affects immunocompromised patients but can also affect immunocompetent individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Naegleria fowleri:&nbsp;</strong>Known as the “<strong>brain-eating amoeba</strong>,” Naegleria fowleri causes <strong>primary amoebic meningoencephalitis (PAM)</strong>, a rapidly progressive and nearly universally fatal CNS disease following exposure to warm freshwater.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acanthamoeba species:&nbsp;</strong>Acanthamoeba can lead to <strong>granulomatous amoebic encephalitis</strong> in immunocompromised individuals. It can also cause <strong>keratitis</strong>, particularly in contact lens users.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dientamoeba fragilis is a gastrointestinal parasite and is not associated with CNS disease, unlike other free-living amoebae such as Naegleria, Acanthamoeba, and Balamuthia which are neuropathogenic.</span></p>",
      "correct_choice_id": 315039,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79069/Microbiology_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79069/Microbiology_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79071,
      "choices": [
        {
          "id": 315045,
          "text": "<p><span style=\"font-size:14.0pt;\">Newcastle disease virus</span></p>"
        },
        {
          "id": 315046,
          "text": "<p><span style=\"font-size:14.0pt;\">Parainfluenza virus</span></p>"
        },
        {
          "id": 315047,
          "text": "<p><span style=\"font-size:14.0pt;\">Influenza virus</span></p>"
        },
        {
          "id": 315048,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory syncytial virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old child is brought to the clinic during flu season with high-grade fever, dry cough, myalgia, and nasal congestion. The symptoms began abruptly two days ago. A rapid antigen test confirms infection with a virus that has a negative-sense RNA genome and neuraminidase activity as part of its envelope glycoproteins. Which of the following is the most likely causative organism?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4919125",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Influenza virus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>influenza virus</strong> is a <strong>negative-sense, single-stranded RNA virus</strong> belonging to the <strong>Orthomyxoviridae</strong> family.</span></li><li><span style=\"font-size:14.0pt;\">It is unique among human viruses in possessing <strong>two key surface glycoproteins</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hemagglutinin (HA)</strong> – for binding to host cell receptors</span></li><li><span style=\"font-size:14.0pt;\"><strong>Neuraminidase (NA)</strong> – for viral release by cleaving sialic acid</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The presence of <strong>neuraminidase activity</strong> and <strong>negative-sense RNA genome</strong> identifies the virus as <strong>Influenza</strong>.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Newcastle disease virus:&nbsp;</strong>A paramyxovirus affecting <strong>birds</strong>, rarely infects humans, but does contain <strong>neuraminidase</strong>. However, it is <strong>not a common cause of human respiratory disease</strong> in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Parainfluenza virus:</strong> Also a <strong>paramyxovirus</strong> and negative-sense RNA virus, it lacks significant <strong>neuraminidase activity</strong> and primarily causes <strong>croup (laryngotracheobronchitis)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Respiratory syncytial virus (RSV):&nbsp;</strong>Negative-sense RNA virus from <strong>Paramyxoviridae</strong>, causes bronchiolitis and pneumonia in infants, but does <strong>not possess neuraminidase</strong>. It uses <strong>fusion (F) protein</strong> for entry.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Influenza virus is a negative-sense RNA virus that uniquely expresses both hemagglutinin and neuraminidase on its surface—key for viral entry and release—distinguishing it from other respiratory viruses.</span></p>",
      "correct_choice_id": 315047,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79071/Microbiology_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79071/Microbiology_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79057,
      "choices": [
        {
          "id": 314989,
          "text": "<p><span style=\"font-size:14.0pt;\">Rickettsia conorii</span></p>"
        },
        {
          "id": 314990,
          "text": "<p><span style=\"font-size:14.0pt;\">Rickettsia typhi</span></p>"
        },
        {
          "id": 314991,
          "text": "<p><span style=\"font-size:14.0pt;\">Rickettsia prowazekii</span></p>"
        },
        {
          "id": 314992,
          "text": "<p><span style=\"font-size:14.0pt;\">Rickettsia akari</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man who recently returned from a conflict zone presents with fever and generalized rash. On examination, he is febrile and found to have body lice in his clothing. The rash is widespread but notably spares the palms and soles. Which of the following is the most likely etiologic agent?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9055600",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Rickettsia prowazekii</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rickettsia prowazekii</strong> causes <strong>epidemic typhus</strong>, which classically presents with <strong>fever, rash, and history of louse infestation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The rash typically <strong>starts centrally and spreads peripherally</strong>, <strong>sparing the palms and soles</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It occurs in <strong>crowded, unsanitary conditions</strong>, such as in <strong>military camps, prisons</strong>, or among displaced populations—matching the history of a <strong>militant</strong> in this case.</span></li><li><span style=\"font-size:14.0pt;\">Transmission occurs via <strong>body lice</strong> (Pediculus humanus corporis), which defecate on skin; scratching introduces the organism into circulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rickettsia conorii:&nbsp;</strong>Causes <strong>Mediterranean spotted fever</strong>; presents with <strong>fever,&nbsp;</strong>and <strong>rash that includes palms and soles</strong>—<strong>not consistent</strong> with this vignette.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rickettsia typhi:&nbsp;</strong>Causes <strong>endemic (murine) typhus</strong>, transmitted by <strong>fleas</strong>, not lice. Rash is <strong>less common</strong> and nonspecific; not typically associated with epidemic outbreaks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rickettsia akari:</strong> Agent of <strong>rickettsialpox</strong>, transmitted by mites; causes <strong>vesicular rash</strong> and <strong>eschar</strong>, often confused with <strong>chickenpox</strong>, and lacks lice association.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rickettsia prowazekii causes epidemic typhus, transmitted by body lice, and presents with fever and a rash that spares the palms and soles—commonly seen in overcrowded or military settings.</span></p>",
      "correct_choice_id": 314991,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79057/Microbiology_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79057/Microbiology_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78951,
      "choices": [
        {
          "id": 314569,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, and 5 only</span></p>"
        },
        {
          "id": 314570,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 5 only</span></p>"
        },
        {
          "id": 314571,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, and 4 only</span></p>"
        },
        {
          "id": 314572,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding hematological changes in normal pregnancy are true?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Pregnancy is considered a hypercoagulable state.</span></li><li><span style=\"font-size:14.0pt;\">Plasma fibrinogen levels decrease due to increased consumption.</span></li><li><span style=\"font-size:14.0pt;\">Platelet count may slightly decrease due to hemodilution and increased consumption, typically without adverse pregnancy outcomes.</span></li><li><span style=\"font-size:14.0pt;\">There is an increase in plasma levels of clotting factors I, II, VII, VIII, IX, and X.</span></li><li><span style=\"font-size:14.0pt;\">Clotting time is significantly prolonged in the third trimester.</span></li></ol>",
      "unique_key": "Q4491376",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 3, and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1 is true:</strong> Pregnancy is a <strong>hypercoagulable state</strong>, an adaptive change to reduce bleeding during delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3 is true:</strong> <strong>Mild thrombocytopenia</strong> (gestational thrombocytopenia) can occur due to <strong>hemodilution and increased platelet consumption</strong>, usually seen in the <strong>third trimester</strong> and <strong>does not adversely affect pregnancy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4 is true:</strong> There is an increase in plasma levels of clotting factors <strong>I, II, VII, VIII, IX, and X</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Note – Factor XI and XIII actually decrease during pregnancy.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2 is false:</strong> <strong>Fibrinogen levels actually increase</strong> by about 50% (from 200–400 mg/dL to 300–600 mg/dL).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5 is false:</strong> <strong>Clotting time remains unaffected</strong> during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pregnancy induces a <strong>hypercoagulable state</strong>, marked by increased fibrinogen and several clotting factors, with mild thrombocytopenia in late pregnancy due to hemodilution and platelet consumption. Clotting time remains unchanged.</span></p>",
      "correct_choice_id": 314571,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78951/Obg_Q_15_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78951/Obg_Q_15_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78890,
      "choices": [
        {
          "id": 314325,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-A, 4-D</span></p>"
        },
        {
          "id": 314326,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-C, 3-B, 4-D</span></p>"
        },
        {
          "id": 314327,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-A, 4-C</span></p>"
        },
        {
          "id": 314328,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-A, 4-B&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following types of delusions with their definitions:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dczhBfl.png\" width=\"1292\" height=\"302\"></span></p>",
      "unique_key": "Q9365209",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) 1-D, 2-B, 3-A, 4-C</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Delusion of persecution</strong> – <strong>D. Belief that one is being conspired against:</strong> This is the most common type of delusion in <strong>paranoid schizophrenia</strong>, where the person believes that others are plotting harm against them.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Delusion of grandeur</strong> – <strong>B. Belief that one has special powers:</strong> The person believes they are <strong>famous, powerful, or possess extraordinary abilities</strong>, commonly seen in <strong>manic episodes</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Delusion of reference</strong> – <strong>A. Belief that external events are referring to oneself:</strong> The individual believes that <strong>newspapers, TV shows, or random comments</strong> are <strong>specifically about them</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nihilistic delusion</strong> – <strong>C. Belief that oneself or the world does not exist:</strong> A delusion often associated with <strong>severe depression or psychosis</strong>, particularly <strong>Cotard syndrome</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Delusion of persecution</strong>: The belief that one is being harmed, harassed, or conspired against — <strong>classic in paranoid schizophrenia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Delusion of grandeur</strong>: The belief that one possesses extraordinary powers, wealth, or fame — commonly seen in <strong>mania</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Delusion of reference</strong>: Believing that neutral events (like TV shows or newspaper articles) have a special and personal meaning — often observed in <strong>schizophrenia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nihilistic delusion</strong>: The false belief that oneself, others, or the world does not exist — seen in <strong>severe depressive states or Cotard syndrome</strong>.</span></li></ul>",
      "correct_choice_id": 314327,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78890/Psychiatry_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78890/Psychiatry_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78801,
      "choices": [
        {
          "id": 313977,
          "text": "<p><span style=\"font-size:14.0pt;\">If she belongs to a tribal area where education criteria are relaxed</span></p>"
        },
        {
          "id": 313978,
          "text": "<p><span style=\"font-size:14.0pt;\">If she completes a special government-sponsored bridge training course</span></p>"
        },
        {
          "id": 313979,
          "text": "<p><span style=\"font-size:14.0pt;\">If she has previous experience working as an Anganwadi worker</span></p>"
        },
        {
          "id": 313980,
          "text": "<p><span style=\"font-size:14.0pt;\">If she is nominated by the Panchayat based on community support</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old woman from a rural community is interested in becoming an ASHA worker. She has completed formal education up to 8th grade and is fluent in the local language. However, she does not meet the standard eligibility criteria. Under which of the following conditions can she still be selected as an ASHA worker?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8362581",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) If she belongs to a tribal area where education criteria are relaxed</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to ASHA worker selection criteria, the <strong>minimum</strong> education requirement is a <strong>10th-grade</strong> education, but this requirement is relaxed for <strong>tribal/ remote/ underserved areas</strong>, allowing selection <strong>based on community</strong> need rather than formal education.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>If she completes a special government-sponsored bridge training course:</strong> Incorrect, no bridge training exists to waive formal education criteria. Training is only provided post-selection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. If she has previous experience working as an Anganwadi worker:</strong> Incorrect, Previous Anganwadi work does not waive educational requirements.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>If she is nominated by the Panchayat based on community support:&nbsp;</strong>Incorrect, Panchayat approval is essential, but it cannot override national eligibility guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">ASHA worker selection requires a minimum 10th-grade education, but this is relaxed for tribal areas where literacy levels are lower.</span></p>",
      "correct_choice_id": 313977,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78801/Psm_Q_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78801/Psm_Q_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79042,
      "choices": [
        {
          "id": 314929,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudochylothorax</span></p>"
        },
        {
          "id": 314930,
          "text": "<p><span style=\"font-size:14.0pt;\">Empyema</span></p>"
        },
        {
          "id": 314931,
          "text": "<p><span style=\"font-size:14.0pt;\">Chylothorax</span></p>"
        },
        {
          "id": 314932,
          "text": "<p><span style=\"font-size:14.0pt;\">Tuberculous pleuritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man with longstanding seropositive rheumatoid arthritis presents with progressive dyspnea and mild pleuritic chest pain. He denies fever or cough. Chest X-ray reveals bilateral pleural effusions. Thoracentesis yields a cloudy, milky-appearing fluid. Pleural fluid analysis shows &nbsp;protein 4.5 g/dL, cholesterol 280 mg/dL, triglycerides 35 mg/dL, and presence of cholesterol crystals. Gram stain and culture are negative, and there is no neutrophilic predominance. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q8669254",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pseudochylothorax</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>pseudochylothorax</strong>, a rare <strong>chronic exudative pleural effusion</strong> seen in <strong>longstanding inflammatory diseases</strong> like <strong>rheumatoid arthritis and tuberculosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>milky appearance</strong> of fluid is due to <strong>high cholesterol content</strong>, not triglycerides.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cholesterol crystals</strong> are diagnostic.</span></li><li><span style=\"font-size:14.0pt;\">Pseudochylothorax occurs due to <strong>chronic pleural inflammation and fibrosis</strong>, leading to degeneration of cellular lipids over time.</span></li><li><span style=\"font-size:14.0pt;\">Triglyceride levels are usually <strong>&lt;110 mg/dL</strong>, helping to differentiate from chylothorax.</span></li><li><span style=\"font-size:14.0pt;\">Unlike empyema, fluid is not purulent, and cultures are negative.</span></li><li><span style=\"font-size:14.0pt;\">TB can also cause pseudochylothorax, but typically with unilateral effusion and more constitutional symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Comparison of Milky Pleural Effusions:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_UVGAgep.png\" width=\"1419\" height=\"365\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Empyema:</strong> Purulent, foul-smelling fluid with high neutrophils and often positive cultures; not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chylothorax:</strong> Triglyceride-rich effusion (&gt;110 mg/dL), commonly due to thoracic duct injury or malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tuberculous pleuritis</strong>: May cause chronic effusion or pseudochyle but usually lymphocytic, not milky initially.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pseudochylothorax is a chronic cholesterol-rich exudative pleural effusion, typically seen in rheumatoid arthritis or tuberculosis, characterized by high cholesterol, low triglycerides, and cholesterol crystals in pleural fluid.</span></p>",
      "correct_choice_id": 314929,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79042/Dr._Dilip_Mock_Test_2_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79042/Dr._Dilip_Mock_Test_2_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78875,
      "choices": [
        {
          "id": 314269,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of HMG-CoA reductase</span></p>"
        },
        {
          "id": 314270,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of cholesterol absorption in the small intestine</span></p>"
        },
        {
          "id": 314271,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of microsomal triglyceride transfer protein</span></p>"
        },
        {
          "id": 314272,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of peroxisome proliferator-activated receptor alpha (PPAR-α)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes the mechanism of action of ezetimibe in the treatment of hypercholesterolemia?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9790874",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Inhibition of cholesterol absorption in the small intestine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ezetimibe</strong> is a <strong>cholesterol absorption inhibitor</strong>. It acts on the <strong>Niemann-Pick C1-like 1 (NPC1L1) transporter</strong> located in the <strong>brush border of the small intestine</strong>, blocking the <strong>absorption of dietary and biliary cholesterol</strong>.</span><ul><li><span style=\"font-size:14.0pt;\">This leads to <strong>reduced delivery of cholesterol to the liver</strong>, upregulation of <strong>hepatic LDL receptors</strong>, and <strong>increased clearance of LDL cholesterol</strong> from the blood.</span></li><li><span style=\"font-size:14.0pt;\">It is often used as <strong>adjunct therapy with statins</strong> to further lower LDL levels.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inhibition of HMG-CoA reductase:&nbsp;</strong>This is the mechanism of <strong>statins</strong>, not ezetimibe. Statins inhibit cholesterol <strong>synthesis</strong>, whereas ezetimibe inhibits <strong>absorption</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Inhibition of microsomal triglyceride transfer protein (MTP):&nbsp;</strong>This describes the action of <strong>lomitapide</strong>, used in <strong>familial hypercholesterolemia</strong>, not ezetimibe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Activation of peroxisome proliferator-activated receptor alpha (PPAR-α):&nbsp;</strong>This is the mechanism of <strong>fibrates</strong>, which are used to treat <strong>hypertriglyceridemia</strong>, not primarily for LDL lowering like ezetimibe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ezetimibe lowers LDL cholesterol by inhibiting cholesterol absorption in the small intestine via NPC1L1 transporters. It is often used in combination with statins for enhanced lipid-lowering efficacy.</span></li></ul>",
      "correct_choice_id": 314270,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78875/Pharmacology_Q_19_Test_2_IemTXZj.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78875/Pharmacology_Q_19_Test_2_IemTXZj.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78812,
      "choices": [
        {
          "id": 314021,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop leprosy drugs and add steroids</span></p>"
        },
        {
          "id": 314022,
          "text": "<p><span style=\"font-size:14.0pt;\">Thalidomide</span></p>"
        },
        {
          "id": 314023,
          "text": "<p><span style=\"font-size:14.0pt;\">Thalidomide + steroids</span></p>"
        },
        {
          "id": 314024,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue anti-leprosy drugs and add steroids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old pregnant lady on leprosy treatment has type 2 Lepra reaction. Next line of management is?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1385325",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Continue anti-leprosy drugs and add steroids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Type 2 Lepra reaction</strong> (Erythema Nodosum Leprosum or ENL) is a <strong>Type III hypersensitivity reaction</strong> characterized by <strong>immune complex deposition</strong>. It occurs in <strong>lepromatous or borderline lepromatous leprosy</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">In <strong>pregnancy</strong>, <strong>thalidomide is absolutely contraindicated</strong> due to its well-known <strong>teratogenic effects</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The treatment involves continuing the <strong>anti-leprosy multidrug therapy (MDT)</strong> (Rifampicin, Dapsone, Clofazimine) as stopping it may worsen disease control.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Systemic corticosteroids</strong> (like prednisolone) are the <strong>drug of choice</strong> for controlling inflammation and systemic symptoms of ENL in pregnant patients.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Stop leprosy drugs and add steroids:</strong> Incorrect, Stopping MDT is not recommended even during lepra reactions, unless there's a specific contraindication. Continuation is essential to prevent resistance and relapse.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Thalidomide:</strong> Contraindicated in pregnancy due to <strong>teratogenicity</strong> (phocomelia and other severe birth defects). Although thalidomide is highly effective for ENL, it is only used in <strong>non-pregnant patients</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Thalidomide + steroids:</strong> Also contraindicated in pregnancy because <strong>thalidomide should not be used</strong> under any circumstance in pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>pregnant woman with Type 2 Lepra reaction</strong>, the correct approach is to <strong>continue anti-leprosy treatment and add corticosteroids</strong>. <strong>Thalidomide is contraindicated in pregnancy</strong>, and anti-leprosy therapy should never be stopped during a lepra reaction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Treatment of Type 1 Lepra reaction: Prednisolone&nbsp;</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment for type 2 lepra reaction:&nbsp;</strong></span><ul><li><span style=\"font-size:14.0pt;\"><strong>For Mild cases – Antipyretic analgesics (Aspirin)&nbsp;</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>For Severe cases – Prednisolone&nbsp;</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>For steroid withdrawal symptoms - Clofazimine</strong></span></li></ul></li></ul>",
      "correct_choice_id": 314024,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78812/Psm_Q_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78812/Psm_Q_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79040,
      "choices": [
        {
          "id": 314921,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral vancomycin</span></p>"
        },
        {
          "id": 314922,
          "text": "<p><span style=\"font-size:14.0pt;\">IV metronidazole</span></p>"
        },
        {
          "id": 314923,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral metronidazole</span></p>"
        },
        {
          "id": 314924,
          "text": "<p><span style=\"font-size:14.0pt;\">IV vancomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 74-year-old man from Coimbatore is admitted for community-acquired pneumonia and has been receiving intravenous ceftriaxone for 6 days. He now develops watery, foul-smelling diarrhea associated with mild cramping and generalized fatigue. Vitals: T 99.8°F, HR 94/min, BP 116/72 mmHg. He is not hypotensive and has no abdominal distension. Labs reveal WBC 13,800/mm³ and creatinine 1.2 mg/dL (baseline 1.0). Colonoscopy shows the following lesions. What is the most appropriate treatment?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LTW4hzV.png\" width=\"516\" height=\"407\"></span></p>",
      "unique_key": "Q8897404",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Oral vancomycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Colonoscopy and clinical picture is very much suggestive of pseudomembranous colitis caused by C. difficile infection (CDI).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This patient has <strong>nonfulminant CDI</strong> (mild-moderate), as there is <strong>no shock, ileus, or megacolon</strong>, and his <strong>WBC &lt;15,000</strong> and <strong>creatinine &lt;1.5 mg/dL rise</strong> from baseline.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Oral vancomycin (125 mg QID for 10 days)</strong> is the first-line treatment for initial CDI episodes across <strong>all severities</strong> as per current guidelines.</span></li><li><span style=\"font-size:14.0pt;\">While <strong>fidaxomicin</strong> is preferred when available due to lower recurrence rates, <strong>oral vancomycin</strong> remains the most widely used and guideline-approved option in many settings.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IV vancomycin</strong> has no therapeutic role in CDI since it does not penetrate the colonic lumen.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Oral metronidazole</strong> is now considered inferior and is <strong>not recommended as first-line</strong>, particularly in <strong>elderly or hospitalized patients</strong>.</span></li><li><span style=\"font-size:14.0pt;\">For fulminant CDI (hypotension, ileus, or megacolon), high-dose <strong>oral vancomycin plus IV metronidazole</strong> is used, and <strong>rectal vancomycin</strong> may be added in ileus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Assessment of CDI Severity:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_N9dqm50.png\" width=\"928\" height=\"303\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IV metronidazole:&nbsp;</strong>Used in <strong>fulminant CDI</strong>, especially when ileus is present; not monotherapy in nonsevere cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oral metronidazole:</strong> Previously first-line; now <strong>inferior efficacy</strong>, especially in elderly or hospitalized patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. IV vancomycin</strong>: <strong>Ineffective in CDI</strong> as it does not reach the colonic lumen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In nonfulminant Clostridioides difficile infection, oral vancomycin is the current first-line treatment over metronidazole, especially in elderly or hospitalized patients. Route and severity stratification guide therapy; IV vancomycin has no role in treating CDI.</span></p>",
      "correct_choice_id": 314921,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79040/Dr._Dilip_Mock_Test_2_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79040/Dr._Dilip_Mock_Test_2_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78864,
      "choices": [
        {
          "id": 314225,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregabalin</span></p>"
        },
        {
          "id": 314226,
          "text": "<p><span style=\"font-size:14.0pt;\">Perampanel</span></p>"
        },
        {
          "id": 314227,
          "text": "<p><span style=\"font-size:14.0pt;\">Lacosamide</span></p>"
        },
        {
          "id": 314228,
          "text": "<p><span style=\"font-size:14.0pt;\">Valproate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old male with treatment-resistant focal seizures is prescribed a newer-generation antiepileptic drug. The chosen medication exerts its anticonvulsant effect by antagonizing AMPA receptors. Which of the following drugs was most likely prescribed?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6738453",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) &nbsp;Perampanel</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Perampanel</strong> is a <strong>newer-generation antiepileptic drug</strong> that acts as a <strong>selective, non-competitive antagonist</strong> of the <strong>AMPA receptor</strong>, a subtype of the ionotropic <strong>glutamate receptor</strong>.</span></li><li><span style=\"font-size:14.0pt;\">By inhibiting AMPA receptors, Perampanel <strong>dampens excitatory neurotransmission</strong>, which helps reduce seizure activity in <strong>focal and generalized tonic-clonic seizures</strong>.</span></li><li><span style=\"font-size:14.0pt;\">AMPA receptor antagonism represents a unique mechanism of action compared to many older antiepileptic drugs, and this <strong>glutamatergic inhibition</strong> helps suppress <strong>neuronal hyperexcitability</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pregabalin:&nbsp;</strong>&nbsp;Pregabalin binds to the <strong>alpha-2-delta subunit of voltage-gated calcium channels</strong>, <strong>not AMPA receptors</strong>. It reduces neurotransmitter release, particularly <strong>glutamate, norepinephrine, and substance P</strong>, but through a <strong>presynaptic calcium modulation</strong> mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lacosamide:</strong> Lacosamide enhances the <strong>slow inactivation of voltage-gated sodium channels</strong>, stabilizing hyperexcitable neuronal membranes. It <strong>does not interact with AMPA receptors</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Valproate:&nbsp;</strong>Valproate has multiple mechanisms, including <strong>increasing GABA levels</strong>, <strong>blocking sodium channels</strong>, and <strong>modulating T-type calcium channels</strong>, but it does <strong>not inhibit AMPA receptors</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Perampanel is an antiepileptic drug that acts by antagonizing AMPA receptors, thereby reducing excitatory glutamatergic transmission in seizure disorders.</span></li></ul>",
      "correct_choice_id": 314226,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78864/Pharmacology_Q_11_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78864/Pharmacology_Q_11_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78849,
      "choices": [
        {
          "id": 314165,
          "text": "<p><span style=\"font-size:14.0pt;\">Neutrophil with toxic granulations</span></p>"
        },
        {
          "id": 314166,
          "text": "<p><span style=\"font-size:14.0pt;\">Hairy cell</span></p>"
        },
        {
          "id": 314167,
          "text": "<p><span style=\"font-size:14.0pt;\">Target cell</span></p>"
        },
        {
          "id": 314168,
          "text": "<p><span style=\"font-size:14.0pt;\">Lipid-laden macrophage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old man presents with complaints of fatigue and early satiety. Physical examination reveals splenomegaly. Laboratory findings show pancytopenia. A bone marrow biopsy is performed, and electron microscopy of one of the abnormal cells is shown in the image. Which of the following best identifies the cell shown?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QMnOn1p.png\" width=\"508\" height=\"452\"></span></p>",
      "unique_key": "Q5696359",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hairy cell</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image depicts a <strong>\"hairy cell\"</strong>, which is a <strong>neoplastic B cell</strong> characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Irregular cytoplasmic projections</strong> seen best on <strong>electron microscopy</strong></span></li><li><span style=\"font-size:14.0pt;\">Associated with <strong>Hairy Cell Leukemia (HCL)</strong></span></li><li><span style=\"font-size:14.0pt;\">Clinical features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Pancytopenia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Splenomegaly</strong> (due to red pulp infiltration)</span></li><li><span style=\"font-size:14.0pt;\"><strong>\"Dry tap\"</strong> on bone marrow aspiration (due to marrow fibrosis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Honey comb</strong> appearance and <strong>Fried egg appearance</strong> on bone marrow biopsy (due to perinuclear halo)</span></li><li><span style=\"font-size:14.0pt;\">High risk of development of <strong>atypical mycobacterial infections</strong></span></li><li><span style=\"font-size:14.0pt;\">Involvement of <strong>red pulp of spleen</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Stains positive for <strong>tartrate-resistant acid phosphatase (TRAP)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hairy cells classically show <strong>“hair-like” cytoplasmic extensions</strong>, as seen in this EM image, distinguishing them from other abnormal blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Neutrophil with toxic granulations: </strong>Toxic granulations are coarse, dark granules in neutrophils seen during severe infections or inflammation. They do not appear as <strong>cytoplasmic projections</strong> and would not explain the <strong>splenomegaly or pancytopenia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Target cell:&nbsp;</strong>Target cells are <strong>erythrocytes</strong> with a central area of staining surrounded by a ring of pallor, giving a <strong>bullseye</strong> appearance. These are seen in liver disease, thalassemia, and postsplenectomy—not in leukemias. They are identified on peripheral smear, not electron microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lipid-laden macrophage:&nbsp;</strong>This describes <strong>Gaucher cells</strong>, seen in <strong>Gaucher disease</strong>, a lysosomal storage disorder. These cells have a <strong>“crumpled tissue paper” cytoplasm</strong> and are not seen with hairy projections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hairy cell leukemia is a B-cell neoplasm characterized by cytoplasmic projections visible on electron microscopy. It presents with splenomegaly, pancytopenia, and a “dry tap” on bone marrow aspiration due to marrow fibrosis.</span></p>",
      "correct_choice_id": 314166,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78849/Pathology_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78849/Pathology_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78952,
      "choices": [
        {
          "id": 314573,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase the magnesium sulfate infusion rate</span></p>"
        },
        {
          "id": 314574,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer intravenous calcium gluconate</span></p>"
        },
        {
          "id": 314575,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer intravenous furosemide</span></p>"
        },
        {
          "id": 314576,
          "text": "<p><span style=\"font-size:14.0pt;\">Intubate and start mechanical ventilation immediately</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old primigravida woman at 34 weeks gestation with preeclampsia with severe features is receiving intravenous magnesium sulfate for seizure prophylaxis. After 8 hours of infusion, the nurse reports that the patient appears drowsy, has a respiratory rate of 10/min, and no elicitable patellar reflexes. Her urine output is 20 mL/hour. What is the next best step in the management of this patient?&nbsp;</span></p>",
      "unique_key": "Q5101126",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Administer intravenous calcium gluconate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient is exhibiting signs of <strong>magnesium sulfate toxicity</strong>, which include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Loss of deep tendon reflexes (DTRs):</strong> First clinical sign, typically at serum magnesium levels of <strong>7–10 mEq/L</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Respiratory depression:</strong> Occurs at levels <strong>10–12 mEq/L</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Respiratory arrest or cardiac arrest:</strong> Occurs at levels <strong>&gt;12 mEq/L and &gt;25 mEq/L</strong>, respectively</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Toxicity is more likely when <strong>urine output is decreased</strong>, as magnesium is excreted renally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management includes:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">First step should be to confirm magnesium toxicity through serum magnesium level</span></li><li><span style=\"font-size:14.0pt;\">Immediate <strong>discontinuation of magnesium sulfate</strong></span></li><li><span style=\"font-size:14.0pt;\">Administration of <strong>calcium gluconate (1 g IV)</strong>, which antagonizes magnesium’s effects and reverses neuromuscular and respiratory depression</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increase the magnesium sulfate infusion rate: &nbsp;Increasing the MgSO₄ dose</strong> would worsen the toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Administer intravenous furosemide: Furosemide</strong> is not the first-line treatment; it may be used in cases of fluid overload, not MgSO₄ toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. D.&nbsp;Intubate and start mechanical ventilation immediately: Intubation</strong> is considered if the patient is in respiratory arrest; however, this patient still has respiratory effort and should first receive calcium gluconate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Loss of deep tendon reflexes</strong> is the earliest clinical sign of magnesium sulfate toxicity. <strong>Calcium gluconate</strong> is the antidote and should be administered immediately in symptomatic cases, along with stopping MgSO₄ infusion.</span></p>",
      "correct_choice_id": 314574,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78952/Obg_Q_16_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78952/Obg_Q_16_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78917,
      "choices": [
        {
          "id": 314433,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 314434,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-D, 3-B, 4-C</span></p>"
        },
        {
          "id": 314435,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-C, 3-B, 4-D</span></p>"
        },
        {
          "id": 314436,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following: Muscles of Mastication and Their Actions:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column A (Muscles)</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Temporalis</span></li><li><span style=\"font-size:14.0pt;\">Masseter</span></li><li><span style=\"font-size:14.0pt;\">Lateral pterygoid</span></li><li><span style=\"font-size:14.0pt;\">Medial pterygoid</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column B (Action on Mandible)</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Elevation and Retraction (posterior fibers)</span></li><li><span style=\"font-size:14.0pt;\">Depression and Unilateral Jaw Swinging</span></li><li><span style=\"font-size:14.0pt;\">Elevation and Protrusion (superficial fibers)</span></li><li><span style=\"font-size:14.0pt;\">Elevation and Protrusion<strong>&nbsp;</strong></span></li></ol>",
      "unique_key": "Q6071613",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1-A, 2-C, 3-B, 4-D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Temporalis (1-A):</strong> Elevates the mandible; posterior fibers retract the mandible.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Masseter (2-C):</strong> Elevates the mandible and the superficial fibers assist in protrusion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lateral Pterygoid (3-B):</strong> Only muscle of mastication that causes depression of the mandible and swings the jaw side-to-side unilaterally.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Medial Pterygoid (4-D):</strong> Helps elevate the mandible and also contributes to protrusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">All muscles of mastication are supplied by the <strong>mandibular branch of the trigeminal nerve (CN V3)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their coordinated actions help in complex jaw movements like chewing, biting, and grinding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6qZj7Zg.png\" width=\"810\" height=\"299\"></span></p>",
      "correct_choice_id": 314435,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78917/Anatomy_Q_9Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78917/Anatomy_Q_9Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78829,
      "choices": [
        {
          "id": 314089,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-E, 4-D, 5-C</span></p>"
        },
        {
          "id": 314090,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-E, 4-C, 5-D</span></p>"
        },
        {
          "id": 314091,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-D, 4-C, 5-E</span></p>"
        },
        {
          "id": 314092,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-C, 3-B, 4-E, 5-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column A</strong> (Oxygen Delivery Devices)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Nasal Cannula</span></li><li><span style=\"font-size:14.0pt;\">Simple Face Mask</span></li><li><span style=\"font-size:14.0pt;\">Venturi Mask</span></li><li><span style=\"font-size:14.0pt;\">Non-Rebreather Mask</span></li><li><span style=\"font-size:14.0pt;\">High-Flow Nasal Cannula (HFNC)</span></li></ol><p><br><span style=\"font-size:14.0pt;\"><strong>Column B</strong> (Maximum FiO₂ Delivered)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Up to 40%</span></li><li><span style=\"font-size:14.0pt;\">Up to 50-60%</span></li><li><span style=\"font-size:14.0pt;\">Up to 80%</span></li><li><span style=\"font-size:14.0pt;\">Up to 100%</span></li><li><span style=\"font-size:14.0pt;\">Up to 60%</span></li></ol>",
      "unique_key": "Q7999389",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) 1-A, 2-B, 3-E, 4-C, 5-D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1 – A: Nasal cannulae</strong> deliver <strong>FiO₂ ranging from 24-40%</strong>, with a maximum FiO₂ of <strong>up to 40%</strong> at a flow rate of <strong>1-5 L/min</strong>, making them suitable for patients requiring <strong>low-flow oxygen therapy</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2 – B: Simple face masks</strong> provide an FiO₂ of <strong>40-60%</strong>, with a maximum FiO₂ of <strong>up to 50-60%</strong> at <strong>6-10 L/min</strong>, commonly used in moderate hypoxia.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3 – E: Venturi masks</strong> allow for <strong>precise FiO₂ titration</strong>, ranging from <strong>24-60%</strong>, with a maximum FiO₂ of <strong>up to 60%</strong>, making them ideal for patients with <strong>chronic obstructive pulmonary disease (COPD)</strong> who require controlled oxygenation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4 – C: Non-rebreather masks (NRBMs)</strong> provide <strong>high FiO₂ levels (60-100%)</strong>, with a maximum FiO₂ of <strong>up to 80%</strong>, using a <strong>reservoir bag and high-flow oxygen</strong>, making them useful in <strong>severe hypoxia and critical care settings</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5 – D:</strong> <strong>High-flow nasal cannula (HFNC)</strong> can deliver <strong>humidified and heated oxygen</strong> at <strong>30-60 L/min</strong>, achieving a <strong>maximum FiO₂ of up to 100%</strong>, making it an effective alternative to <strong>non-invasive ventilation (NIV) in respiratory distress</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AjEocJH.png\" width=\"708\" height=\"260\"></strong></span></p>",
      "correct_choice_id": 314090,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78829/Q_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78829/Q_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79079,
      "choices": [
        {
          "id": 315077,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium kansasii</span></p>"
        },
        {
          "id": 315078,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium leprae&nbsp;</span></p>"
        },
        {
          "id": 315079,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium tuberculosis</span></p>"
        },
        {
          "id": 315080,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium avium complex (MAC)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man presents with a 1-month history of chronic cough, progressive shortness of breath, night sweats, and unintentional weight loss. Chest X-ray reveals bilateral upper lobe infiltrates with cavitary lesions. Sputum culture grown on Lowenstein-Jensen (LJ) medium yields colonies that test positive for MPT64 antigen. Which of the following organisms is the most likely cause of his condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8866150",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mycobacterium tuberculosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient presents with <strong>classic signs of pulmonary tuberculosis (TB)</strong>, including:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chronic cough</span></li><li><span style=\"font-size:14.0pt;\">Weight loss</span></li><li><span style=\"font-size:14.0pt;\">Night sweats</span></li><li><span style=\"font-size:14.0pt;\">Cavitary lesions in the upper lobes on imaging</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The culture result grown on <strong>Lowenstein-Jensen medium</strong> and testing <strong>positive for MPT64 antigen</strong> confirms that the causative organism belongs to the <strong>Mycobacterium tuberculosis complex (MTBC)</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>MPT64</strong> is a <strong>specific protein antigen secreted by MTBC organisms</strong>, including M. tuberculosis and M. bovis.</span></li><li><span style=\"font-size:14.0pt;\">It is commonly used in rapid diagnostic tests to distinguish <strong>MTBC from non-tuberculous mycobacteria (NTM)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Among the MTBC group, <strong>Mycobacterium tuberculosis</strong> is by far the most <strong>common cause of pulmonary TB</strong>, especially in <strong>immunocompetent individuals</strong> with <strong>typical clinical and radiographic features</strong> as seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mycobacterium kansasii:&nbsp;</strong>A <strong>non-tuberculous mycobacterium (NTM)</strong> that can mimic TB in the lungs, but it <strong>does not produce MPT64 antigen</strong>. Therefore, it can be ruled out by the antigen result.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mycobacterium leprae:</strong> Causes leprosy, a chronic disease affecting the <strong>skin and peripheral nerves</strong>, not the lungs. It is not cultured on LJ medium and <strong>does not produce MPT64 antigen</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mycobacterium avium complex (MAC):&nbsp;</strong>A group of <strong>NTMs</strong> more commonly seen in <strong>immunocompromised patients</strong> (e.g., HIV/AIDS). MAC <strong>does not express MPT64 antigen</strong> and usually does <strong>not produce cavitary lesions</strong> in the upper lobes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Detection of MPT64 antigen confirms infection with the Mycobacterium tuberculosis complex. Among its members, Mycobacterium tuberculosis is the most common cause of pulmonary TB, particularly in immunocompetent patients with typical cavitary lung lesions.</span></p>",
      "correct_choice_id": 315079,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79079/Microbiology_Q_15_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79079/Microbiology_Q_15_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78831,
      "choices": [
        {
          "id": 314097,
          "text": "<p><span style=\"font-size:14.0pt;\">Variceal banding</span></p>"
        },
        {
          "id": 314098,
          "text": "<p><span style=\"font-size:14.0pt;\">TIPSS (Transjugular Intrahepatic Portosystemic Shunt)</span></p>"
        },
        {
          "id": 314099,
          "text": "<p><span style=\"font-size:14.0pt;\">Transabdominal gastroesophageal devascularization</span></p>"
        },
        {
          "id": 314100,
          "text": "<p><span style=\"font-size:14.0pt;\">Balloon tamponade</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female with a history of chronic liver disease presents to the emergency department with massive hematemesis and signs of hypovolemic shock, including hypotension and tachycardia. Immediate stabilization with IV fluids, Terlipressin, and blood transfusion is initiated. What is the next immediate step in the management of this patient?&nbsp;</span></p>",
      "unique_key": "Q8175197",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Variceal banding</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acute variceal bleeding is a life-threatening complication of portal hypertension, often seen in cirrhotic patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The immediate priority in management is <strong>hemodynamic stabilization</strong> (IV fluids, blood transfusion, correction of coagulopathy) followed by definitive control of bleeding.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Endoscopic variceal band ligation (EVL) is the first-line treatment for active esophageal variceal bleeding.</strong> It involves placing elastic bands around the varices to induce thrombosis and prevent further hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pharmacologic therapy with vasoactive drugs</strong> (e.g., octreotide, terlipressin) is also initiated to reduce portal pressure and decrease variceal bleeding.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. TIPSS (Transjugular Intrahepatic Portosystemic Shunt):&nbsp;</strong>This is a second-line therapy for patients with refractory variceal bleeding despite band ligation and vasoactive therapy. It is not an immediate first-step intervention in acute bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Transabdominal gastroesophageal devascularization:&nbsp;</strong>This is a <strong>surgical option</strong> used for refractory variceal bleeding in patients who are not candidates for TIPSS. It is <strong>not a first-line treatment</strong> in acute management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Balloon tamponade (e.g., Sengstaken-Blakemore tube):&nbsp;</strong>This is a <strong>temporary measure</strong> used only in <strong>massive bleeding when endoscopic therapy is not immediately available</strong>. However, it carries risks of complications like esophageal rupture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a patient with massive hematemesis due to esophageal varices, the <strong>next immediate step in management</strong> is <strong>endoscopic variceal banding</strong> to control active bleeding.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pharmacologic therapy with <strong>vasoactive agents</strong> (e.g., octreotide) should be started simultaneously.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">TIPSS and surgical options are reserved for refractory cases, while balloon tamponade is used only as a bridge in uncontrolled bleeding.</span></li></ul>",
      "correct_choice_id": 314097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78831/Surgery_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78831/Surgery_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79074,
      "choices": [
        {
          "id": 315057,
          "text": "<p><span style=\"font-size:14.0pt;\">Presynaptic inhibition of GABA and glycine release</span></p>"
        },
        {
          "id": 315058,
          "text": "<p><span style=\"font-size:14.0pt;\">Postsynaptic blockade of acetylcholine receptors</span></p>"
        },
        {
          "id": 315059,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of glycine receptor expression</span></p>"
        },
        {
          "id": 315060,
          "text": "<p><span style=\"font-size:14.0pt;\">Cleavage of SNARE proteins, preventing acetylcholine release</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents to the emergency department with severe generalized muscle spasms and opisthotonos (arching of the back), several days after sustaining a puncture wound to the foot while working outdoors. He had not received tetanus immunization in over 15 years. The person shows a classic hyperextended posture consistent with tetanic spasms. The toxin responsible for this condition acts through which of the following mechanisms?</span></p>",
      "unique_key": "Q7472532",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Presynaptic inhibition of GABA and glycine release</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is consistent with <strong>tetanus</strong>, caused by Clostridium tetani.</span></li><li><span style=\"font-size:14.0pt;\">The responsible neurotoxin, <strong>tetanospasmin</strong>, reaches the central nervous system through retrograde axonal transport.</span></li><li><span style=\"font-size:14.0pt;\">It <strong>cleaves synaptobrevin</strong>, a SNARE protein required for neurotransmitter release from <strong>inhibitory interneurons</strong>, leading to <strong>presynaptic inhibition of GABA and glycine</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This <strong>disinhibition of motor neurons</strong> causes the hallmark <strong>muscle rigidity and spasms</strong> (e.g., lockjaw, opisthotonos).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qiwUgzR.png\" width=\"505\" height=\"231\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Postsynaptic blockade of acetylcholine receptors:&nbsp;</strong>This describes the mechanism of <strong>botulinum toxin at the neuromuscular junction</strong>, but tetanus affects <strong>inhibitory neurons in the CNS</strong>, not postsynaptic Ach receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Inhibition of glycine receptor expression:&nbsp;</strong>This is not the mechanism of tetanospasmin. The toxin <strong>prevents glycine release</strong>, not receptor expression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cleavage of SNARE proteins, preventing acetylcholine release:&nbsp;</strong>This is the mechanism of <strong>botulinum toxin</strong>, which blocks <strong>Ach release</strong> at the neuromuscular junction, causing <strong>flaccid paralysis</strong>—not the spastic paralysis seen in tetanus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tetanospasmin inhibits the release of inhibitory neurotransmitters (GABA and glycine) by cleaving SNARE proteins in interneurons, leading to unopposed muscle contraction and spastic paralysis.</span></p>",
      "correct_choice_id": 315057,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79074/Microbiology_Q_10_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79074/Microbiology_Q_10_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78922,
      "choices": [
        {
          "id": 314453,
          "text": "<p><span style=\"font-size:14.0pt;\">Administration of intravenous immunoglobulin (IVIG)</span></p>"
        },
        {
          "id": 314454,
          "text": "<p><span style=\"font-size:14.0pt;\">Isolation and symptomatic treatment only</span></p>"
        },
        {
          "id": 314455,
          "text": "<p><span style=\"font-size:14.0pt;\">Review at 12 weeks for early anomaly scan</span></p>"
        },
        {
          "id": 314456,
          "text": "<p><span style=\"font-size:14.0pt;\">Detailed counseling about potential fetal risks and management options</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman, currently 9 weeks pregnant, presents with a 4-day history of low-grade fever and a maculopapular rash that began on her face and has spread downward to her trunk and extremities. She also complains of mild arthralgias. She has no documented history of MMR vaccination or prior rubella infection. On examination, she is febrile (38.3°C), and there is postauricular lymphadenopathy. Laboratory tests confirm a positive rubella-specific IgM. What is the most appropriate next step in management?&nbsp;</span></p><p>&nbsp;</p>",
      "unique_key": "Q6420923",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Detailed counseling about potential fetal risks and management options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rubella infection during the <strong>first trimester</strong> poses a significant risk for the fetus, particularly for <strong>congenital rubella syndrome (CRS) in 90% of cases</strong>. CRS commonly includes:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Congenital cataracts</span></li><li><span style=\"font-size:14.0pt;\">Congenital heart defects (especially PDA)</span></li><li><span style=\"font-size:14.0pt;\">Sensorineural hearing loss</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">There is <strong>no antiviral treatment or curative intervention</strong> for rubella in pregnancy. Therefore, the primary management includes:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Thorough counseling</strong> about the high risk of fetal infection and associated complications</span></li><li><span style=\"font-size:14.0pt;\">Discussing the option of continuing vs terminating the pregnancy based on the patient’s values and preferences</span></li><li><span style=\"font-size:14.0pt;\">Optionally, <strong>rubella avidity testing</strong> can help determine whether infection is recent or remote, but it does <strong>not change the need for counseling</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administration of intravenous immunoglobulin (IVIG): IVIG</strong> is <strong>not effective</strong> in reducing fetal transmission or preventing CRS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Isolation and symptomatic treatment only: Maternal isolation</strong> may help prevent spread to others but is <strong>not a management strategy</strong> for the fetal risk or clinical decision-making.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Review at 12 weeks for early anomaly scan:&nbsp;</strong>While an early anomaly scan is important and part of follow-up, <strong>waiting without immediate counseling</strong> is inappropriate. The <strong>first and immediate next step</strong> should be <strong>counseling about fetal risks</strong> based on the confirmed rubella infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rubella infection in early pregnancy requires <strong>comprehensive counseling</strong> regarding the high risk of <strong>congenital rubella syndrome</strong>, rather than immediate treatment or termination. The management is centered on informed decision-making rather than interventions.</span></p>",
      "correct_choice_id": 314456,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78922/Obg_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78922/Obg_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79075,
      "choices": [
        {
          "id": 315061,
          "text": "<p><span style=\"font-size:14.0pt;\">HBV DNA</span></p>"
        },
        {
          "id": 315062,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-HBc</span></p>"
        },
        {
          "id": 315063,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-HBs</span></p>"
        },
        {
          "id": 315064,
          "text": "<p><span style=\"font-size:14.0pt;\">Core antigen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old healthcare worker presents for follow-up after a documented needle-stick injury involving a patient later found to be positive for hepatitis B virus (HBV). His serological results are being monitored over time to assess for acute infection, resolution, or chronicity. Which of the following markers is expected to be detectable regardless of whether the patient completely recovers or progresses to chronic HBV infection?</span></p>",
      "unique_key": "Q4617919",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Anti-HBc</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anti-HBc (antibody to hepatitis B core antigen)</strong> is produced in <strong>both acute and chronic HBV infections</strong> and also remains <strong>detectable after recovery</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It reflects <strong>exposure to the actual virus</strong>, as it is not present in vaccinated individuals (since the vaccine contains only HBsAg).</span></li><li><span style=\"font-size:14.0pt;\"><strong>IgM anti-HBc</strong> indicates <strong>acute infection</strong>, while <strong>IgG anti-HBc</strong> persists for life and is seen in <strong>both chronic and resolved infection</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. HBV DNA:&nbsp;</strong>Indicates active viral replication and is present only during <strong>active infection</strong>, whether acute or chronic. It <strong>disappears after recovery</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anti-HBs:&nbsp;</strong>Appears <strong>only after recovery</strong> or vaccination. It is <strong>absent</strong> in chronic infection where the virus persists.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Core antigen (HBcAg):</strong> <strong>Not detectable in serum</strong>; it is found <strong>only within infected hepatocytes</strong> and is not used as a serum marker in clinical practice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Anti-HBc antibodies are present in all individuals with past or current HBV infection, regardless of recovery or progression to chronic hepatitis B.</span></p>",
      "correct_choice_id": 315062,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79075/Microbiology_Q_11_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79075/Microbiology_Q_11_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78947,
      "choices": [
        {
          "id": 314553,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 2, and 4 are correct</span></p>"
        },
        {
          "id": 314554,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 2, 3, and 5 are correct</span></p>"
        },
        {
          "id": 314555,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 2, 3, 4, and 5 are correct</span></p>"
        },
        {
          "id": 314556,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding cardiovascular examination findings in pregnancy are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The apex beat is displaced to the 4th intercostal space and lies 2.5 cm medial to the midclavicular line.</span></li><li><span style=\"font-size:14.0pt;\">A physiological systolic murmur may be heard at the apical or pulmonary area due to increased blood volume.</span></li><li><span style=\"font-size:14.0pt;\">A mammary murmur can be heard in the 2nd and 3rd left intercostal spaces due to increased internal mammary blood flow.</span></li><li><span style=\"font-size:14.0pt;\">An S3 heart sound may be present due to rapid diastolic ventricular filling.</span></li><li><span style=\"font-size:14.0pt;\">ECG may show left axis deviation but is otherwise typically normal.</span></li></ol>",
      "unique_key": "Q7464973",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Statements 2, 3, 4, and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2:</strong> Correct – A <strong>systolic murmur</strong> at the apical or pulmonary area is common due to increased blood flow and cardiac output.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3:</strong> Correct – A <strong>mammary murmur</strong> may be auscultated in the <strong>left 2nd and 3rd intercostal spaces</strong> due to increased flow through internal mammary arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4:</strong> Correct – An <strong>S3</strong> may be heard due to <strong>rapid ventricular filling</strong> during diastole, which is a normal physiological change.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5:</strong> Correct – ECG is usually normal but <strong>left axis deviation</strong> may be seen due to anatomical displacement of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1:</strong> Incorrect – The apex beat shifts <strong>outwards</strong> (laterally) and <strong>upwards</strong> during pregnancy due to diaphragm elevation; it is located <strong>2.5 cm lateral</strong> to the midclavicular line, <strong>not medial</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During pregnancy, cardiovascular adaptations include lateral displacement of the heart, increased cardiac output, and blood volume, often manifesting as benign auscultatory findings like <strong>systolic murmurs</strong>, <strong>mammary murmurs</strong>, and <strong>S3</strong>. ECG changes such as <strong>left axis deviation</strong> may be observed but are generally benign.</span></p>",
      "correct_choice_id": 314555,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78947/Obg_Q_11_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78947/Obg_Q_11_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79055,
      "choices": [
        {
          "id": 314981,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency laparotomy</span></p>"
        },
        {
          "id": 314982,
          "text": "<p><span style=\"font-size:14.0pt;\">IV broad-spectrum antibiotics</span></p>"
        },
        {
          "id": 314983,
          "text": "<p><span style=\"font-size:14.0pt;\">CT Angiography</span></p>"
        },
        {
          "id": 314984,
          "text": "<p><span style=\"font-size:14.0pt;\">Colonoscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 74-year-old man from Surat with a history of diabetes and atrial fibrillation presents with sudden severe diffuse abdominal pain, multiple episodes of vomiting, and mild generalized abdominal tenderness. BP is 110/70 mmHg, HR is 36/min, and SpO₂ is 97% on room air. Serum lactate is markedly elevated at 6.1 mmol/L. ECG is shown. On examination, his abdomen is soft without guarding or rebound tenderness. What is the next best step?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Nkjfn9M.png\" width=\"767\" height=\"420\"></span></p>",
      "unique_key": "Q8183621",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) CT Angiography</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a classic presentation of <strong>acute mesenteric ischemia (AMI)</strong>, particularly of embolic origin given the history of atrial fibrillation and sudden-onset abdominal pain.</span></li><li><span style=\"font-size:14.0pt;\">The hallmark of AMI is <strong>pain out of proportion to physical examination findings</strong>; despite severe pain, the abdomen remains soft early in the disease course.</span></li><li><span style=\"font-size:14.0pt;\">Elevated lactate indicates tissue ischemia and metabolic acidosis, further supporting the diagnosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>CT angiography</strong> is the diagnostic test of choice to visualize arterial occlusion, guide revascularization decisions, and assess for bowel viability.</span></li><li><span style=\"font-size:14.0pt;\">Immediate imaging is crucial as early identification, and intervention can prevent progression to bowel necrosis and death.</span></li><li><span style=\"font-size:14.0pt;\">Surgery is reserved for patients with clinical signs of peritonitis or bowel gangrene.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Acute Mesenteric Ischemia vs Other Acute Abdomen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_94lRVhF.png\" width=\"1591\" height=\"339\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Emergency laparotomy</strong>: Reserved for patients with signs of peritonitis such as guarding, rigidity, or rebound tenderness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IV broad-spectrum antibiotics:</strong> Important adjunctive therapy but not the initial diagnostic step; diagnosis must first be confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Colonoscopy:</strong> Contraindicated due to the high risk of perforation in ischemic and necrotic bowel.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with atrial fibrillation and sudden severe abdominal pain disproportionate to examination findings, acute mesenteric ischemia must be suspected, and CT angiography is the essential first diagnostic step to confirm vascular occlusion and guide management.</span></p>",
      "correct_choice_id": 314983,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79055/Dr._Dilip_Mock_Test_2_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79055/Dr._Dilip_Mock_Test_2_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78862,
      "choices": [
        {
          "id": 314217,
          "text": "<p><span style=\"font-size:14.0pt;\">Formoterol plus budesonide</span></p>"
        },
        {
          "id": 314218,
          "text": "<p><span style=\"font-size:14.0pt;\">Montelukast</span></p>"
        },
        {
          "id": 314219,
          "text": "<p><span style=\"font-size:14.0pt;\">Theophylline</span></p>"
        },
        {
          "id": 314220,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrocortisone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old woman presents to the emergency department with severe respiratory distress, audible wheezing, and use of accessory muscles. She is unable to speak in full sentences. Vital signs show tachypnea, tachycardia, and an oxygen saturation of 90% on room air. She is diagnosed with status asthmaticus. Which of the following drugs is most appropriate for initial administration via nebulization?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7239772",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Formoterol plus budesonide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Status asthmaticus</strong> is a <strong>severe, life-threatening asthma exacerbation</strong> that requires <strong>immediate treatment</strong> to reverse airway obstruction. The <strong>initial management</strong> includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Rapid-acting bronchodilators</strong> (inhaled β₂-agonists)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Systemic corticosteroids</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Oxygen supplementation</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Formoterol</strong> is a <strong>long-acting β₂-agonist (LABA)</strong> with a <strong>rapid onset of action</strong>, unlike other LABAs (e.g., salmeterol). When <strong>combined with budesonide</strong>, an <strong>inhaled corticosteroid</strong>, the combination provides <strong>both immediate bronchodilation and anti-inflammatory effects</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This combination is now approved for <strong>as-needed and reliever therapy</strong>, especially in <strong>severe asthma</strong>, and can be <strong>administered via nebulization or metered-dose inhaler</strong> in acute settings.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It allows for <strong>rapid relief with added anti-inflammatory action</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Montelukast:&nbsp; </strong>A <strong>leukotriene receptor antagonist</strong>, used for <strong>maintenance therapy</strong>, not in acute or emergency settings. It is <strong>not administered via nebulization</strong> and has <strong>delayed onset</strong> of action.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Theophylline:</strong> A <strong>methylxanthine</strong> bronchodilator with a <strong>narrow therapeutic index</strong> and <strong>significant side effects</strong>. It is <strong>not used in acute asthma management</strong> due to <strong>limited efficacy</strong> and <strong>toxicity concerns, also this cannot be given trough inhalational route.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hydrocortisone:&nbsp;</strong>While <strong>systemic corticosteroids</strong> are essential in status asthmaticus, <strong>they are not administered via nebulization</strong>. Hydrocortisone is given <strong>intravenously</strong>, and although important, <strong>bronchodilators are prioritized for immediate nebulized therapy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Formoterol (a fast-acting LABA) combined with budesonide (an inhaled corticosteroid) can be nebulized for rapid relief in status asthmaticus, offering both bronchodilation and anti-inflammatory effects.</span></li></ul>",
      "correct_choice_id": 314217,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78862/Pharmacology_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78862/Pharmacology_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78928,
      "choices": [
        {
          "id": 314477,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uspX7bG.png\" width=\"347\" height=\"120\"></p>"
        },
        {
          "id": 314478,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_bzBods8.png\" width=\"478\" height=\"244\"></p>"
        },
        {
          "id": 314479,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zUiW52Y.png\" width=\"489\" height=\"220\"></p>"
        },
        {
          "id": 314480,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qSSOjvk.png\" width=\"520\" height=\"211\"></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman undergoes renal function testing as part of a clinical research study. Her urine sample shows a high concentration of a test substance, and the goal is to determine the rate at which her kidneys clear this substance from plasma. Which of the following is the correct formula for calculating the renal clearance rate (Cₛ) of a substance?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Us​ = Urine concentration of the substance</span></li><li><span style=\"font-size:14.0pt;\">V = Urine flow rate</span></li><li><span style=\"font-size:14.0pt;\">Ps​ = Plasma concentration of the substance</span></li></ul>",
      "unique_key": "Q3724594",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp; &nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RblweMs.png\" width=\"355\" height=\"136\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>renal clearance rate</strong> (Cₛ) is defined as the <strong>volume of plasma from which a substance is completely removed by the kidneys per unit time</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The correct formula is:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VmvBODp.png\" width=\"355\" height=\"136\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This equation allows the estimation of how effectively the kidneys are clearing a specific substance from the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><br><span style=\"font-size:14.0pt;\">The renal clearance of a substance is calculated using the formula</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dqTFgel.png\" width=\"355\" height=\"136\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">reflecting the efficiency of renal elimination and forming the basis of key renal function tests.</span></p>",
      "correct_choice_id": 314478,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78928/Physiology_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78928/Physiology_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78948,
      "choices": [
        {
          "id": 314557,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue warfarin until the onset of labor</span></p>"
        },
        {
          "id": 314558,
          "text": "<p><span style=\"font-size:14.0pt;\">Switch to unfractionated heparin at 36 weeks gestation</span></p>"
        },
        {
          "id": 314559,
          "text": "<p><span style=\"font-size:14.0pt;\">Discontinue anticoagulation until delivery</span></p>"
        },
        {
          "id": 314560,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer low-dose aspirin instead of warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old pregnant woman with a history of mechanical mitral valve replacement is being managed with anticoagulation therapy. She is currently 35 weeks pregnant and has been on warfarin since the end of the first trimester. She presents for a routine prenatal follow-up. Her INR is within the therapeutic range, and she has no signs of bleeding or thromboembolism. What is the most appropriate next step in her anticoagulation management?&nbsp;</span></p>",
      "unique_key": "Q8219906",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Switch to unfractionated heparin at 36 weeks gestation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In pregnant women on <strong>warfarin</strong> for mechanical valves or thromboembolic conditions:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Warfarin is <strong>teratogenic</strong>, particularly between <strong>6–12 weeks</strong> gestation.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>discontinued</strong> once pregnancy is confirmed (especially if dose &gt;5 mg/day) and replaced with <strong>heparin</strong> (UFH or LMWH) until 12 weeks.</span></li><li><span style=\"font-size:14.0pt;\">Warfarin may be resumed <strong>after 12 weeks</strong> and continued until <strong>36 weeks</strong>.</span></li><li><span style=\"font-size:14.0pt;\">At <strong>36 weeks</strong>, warfarin is <strong>switched back to heparin</strong> due to its <strong>shorter half-life and ease of reversal</strong> at the time of delivery.</span></li><li><span style=\"font-size:14.0pt;\">Heparin is then <strong>stopped just before delivery</strong> to reduce the risk of peripartum bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Continue warfarin until the onset of labor: Incorrect.</strong> Warfarin crosses the placenta and increases the risk of <strong>fetal bleeding</strong>, particularly <strong>intracranial hemorrhage during labor</strong>. Continuing warfarin beyond 36 weeks is not recommended because spontaneous labor can occur anytime near term.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Discontinue anticoagulation until delivery</strong>: <strong>Incorrect.</strong> This would leave the patient with a <strong>mechanical heart valve unprotected</strong>, leading to <strong>a high risk of valve thrombosis and maternal mortality</strong>. Anticoagulation must be maintained throughout pregnancy, including the peripartum period (with careful timing).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Administer low-dose aspirin instead of warfarin: Incorrect.</strong> <strong>Aspirin alone is insufficient</strong> for preventing thromboembolic events in patients with <strong>mechanical heart valves</strong>. It may be <strong>used adjunctively</strong> in certain high-risk cases, but <strong>never as a substitute</strong> for heparin or warfarin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In pregnant women requiring long-term anticoagulation (e.g., for mechanical heart valves), <strong>warfarin should be stopped at 36 weeks gestation</strong> and replaced by <strong>heparin</strong> to allow safer peripartum management and minimize bleeding complications during delivery.</span></p>",
      "correct_choice_id": 314558,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78948/Obg_Q_12_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78948/Obg_Q_12_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78914,
      "choices": [
        {
          "id": 314421,
          "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
        },
        {
          "id": 314422,
          "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
        },
        {
          "id": 314423,
          "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
        },
        {
          "id": 314424,
          "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man presents with resting tremor, bradykinesia, rigidity, and postural instability. A coronal section of the brain is shown. Which of the following regions, when affected, is responsible for the observed neurotransmitter deficiency in this patient?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0mkrVh6.png\" width=\"398\" height=\"416\"></strong></span></p>",
      "unique_key": "Q9853627",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The area labelled <strong>B</strong> is the <strong>Substantia Nigra</strong>, located in the midbrain. It is responsible for the synthesis of dopamine, a key neurotransmitter involved in movement control.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In Parkinson's disease, the neurons in the Substantia Nigra degenerate, leading to a deficiency in dopamine production, which causes the characteristic motor symptoms of the disease, such as tremors, rigidity, and bradykinesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A:</strong> This is the corpus callosum, involved in motor control but not directly linked to dopamine synthesis in Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C:</strong> This area is likely part of the pons, which has no direct connection to Parkinson's disease or dopamine synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D:</strong> This area points to the medulla oblongata, which is involved in autonomic functions, not the synthesis of dopamine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Degeneration of the <strong>Substantia Nigra</strong> results in a dopamine deficit, which is the primary cause of the motor symptoms seen in Parkinson's disease.</span></li></ul>",
      "correct_choice_id": 314422,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78914/Anatomy_Q_8Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78914/Anatomy_Q_8Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78826,
      "choices": [
        {
          "id": 314077,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and Reason correctly explains the Assertion.</span></p>"
        },
        {
          "id": 314078,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but Reason does not correctly explain the Assertion.</span></p>"
        },
        {
          "id": 314079,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but Reason is false.</span></p>"
        },
        {
          "id": 314080,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is false, but Reason is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> During head and neck surgeries, accidental injury to the internal jugular vein can result in venous air embolism, leading to a sudden drop in end-tidal CO₂ (etCO₂), hypotension, and cardiac arrhythmias.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> Venous air embolism occurs because positive intrathoracic pressure during inspiration forces air into the venous system, particularly in a head-up surgical position.<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3978934",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Assertion is true, but Reason is false.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Assertion (True):</strong> Venous air embolism (VAE) <strong>is a well-known complication of neck surgeries</strong>, particularly when large veins like the <strong>internal jugular vein</strong> are injured. It can cause <strong>a sudden drop in etCO₂, hypotension, and cardiac arrhythmias</strong> due to air entering the venous system and traveling to the right heart and pulmonary circulation.</span><br><br>&nbsp;</li><li><span style=\"font-size:14.0pt;\"><strong>Reason (False):</strong> The <strong>mechanism described in the reason is incorrect</strong>. <strong>Air entry into the venous system does not occur due to positive intrathoracic pressure during inspiration</strong>. Instead, <strong>negative intrathoracic pressure during inspiration creates a suction effect, pulling air into open veins</strong>. The <strong>head-up position lowers venous pressure</strong>, further increasing this risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1Gxb4FL.png\" width=\"699\" height=\"214\"></strong></span></p>",
      "correct_choice_id": 314079,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78826/Q_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78826/Q_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78920,
      "choices": [
        {
          "id": 314445,
          "text": "<p><span style=\"font-size:14.0pt;\">0.7</span></p>"
        },
        {
          "id": 314446,
          "text": "<p><span style=\"font-size:14.0pt;\">0.8</span></p>"
        },
        {
          "id": 314447,
          "text": "<p><span style=\"font-size:14.0pt;\">0.9</span></p>"
        },
        {
          "id": 314448,
          "text": "<p><span style=\"font-size:14.0pt;\">1.0</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman is participating in a controlled metabolic study. Her oxygen consumption is measured at 300 mL/min, and her carbon dioxide output is recorded as 270 mL/min. What is the estimated respiratory quotient (RQ) in this individual?</span></p>",
      "unique_key": "Q4541413",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 0.9</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Respiratory Quotient (RQ)</strong> is calculated using the formula:</span></li><li><span style=\"font-size:14.0pt;\"><strong>RQ = CO₂ eliminated / O₂ consumed</strong></span></li><li><span style=\"font-size:14.0pt;\">Substituting the given values: <strong>RQ = 270 / 300 = 0.9</strong></span><br><br>&nbsp;</li><li><span style=\"font-size:14.0pt;\">This RQ value suggests a <strong>mixed substrate metabolism</strong>, commonly seen with a balanced diet of carbohydrates and fats.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 0.7:</strong> Corresponds to <strong>fat metabolism</strong>; not applicable here as the CO₂/O₂ ratio is higher.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. 0.8:</strong> Suggests <strong>protein metabolism</strong>, which would result from a lower CO₂ output relative to O₂.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. 1.0:</strong> Represents <strong>pure carbohydrate metabolism</strong>, where CO₂ output equals O₂ consumption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The respiratory quotient (RQ) is the ratio of carbon dioxide produced to oxygen consumed and helps identify the predominant metabolic fuel being utilized:&nbsp;</span></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>carbohydrates (RQ = 1.0), fats (RQ = 0.7), proteins (RQ = 0.8)</strong>. A value of <strong>0.9</strong> indicates a mixed fuel utilization.</span></li></ul>",
      "correct_choice_id": 314447,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78920/Physiology_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78920/Physiology_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78931,
      "choices": [
        {
          "id": 314489,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 3, and 4 are correct</span></p>"
        },
        {
          "id": 314490,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 2, and 5 are correct</span></p>"
        },
        {
          "id": 314491,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 2, 4, and 5 are correct</span></p>"
        },
        {
          "id": 314492,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding supine vena cava syndrome are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The condition is caused by compression of the inferior vena cava by the gravid uterus, especially in the supine position.</span></li><li><span style=\"font-size:14.0pt;\">The aorta is more commonly compressed than the inferior vena cava in late pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Collateral venous circulation via the azygous and paravertebral veins usually compensates for vena cava compression.</span></li><li><span style=\"font-size:14.0pt;\">Symptoms may include hypotension, tachycardia, and syncope when collateral circulation fails.</span></li><li><span style=\"font-size:14.0pt;\">Supine vena cava syndrome is managed by placing the patient in a Trendelenburg position.</span></li></ol>",
      "unique_key": "Q4559906",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Statements 1, 3, and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1:</strong> Correct – The inferior vena cava is compressed by the gravid uterus in the supine position, leading to reduced venous return.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3:</strong> Correct – Collateral circulation via <strong>azygous and paravertebral veins</strong> helps compensate for the reduced IVC flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4:</strong> Correct – Failure of collateral flow results in symptoms like <strong>hypotension</strong>, <strong>tachycardia</strong>, and <strong>syncope</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2:</strong>&nbsp; Incorrect – The <strong>aorta is relatively resistant</strong> to compression due to its muscular structure; the <strong>vena cava is more susceptible</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5:</strong>&nbsp; Incorrect – Management involves <strong>left lateral positioning</strong>, not the Trendelenburg position.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Supine vena cava syndrome</strong> is caused by gravid uterine compression of the <strong>inferior vena cava</strong>, especially in the <strong>supine position</strong>, leading to reduced venous return and symptoms such as <strong>hypotension and syncope</strong>. Management includes placing the patient in the <strong>lateral decubitus position</strong> to relieve compression.</span></p>",
      "correct_choice_id": 314489,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78931/Obg_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78931/Obg_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78894,
      "choices": [
        {
          "id": 314341,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 314342,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 314343,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 3 only</span></p>"
        },
        {
          "id": 314344,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding typical HRCT findings in fungal pneumonia are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Cavitary lung lesions with surrounding ground-glass opacities (halo sign) are commonly seen.</span></li><li><span style=\"font-size:14.0pt;\">The presence of Kerley B lines is a classic feature of fungal pneumonia.</span></li><li><span style=\"font-size:14.0pt;\">Hilar lymphadenopathy is a hallmark feature of invasive aspergillosis.</span></li><li><span style=\"font-size:14.0pt;\">The “air crescent sign” may appear in the healing phase of fungal pneumonia.</span></li></ol>",
      "unique_key": "Q7901269",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Fungal pneumonia</strong>, particularly <strong>invasive aspergillosis</strong>, shows characteristic findings on high-resolution CT (HRCT):</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1: Correct.</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Cavitary lesions with surrounding ground-glass opacities</strong>, known as the <strong>halo sign</strong>, are a <strong>classic early finding</strong> in invasive fungal infections. The ground-glass halo represents hemorrhage around a fungal lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4: Correct.</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The <strong>air crescent sign</strong>, which represents <strong>retraction of necrotic lung tissue</strong>, is typically seen during the <strong>recovery phase</strong> of invasive aspergillosis. It appears as a crescent-shaped air collection in a pre-existing nodule or consolidation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2: Incorrect.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Kerley B lines</strong> are linear opacities seen on imaging due to <strong>interlobular septal thickening</strong>, most often associated with <strong>pulmonary edema</strong>, <strong>lymphangitic carcinomatosis</strong>, or <strong>interstitial lung disease</strong> — <strong>not fungal pneumonia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3: Incorrect.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hilar lymphadenopathy</strong> is <strong>not a hallmark</strong> of invasive aspergillosis or most fungal pneumonias. It is more commonly seen in <strong>tuberculosis</strong>, <strong>sarcoidosis</strong>, or <strong>lymphoproliferative disorders</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The halo sign and air crescent sign are key high-resolution CT findings in fungal pneumonia, particularly invasive aspergillosis, while Kerley B lines and hilar lymphadenopathy are not characteristic.</span></p>",
      "correct_choice_id": 314341,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78894/Radiology_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78894/Radiology_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78908,
      "choices": [
        {
          "id": 314397,
          "text": "<p><span style=\"font-size:14.0pt;\">A</span></p>"
        },
        {
          "id": 314398,
          "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
        },
        {
          "id": 314399,
          "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
        },
        {
          "id": 314400,
          "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Injury of which of the following nerves causes drooping of the shoulder?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eC9Ness.png\" width=\"558\" height=\"418\"></strong></span></p>",
      "unique_key": "Q9911472",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Drooping of the shoulder is caused by paralysis of the <strong>trapezius muscle</strong>, which is supplied by the <strong>spinal accessory nerve (cranial nerve XI)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>trapezius muscle</strong> originates from the <strong>external occipital protuberance</strong> and inserts into the <strong>lateral third of the clavicle</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>spinal root of the accessory nerve</strong> (nerve B in the image) is responsible for innervating this muscle, and damage to this nerve leads to weakness or paralysis of the trapezius, causing the characteristic drooping of the shoulder.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lesser occipital nerve:&nbsp;</strong>This nerve supplies the skin of the posterior scalp and has no role in innervating the trapezius muscle or affecting shoulder movement. It is not responsible for shoulder drooping.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mastoid process:&nbsp;</strong>The <strong>mastoid process</strong> is a bony landmark on the temporal bone and does not innervate any muscles or have a role in shoulder movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Transverse cutaneous nerve of the neck:&nbsp;</strong>This nerve supplies the skin of the anterior and lateral neck. It is unrelated to the innervation of the trapezius muscle and does not contribute to shoulder movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Injury to the <strong>spinal accessory nerve</strong>, which innervates the <strong>trapezius muscle</strong>, leads to shoulder drooping. The nerve responsible is identified as B in the image.</span></li></ul>",
      "correct_choice_id": 314398,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78908/Anatomy_Q_6Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78908/Anatomy_Q_6Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78857,
      "choices": [
        {
          "id": 314197,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A</span></p>"
        },
        {
          "id": 314198,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A</span></p>"
        },
        {
          "id": 314199,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true</span></p>"
        },
        {
          "id": 314200,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> In Bruton’s disease, there is normal opsonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> Bruton’s disease is an inherited immunodeficiency characterized by a deficiency of B lymphocytes.&nbsp;</span></p>",
      "unique_key": "Q9509989",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A is false, but R is true</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Assertion:</strong> \"In Bruton’s disease, there is normal opsonization\" → <strong>False. </strong>Opsonization is impaired in Bruton’s disease because it requires <strong>antibodies</strong>, especially <strong>IgG</strong>, which coat pathogens and enhance phagocytosis. Since Bruton’s patients have <strong>absent or severely reduced B cells</strong>, they lack immunoglobulins, resulting in <strong>defective opsonization</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reason:</strong> \"Bruton’s disease is an inherited immunodeficiency characterized by a deficiency of B lymphocytes.\" → <strong>True. </strong>Bruton’s disease is an <strong>X-linked recessive</strong> disorder caused by mutations in the <strong>Bruton tyrosine kinase (BTK)</strong> gene. This blocks <strong>B cell maturation</strong>, leading to very low or absent peripheral B cells and immunoglobulins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bruton’s disease (X-linked agammaglobulinemia) leads to defective humoral immunity due to absent B cells and immunoglobulins, resulting in impaired opsonization and susceptibility to encapsulated bacterial infections.</span></p>",
      "correct_choice_id": 314199,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78857/Pathology_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78857/Pathology_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78810,
      "choices": [
        {
          "id": 314013,
          "text": "<p><span style=\"font-size:14.0pt;\">It cannot be used for complex, multidimensional problems requiring dynamic decision-making</span></p>"
        },
        {
          "id": 314014,
          "text": "<p><span style=\"font-size:14.0pt;\">It fails to eliminate personal bias among participating experts</span></p>"
        },
        {
          "id": 314015,
          "text": "<p><span style=\"font-size:14.0pt;\">It allows uncontrolled discussions, leading to dominance by strong personalities</span></p>"
        },
        {
          "id": 314016,
          "text": "<p><span style=\"font-size:14.0pt;\">It forces consensus, eliminating diverse perspectives from consideration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the most significant limitation of the Delphi Method in clinical decision-making?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1863092",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) It cannot be used for complex, multidimensional problems requiring dynamic decision-making</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Delphi method is best suited for answering a single-dimension, well-defined question (e.g., determining best guidelines for a particular clinical practice).</span></li><li><span style=\"font-size:14.0pt;\">It is not suitable for complex, multifactorial problems that require real-time dynamic decision-making, such as emergent surgical procedures.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>It fails to eliminate personal bias among participating experts:</strong> Incorrect, While Delphi reduces bias, no method can eliminate it completely.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>It allows uncontrolled discussions, leading to dominance by strong personalities:</strong> Incorrect, Delphi controls discussions through structured questionnaires, preventing dominance by individuals.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>It forces consensus, eliminating diverse perspectives from consideration:</strong> Incorrect, it seeks consensus but does not necessarily eliminate diversity of thought.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Delphi method is effective for structured, single-dimension decision-making but is limited in addressing complex, real-time, multidimensional problems.</span></p>",
      "correct_choice_id": 314013,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78810/Psm_Q_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78810/Psm_Q_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79078,
      "choices": [
        {
          "id": 315073,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1</span></p>"
        },
        {
          "id": 315074,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 315075,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 315076,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with suspected brucellosis has repeatedly negative results on the Standard Agglutination Test (SAT), despite high clinical suspicion. Which of the following statements regarding possible causes of false-negative SAT results is incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The prozone phenomenon occurs due to an excess of antigens in the patient's serum.</span></li><li><span style=\"font-size:14.0pt;\">Blocking antibodies like IgG or IgA can interfere with visible agglutination.</span></li><li><span style=\"font-size:14.0pt;\">Non-agglutinating antibodies may prevent detection of a true positive case.</span></li><li><span style=\"font-size:14.0pt;\">Prozone phenomenon can lead to underestimation of antibody levels.</span></li></ol>",
      "unique_key": "Q3082665",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. The prozone phenomenon occurs due to an excess of antigens in the patient's serum:&nbsp;</strong>This statement is <strong>incorrect</strong>. The <strong>prozone phenomenon</strong> results from an <strong>excess of antibodies</strong>, not antigens, in the patient's serum. When there is a high concentration of antibodies, they may interfere with lattice formation needed for visible agglutination, leading to a <strong>false-negative</strong> result in tests like SAT. Thus, the claim that the prozone effect is due to excess <strong>antigen</strong> is false.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Blocking antibodies like IgG or IgA can interfere with visible agglutination:</strong> <strong>Correct</strong>. Non-agglutinating antibodies such as <strong>IgG or IgA</strong> can bind antigens without causing the cross-linking necessary for visible clumping. These are sometimes referred to as <strong>blocking antibodies</strong> and can mask a true positive result, producing a <strong>false-negative SAT</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Non-agglutinating antibodies may prevent detection of a true positive case:</strong> <strong>Correct</strong>. Non-agglutinating antibodies like certain forms of IgG or IgA bind without causing agglutination, thus preventing the appearance of a positive reaction in the SAT, despite the presence of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Prozone phenomenon can lead to underestimation of antibody levels:</strong> <strong>Correct</strong>. In the <strong>prozone effect</strong>, the excess antibodies interfere with agglutination, and the test may falsely appear negative or indicate low titers, leading to <strong>underestimation</strong> of antibody levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">False-negative Standard Agglutination Tests (SAT) may occur due to the prozone phenomenon caused by excess antibodies or the presence of non-agglutinating/blocking IgG or IgA antibodies.</span></p>",
      "correct_choice_id": 315073,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79078/Microbiology_Q_14_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79078/Microbiology_Q_14_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79089,
      "choices": [
        {
          "id": 315113,
          "text": "<p><span style=\"font-size:14.0pt;\">Aldolase B</span></p>"
        },
        {
          "id": 315114,
          "text": "<p><span style=\"font-size:14.0pt;\">Galactose-1-phosphate uridyl transferase</span></p>"
        },
        {
          "id": 315115,
          "text": "<p><span style=\"font-size:14.0pt;\">Galactokinase</span></p>"
        },
        {
          "id": 315116,
          "text": "<p><span style=\"font-size:14.0pt;\">Fructokinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-day-old neonate is brought in with persistent vomiting, jaundice, and poor feeding. The parents mention that the symptoms began shortly after introducing breast milk. Physical examination reveals hepatomegaly and bilateral lens opacities. Laboratory evaluation shows elevated liver transaminases, indirect hyperbilirubinemia, and hypoglycemia. Urinalysis is positive for reducing substances, but glucose is not detected. Based on the likely diagnosis, which of the following enzymes is most likely deficient in this patient?</span></p>",
      "unique_key": "Q2201385",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Galactose-1-phosphate uridyl transferase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation is classic for <strong>classic galactosemia</strong>, a <strong>life-threatening metabolic disorder</strong> presenting in the <strong>neonatal period</strong> with vomiting, jaundice, hepatomegaly, cataracts, and hypoglycemia, often shortly after the ingestion of breast milk or formula (which contains lactose).</span></li><li><span style=\"font-size:14.0pt;\">The underlying cause is a <strong>deficiency of the enzyme galactose-1-phosphate uridyl transferase (GALT)</strong>, which impairs the conversion of <strong>galactose-1-phosphate to UDP-galactose</strong> in the Leloir pathway. As a result, <strong>galactose-1-phosphate accumulates</strong>, leading to liver dysfunction, renal damage, and neurotoxicity.</span></li><li><span style=\"font-size:14.0pt;\">The finding of <strong>urinary reducing substances in the absence of glucosuria</strong> is key to diagnosing a disorder of galactose metabolism. Prompt diagnosis and <strong>removal of galactose/lactose from the diet</strong> can prevent irreversible damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aldolase B:&nbsp;</strong>Deficiency of aldolase B causes <strong>hereditary fructose intolerance</strong>, which presents after ingestion of fructose-containing foods. It is associated with <strong>hypoglycemia, vomiting, and hepatomegaly</strong>, but not cataracts or positive reducing substances in the urine from birth.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Galactokinase:&nbsp;</strong>Deficiency causes a <strong>milder form of galactosemia</strong>, usually limited to the development of <strong>cataracts</strong> due to accumulation of galactitol, but <strong>without hepatomegaly, vomiting, or hypoglycemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fructokinase:&nbsp;</strong>Deficiency results in <strong>essential fructosuria</strong>, a <strong>benign</strong> condition causing fructose to spill into the urine. It is <strong>asymptomatic</strong> and unrelated to the neonatal presentation seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Classic galactosemia is caused by a deficiency of galactose-1-phosphate uridyl transferase, leading to accumulation of toxic galactose metabolites. Early signs include vomiting, jaundice, hepatomegaly, cataracts, and positive urinary reducing substances.</span></p>",
      "correct_choice_id": 315114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79089/Biochem_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79089/Biochem_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78904,
      "choices": [
        {
          "id": 314381,
          "text": "<p><span style=\"font-size:14.0pt;\">The toxicology expert’s testimony is inadmissible because they did not have first-hand knowledge of the victim’s condition at the time of death.</span></p>"
        },
        {
          "id": 314382,
          "text": "<p><span style=\"font-size:14.0pt;\">The toxicology testimony is admissible as it is based on expert opinion, not on first-hand knowledge.</span></p>"
        },
        {
          "id": 314383,
          "text": "<p><span style=\"font-size:14.0pt;\">The forensic expert’s testimony is admissible only if it can be corroborated by a common witness who had first-hand knowledge of the victim’s condition.</span></p>"
        },
        {
          "id": 314384,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a case of death due to alleged poisoning, the prosecution presents a toxicology expert who testifies that the victim’s body had toxic substance based on the analysis of the stomach contents. The defence argues that the expert’s testimony should be inadmissible as toxicology expert neither examined the victim while he was alive, nor he conducted the autopsy himself. Which of the below is true?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3619411",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) The toxicology testimony is admissible as it is based on expert opinion, not on first-hand knowledge.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under the <strong>Indian Evidence Act (Section 45)</strong> and general legal principles applicable in most jurisdictions, <strong>expert opinions</strong> are admissible in court when the matter involves <strong>scientific, technical, or specialized knowledge</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The law specifically allows for <strong>expert testimony</strong> even if the expert <strong>did not directly examine the victim</strong>, as long as their opinion is based on valid scientific analysis, such as laboratory examination of bodily specimens (in this case, stomach contents).</span></li><li><span style=\"font-size:14.0pt;\">In expert evidence witness can be of 3 types: Expert evidence (technical expertise), Common witness (first hand knowledge) and Hostile witness.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>expert's role</strong> is not to testify on direct facts but to <strong>interpret findings based on scientific knowledge</strong>. Hence, the toxicologist’s report and opinion about the presence of toxic substances are <strong>legally admissible</strong> despite the absence of direct involvement in the autopsy or victim’s treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The toxicology expert’s testimony is inadmissible because they did not have first-hand knowledge of the victim’s condition at the time of death: Incorrect</strong>, The <strong>law does not require first-hand knowledge</strong> for an expert’s opinion to be admissible. The expert's admissibility hinges on their <strong>technical expertise and the scientific basis</strong> of their conclusion, not on personal observation of the victim.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The forensic expert’s testimony is admissible only if it can be corroborated by a common witness who had first-hand knowledge of the victim’s condition:</strong> <strong>Incorrect</strong>, <strong>Expert evidence stands on its own</strong> and <strong>does not require corroboration by a non-expert or common witness</strong>. While corroborative evidence may strengthen the case, it is not a <strong>legal requirement for admissibility</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Both A and C:</strong> <strong>Incorrect,</strong> for the reasons above. Neither A nor C is correct individually, so both cannot be correct together.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Expert testimony is admissible in court even if the expert did not have first-hand knowledge of the victim, as long as it is based on scientific analysis within their expertise.</strong></span></p>",
      "correct_choice_id": 314382,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78904/Fmt_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78904/Fmt_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79086,
      "choices": [
        {
          "id": 315105,
          "text": "<p><span style=\"font-size:14.0pt;\">Serine</span></p>"
        },
        {
          "id": 315106,
          "text": "<p><span style=\"font-size:14.0pt;\">Valine</span></p>"
        },
        {
          "id": 315107,
          "text": "<p><span style=\"font-size:14.0pt;\">Alanine</span></p>"
        },
        {
          "id": 315108,
          "text": "<p><span style=\"font-size:14.0pt;\">Methionine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The genetic code is degenerate, meaning that most amino acids are encoded by more than one codon. This degeneracy often allows silent mutations (point mutations that do not change the amino acid) to occur without affecting the protein function. However some amino acids are coded by a single unique codon, and any mutation in that codon is more likely to result in a change in protein synthesis. Which of the following amino acids is coded by only one codon and thus does not exhibit degeneracy in the genetic code?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1926878",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Methionine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Methionine (AUG)</strong> is <strong>the only amino acid (besides tryptophan)</strong> that is coded by a <strong>single codon</strong>—<strong>AUG</strong>—which also serves as the <strong>start codon</strong> in mRNA translation. Therefore, <strong>methionine does not show degeneracy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Serine, B. Valine and C. Alanine</strong>: Are each encoded by <strong>multiple codons</strong>, illustrating the degeneracy of the genetic code, which provides a buffer against some mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Methionine is coded exclusively by a single codon (AUG), which also serves as the universal start codon in protein synthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike most amino acids that have multiple codons (degeneracy), methionine’s lack of codon redundancy means mutations affecting AUG are more likely to disrupt protein initiation or alter protein function.</span></li></ul>",
      "correct_choice_id": 315108,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79086/Biochem_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79086/Biochem_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79051,
      "choices": [
        {
          "id": 314965,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer IV magnesium sulfate</span></p>"
        },
        {
          "id": 314966,
          "text": "<p><span style=\"font-size:14.0pt;\">Defibrillation</span></p>"
        },
        {
          "id": 314967,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer IV sodium bicarbonate</span></p>"
        },
        {
          "id": 314968,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer lidocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman with a known history of depression and recent upper respiratory tract infection is brought to the emergency department after a witnessed syncopal episode at home. She had been started on oral azithromycin three days ago and has been on long-term amitriptyline therapy. On arrival, her BP is 86/58 mmHg, HR is irregular at 130/min, and she appears confused. Shortly after, she loses consciousness Bedside ECG is taken and shown below. What is the next best step in management?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sBNbOT7.png\" width=\"655\" height=\"456\"></span></p>",
      "unique_key": "Q9450282",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Defibrillation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient is experiencing <strong>torsades de pointes (TdP)</strong>, a form of polymorphic ventricular tachycardia associated with QT prolongation, secondary to combined azithromycin and tricyclic antidepressant use.</span></li><li><span style=\"font-size:14.0pt;\">The clinical presentation of <strong>syncope and hypotension&nbsp;</strong>with polymorphic VT (irregular wide complex tachycardia) on ECG mandates <strong>immediate unsynchronized defibrillation</strong> according to ACLS protocols.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Magnesium sulfate</strong> is the first-line treatment in <strong>stable TdP</strong> (conscious, perfusing patients) but <strong>not appropriate when the patient is unstable</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The presence of prolonged QT and polymorphic VT further supports the diagnosis rather than ischemic monomorphic VT.</span></li><li><span style=\"font-size:14.0pt;\">Administering sodium bicarbonate is beneficial in TCA overdose with wide QRS complexes but is not a primary emergency step in pulseless TdP unless wide QRS with acidosis is prominent.</span></li><li><span style=\"font-size:14.0pt;\">Lidocaine is ineffective in torsades and is primarily used in ischemic, <strong>monomorphic VT</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rl0TxME.png\" width=\"1370\" height=\"245\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administer IV magnesium sulfate:</strong> Correct for stable torsades but <strong>insufficient</strong> in pulseless TdP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Administer IV sodium bicarbonate:</strong> Reserved for TCA-induced cardiotoxicity with wide QRS; not first intervention here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Administer lidocaine:</strong> Indicated for monomorphic VT post-MI; ineffective for polymorphic VT due to QT prolongation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pulseless polymorphic ventricular tachycardia (torsades de pointes) mandates immediate unsynchronized defibrillation rather than magnesium sulfate administration, as per ACLS guidelines for cardiac arrest due to ventricular arrhythmias.</span></p>",
      "correct_choice_id": 314966,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79051/Dr._Dilip_Mock_Test_2_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79051/Dr._Dilip_Mock_Test_2_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78879,
      "choices": [
        {
          "id": 314285,
          "text": "<p><span style=\"font-size:14.0pt;\">Carcinoid tumor</span></p>"
        },
        {
          "id": 314286,
          "text": "<p><span style=\"font-size:14.0pt;\">Large cell carcinoma</span></p>"
        },
        {
          "id": 314287,
          "text": "<p><span style=\"font-size:14.0pt;\">Small cell carcinoma</span></p>"
        },
        {
          "id": 314288,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary hamartoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 59-year-old man with a 20 pack-year smoking history presents with shortness of breath and chest discomfort. Imaging reveals a mass in the central region of the lung. Biopsy is performed, and immunohistochemical staining is positive for chromogranin. Based on these findings, which of the following is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q5129139",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Small cell carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient presents with a <strong>centrally located lung tumor</strong> in the context of a <strong>heavy smoking history</strong>, along with <strong>chromogranin positivity</strong> on biopsy. These findings are characteristic of <strong>small cell lung carcinoma (SCLC)</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>SCLC</strong> is a <strong>high-grade neuroendocrine tumor</strong> most commonly seen in <strong>smokers</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It arises in the <strong>central airways</strong> (hilar region).</span></li><li><span style=\"font-size:14.0pt;\">Cells stain positive for <strong>neuroendocrine markers</strong> such as:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chromogranin</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Synaptophysin</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Neuron-specific enolase (NSE)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NwWWG7R.png\" width=\"511\" height=\"390\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SCLC is often <strong>aggressive</strong>, with early metastasis and <strong>paraneoplastic syndromes</strong> (e.g., SIADH, Cushing's).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Carcinoid tumor:&nbsp;</strong>Although <strong>carcinoid tumors</strong> also stain positive for <strong>chromogranin</strong>, they are typically <strong>low-grade</strong>, often present in <strong>younger, non-smoking individuals</strong>, and usually have <strong>less aggressive behavior</strong> than SCLC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Large cell carcinoma:&nbsp;</strong>Large cell carcinoma is <strong>undifferentiated</strong>, and though it may express some neuroendocrine markers, it typically lacks <strong>chromogranin</strong> expression. It is <strong>not strongly linked to neuroendocrine features</strong> like SCLC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pulmonary hamartoma:&nbsp;</strong>Hamartomas are <strong>benign lung tumors</strong> composed of <strong>disorganized but mature tissue</strong>, such as cartilage and fat. They do <strong>not stain positive for chromogranin</strong>, nor are they linked to <strong>smoking</strong> or <strong>central lung masses</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Small cell carcinoma of the lung is a central, high-grade neuroendocrine tumor strongly associated with smoking and characterized by chromogranin positivity on immunohistochemistry.</span></p>",
      "correct_choice_id": 314287,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78879/Pathology_Q_12_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78879/Pathology_Q_12_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78843,
      "choices": [
        {
          "id": 314141,
          "text": "<p><span style=\"font-size:14.0pt;\">Good prognosis</span></p>"
        },
        {
          "id": 314142,
          "text": "<p><span style=\"font-size:14.0pt;\">Poor prognosis</span></p>"
        },
        {
          "id": 314143,
          "text": "<p><span style=\"font-size:14.0pt;\">Good outcome with trastuzumab</span></p>"
        },
        {
          "id": 314144,
          "text": "<p><span style=\"font-size:14.0pt;\">Good outcome without trastuzumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old pre-menopausal woman is diagnosed with invasive ductal carcinoma of the breast. She undergoes a core needle biopsy, and immunohistochemistry (IHC) staining is performed. The report shows the estrogen receptor (ER), progesterone receptor (PR), and HER2-neu are all negative. Which of the following best describes the prognosis in this patient?&nbsp;</span></p>",
      "unique_key": "Q8341763",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Poor prognosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The immunohistochemistry details provided reveal that the tumor is <strong>triple negative</strong>—i.e., it lacks expression of <strong>estrogen receptor (ER)</strong>, <strong>progesterone receptor (PR)</strong>, and <strong>HER2-neu</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This subtype is referred to as <strong>Triple-Negative Breast Cancer (TNBC)</strong>.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">TNBC is <strong>more common in BRCA + women</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>more aggressive</strong> with <strong>higher rates of recurrence</strong> and <strong>shorter disease-free intervals</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Lacks targeted therapy options like <strong>hormonal therapy</strong> (e.g., tamoxifen) or <strong>HER2-targeted therapy</strong> (e.g., trastuzumab).</span></li><li><span style=\"font-size:14.0pt;\">While it may initially respond well to <strong>chemotherapy</strong>, long-term prognosis is generally <strong>poorer</strong> compared to receptor-positive cancers.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Good prognosis:&nbsp;</strong>Incorrect. TNBC is associated with worse prognosis due to aggressive nature and lack of targeted therapies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Good outcome with trastuzumab:&nbsp;</strong>Incorrect. Trastuzumab is only effective in HER2-positive cancers, but this case is HER2-negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Good outcome without trastuzumab:&nbsp;</strong>Incorrect. While some TNBCs may be chemosensitive, they still carry a <strong>worse long-term prognosis</strong>, and lack of HER2 overexpression makes trastuzumab ineffective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Triple-Negative Breast Cancer (TNBC), characterized by the absence of ER, PR, and HER2 expression on immunohistochemistry, is associated with a <strong>poor prognosis</strong> due to its aggressive nature, lack of response to targeted hormonal or HER2-directed therapy, and higher recurrence risk despite chemosensitivity.</span></li></ul>",
      "correct_choice_id": 314142,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78843/Surgery_Q_12_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78843/Surgery_Q_12_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78856,
      "choices": [
        {
          "id": 314193,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 1 is incorrect</span></p>"
        },
        {
          "id": 314194,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 2 is incorrect</span></p>"
        },
        {
          "id": 314195,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 3 is incorrect</span></p>"
        },
        {
          "id": 314196,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 5 is incorrect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Fosaprepitant is incorrect?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Fosaprepitant is a prodrug that is rapidly converted to aprepitant in the body.</span></li><li><span style=\"font-size:14.0pt;\">It is used primarily for the treatment of chemotherapy-induced diarrhea.</span></li><li><span style=\"font-size:14.0pt;\">Fosaprepitant acts as a neurokinin-1 (NK1) receptor antagonist.</span></li><li><span style=\"font-size:14.0pt;\">It is often administered as part of a multi-drug antiemetic regimen with a 5-HT₃ antagonist and dexamethasone.</span></li><li><span style=\"font-size:14.0pt;\">It helps prevent delayed-phase nausea and vomiting in patients receiving highly emetogenic chemotherapy.</span></li></ol>",
      "unique_key": "Q1679474",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Only statement 2 is incorrect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Fosaprepitant is used for chemotherapy-induced nausea and vomiting (CINV), not diarrhea.&nbsp;</strong>Fosaprepitant is used for <strong>chemotherapy-induced nausea and vomiting (CINV)</strong>, <strong>not diarrhea</strong>. Its mechanism does not affect bowel motility or fluid secretion. <strong>Its mechanism does not affect bowel motility or fluid secretion.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1 – Correct:</strong> Fosaprepitant is a <strong>prodrug of aprepitant</strong>, administered <strong>intravenously</strong>. It is rapidly converted to aprepitant, the active NK1 receptor antagonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3 – Correct:</strong> It blocks <strong>neurokinin-1 (NK1) receptors</strong>, which bind <strong>substance P</strong>, a key mediator in vomiting pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4 – Correct:</strong> It is frequently combined with <strong>ondansetron (a 5-HT₃ antagonist)</strong> and <strong>dexamethasone</strong> for <strong>complete antiemetic coverage</strong>, especially in <strong>highly emetogenic regimens</strong> like cisplatin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5 – Correct:</strong> It is particularly effective at preventing <strong>delayed-phase nausea and vomiting</strong>, which occurs <strong>24–72 hours post-chemotherapy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fosaprepitant is an IV prodrug of aprepitant, used to prevent chemotherapy-induced nausea and vomiting by antagonizing NK1 receptors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is not used for diarrhea and is typically part of combination antiemetic regimens.</span></li></ul>",
      "correct_choice_id": 314194,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78856/Pharmacology_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78856/Pharmacology_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79054,
      "choices": [
        {
          "id": 314977,
          "text": "<p><span style=\"font-size:14.0pt;\">SIADH</span></p>"
        },
        {
          "id": 314978,
          "text": "<p><span style=\"font-size:14.0pt;\">Cerebral salt wasting</span></p>"
        },
        {
          "id": 314979,
          "text": "<p><span style=\"font-size:14.0pt;\">Adrenal insufficiency</span></p>"
        },
        {
          "id": 314980,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man from Patna with known tuberculous meningitis presents with progressive confusion, worsening drowsiness, and generalized weakness. BP is 90/60 mmHg. Serum sodium is 118 mEq/L, urine sodium is 64 mEq/L, and urine osmolality is 500 mOsm/kg. Other electrolytes are normal. Clinical examination reveals signs of dehydration with poor skin turgor. What is the most likely cause of his hyponatremia?</span></p>",
      "unique_key": "Q5763240",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cerebral salt wasting</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cerebral salt wasting (CSW) is a common cause of hyponatremia in patients with CNS infections such as tuberculous meningitis.</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by hypovolemia with high urine sodium (&gt;40 mEq/L) and high urine osmolality, as seen in this patient.</span></li><li><span style=\"font-size:14.0pt;\">The key distinguishing factor from SIADH is volume status: CSW presents with clinical dehydration, while SIADH is euvolemic.</span></li><li><span style=\"font-size:14.0pt;\">Pathophysiology involves excessive natriuresis mediated by increased brain natriuretic peptide leading to salt and water loss.</span></li><li><span style=\"font-size:14.0pt;\">Correct management requires volume repletion with isotonic or hypertonic saline and salt supplementation, not fluid restriction.</span></li><li><span style=\"font-size:14.0pt;\">Failure to recognize CSW can worsen hypovolemia and hyponatremia, leading to seizures or death.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>CSW vs SIADH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nHhSaLe.png\" width=\"986\" height=\"266\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. SIADH:</strong> Presents with euvolemia, not hypovolemia; fluid restriction is the treatment, not saline replacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Adrenal insufficiency:</strong> Would present with hyperkalemia, hypotension, and sometimes eosinophilia, which are absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hypothyroidism:</strong> Rarely causes severe hyponatremia and would be associated with bradycardia, constipation, and dry skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with CNS infections like tuberculous meningitis, hyponatremia with clinical hypovolemia, high urine sodium, and high urine osmolality is characteristic of cerebral salt wasting, requiring volume and sodium repletion rather than fluid restriction.</span></p>",
      "correct_choice_id": 314978,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79054/Dr._Dilip_Mock_Test_2_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79054/Dr._Dilip_Mock_Test_2_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78886,
      "choices": [
        {
          "id": 314309,
          "text": "<p><span style=\"font-size:14.0pt;\">MYC</span></p>"
        },
        {
          "id": 314310,
          "text": "<p><span style=\"font-size:14.0pt;\">BCL2</span></p>"
        },
        {
          "id": 314311,
          "text": "<p><span style=\"font-size:14.0pt;\">TGF-beta</span></p>"
        },
        {
          "id": 314312,
          "text": "<p><span style=\"font-size:14.0pt;\">Beta-catenin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 76-year-old male presents with chronic, progressive abdominal discomfort over the past year. Cross-sectional imaging reveals a 10 cm pancreatic mass. Histological examination of the biopsy specimen confirms pancreatic adenocarcinoma, and molecular analysis identifies inactivation of the SMAD4 gene. Alteration in which of the following regulatory pathways is most likely responsible for the pathogenesis of this tumor?&nbsp;</span></p>",
      "unique_key": "Q1718948",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) TGF-beta</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SMAD4 is a tumor suppressor gene that functions within the TGF-beta (Transforming Growth Factor-beta) signaling pathway.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In normal cells, TGF-beta binds to its receptor and triggers phosphorylation of SMAD2 and SMAD3, which then form a complex with SMAD4.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This complex translocates to the nucleus to regulate genes involved in cell cycle arrest, differentiation, and apoptosis.</span></li><li><span style=\"font-size:14.0pt;\">In pancreatic adenocarcinoma, inactivation of SMAD4 results in disruption of this tumor-suppressive signaling, allowing unchecked proliferation and progression of malignancy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the regulatory pathway most commonly altered by SMAD4 loss is the TGF-beta pathway.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. MYC:&nbsp;</strong>Is a proto-oncogene involved in cell cycle progression and proliferation, but it is not regulated by the SMAD4 pathway or directly linked to TGF-beta signaling. MYC is associated with nuclear transcription factor and other type of malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. BCL2:</strong> Regulates apoptosis and is often involved in lymphoid malignancies, particularly follicular lymphoma. It is not associated with the TGF-beta pathway or SMAD4 mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Beta-catenin:&nbsp;</strong>Is part of the Wnt signaling pathway, which is important in other malignancies like colorectal cancer (as Beta catenin has the close association with APC gene), but not directly affected by SMAD4 inactivation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">SMAD4 is an essential mediator of the TGF-beta signaling pathway. Inactivation of SMAD4 leads to disruption of growth-inhibitory signals and contributes to pancreatic adenocarcinoma development.</span></p>",
      "correct_choice_id": 314311,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78886/Pathology_Q_14_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78886/Pathology_Q_14_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78918,
      "choices": [
        {
          "id": 314437,
          "text": "<p><span style=\"font-size:14.0pt;\">Bezold-Jarisch Reflex – Bradycardia and hypotension due to stimulation of ventricular chemoreceptors; afferent and efferent limbs via vagus nerve.</span></p>"
        },
        {
          "id": 314438,
          "text": "<p><span style=\"font-size:14.0pt;\">Bainbridge Reflex – Bradycardia due to increased venous return, mediated by stretch receptors in the right atrium.</span></p>"
        },
        {
          "id": 314439,
          "text": "<p><span style=\"font-size:14.0pt;\">Cushing Reflex – Protective response to cerebral ischemia involving systemic hypertension and reflex bradycardia.</span></p>"
        },
        {
          "id": 314440,
          "text": "<p><span style=\"font-size:14.0pt;\">J Reflex – Bradycardia, hypotension, and apnea due to stimulation of juxta-pulmonary capillary (J) receptors.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding various cardiovascular reflexes, which of the following is incorrectly matched with its description?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7842837",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Bainbridge Reflex – Bradycardia due to increased venous return, mediated by stretch receptors in the right atrium.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Bainbridge reflex</strong> is a <strong>cardioacceleratory reflex</strong> triggered by <strong>increased venous return</strong>, which stimulates stretch receptors in the <strong>right atrium</strong>, leading to inhibition of the vasodilator area, reduction in vagal tone, and a <strong>reflex tachycardia</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The option incorrectly associates it with <strong>bradycardia</strong>, which makes it the <strong>wrong match</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bezold-Jarisch Reflex:</strong> Correctly described. It involves chemoreceptors in the <strong>left ventricle</strong>, activated by chemical substances (e.g., alkaloids), leading to <strong>bradycardia and hypotension</strong> via vagal pathways.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Cushing Reflex:</strong> Correct. It is a protective reflex during <strong>raised intracranial pressure</strong>, leading to <strong>systemic hypertension, reflex bradycardia</strong>, and respiratory irregularities.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. J Reflex:</strong> Correct. Triggered by stimulation of <strong>juxta-pulmonary capillary (J) receptors</strong>, leading to <strong>apnea</strong>, <strong>bradycardia</strong>, and <strong>hypotension</strong>—seen in pulmonary edema or congestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The Bainbridge reflex causes <strong>tachycardia</strong> in response to increased venous return via right atrial stretch receptors.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Confusing it with bradycardia reflexes like Bezold-Jarisch or Cushing reflex is a common error and must be clearly distinguished in physiology-based&nbsp;</span></p>",
      "correct_choice_id": 314438,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78918/Physiology_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78918/Physiology_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78889,
      "choices": [
        {
          "id": 314321,
          "text": "<p><span style=\"font-size:14.0pt;\">Echolalia</span></p>"
        },
        {
          "id": 314322,
          "text": "<p><span style=\"font-size:14.0pt;\">Waxy flexibility</span></p>"
        },
        {
          "id": 314323,
          "text": "<p><span style=\"font-size:14.0pt;\">Pressured speech</span></p>"
        },
        {
          "id": 314324,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutism&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a feature of catatonia?&nbsp;</span></p>",
      "unique_key": "Q2836131",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Pressured speech</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Catatonia</strong> is a <strong>psychomotor syndrome</strong> characterized by a range of motor, behavioral, and speech abnormalities.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Core features include <strong>mutism</strong>, <strong>echolalia</strong> (repeating others' words), <strong>echopraxia</strong> (mimicking others' movements), <strong>waxy flexibility</strong> (maintaining imposed postures), <strong>stupor</strong>, and <strong>posturing</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These symptoms reflect <strong>motor and behavioral inhibition or repetition</strong>, not hyperactivity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pressured speech</strong> is a feature of <strong>mania</strong>, not catatonia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It refers to <strong>rapid, excessive, and hard-to-interrupt speech</strong>, which is the <strong>opposite of the speech disturbances seen in catatonia</strong> (like mutism).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Echolalia</strong>: A classic feature of catatonia involving <strong>repetitive echoing of another’s speech</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Waxy flexibility</strong>: A <strong>hallmark sign</strong>, where patients maintain positions into which they are placed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mutism</strong>: A <strong>common symptom</strong>, indicating absence or near-absence of verbal response.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clinical features of catatonia includes-</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_teeR84n.png\" width=\"987\" height=\"952\"></span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AqWhNqT.png\" width=\"987\" height=\"803\"></span></p>",
      "correct_choice_id": 314323,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78889/Psychiatry_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78889/Psychiatry_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78870,
      "choices": [
        {
          "id": 314249,
          "text": "<p><span style=\"font-size:14.0pt;\">Clarithromycin</span></p>"
        },
        {
          "id": 314250,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregabalin</span></p>"
        },
        {
          "id": 314251,
          "text": "<p><span style=\"font-size:14.0pt;\">Rivaroxaban</span></p>"
        },
        {
          "id": 314252,
          "text": "<p><span style=\"font-size:14.0pt;\">Teriparatide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man is being treated for dyslipidemia with rosuvastatin. At a follow-up visit, he reports symptoms of muscle pain and weakness. Which of the following drugs should be avoided due to a known interaction that increases the risk of statin-induced myopathy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8528262",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Clarithromycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Clarithromycin</strong> is a <strong>macrolide antibiotic</strong> and a <strong>potent CYP3A4 inhibitor</strong>. While <strong>rosuvastatin</strong> is primarily cleared by <strong>non-CYP3A4 pathways</strong>, <strong>concomitant use of strong CYP3A4 inhibitors (like clarithromycin, erythromycin, ciprofloxacin, ketoconazole)</strong> can still <strong>increase plasma levels of statins</strong>, especially with statins that are CYP-metabolized.</span></li><li><span style=\"font-size:14.0pt;\">This interaction can <strong>raise the risk of myopathy and rhabdomyolysis</strong>, particularly when statins are used in higher doses or combined with other interacting agents.</span></li><li><span style=\"font-size:14.0pt;\">Even though rosuvastatin is less dependent on CYP3A4 than simvastatin or atorvastatin, caution is still advised with strong inhibitors like clarithromycin, especially in patients with other risk factors for myopathy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pregabalin:&nbsp;</strong>Used for neuropathic pain. It does <strong>not interact with statins</strong> and does not increase the risk of myopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rivaroxaban:&nbsp;</strong>&nbsp;An oral factor Xa inhibitor. Though metabolized by CYP3A4, it has <strong>no clinically significant interaction with statins</strong> in terms of increasing myopathy risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Teriparatide:&nbsp;</strong>A recombinant PTH analog used for osteoporosis. It does <strong>not interact with statins</strong> and is not associated with statin-related muscle toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clarithromycin, a strong CYP3A4 inhibitor, can increase statin plasma concentrations and raise the risk of myopathy. It should be avoided or used with caution in patients taking statins like rosuvastatin.</span></li></ul>",
      "correct_choice_id": 314249,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78870/Pharmacology_Q_16_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78870/Pharmacology_Q_16_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78802,
      "choices": [
        {
          "id": 313981,
          "text": "<p><span style=\"font-size:14.0pt;\">Treat</span></p>"
        },
        {
          "id": 313982,
          "text": "<p><span style=\"font-size:14.0pt;\">Test</span></p>"
        },
        {
          "id": 313983,
          "text": "<p><span style=\"font-size:14.0pt;\">Tell</span></p>"
        },
        {
          "id": 313984,
          "text": "<p><span style=\"font-size:14.0pt;\">Talk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Under Anemia Mukt Bharat Program, \"T3 Camps\" include all except:&nbsp;</span></p>",
      "unique_key": "Q3286454",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tell</strong></span></p><p><br><br><span style=\"font-size:14.0pt;\">Under the <strong>Anemia Mukt Bharat (AMB)</strong> strategy, <strong>“T3 Camps”</strong> stand for:</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Test</strong> – Screening individuals for anemia using appropriate tools like hemoglobin testing.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Treat</strong> – Providing the necessary treatment to those who are anemic (e.g., iron, folic acid, deworming).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Talk</strong> – Counseling individuals and families on nutrition, hygiene, and compliance with iron-folic acid supplementation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">There is <strong>no component called \"Tell\"</strong> in the official T3 framework. “Tell” is a distractor not aligned with the structured communication or intervention methods under AMB.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">To identify the components of the <strong>T3 strategy under the Anemia Mukt Bharat Program</strong>, which focuses on screening, treating, and counseling to reduce the burden of anemia across target populations, especially in children, adolescents, and pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Note – Now, its expanded to include one additional “<strong>T”</strong> as “<strong>Track</strong>” i.e. follow up through AMB T4 app.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4Qo7t97.png\" width=\"773\" height=\"689\"></span></p>",
      "correct_choice_id": 313983,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78802/Psm_Q_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78802/Psm_Q_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78866,
      "choices": [
        {
          "id": 314233,
          "text": "<p><span style=\"font-size:14.0pt;\">Tamsulosin</span></p>"
        },
        {
          "id": 314234,
          "text": "<p><span style=\"font-size:14.0pt;\">Doxazosin</span></p>"
        },
        {
          "id": 314235,
          "text": "<p><span style=\"font-size:14.0pt;\">Phentolamine</span></p>"
        },
        {
          "id": 314236,
          "text": "<p><span style=\"font-size:14.0pt;\">Alfuzosin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man presents with increased urinary frequency, nocturia, and difficulty initiating urination. His blood pressure is within normal limits. After evaluation, he is diagnosed with benign prostatic hyperplasia (BPH). The physician chooses a drug that relieves urinary obstruction without causing significant systemic hypotension. Which of the following agents is most appropriate for this patient?</span></p>",
      "unique_key": "Q2401889",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Tamsulosin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tamsulosin</strong> is a <strong>selective α1A-adrenergic receptor antagonist</strong>, primarily acting on smooth muscle in the <strong>prostate and bladder neck</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because it has <strong>minimal action on vascular α1B receptors</strong>, it improves <strong>urinary flow</strong> in patients with BPH <strong>without significantly affecting blood pressure</strong>, making it particularly suitable for normotensive or elderly patients at risk of postural hypotension.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Doxazosin:&nbsp;</strong>Though effective for both <strong>BPH and hypertension</strong>, Doxazosin is a <strong>non-selective α1-blocker</strong> that acts on <strong>both vascular and prostate α1 receptors</strong>, often leading to <strong>orthostatic hypotension</strong>, especially in older adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Phentolamine:&nbsp;</strong>&nbsp;A <strong>non-selective α-adrenergic antagonist</strong> used primarily in the diagnosis and management of <strong>pheochromocytoma</strong> and for <strong>catecholamine-induced hypertensive crises</strong>. It is <strong>not used in BPH</strong>, and it causes profound vasodilation and hypotension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Alfuzosin:&nbsp;</strong>Alfuzosin is <strong>used in BPH</strong>, but it is <strong>less uroselective</strong> compared to tamsulosin, and while better tolerated than doxazosin, it still carries <strong>greater risk of hypotension</strong> than tamsulosin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tamsulosin is a selective α1A-adrenergic blocker that relieves lower urinary tract symptoms in BPH without significantly affecting blood pressure, due to its specificity for receptors in the prostate and bladder neck.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note - Tamsulosin and Silodosin (new drug) used for the BPH treatment, which do not cause postural hypotension</strong></span></p>",
      "correct_choice_id": 314233,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78866/Pharmacology_Q_13_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78866/Pharmacology_Q_13_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78825,
      "choices": [
        {
          "id": 314073,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbamoyl phosphate synthetase I (CPS1)</span></p>"
        },
        {
          "id": 314074,
          "text": "<p><span style=\"font-size:14.0pt;\">Ornithine transcarbamylase (OTC)</span></p>"
        },
        {
          "id": 314075,
          "text": "<p><span style=\"font-size:14.0pt;\">Arginase</span></p>"
        },
        {
          "id": 314076,
          "text": "<p><span style=\"font-size:14.0pt;\">Argininosuccinate lyase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-month-old infant presents with vomiting and failure to thrive. The child improves with IV glucose, but symptoms recur after one month. On investigation, elevated glutamine and uracil levels are noted.Which of the following enzyme deficiencies is the most likely cause of this clinical presentation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2353964",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ornithine transcarbamylase (OTC)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This clinical picture is suggestive of a <strong>urea cycle disorder</strong> with <strong>hyperammonemia</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Urea cycle defects</strong> lead to accumulation of <strong>ammonia</strong>, which manifests as vomiting, lethargy, failure to thrive, and encephalopathy.</span></li><li><span style=\"font-size:14.0pt;\">The fact that <strong>IV glucose improves</strong> the condition supports a metabolic disorder where <strong>catabolism (e.g., fasting)</strong> increases ammonia load.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Elevated glutamine</strong> is a marker of <strong>hyperammonemia</strong>, as glutamine acts as a temporary ammonia sink.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Elevated uracil and orotic acid</strong> are markers <strong>specifically associated with OTC deficiency</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Most common urea cycle disorder (X-linked recessive)</strong>.<strong> Hyperammonemia</strong> with <strong>elevated glutamine</strong>. <strong>Increased orotic acid/uracil</strong> in urine due to excess carbamoyl phosphate shunted into pyrimidine synthesis. Classic presentation: vomiting, encephalopathy, failure to thrive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CPS1 deficiency:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Hyperammonemia present.</span></li><li><span style=\"font-size:14.0pt;\">But <strong>no orotic aciduria</strong>, because CPS1 acts before carbamoyl phosphate enters the cytosolic pyrimidine synthesis pathway.</span></li><li><span style=\"font-size:14.0pt;\">No uracil accumulation.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Arginase deficiency:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Usually presents later in childhood.</span></li><li><span style=\"font-size:14.0pt;\">Spastic diplegia and developmental delay.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No orotic acid elevation</strong>; <strong>ammonia levels only mildly elevated</strong>.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Argininosuccinate lyase deficiency:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hyperammonemia</strong> with accumulation of <strong>argininosuccinic acid</strong>.</span></li><li><span style=\"font-size:14.0pt;\">No uracil elevation.</span></li><li><span style=\"font-size:14.0pt;\">May present with brittle hair (trichorrhexis nodosa).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Ornithine transcarbamylase (OTC) deficiency</strong> is the most common urea cycle defect, often presenting in infancy with <strong>hyperammonemia</strong>, vomiting, failure to thrive, and <strong>elevated glutamine and orotic acid (uracil)</strong> due to diversion of excess carbamoyl phosphate into pyrimidine synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vbdXdAh.png\" width=\"706\" height=\"589\"></span></p>",
      "correct_choice_id": 314074,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78825/Pediatrics_Q_10_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78825/Pediatrics_Q_10_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78903,
      "choices": [
        {
          "id": 314377,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexes, abducts, and laterally rotates the thigh at the hip joint; extends the knee</span></p>"
        },
        {
          "id": 314378,
          "text": "<p><span style=\"font-size:14.0pt;\">Extends, adducts, and medially rotates the thigh at the hip joint; flexes the knee</span></p>"
        },
        {
          "id": 314379,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexes, abducts, and laterally rotates the thigh at the hip joint; flexes the knee</span></p>"
        },
        {
          "id": 314380,
          "text": "<p><span style=\"font-size:14.0pt;\">Extends, abducts, and laterally rotates the thigh at the hip joint; extends the knee</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes the action of the sartorius muscle?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5914242",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Flexes, abducts, and laterally rotates the thigh at the hip joint; flexes the knee</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pojbmT0.png\" width=\"456\" height=\"570\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>sartorius</strong> is the longest muscle in the human body. It originates from the <strong>ASIS</strong> (anterior superior iliac spine) and inserts into the <strong>tibia behind the knee joint</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The muscle is also known as the <strong>tailor’s muscle or honeymoon muscle</strong>, responsible for helping people sit in the <strong>cross-legged position</strong> (palati position).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>sartorius</strong> causes <strong>flexion at the hip</strong>, <strong>flexion at the knee</strong>, <strong>abduction of the hip</strong>, and <strong>lateral rotation of the thigh</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is not responsible for <strong>extension at the knee</strong>, which rules out some of the incorrect options.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The correct option reflects the actions of <strong>flexion, abduction, and lateral rotation at the hip</strong> and <strong>flexion at the knee</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Flexes, abducts, and laterally rotates the thigh at the hip joint; extends the knee:&nbsp;</strong>This is incorrect because the sartorius <strong>flexes the knee</strong>, it does not extend the knee.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Extends, adducts, and medially rotates the thigh at the hip joint; flexes the knee:&nbsp;</strong>This is incorrect because the sartorius <strong>flexes the thigh</strong>, not extends it. It also abducts and laterally rotates the thigh rather than adducting and medially rotating it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Extends, abducts, and laterally rotates the thigh at the hip joint; extends the knee:&nbsp;</strong>This is incorrect because the sartorius muscle does not extend the knee; it is involved in knee <strong>flexion</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The sartorius muscle is responsible for <strong>flexion, abduction, and lateral rotation of the thigh at the hip joint</strong> and <strong>flexion at the knee</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It helps in the <strong>cross-legged position</strong> and is referred to as the <strong>tailor’s muscle</strong>.</span></li></ul>",
      "correct_choice_id": 314379,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78903/Anatomy_Q_4Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78903/Anatomy_Q_4Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79041,
      "choices": [
        {
          "id": 314925,
          "text": "<p><span style=\"font-size:14.0pt;\">It can be associated with heparin flushes</span></p>"
        },
        {
          "id": 314926,
          "text": "<p><span style=\"font-size:14.0pt;\">Platelet counts often fall below 20,000/µL</span></p>"
        },
        {
          "id": 314927,
          "text": "<p><span style=\"font-size:14.0pt;\">Risk is higher in medical vs surgical patients and occurs more in males</span></p>"
        },
        {
          "id": 314928,
          "text": "<p><span style=\"font-size:14.0pt;\">Arterial and venous thrombosis occur at equal rates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man is admitted to the ICU with sepsis and is started on unfractionated heparin for DVT prophylaxis. On day 5, he develops swelling in the left leg, and Doppler confirms proximal deep vein thrombosis. Repeat labs show a drop in platelet count from 145,000/µL on admission to 60,000/µL today. He is afebrile, and there are no signs of active bleeding. A peripheral smear shows thrombocytopenia without schistocytes. What is true regarding the likely diagnosis?</span></p>",
      "unique_key": "Q3451898",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) It can be associated with heparin flushes</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient likely has <strong>heparin-induced thrombocytopenia (HIT)</strong> — a <strong>prothrombotic immune-mediated disorder</strong> caused by antibodies against platelet factor 4 (PF4)-heparin complexes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>HIT can occur even after low-dose exposure</strong>, including <strong>heparin flushes</strong> used for catheter patency.</span></li><li><span style=\"font-size:14.0pt;\">Thrombocytopenia typically begins <strong>5–10 days after heparin exposure</strong>, and is usually <strong>moderate</strong> (platelets fall &gt;50% but rarely below 20,000/μL).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Venous thromboses</strong> (DVT, PE) are more common than arterial events (stroke, limb ischemia).</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis is <strong>clinical</strong>, supported by the <strong>4 Ts score</strong> (Thrombocytopenia, Timing, Thrombosis, alternative causes). A presumptive diagnosis is sufficient to initiate treatment while confirmatory tests are pending.</span></li><li><span style=\"font-size:14.0pt;\">Immediate steps include <strong>stopping all heparin</strong>, avoiding warfarin initially, and starting <strong>non-heparin anticoagulation</strong> (e.g., argatroban, fondaparinux, or DOACs).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HIT – Diagnostic and Management Framework:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IDTsuL1.png\" width=\"1208\" height=\"591\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Platelet counts often fall below 20,000/µL:</strong> This is <strong>uncommon</strong> in HIT; counts typically stay above 30,000/µL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Risk is higher in medical vs surgical patients and occurs more in males:</strong> Incorrect. <strong>Surgical patients and females</strong> are at higher risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Arterial and venous thrombosis occur at equal rates:</strong> <strong>Venous thrombosis predominates</strong> (DVT &gt; PE &gt; arterial events).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HIT is an immune-mediated prothrombotic condition that can occur even after minimal heparin exposure. It should be suspected when thrombocytopenia and thrombosis co-occur within 5–10 days of heparin use. Management requires immediate cessation of all heparin and initiation of non-heparin anticoagulation.</span></p>",
      "correct_choice_id": 314925,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79041/Dr._Dilip_Mock_Test_2_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79041/Dr._Dilip_Mock_Test_2_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78838,
      "choices": [
        {
          "id": 314125,
          "text": "<p><span style=\"font-size:14.0pt;\">Richter’s hernia</span></p>"
        },
        {
          "id": 314126,
          "text": "<p><span style=\"font-size:14.0pt;\">Maydl’s hernia</span></p>"
        },
        {
          "id": 314127,
          "text": "<p><span style=\"font-size:14.0pt;\">Pantaloon hernia</span></p>"
        },
        {
          "id": 314128,
          "text": "<p><span style=\"font-size:14.0pt;\">Sliding Hernia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man presents with a bulge in the left groin that has progressively enlarged over the past year. On examination, the bulge becomes more prominent when the patient coughs and decreases in size when lying down. The patient has a history of chronic obstructive pulmonary disease (COPD). On further inspection, a part of the bowel appears to be forming a wall of the hernia sac as shown. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_E1bpdxr.png\" width=\"401\" height=\"296\"></span></p>",
      "unique_key": "Q8247790",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Sliding hernia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inguinal hernias are sometimes referred to as <strong>‘sliding’</strong> in type. These are acquired indirect hernias arising at the deep inguinal ring lateral to the inferior epigastric vessels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Retroperitoneal fatty tissue is pushed downwards along the inguinal canal</strong>. As more tissue enters the hernia, peritoneum is pulled with it, thus creating a sac. However, the sac has formed secondarily, distinguishing it from a classic indirect hernia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>On the left side, the sigmoid colon may descend into a sliding hernia</strong> (the caecum may do so on the right).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Surgeons need extra caution during repair because the bowel may form part of the sac itself and can be damaged during the dissection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is the correct term for a hernia in which part of the hernia sac wall is formed by an organ that \"slides\" into it.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the image and the history suggest that part of the bowel (possibly the sigmoid colon) has become part of the hernia sac, which is characteristic of a sliding hernia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Richter’s hernia:&nbsp;</strong>Where a knuckle of bowel wall/circumference of bowel forms the content.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Maydl’s hernia:&nbsp;</strong>Where two loops of bowel form the content.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pantaloon Hernia:&nbsp;</strong>This term describes a situation where both an indirect and a direct inguinal hernia are present simultaneously, creating a \"pantaloon\" shape as the hernia sacs straddle the inferior epigastric vessels. This is not what is being shown in the provided image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A sliding hernia is one in which an organ, such as the sigmoid colon or bladder, forms part of the hernia sac wall and can \"slide\" into the sac.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition is particularly risky during surgical repair due to the potential for organ injury.</span></li></ul>",
      "correct_choice_id": 314128,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78838/Surgery_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78838/Surgery_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79088,
      "choices": [
        {
          "id": 315109,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyruvate</span></p>"
        },
        {
          "id": 315110,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetyl-CoA</span></p>"
        },
        {
          "id": 315111,
          "text": "<p><span style=\"font-size:14.0pt;\">Lactate</span></p>"
        },
        {
          "id": 315112,
          "text": "<p><span style=\"font-size:14.0pt;\">Urea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man is evaluated after experiencing sudden muscle fatigue and cramps following high-intensity interval training in a poorly ventilated environment. He reports that his legs feel “heavy” and “burning” shortly after starting his workouts. Laboratory studies show a transient drop in blood pH and increased anion gap. Given the likely metabolic shift in skeletal muscle during intense physical exertion under low oxygen availability, which of the following substances is expected to accumulate as the primary end product of glucose metabolism?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4160727",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Lactate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During <strong>intense physical exertion</strong>, especially in conditions of <strong>limited oxygen availability</strong>, skeletal muscle cells rely on <strong>anaerobic glycolysis</strong> for energy production. Under these hypoxic conditions, <strong>pyruvate</strong> formed from glycolysis cannot proceed through the aerobic pathway (i.e., conversion to Acetyl-CoA and entry into the citric acid cycle). Instead, it is converted to <strong>lactate</strong> by the enzyme <strong>lactate dehydrogenase</strong>, which simultaneously regenerates <strong>NAD⁺</strong> needed for continued glycolytic flux.</span></li><li><span style=\"font-size:14.0pt;\">As a result, <strong>lactate accumulates as the major end product</strong> of glucose metabolism in tissues undergoing anaerobic respiration. This accumulation can lead to a <strong>transient metabolic acidosis</strong> during intense exertion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pyruvate:&nbsp;</strong>Although pyruvate is the immediate product of glycolysis, it does not accumulate under anaerobic conditions. It is instead <strong>converted to lactate</strong>, making it an <strong>intermediate</strong> rather than a major end product.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acetyl-CoA:&nbsp;</strong>Formation of Acetyl-CoA from pyruvate via the <strong>pyruvate dehydrogenase complex</strong> requires oxygen and occurs in the mitochondria. Under hypoxic conditions, this aerobic pathway is suppressed, so Acetyl-CoA is <strong>not the major product</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Urea:&nbsp;</strong>Urea is a <strong>nitrogen-containing waste product</strong> formed from amino acid catabolism in the <strong>urea cycle</strong>, unrelated to <strong>glucose metabolism</strong>. It does <strong>not accumulate</strong> in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lactate is the primary end product of glucose metabolism in hypoxic or anaerobic conditions, such as during vigorous exercise with limited oxygen availability.</span></p>",
      "correct_choice_id": 315111,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79088/Biochem_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79088/Biochem_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78924,
      "choices": [
        {
          "id": 314461,
          "text": "<p><span style=\"font-size:14.0pt;\">Atrial fibrillation</span></p>"
        },
        {
          "id": 314462,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary stenosis</span></p>"
        },
        {
          "id": 314463,
          "text": "<p><span style=\"font-size:14.0pt;\">Tricuspid regurgitation</span></p>"
        },
        {
          "id": 314464,
          "text": "<p><span style=\"font-size:14.0pt;\">Constrictive pericarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man with a history of rheumatic heart disease presents with progressive fatigue and lower limb edema. On physical examination, he has an elevated jugular venous pressure (JVP) with prominent \"v waves\" visible during the cardiac cycle. Auscultation reveals a pansystolic murmur best heard at the lower left sternal border. Which of the following is the most likely underlying condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4649546",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tricuspid regurgitation</strong></span><br><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Large v waves</strong> on the jugular venous pressure waveform are characteristic of <strong>tricuspid regurgitation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this condition, during right ventricular systole, blood abnormally flows back into the right atrium due to incompetent tricuspid valve closure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This retrograde flow leads to a sharp rise in atrial pressure and a prominent <strong>v wave</strong> in the JVP waveform.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Atrial fibrillation:</strong> Associated with <strong>absent a waves</strong> due to lack of coordinated atrial contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pulmonary stenosis:</strong> Leads to <strong>large a waves</strong> due to increased resistance against which the right atrium contracts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Constrictive pericarditis:</strong> Characterized by a <strong>rise in JVP during inspiration</strong> (Kussmaul’s sign), not prominent v waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Prominent or large <strong>v waves</strong> on the JVP waveform are a hallmark of <strong>tricuspid regurgitation</strong>, resulting from systolic backflow of blood into the right atrium.</span></p>",
      "correct_choice_id": 314463,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78924/Physiology_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78924/Physiology_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78867,
      "choices": [
        {
          "id": 314237,
          "text": "<p><span style=\"font-size:14.0pt;\">Use a bronchodilator at the same time</span></p>"
        },
        {
          "id": 314238,
          "text": "<p><span style=\"font-size:14.0pt;\">Add a short course of oral antifungal therapy</span></p>"
        },
        {
          "id": 314239,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduce inhaler use to once daily</span></p>"
        },
        {
          "id": 314240,
          "text": "<p><span style=\"font-size:14.0pt;\">Rinse the mouth and throat with water after each use</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A male patient is started on an inhaled corticosteroid using a metered-dose inhaler (MDI), prescribed at two actuations twice daily for asthma control. To reduce the risk of developing oropharyngeal candidiasis, which of the following is the most appropriate preventive measure?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9702245",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Rinse the mouth and throat with water after each use</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Inhaled corticosteroids (ICS)</strong> are commonly used in the management of <strong>persistent asthma</strong> to reduce airway inflammation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, they can <strong>deposit in the oropharynx</strong>, where local immunosuppression can lead to <strong>oropharyngeal candidiasis</strong> (oral thrush).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The best way to prevent this complication is to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Rinse the mouth and gargle with water</strong> after using the inhaler</span></li><li><span style=\"font-size:14.0pt;\"><strong>Spit out the water</strong> rather than swallowing</span></li><li><span style=\"font-size:14.0pt;\">Use a <strong>spacer</strong> with MDI to decrease oropharyngeal deposition</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Use a bronchodilator at the same time:&nbsp;</strong>Bronchodilators do not prevent fungal overgrowth and are not a substitute for rinsing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Add a short course of oral antifungal therapy:&nbsp;</strong>&nbsp;Prophylactic antifungals are <strong>not routinely indicated</strong> and may promote resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Reduce inhaler use to once daily:&nbsp;</strong>Reducing the prescribed dose <strong>may compromise asthma control</strong> and is not appropriate without physician approval.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients using inhaled corticosteroids should rinse their mouth and gargle with water after each use to prevent oropharyngeal candidiasis due to local immunosuppressive effects.</span></li></ul>",
      "correct_choice_id": 314240,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78867/Pharmacology_Q_14_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78867/Pharmacology_Q_14_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78923,
      "choices": [
        {
          "id": 314457,
          "text": "<p><span style=\"font-size:14.0pt;\">Generation of action potential → Neuromuscular junction activation → Calcium release → T-tubule activation → Contraction</span></p>"
        },
        {
          "id": 314458,
          "text": "<p><span style=\"font-size:14.0pt;\">Neuromuscular junction activation → Action potential in muscle fiber → T-tubule propagation → Calcium release from cisternae → Contraction</span></p>"
        },
        {
          "id": 314459,
          "text": "<p><span style=\"font-size:14.0pt;\">Calcium binds to actin → Action potential spreads → Calcium released → Neuromuscular stimulation → Muscle contracts</span></p>"
        },
        {
          "id": 314460,
          "text": "<p><span style=\"font-size:14.0pt;\">Action potential in T-tubule → Muscle contraction → Calcium movement → Action potential in cisternae → Relaxation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man is participating in a study on skeletal muscle physiology. During muscle fiber stimulation, which of the following represents the correct sequence of events involved in excitation-contraction coupling in skeletal muscle?</span></p>",
      "unique_key": "Q6621363",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Neuromuscular junction activation → Action potential in muscle fiber → T-tubule propagation → Calcium release from cisternae → Contraction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>correct order</strong> of events in <strong>skeletal muscle excitation-contraction coupling</strong> is:</span><br>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Excitation of muscle fibers</strong> by motor nerve impulses at the <strong>neuromuscular junction</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Generation of action potential</strong> in the muscle fiber membrane</span></li><li><span style=\"font-size:14.0pt;\"><strong>Spread of action potential</strong> along <strong>T-tubules</strong></span></li><li><span style=\"font-size:14.0pt;\">Entry of the action potential into <strong>terminal cisternae</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Release of calcium ions</strong> from the sarcoplasmic reticulum cisternae</span></li><li><span style=\"font-size:14.0pt;\"><strong>Calcium binds to actin filaments</strong> (specifically to troponin), initiating interaction with myosin</span></li><li><span style=\"font-size:14.0pt;\"><strong>Contraction of the muscle fibers</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Generation of action potential → Neuromuscular junction activation → Calcium release → T-tubule activation → Contraction: &nbsp;</strong>Incorrect order — action potential cannot precede neuromuscular junction activation.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Calcium binds to actin → Action potential spreads → Calcium released → Neuromuscular stimulation → Muscle contracts:</strong> Incorrect — calcium does not bind to actin before the action potential spreads or is generated.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Action potential in T-tubule → Muscle contraction → Calcium movement → Action potential in cisternae → Relaxation:</strong> Incorrect — contraction does not precede the movement of calcium or action potential initiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Excitation-contraction coupling in skeletal muscle begins with stimulation at the neuromuscular junction and proceeds through a well-ordered sequence: action potential generation, T-tubule propagation, calcium release, and finally muscle fiber contraction.</span></p>",
      "correct_choice_id": 314458,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78923/Physiology_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78923/Physiology_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78861,
      "choices": [
        {
          "id": 314213,
          "text": "<p><span style=\"font-size:14.0pt;\">Solifenacin</span></p>"
        },
        {
          "id": 314214,
          "text": "<p><span style=\"font-size:14.0pt;\">Vibegron</span></p>"
        },
        {
          "id": 314215,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxybutynin</span></p>"
        },
        {
          "id": 314216,
          "text": "<p><span style=\"font-size:14.0pt;\">Darifenacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old woman presents with symptoms of urinary urgency, increased frequency, and nocturia. She is diagnosed with overactive bladder syndrome. Which of the following newly approved agents acts as a β₃-adrenergic receptor agonist and is appropriate for her condition?</span></p>",
      "unique_key": "Q9039259",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Vibegron</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vibegron is a newly approved β₃-adrenergic receptor agonist used in the management of overactive bladder syndrome.</span></li><li><span style=\"font-size:14.0pt;\">It works by relaxing the detrusor smooth muscle during the storage phase of the micturition cycle, thereby increasing bladder capacity and reducing urgency, frequency, and nocturia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Unlike antimuscarinic agents, β₃-agonists like vibegron:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Have <strong>fewer anticholinergic side effects</strong> (e.g., dry mouth, constipation)</span></li><li><span style=\"font-size:14.0pt;\">Are <strong>well tolerated</strong> in elderly patients</span></li><li><span style=\"font-size:14.0pt;\">Do <strong>not impair cognition</strong>, making them suitable for older adults</span></li><li><span style=\"font-size:14.0pt;\"><strong>Vibegron</strong> is similar in function to <strong>mirabegron</strong>, another β₃-agonist, but vibegron has a more recent approval and a favorable side effect profile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Solifenacin:&nbsp; </strong>A <strong>muscarinic receptor antagonist</strong> (anticholinergic). Commonly used for OAB, but can cause <strong>dry mouth and constipation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oxybutynin:&nbsp;</strong>A <strong>non-selective antimuscarinic</strong>. Effective but associated with significant <strong>anticholinergic side effects</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Darifenacin:&nbsp;</strong>Another <strong>M3-selective antimuscarinic</strong>. Though more selective, it still poses <strong>anticholinergic risks</strong>, especially in older adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mirabegron is a β₃-adrenergic agonist used in the treatment of overactive bladder, especially in patients who cannot tolerate the anticholinergic side effects of traditional therapies.</span></li></ul>",
      "correct_choice_id": 314214,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78861/Pharmacology_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78861/Pharmacology_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78996,
      "choices": [
        {
          "id": 314749,
          "text": "<p><span style=\"font-size:14.0pt;\">The most common cause is vocal cord trauma</span></p>"
        },
        {
          "id": 314750,
          "text": "<p><span style=\"font-size:14.0pt;\">Histologically, it is a malignant lesion of the vocal cords</span></p>"
        },
        {
          "id": 314751,
          "text": "<p><span style=\"font-size:14.0pt;\">The edema fluid accumulates in the Reinke's space (subepithelial space)</span></p>"
        },
        {
          "id": 314752,
          "text": "<p><span style=\"font-size:14.0pt;\">The treatment of choice is tracheostomy and radiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old chronic smoker presents with progressive hoarseness of voice. Laryngoscopic examination is as shown in the image below. Which of the following statements is true about this condition?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3Z67OQb.png\" width=\"522\" height=\"351\"></strong></span></p>",
      "unique_key": "Q1665732",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) The edema fluid accumulates in the Reinke's space (subepithelial space)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The condition shown is <strong>Reinke’s edema (polypoid corditis)</strong>, characterized by <strong>diffuse collection of fluid in the Reinke’s space</strong>, which is the subepithelial space of the vocal cords.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>strongly associated with chronic smoking</strong>, with up to <strong>97% of cases seen in smokers</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Laryngoscopy</strong> reveals the classical <strong>“saddle-bag” appearance</strong> of the vocal cords.</span></li><li><span style=\"font-size:14.0pt;\">It is a benign lesion and not a malignancy.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>treatment of choice</strong> is <strong>micro laryngeal surgery</strong>, not tracheostomy or radiotherapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The most common cause is vocal cord trauma:&nbsp;</strong>False, the main cause is <strong>chronic smoking</strong> (also voice abuse, but not trauma alone)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Histologically, it is a malignant lesion of the vocal cords:&nbsp;</strong>False,<strong> Reinke's edema is a benign lesion</strong>, not malignant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>The treatment of choice is tracheostomy and radiotherapy:</strong> False, treatment is <strong>microlaryngoscopic surgery</strong> and <strong>voice therapy</strong>, not tracheostomy or radiotherapy (those are for cancers)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nkBuFyx.png\" width=\"1028\" height=\"290\"></strong></span></p>",
      "correct_choice_id": 314751,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78996/Ent_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78996/Ent_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78988,
      "choices": [
        {
          "id": 314717,
          "text": "<p><span style=\"font-size:14.0pt;\">The crus commune is a part of the cochlea responsible for high-frequency sound detection.&nbsp;</span></p>"
        },
        {
          "id": 314718,
          "text": "<p><span style=\"font-size:14.0pt;\">It is a shared bony canal connecting the posterior and superior semicircular canals.&nbsp;</span></p>"
        },
        {
          "id": 314719,
          "text": "<p><span style=\"font-size:14.0pt;\">The crus commune contains the utricle, a structure involved in detecting linear acceleration.&nbsp;</span></p>"
        },
        {
          "id": 314720,
          "text": "<p><span style=\"font-size:14.0pt;\">It is an extension of the auditory tube and plays a role in equalizing ear pressure.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old individual presents with a long-standing history of recurrent vertigo and imbalance, especially with rapid head movements. Neurologic examination is unremarkable. Audio vestibular testing reveals signs suggestive of a structural abnormality within the inner ear, specifically affecting the semicircular canals. Which of the following statements regarding the&nbsp;crus commune in the inner ear is accurate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4606186",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It is a shared bony canal connecting the posterior and superior semicircular canals.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>crus commune</strong>, correctly stated here, is a <strong>shared canal</strong> that <strong>connects</strong> the <strong>posterior</strong> and <strong>superior semicircular canals</strong> in the inner ear. This structure is <strong>part</strong> of the <strong>vestibular system</strong>, which plays a <strong>crucial role in balance</strong> and <strong>spatial orientation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Semicircular canals are <strong>three in number</strong>, the <strong>lateral</strong>, <strong>posterior</strong> and <strong>superior</strong>, and lie in <strong>planes</strong> at <strong>right angles</strong> to one another. Each canal has an <strong>ampullated end</strong> which <strong>opens independently</strong> into the <strong>vestibule</strong> and a <strong>non-ampullated end</strong>. The <strong>non-ampullatedends</strong> of <strong>posterior</strong> and <strong>superior canals</strong> <strong>unite to form a common channel</strong> called <strong>crus commune</strong>. Thus, the <strong>three canals</strong> open into the <strong>vestibule by five openings</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eR1KuiS.png\" width=\"1267\" height=\"423\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The crus commune is a part of the cochlea responsible for high-frequency sound detection:</strong> This statement is <strong>incorrect</strong>. The <strong>cochlea</strong>, not the crus commune, is involved in <strong>sound detection</strong>, with different parts responsible for detecting different frequencies of sound.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The crus commune contains the utricle, a structure involved in detecting linear acceleration:</strong> This statement is <strong>incorrect</strong>. The <strong>utricle</strong>, along with the <strong>saccule</strong>, is indeed <strong>involved</strong> in <strong>detecting linear acceleration</strong>, but it is not contained within the crus commune. These structures are <strong>located</strong> in the <strong>vestibule</strong>, not the semicircular canals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is an extension of the auditory tube and plays a role in equalizing ear pressure:</strong> This statement is <strong>incorrect</strong>. The <strong>auditory tube</strong> (<strong>Eustachian tube</strong>) is <strong>responsible</strong> for <strong>equalizing pressure</strong> between the <strong>middle ear</strong> and the <strong>atmosphere</strong>. The crus commune is <strong>part</strong> of the <strong>bony labyrinth</strong> of the <strong>inner ear</strong> and is <strong>unrelated</strong> to the <strong>auditory tube</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Identify the crus commune as a <strong>shared bony canal</strong> in the <strong>inner ear</strong> that <strong>connects</strong> the <strong>posterior</strong> and <strong>superior semicircular canals</strong> and is <strong>involved</strong> in the <strong>vestibular system</strong>, not in hearing or pressure equalization.</span></p>",
      "correct_choice_id": 314718,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78988/Ent_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78988/Ent_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78816,
      "choices": [
        {
          "id": 314037,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B</span></p>"
        },
        {
          "id": 314038,
          "text": "<p><span style=\"font-size:14.0pt;\">A, E</span></p>"
        },
        {
          "id": 314039,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B, E</span></p>"
        },
        {
          "id": 314040,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B, C, E</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-year-old boy is brought in for evaluation of short stature. Which of the following statements regarding constitutional growth delay are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">He had normal length and weight at birth</span></li><li><span style=\"font-size:14.0pt;\">Catch-up growth typically occurs at 6–12 months of age</span></li><li><span style=\"font-size:14.0pt;\">His bone age is greater than chronological age</span></li><li><span style=\"font-size:14.0pt;\">His height velocity assumes a normal rate during middle childhood</span></li><li><span style=\"font-size:14.0pt;\">Final adult height is typically normal</span></li></ol>",
      "unique_key": "Q7362085",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) A, E</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The scenario describes <strong>Constitutional Growth Delay (CGD)</strong>, a common cause of short stature in children with <strong>delayed skeletal maturation</strong> and <strong>late onset of puberty</strong>, but eventual attainment of <strong>normal adult height</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A.</strong> <strong>He had normal length and weight at birth:</strong> Correct<strong>,</strong> Children with CGD are born with <strong>normal length and weight</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>E.</strong> <strong>Final adult height is typically normal:&nbsp;</strong>Correct<strong>,</strong> Final adult height is usually <strong>normal</strong>, though delayed in attainment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B.</strong> <strong>Catch-up growth typically occurs at 6–12 months of age:&nbsp;</strong>Incorrect, Catch-up growth <strong>does not typically occur at 6–12 months</strong>; rather, these children continue to grow slowly in early years and catch-up during adolescence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C.</strong> <strong>His bone age is greater than chronological age:&nbsp;</strong>Incorrect, Bone age in CGD is <strong>delayed</strong>, i.e., <strong>less than chronological age</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D.</strong> <strong>His height velocity assumes a normal rate during middle childhood:&nbsp;</strong>Incorrect, Height velocity is <strong>slower than normal during early years</strong> but normalizes later.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In constitutional growth delay, children have normal birth parameters, delayed bone age, and delayed puberty, but they ultimately reach normal adult height.</span></li><li><span style=\"font-size:14.0pt;\">The key distinguishing feature is the bone age lag behind chronological age with no pathological findings.</span></li></ul>",
      "correct_choice_id": 314038,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78816/Pediatrics_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78816/Pediatrics_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78958,
      "choices": [
        {
          "id": 314597,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1 and 2 are correct</span></p>"
        },
        {
          "id": 314598,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 3 and 4 are correct</span></p>"
        },
        {
          "id": 314599,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3, and 4 are correct</span></p>"
        },
        {
          "id": 314600,
          "text": "<p><span style=\"font-size:14.0pt;\">All four statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding early pregnancy signs is/are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Chadwick’s sign is characterized by a bluish discoloration of the anterior vaginal wall observed around the 8th week of pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Osiander’s sign involves increased pulsation felt through the lateral fornices and typically appears before the 4th week.</span></li><li><span style=\"font-size:14.0pt;\">Goodell’s sign refers to cervical softening and is evident as early as the 6th week of gestation.</span></li><li><span style=\"font-size:14.0pt;\">Palmer’s sign involves rhythmic uterine contractions and is elicited on bimanual examination between the 4th and 8th weeks.</span></li></ol>",
      "unique_key": "Q9645912",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Only 1, 3, and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Chadwick’s sign is characterized by a bluish discoloration of the anterior vaginal wall observed around the 8th week of pregnancy:</strong> Correct. Chadwick’s sign (also called Jacquemier’s sign) is the bluish discoloration of the anterior vaginal wall, seen by the <strong>8th week</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Goodell’s sign refers to cervical softening and is evident as early as the 6th week of gestation:</strong> Correct. Goodell’s sign refers to a soft cervix, seen by the <strong>6th week</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Palmer’s sign involves rhythmic uterine contractions and is elicited on bimanual examination between the 4th and 8th weeks:</strong> Correct. Palmer’s sign is characterized by <strong>rhythmic uterine contractions</strong> elicited on <strong>bimanual examination</strong>, typically between <strong>4–8 weeks</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Osiander’s sign involves increased pulsation felt through the lateral fornices and typically appears before the 4th week.:</strong> Incorrect. Osiander’s sign appears at <strong>6–8 weeks</strong>, not before the 4th week.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Several clinical signs aid in the early diagnosis of pregnancy. These signs are classified based on their anatomical location (vaginal, cervical, uterine) and the time at which they typically appear. Recognizing these signs can support clinical diagnosis before imaging confirmation.</span></p>",
      "correct_choice_id": 314599,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78958/Obg_Q_19_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78958/Obg_Q_19_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78933,
      "choices": [
        {
          "id": 314497,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-A, 3-C, 4-B</span></p>"
        },
        {
          "id": 314498,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-A, 4-D</span></p>"
        },
        {
          "id": 314499,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-D, 4-C</span></p>"
        },
        {
          "id": 314500,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-C, 4-D&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following HPV vaccines<strong>&nbsp;</strong>with the<strong>&nbsp;</strong>HPV types they protect against<strong>:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column A: HPV Vaccine</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Cervarix</span></li><li><span style=\"font-size:14.0pt;\">Gardasil</span></li><li><span style=\"font-size:14.0pt;\">Gardasil 9 (Nonavalent)</span></li><li><span style=\"font-size:14.0pt;\">Cervavac (India)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column B: HPV Types Covered</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">6, 11, 16, 18</span></li><li><span style=\"font-size:14.0pt;\">16, 18</span></li><li><span style=\"font-size:14.0pt;\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></li><li><span style=\"font-size:14.0pt;\">6, 11, 16, 18 (Indian quadrivalent)</span></li></ol>",
      "unique_key": "Q1688742",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) 1-B, 2-A, 3-C, 4-D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cervarix (Bivalent):</strong> Covers high-risk types <strong>16, 18</strong> → <strong>B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Gardasil (Quadrivalent):</strong> Covers types <strong>6, 11, 16, 18</strong> → <strong>A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Gardasil 9 (Nonavalent):</strong> Covers types <strong>6, 11, 16, 18, 31, 33, 45, 52, 58</strong> → <strong>C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cervavac (India's vaccine):</strong> A <strong>quadrivalent</strong> vaccine covering <strong>6, 11, 16, 18</strong> → <strong>D</strong></span></p><p>&nbsp;</p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\">HPV Vaccines available are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Cervarix (Bivalent): 16, 18</span></li><li><span style=\"font-size:14.0pt;\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></li><li><span style=\"font-size:14.0pt;\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18,31,33,45,52,58.</span></li><li><span style=\"font-size:14.0pt;\">Cervavac (India’s indigenous HPV vaccine): Quadrivalent: 6,11,16,18</span></li></ol>",
      "correct_choice_id": 314500,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78933/Obg_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78933/Obg_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78809,
      "choices": [
        {
          "id": 314009,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased rainfall leading to cleaner water sources</span></p>"
        },
        {
          "id": 314010,
          "text": "<p><span style=\"font-size:14.0pt;\">Higher temperatures and humidity promoting flea reproduction</span></p>"
        },
        {
          "id": 314011,
          "text": "<p><span style=\"font-size:14.0pt;\">Improved urban hygiene reducing flea populations</span></p>"
        },
        {
          "id": 314012,
          "text": "<p><span style=\"font-size:14.0pt;\">Global mosquito control efforts eliminating vector competition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following environmental factors is most likely to contribute to increased Xenopsylla cheopis-mediated Yersinia pestis outbreaks?</span></p>",
      "unique_key": "Q1423316",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Higher temperatures and humidity promoting flea reproduction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Warm, humid environments favor flea reproduction, increasing transmission risk.</span></li><li><span style=\"font-size:14.0pt;\">Rodent population booms due to climate change further amplify transmission cycles.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Increased rainfall leading to cleaner water sources:</strong> Incorrect, Plague thrives in dry, overcrowded conditions, not clean environments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Improved urban hygiene reducing flea populations:</strong> Incorrect, Better hygiene reduces, rather than increases, flea populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Global mosquito control efforts eliminating vector competition:</strong> Incorrect, Mosquitoes do not compete with Xenopsylla cheopis for transmission niches.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rising temperatures and humidity due to climate change favor Xenopsylla cheopis proliferation, increasing the risk of plague outbreaks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Xenopsylla cheopis and Plague</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2oY9kKt.png\" width=\"587\" height=\"269\"></strong></span></p>",
      "correct_choice_id": 314010,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78809/Psm_Q_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78809/Psm_Q_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78822,
      "choices": [
        {
          "id": 314061,
          "text": "<p><span style=\"font-size:14.0pt;\">Gynecomastia with long thin limbs</span></p>"
        },
        {
          "id": 314062,
          "text": "<p><span style=\"font-size:14.0pt;\">Short stature with polydactyly</span></p>"
        },
        {
          "id": 314063,
          "text": "<p><span style=\"font-size:14.0pt;\">Webbed neck with widely spaced nipples</span></p>"
        },
        {
          "id": 314064,
          "text": "<p><span style=\"font-size:14.0pt;\">Rocker bottom feet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following clinical features is most likely expected in this patient?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XlxaT16.png\" width=\"621\" height=\"435\"></strong></span></p>",
      "unique_key": "Q2885395",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Gynecomastia with long thin limbs</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The <strong>47, XXY</strong> karyotype indicates <strong>Klinefelter syndrome</strong>, a chromosomal disorder affecting males. It is characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tall stature with long limbs</strong> (eunuchoid body habitus)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Gynecomastia</strong> (increased estrogen-to-testosterone ratio)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Small testes with infertility</strong> (due to primary testicular failure)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Learning difficulties or mild intellectual disability</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These features arise due to an extra X chromosome, leading to hypogonadism and altered androgen-estrogen balance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Short stature with polydactyly</strong> – Suggestive of <strong>Ellis–van Creveld syndrome</strong> or <strong>Trisomy 13</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Webbed neck with widely spaced nipples</strong> – Characteristic of <strong>Turner syndrome (45, X)</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Rocker bottom feet</strong> – Seen in <strong>Trisomy 18 (Edwards syndrome)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Klinefelter syndrome (47, XXY)</strong> is characterized by tall stature, long limbs, gynecomastia, hypogonadism, and infertility. It results from an additional X chromosome in males and is a common cause of male infertility.</span></p>",
      "correct_choice_id": 314061,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78822/Pediatrics_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78822/Pediatrics_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78845,
      "choices": [
        {
          "id": 314149,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-A, 4-B</span></p>"
        },
        {
          "id": 314150,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-D, 4-A</span></p>"
        },
        {
          "id": 314151,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-B, 4-A&nbsp;</span></p>"
        },
        {
          "id": 314152,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-A, 3-C, 4-B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>Match the columns</strong> in&nbsp;A (Types of Shock) with B (classical presentation):&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column A (Types of Shock)</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Anaphylactic shock</span></li><li><span style=\"font-size:14.0pt;\">Hemorrhagic shock</span></li><li><span style=\"font-size:14.0pt;\">Cardiogenic shock</span></li><li><span style=\"font-size:14.0pt;\">Neurogenic shock</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Column B (Classical Presentation):</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Bradycardia with warm, dry skin and hypotension&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Elevated jugular venous pressure, pulmonary edema</span></li><li><span style=\"font-size:14.0pt;\">Hypotension with cold, clammy extremities&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hypotension, bronchospasm, and urticaria</span></li></ol>",
      "unique_key": "Q1358093",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-D, 2-C, 3-B, 4-A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>(1-D) Anaphylactic shock:</strong> Presents with vasodilation, bronchospasm, and urticaria due to IgE-mediated hypersensitivity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>(2-C) Hemorrhagic shock:</strong> Typically results from acute blood loss with signs of hypovolemia like cold, clammy skin and hypotension.</span></li><li><span style=\"font-size:14.0pt;\"><strong>(3-B) Cardiogenic shock:</strong> Results from pump failure (e.g., MI), leading to pulmonary edema, raised JVP, and hypotension.</span></li><li><span style=\"font-size:14.0pt;\"><strong>(4-A) Neurogenic shock:</strong> Often seen after spinal cord injury with autonomic disruption causing bradycardia and hypotension, unlike other forms of shock.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WFESvDc.png\" width=\"1029\" height=\"363\"></p>",
      "correct_choice_id": 314151,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78845/Surgery_Q_14_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78845/Surgery_Q_14_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78835,
      "choices": [
        {
          "id": 314113,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic dissection</span></p>"
        },
        {
          "id": 314114,
          "text": "<p><span style=\"font-size:14.0pt;\">Atherosclerotic aneurysm of the abdominal aorta</span></p>"
        },
        {
          "id": 314115,
          "text": "<p><span style=\"font-size:14.0pt;\">Psoas abscess after Pott’s spine</span></p>"
        },
        {
          "id": 314116,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute mesenteric ischemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old male with a history of hypertension and smoking presents with a pulsatile abdominal mass and complaints of vague lower back pain. The patient undergoes the procedure shown in the image. What is the most likely underlying pathology being treated?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_SC2SyFO.png\" width=\"240\" height=\"416\"></strong></span></p>",
      "unique_key": "Q5497813",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Atherosclerotic aneurysm of the abdominal aorta</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows an <strong>Endovascular Aneurysm Repair (EVAR)</strong>, a minimally invasive procedure used for treating <strong>abdominal aortic aneurysm (AAA)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition occurs due to <strong>degenerative changes and weakening of the aortic wall</strong>, primarily caused by <strong>atherosclerosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Risk factors include <strong>hypertension, smoking, male gender, and advanced age</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>classic presentation</strong> includes a <strong>pulsatile abdominal mass</strong> and possible lower back or flank pain.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If left untreated, it can <strong>rupture</strong>, leading to catastrophic hemorrhage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aortic dissection:&nbsp;</strong>Aortic dissection results from a <strong>tear in the intimal layer</strong>, leading to the formation of a false lumen. It usually occurs in the thoracic aorta.&nbsp;It is commonly managed using <strong>open surgery</strong> or <strong>stenting in selected cases</strong>, but <strong>EVAR is not the standard treatment</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Psoas abscess after Pott’s spine:&nbsp;</strong>Psoas abscess is treated by drainage and anti-TB therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute mesenteric ischemia:&nbsp;</strong>This is a <strong>vascular emergency</strong> caused by occlusion or reduced blood flow to the intestines, commonly involving the <strong>superior mesenteric artery (SMA)</strong>. It is managed with <strong>embolectomy, revascularization, or bowel resection</strong>, but not <strong>EVAR</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">EVAR (Endovascular Aneurysm Repair) is a <strong>minimally invasive procedure</strong> used to treat <strong>abdominal aortic aneurysm (AAA)</strong>, which is most commonly caused by <strong>atherosclerosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">AAA typically presents as a <strong>pulsatile abdominal mass</strong> and can be asymptomatic until rupture occurs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Screening is recommended for high-risk individuals, and timely intervention prevents life-threatening complications.</span></li></ul>",
      "correct_choice_id": 314114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78835/Surgery_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78835/Surgery_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78905,
      "choices": [
        {
          "id": 314385,
          "text": "<p><span style=\"font-size:14.0pt;\">Secondary</span></p>"
        },
        {
          "id": 314386,
          "text": "<p><span style=\"font-size:14.0pt;\">Primary</span></p>"
        },
        {
          "id": 314387,
          "text": "<p><span style=\"font-size:14.0pt;\">Tertiary</span></p>"
        },
        {
          "id": 314388,
          "text": "<p><span style=\"font-size:14.0pt;\">Quaternary</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Autopsy of a bombing victim reveals:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Intestinal perforation</span></li><li><span style=\"font-size:14.0pt;\">Skull base fracture with underlying brain contusions</span></li><li><span style=\"font-size:14.0pt;\">Absence of external lacerations</span></li><li><span style=\"font-size:14.0pt;\">Carboxyhemoglobin level of 38%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the least likely blast injury type present?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9927478",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Secondary</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The correct answer is <strong>Secondary</strong>, because <strong>no evidence of external lacerations</strong> was found during autopsy, which are typically <strong>hallmark features of secondary blast injuries</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Secondary blast injuries</strong> are caused by <strong>projectiles or fragments</strong> propelled by the explosion, and they typically cause <strong>penetrating injuries or lacerations</strong> to the body. They lead to abrasions, contusions and lacerations. However, in this case, the <strong>absence of external lacerations</strong> makes it <strong>least likely</strong> that secondary blast injuries are present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Primary: Primary blast injuries</strong> are due to the shock waves. <strong>Direct effect of blast overpressure waves</strong>, and commonly affect hollow internal organs/<strong>air-filled organs</strong> like lungs, intestines, and ears. The <strong>intestinal perforation</strong> seen here is <strong>classic</strong> for primary blast injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tertiary:</strong> <strong>Tertiary blast injuries</strong> result from the <strong>body being thrown by the high velocity blast wind</strong> and hitting a hard surface, leading to <strong>blunt trauma</strong>. The <strong>skull base fracture and brain contusions</strong> fit well within this category.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Quaternary:</strong> <strong>Quaternary injuries</strong> include any other injury like <strong>burns, inhalational injuries, and toxic effects</strong> from the explosion environment. The <strong>carboxyhemoglobin level of 38%</strong> is a strong indicator of <strong>carbon monoxide poisoning</strong>, hence clearly a <strong>quaternary injury</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Absence of external lacerations makes secondary blast injury the least likely; these injuries typically result from penetrating fragments or shrapnel.</span></p>",
      "correct_choice_id": 314385,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78905/Fmt_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78905/Fmt_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78863,
      "choices": [
        {
          "id": 314221,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 314222,
          "text": "<p><span style=\"font-size:14.0pt;\">Pindolol</span></p>"
        },
        {
          "id": 314223,
          "text": "<p><span style=\"font-size:14.0pt;\">Nebivolol</span></p>"
        },
        {
          "id": 314224,
          "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman is recovering from a recently treated ST-elevation myocardial infarction (STEMI). She received appropriate acute therapy and is now discharged on dual antiplatelet therapy, atorvastatin, and a beta-blocker. Which of the following beta-blockers should be avoided in this patient due to its partial agonist activity?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5626989",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Pindolol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Beta-blockers</strong> are standard post-MI therapy because they:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Reduce myocardial oxygen demand</strong></span></li><li><span style=\"font-size:14.0pt;\">Lower risk of <strong>arrhythmias</strong></span></li><li><span style=\"font-size:14.0pt;\">Improve <strong>survival</strong> after myocardial infarction</span></li></ul></li><li><span style=\"font-size:14.0pt;\">However, not all beta-blockers are appropriate in this context. <strong>Pindolol</strong> has <strong>intrinsic sympathomimetic activity (ISA)</strong> — meaning it has <strong>partial agonist</strong> effects at β-adrenergic receptors, especially <strong>β1-receptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Because of this partial agonist activity:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Pindolol <strong>does not fully suppress heart rate and contractility</strong>, which are essential goals post-MI</span></li><li><span style=\"font-size:14.0pt;\">It <strong>may reduce the protective effects</strong> of beta-blockade in myocardial infarction recovery</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>pindolol is contraindicated or should be avoided in patients with ischemic heart disease or post-MI</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Propranolol:&nbsp; </strong>A <strong>non-selective beta-blocker</strong> with <strong>no intrinsic sympathomimetic activity</strong>. Although not cardioselective, it is used in some cardiovascular conditions and <strong>is acceptable post-MI</strong> if needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Nebivolol:</strong> A <strong>cardioselective β1-blocker</strong> with <strong>vasodilatory properties</strong> due to nitric oxide release. It has <strong>no partial agonist activity</strong> and may be appropriate in patients with cardiovascular disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metoprolol:&nbsp;</strong>A <strong>β1-selective blocker</strong> (cardioselective) with <strong>no ISA</strong>. It is one of the <strong>most commonly used beta-blockers post-MI</strong>, supported by strong clinical evidence for improving survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Beta-blockers with intrinsic sympathomimetic activity, such as pindolol, celiprolol, alprenolol, acebutolol should be avoided in patients recovering from myocardial infarction due to their partial agonist effect, which may blunt the cardioprotective benefits of beta-blockade.</span></li></ul>",
      "correct_choice_id": 314222,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78863/Pharmacology_Q_10_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78863/Pharmacology_Q_10_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78851,
      "choices": [
        {
          "id": 314173,
          "text": "<p><span style=\"font-size:14.0pt;\">Aβ2</span></p>"
        },
        {
          "id": 314174,
          "text": "<p><span style=\"font-size:14.0pt;\">ACal</span></p>"
        },
        {
          "id": 314175,
          "text": "<p><span style=\"font-size:14.0pt;\">AA</span></p>"
        },
        {
          "id": 314176,
          "text": "<p><span style=\"font-size:14.0pt;\">Aβ</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old woman presents with a slowly enlarging, painless thyroid nodule. She denies any symptoms of thyrotoxicosis or hypothyroidism. Fine-needle aspiration reveals cells with neuroendocrine features, and the biopsy specimen shows amyloid deposition in the stroma, as highlighted in the image below. Which of the following is the most likely type of amyloid protein associated with this condition?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ooLUY6n.png\" width=\"438\" height=\"296\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q9699037",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) ACal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient presents with a <strong>thyroid mass</strong> that on histology shows <strong>amyloid deposition</strong>—a key finding in <strong>medullary thyroid carcinoma (MTC)</strong>. MTC arises from <strong>parafollicular C-cells</strong>, which secrete <strong>calcitonin</strong>. This calcitonin is abnormally folded and deposited as <strong>amyloid</strong> in the tumor stroma.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The amyloid found in MTC is derived from <strong>calcitonin</strong>, and the amyloid protein subtype is known as <strong>ACal (amyloid derived from calcitonin)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This explains the presence of <strong>amyloid</strong> on biopsy in this setting.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, based on the diagnosis of <strong>medullary thyroid carcinoma</strong>, <strong>amyloid derived from calcitonin (ACal)</strong> is the most appropriate answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Medullary thyroid carcinoma is associated with development of <strong>Multiple Endocrine Neoplasia Type 2A and Type 2B (MEN2A and MEN2B) Syndrome</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aβ2:&nbsp;</strong>Aβ2 is associated with <strong>hemodialysis-related amyloidosis</strong>, derived from <strong>β2-microglobulin</strong>, and does not relate to thyroid tumors or medullary carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. AA:&nbsp;</strong>AA amyloid is derived from <strong>serum amyloid A</strong>, seen in <strong>chronic inflammatory conditions</strong> (e.g., TB, RA). It is not related to <strong>neuroendocrine tumors</strong> or the <strong>thyroid</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Aβ:&nbsp;</strong>Aβ (amyloid-beta) is found in the <strong>central nervous system</strong>, especially in <strong>Alzheimer disease</strong> plaques. It is unrelated to medullary thyroid carcinoma or calcitonin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In medullary thyroid carcinoma, amyloid deposits are composed of ACal, which is derived from calcitonin secreted by neoplastic C cells.</span></p>",
      "correct_choice_id": 314174,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78851/Pathology_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78851/Pathology_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79068,
      "choices": [
        {
          "id": 315033,
          "text": "<p><span style=\"font-size:14.0pt;\">Strongyloides infection; 2-layered cyst</span></p>"
        },
        {
          "id": 315034,
          "text": "<p><span style=\"font-size:14.0pt;\">Paragonimus infection; 3-layered cyst</span></p>"
        },
        {
          "id": 315035,
          "text": "<p><span style=\"font-size:14.0pt;\">Echinococcal cyst; 3-layered cyst</span></p>"
        },
        {
          "id": 315036,
          "text": "<p><span style=\"font-size:14.0pt;\">Cysticercosis; 2-layered cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman presents with progressive shortness of breath over the past 4 months. Imaging reveals a cavitatory lesion in the right lower lobe of the lung. She undergoes a lobectomy, and the histopathological section from the lesion is shown. Based on this, what is the most likely diagnosis and characteristic cyst wall structure?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0TKaoO1.png\" width=\"301\" height=\"233\"></strong></span></p>",
      "unique_key": "Q1433171",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Echinococcal cyst; 3-layered cyst</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The classic histological appearance shown is of a <strong>hydatid cyst</strong> caused by Echinococcus granulosus and shows:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Three layers</strong>:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Inner germinal layer</strong> (produces scolices and daughter cysts)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Middle laminated membrane</strong> (acellular, refractile)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Outer fibrous host-derived capsule</strong> (pericyst)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These features match the image and the description provided in the vignette (progressive dyspnea, cavitary lesion, histopathology).</span></li><li><span style=\"font-size:14.0pt;\">Lung involvement is a common extrapulmonary site for hydatid cysts.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>laminated membrane</strong> gives a distinctive appearance with multiple daughter cysts.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Strongyloides infection; 2-layered cyst:</strong> Strongyloides stercoralis is a nematode that primarily causes <strong>intestinal and pulmonary symptoms</strong> but does <strong>not form multilayered cysts</strong> in the lungs. No laminated or germinal layers are seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Paragonimus infection; 3-layered cyst:</strong> Paragonimus westermani (lung fluke) may form cavitary lesions but produces <strong>non-laminated cysts</strong>, usually with <strong>inflammatory granulomas</strong>, not the organized <strong>3-layered hydatid cyst</strong> seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cysticercosis; 2-layered cyst:</strong> Taenia solium larval form can infect many tissues, including brain and muscle. Cysticercus lesions have a <strong>thin wall with only 2 layers</strong> and a central scolex, not the trilaminar structure seen in Echinococcus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Echinococcus granulosus causes hydatid cysts characterized histologically by three layers: an inner germinal layer, a laminated membrane, and an outer fibrous capsule.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This appearance is pathognomonic and helps differentiate it from other parasitic infections.</span></li></ul>",
      "correct_choice_id": 315035,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79068/Microbiology_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79068/Microbiology_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78833,
      "choices": [
        {
          "id": 314105,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatic artery</span></p>"
        },
        {
          "id": 314106,
          "text": "<p><span style=\"font-size:14.0pt;\">Portal Vein&nbsp;</span></p>"
        },
        {
          "id": 314107,
          "text": "<p><span style=\"font-size:14.0pt;\">Bile duct&nbsp;</span></p>"
        },
        {
          "id": 314108,
          "text": "<p><span style=\"font-size:14.0pt;\">IVC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old patient with Child C Cirrhosis and Hepatitis C is undergoing a liver transplant. Which anatomical structure should the surgeon prepare to anastomose first in the recipient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4459651",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) IVC</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The IVC, both supra-hepatic and infra-hepatic, is usually the first part to be anastomosed during liver transplantation to establish venous outflow from the liver, which is critical to providing immediate blood drainage from the graft.</span></li><li><span style=\"font-size:14.0pt;\"><strong>The order of anastomosis is:</strong> IVC &gt; Portal Vein &gt; Hepatic Artery &gt; Bile Duct&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><br><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Hepatic artery:</strong>&nbsp;</span></p><p><br><br><span style=\"font-size:14.0pt;\">Anastomosis of the hepatic artery is performed later during the transplant.</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Although it is critical for oxygenated blood supply to the graft, establishing venous drainage (IVC) takes priority.</span></li><li><span style=\"font-size:14.0pt;\">Arterial anastomosis typically follows portal vein anastomosis.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Portal Vein:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The portal vein is anastomosed after the IVC.</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Portal vein anastomosis establishes portal venous inflow to the graft.</span></li><li><span style=\"font-size:14.0pt;\">Although important for liver function (providing nutrients and partial oxygenation), it is not the first connection made.</span></li></ul><p><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bile duct:</strong></span></p><p><br><br><span style=\"font-size:14.0pt;\">Bile duct anastomosis is done last.</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">It restores the biliary drainage system after vascular anastomoses are completed.</span></li><li><span style=\"font-size:14.0pt;\">A choledochocholedochostomy (duct-to-duct) or Roux-en-Y hepaticojejunostomy is performed depending on circumstances.</span></li></ul><p><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The first structure to be anastomosed in the recipient of a liver transplant is the IVC, specifically starting with the supra-hepatic IVC, followed by the infra-hepatic IVC, to establish adequate venous outflow from the liver.</span></li><li><span style=\"font-size:14.0pt;\">The order of anastomosis in the recipient of a liver transplant is:&nbsp;</span></li></ul><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Supra-hepatic IVC</span></li><li><span style=\"font-size:14.0pt;\">Infra-hepatic IVC&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Portal Vein</span></li><li><span style=\"font-size:14.0pt;\">Hepatic Artery&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Bile duct</span></li></ol>",
      "correct_choice_id": 314108,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78833/Surgery_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78833/Surgery_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79046,
      "choices": [
        {
          "id": 314945,
          "text": "<p><span style=\"font-size:14.0pt;\">Brown-Séquard syndrome</span></p>"
        },
        {
          "id": 314946,
          "text": "<p><span style=\"font-size:14.0pt;\">Conus medullaris syndrome</span></p>"
        },
        {
          "id": 314947,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior spinal cord syndrome</span></p>"
        },
        {
          "id": 314948,
          "text": "<p><span style=\"font-size:14.0pt;\">Central cord syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 80-year-old man from Pune with a history of cervical spondylosis is brought to the emergency department after falling backwards in his bathroom. Since the fall, he reports clumsiness in his hands and difficulty feeding himself and buttoning his shirt. On examination, there is marked weakness of grip and reduced strength in shoulder abduction and elbow flexion. Lower limb strength is relatively preserved, and no sensory level is identified. Deep tendon reflexes are brisk in all four limbs, and there is no bladder involvement at this time. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q2176390",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Central cord syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with <strong>disproportionate weakness in the upper limbs</strong>, particularly in the <strong>distal fine motor functions</strong> like buttoning a shirt, with <strong>relative sparing of lower limbs</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The clinical context of <strong>cervical hyperextension trauma in an elderly individual with cervical spondylosis</strong> is classic for <strong>central cord syndrome (CCS)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Pathophysiologically, CCS involves damage to the central fibers of the corticospinal tract, which <strong>control upper limb function more medially</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Lower limb fibers (located laterally in the cord) remain relatively preserved.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bladder dysfunction</strong> may occur but often develops later.</span></li><li><span style=\"font-size:14.0pt;\">Other spinal syndromes typically show different patterns of motor, sensory, or sphincter involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Spinal Cord Syndromes:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qbfEKpG.png\" width=\"1480\" height=\"553\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Brown-Séquard syndrome</strong>: Produces asymmetrical findings with a <strong>distinct sensory split</strong>; not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Conus medullaris syndrome</strong>: Affects <strong>lower limbs symmetrically</strong> with early sphincter dysfunction — not present in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anterior spinal cord syndrome</strong>: Causes <strong>complete bilateral motor and pain/temp loss</strong> with sparing of posterior column — no such findings here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Central cord syndrome typically presents in elderly patients after cervical hyperextension injury, leading to disproportionately greater upper limb weakness due to central corticospinal tract involvement. Lower limbs are relatively spared, and MRI often reveals cervical cord edema.</span></p>",
      "correct_choice_id": 314948,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79046/Dr._Dilip_Mock_Test_2_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79046/Dr._Dilip_Mock_Test_2_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78874,
      "choices": [
        {
          "id": 314265,
          "text": "<p><span style=\"font-size:14.0pt;\">Enoxaparin</span></p>"
        },
        {
          "id": 314266,
          "text": "<p><span style=\"font-size:14.0pt;\">Lepirudin</span></p>"
        },
        {
          "id": 314267,
          "text": "<p><span style=\"font-size:14.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 314268,
          "text": "<p><span style=\"font-size:14.0pt;\">Clopidogrel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 59-year-old man hospitalized for sepsis develops sudden thrombocytopenia after several days of unfractionated heparin therapy. His platelet count drops by more than 50%, and he is diagnosed with heparin-induced thrombocytopenia (HIT). The treating team discontinues heparin and initiates an alternative anticoagulant that directly inhibits thrombin without requiring antithrombin III and is not neutralized by platelet factor. Which of the following is the most appropriate anticoagulant in this setting?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7122102",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Lepirudin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Lepirudin</strong> is a <strong>recombinant direct thrombin inhibitor</strong> derived from <strong>hirudin</strong>, originally found in leech saliva. It directly inhibits <strong>both free and clot-bound thrombin</strong>, making it particularly useful in <strong>heparin-induced thrombocytopenia (HIT)</strong> because:</span><ul><li><span style=\"font-size:14.0pt;\">It <strong>does not require antithrombin III</strong> for activity</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>not affected by platelet factor 4</strong>, which is central to the pathophysiology of HIT</span></li><li><span style=\"font-size:14.0pt;\">It provides <strong>predictable anticoagulation</strong> and is <strong>monitored using aPTT</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Enoxaparin:&nbsp;</strong>A low molecular weight heparin (LMWH), which still <strong>cross-reacts with heparin antibodies</strong> in HIT. Not safe in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Warfarin:&nbsp;</strong>Should <strong>not be started in acute HIT</strong> as it can worsen thrombosis risk and cause <strong>warfarin-induced skin necrosis</strong> when protein C levels drop rapidly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Clopidogrel:&nbsp;</strong>An <strong>antiplatelet</strong> agent (ADP receptor blocker), not an anticoagulant. It plays no role in treating HIT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lepirudin is a direct thrombin inhibitor used as an alternative anticoagulant in heparin-induced thrombocytopenia. It acts independently of antithrombin III and is not affected by platelet factor 4.</span></li><li><span style=\"font-size:14.0pt;\">Direct thrombin inhibitor like Lepirudin, Argatroban are injectable and Dabigatran is oral.&nbsp;</span></li></ul>",
      "correct_choice_id": 314266,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78874/Pharmacology_Q_18_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78874/Pharmacology_Q_18_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78926,
      "choices": [
        {
          "id": 314469,
          "text": "<p><span style=\"font-size:14.0pt;\">Idiopathic pulmonary fibrosis</span></p>"
        },
        {
          "id": 314470,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe asthma</span></p>"
        },
        {
          "id": 314471,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory muscle weakness</span></p>"
        },
        {
          "id": 314472,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic obstructive pulmonary disease (COPD)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old male presents with progressive shortness of breath and fatigue for the past 6 months. He denies cough, wheezing, or orthopnea. On examination, breath sounds are diminished bilaterally, and there is paradoxical abdominal movement during inspiration. Pulmonary function tests reveal:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">FEV1: Decreased</span></li><li><span style=\"font-size:14.0pt;\">FEV1/FVC: Normal</span></li><li><span style=\"font-size:14.0pt;\">TLC: Decreased</span></li><li><span style=\"font-size:14.0pt;\">DLCO: Normal</span></li><li><span style=\"font-size:14.0pt;\">Maximal Inspiratory Pressure (Pimax): Markedly Decreased</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the most likely diagnosis based on this pulmonary function profile?&nbsp;</span></p>",
      "unique_key": "Q1518376",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Respiratory muscle weakness</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The key to solving this tough question lies in identifying the <strong>pattern of restriction with preserved DLCO</strong> and <strong>significantly reduced inspiratory strength (Pimax)</strong>:</span><br><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>FEV1 ↓</strong>, <strong>TLC ↓</strong> = restrictive pattern</span></li><li><span style=\"font-size:14.0pt;\"><strong>FEV1/FVC normal</strong> = rules out obstructive disease</span></li><li><span style=\"font-size:14.0pt;\"><strong>DLCO normal</strong> = suggests the alveolar-capillary membrane is intact</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pimax ↓↓</strong> = indicates reduced respiratory muscle strength</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These findings strongly point toward <strong>respiratory muscle weakness</strong> (e.g., due to neuromuscular disorders like ALS, myasthenia gravis, or Guillain-Barré syndrome).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Idiopathic pulmonary fibrosis (ILD):</strong> Would present with ↓FEV1, ↓TLC, and ↓DLCO, but <strong>Pimax is typically normal</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Severe asthma:</strong> Would show an <strong>obstructive</strong> pattern (↓FEV1, ↓FEV1/FVC, ↑TLC, ↑DLCO), which is not consistent with this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. COPD:</strong> Characterized by ↓FEV1, ↓FEV1/FVC, ↑TLC (due to air trapping), and ↓DLCO. <strong>Pimax may be slightly reduced</strong> but not as severely as in neuromuscular conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">A restrictive PFT pattern with normal DLCO and significantly decreased inspiratory pressure (Pimax) is highly suggestive of <strong>respiratory muscle weakness</strong>, distinguishing it from interstitial lung diseases or chest wall abnormalities.</span></p>",
      "correct_choice_id": 314471,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78926/Physiology_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78926/Physiology_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78884,
      "choices": [
        {
          "id": 314301,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 1 is incorrect</span></p>"
        },
        {
          "id": 314302,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 2 is incorrect</span></p>"
        },
        {
          "id": 314303,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 3 is incorrect</span></p>"
        },
        {
          "id": 314304,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statement 4 is incorrect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about pleomorphic adenoma is incorrect?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The tumor commonly shows the presence of myoepithelial cells, contributing to its biphasic nature.</span></li><li><span style=\"font-size:14.0pt;\">Areas of chondroid (cartilage-like) differentiation are frequently observed on microscopy.</span></li><li><span style=\"font-size:14.0pt;\">Keratin pearls are a classic histological hallmark of pleomorphic adenoma.</span></li><li><span style=\"font-size:14.0pt;\">Although benign, pleomorphic adenomas can sometimes show perineural invasion or recur if incompletely excised.</span></li></ol>",
      "unique_key": "Q2483402",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Only statement 3 is incorrect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3 - Keratin pearls</strong> are <strong>not a feature</strong> of <strong>pleomorphic adenoma</strong>. They are characteristic of <strong>squamous cell carcinoma</strong>, where concentric layers of keratin are produced by malignant squamous cells. This feature is <strong>not seen</strong> in pleomorphic adenoma, which is a <strong>benign mixed tumor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1 - Myoepithelial cells</strong>: True. Pleomorphic adenoma is called a <strong>mixed tumor</strong> because it contains both <strong>epithelial and myoepithelial components</strong>, contributing to its histologic diversity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2 - Chondroid differentiation</strong>: True. The tumor often displays <strong>mesenchymal-like stroma</strong>, including <strong>chondroid (cartilage-like)</strong>, <strong>myxoid</strong>, or <strong>osseous</strong> elements. This is a classic and diagnostic feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4 - Perineural invasion</strong>: True. Though rare and typically associated with <strong>malignant tumors</strong>, <strong>benign pleomorphic adenomas</strong> can show <strong>perineural involvement</strong>, especially when large or recurrent. This can complicate surgical resection and contribute to <strong>recurrence</strong> if margins are inadequate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pleomorphic adenoma is a benign salivary gland tumor characterized by both epithelial and myoepithelial cells, often displaying chondroid or myxoid stroma. It does not show keratin pearls, which are specific to squamous cell carcinoma.</span></p>",
      "correct_choice_id": 314303,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78884/Pathology_Q_13_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78884/Pathology_Q_13_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78852,
      "choices": [
        {
          "id": 314177,
          "text": "<p><span style=\"font-size:14.0pt;\">Cryptococcus neoformans meningitis</span></p>"
        },
        {
          "id": 314178,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium avium complex (MAC)</span></p>"
        },
        {
          "id": 314179,
          "text": "<p><span style=\"font-size:14.0pt;\">Pneumocystis jirovecii pneumonia (PJP)</span></p>"
        },
        {
          "id": 314180,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasma gondii encephalitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old HIV-positive man with a CD4 count of 170 cells/mm³ presents for routine follow-up. He is asymptomatic and currently not on any prophylactic medications. The physician initiates therapy with a combination drug that inhibits sequential steps in folate metabolism. Which of the following infections is this medication most likely prescribed to prevent?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4629220",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pneumocystis jirovecii pneumonia (PJP)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cotrimoxazole (Trimethoprim–Sulfamethoxazole)</strong> is the <strong>first-line prophylactic and treatment agent</strong> for <strong>Pneumocystis jirovecii pneumonia (PJP)</strong>, particularly in immunocompromised patients such as those with <strong>HIV/AIDS</strong>.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The drug combines <strong>two agents</strong> that <strong>block folate synthesis at different steps</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\"><strong>Sulfamethoxazole</strong> inhibits <strong>dihydropteroate synthase</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Trimethoprim</strong> inhibits <strong>dihydrofolate reductase</strong></span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\">Prophylaxis is indicated in HIV-positive patients with a <strong>CD4 count &lt;200 cells/mm³</strong>, or in others who are immunosuppressed (e.g., transplant patients, chemotherapy).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cotrimoxazole is drug of choice for:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Pneumocystis jirovecii pneumonia</span></li><li><span style=\"font-size:14.0pt;\">Nocardia</span></li><li><span style=\"font-size:14.0pt;\">Burkholderia cepacia</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cryptococcus neoformans meningitis:&nbsp;</strong>Prophylaxis usually involves <strong>fluconazole</strong>. Cotrimoxazole is not used for this fungal infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mycobacterium avium complex (MAC):&nbsp;</strong>Prevented with <strong>azithromycin or clarithromycin</strong> in patients with CD4 &lt;50 cells/mm³. Cotrimoxazole is ineffective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Toxoplasma gondii encephalitis:&nbsp;</strong>Prophylaxis is typically needed at CD4 &lt;100 and is done with <strong>cotrimoxazole</strong>, <strong>but only if IgG seropositive</strong>. However, <strong>PJP prophylaxis is the first indication</strong> once CD4 &lt;200.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cotrimoxazole (Trimethoprim–Sulfamethoxazole) is the drug of choice for prophylaxis and treatment of Pneumocystis jirovecii pneumonia in HIV patients with CD4 &lt;200 cells/mm³. It inhibits folate synthesis at two distinct steps.</span></li></ul>",
      "correct_choice_id": 314179,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78852/Pharmacology_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78852/Pharmacology_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78817,
      "choices": [
        {
          "id": 314041,
          "text": "<p><span style=\"font-size:14.0pt;\">D-A-C-B&nbsp;</span></p>"
        },
        {
          "id": 314042,
          "text": "<p><span style=\"font-size:14.0pt;\">D-C-A-B</span></p>"
        },
        {
          "id": 314043,
          "text": "<p><span style=\"font-size:14.0pt;\">A-C-D-B&nbsp;</span></p>"
        },
        {
          "id": 314044,
          "text": "<p><span style=\"font-size:14.0pt;\">A-D-C-B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">You are evaluating the developmental progress of an infant during a routine well-child visit. You are shown a set of images that represent different developmental milestones achieved at different ages. Arrange the milestones in the correct order based on their typical age of appearance, starting from the earliest to the latest.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5a4ivS0.png\" width=\"451\" height=\"451\"></strong></span></p>",
      "unique_key": "Q4187203",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) D-A-C-B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Image D: Rounded back on sitting (3 months):</strong> This is an early gross motor milestone; infants at this age cannot sit erect and show a rounded back when supported in a sitting position.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Image A: Mouthing (5 months):</strong> Mouthing is a part of early exploration through oral means, typically occurring around 5 months.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Image C: Pivoting (9 months):</strong> Pivoting is part of gross motor development that typically appears around 9-10 months as the infant starts to move on the floor.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Image B: Scribbling (15 months):</strong> Scribbling is a fine motor milestone, developing around 15 months when a child begins to explore drawing/writing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Developmental milestones follow a sequential and predictable pattern. Recognizing the typical age of acquisition of motor and fine motor skills is essential for early identification of developmental delay.</span></p>",
      "correct_choice_id": 314041,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78817/Pediatrics_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78817/Pediatrics_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78915,
      "choices": [
        {
          "id": 314425,
          "text": "<p><span style=\"font-size:14.0pt;\">L3</span></p>"
        },
        {
          "id": 314426,
          "text": "<p><span style=\"font-size:14.0pt;\">L4</span></p>"
        },
        {
          "id": 314427,
          "text": "<p><span style=\"font-size:14.0pt;\">L5</span></p>"
        },
        {
          "id": 314428,
          "text": "<p><span style=\"font-size:14.0pt;\">S1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with lower back pain radiating down the left leg, worse on coughing. On exam, he has a positive straight leg raise at 30°, and weakness of dorsiflexion of the big toe. Which nerve root is most likely affected?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8489761",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) L5</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Motor involvement:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Big toe dorsiflexion (extensor hallucis longus) → L5</span></li><li><span style=\"font-size:14.0pt;\">Also supplies foot dorsiflexors and invertors (tibialis anterior partially), gluteus medius (hip abduction)</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Sensory loss:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Lateral leg and dorsum of the foot, especially 1st web space</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Reflexes:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Usually, no deep tendon reflex is associated directly with L5, but there may be a subtle decrease in medial hamstring reflex.</span></li><li><span style=\"font-size:14.0pt;\">Big toe dorsiflexion = hallmark motor function of L5 root</span></li></ul></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. L3 nerve root:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Motor involvement:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Quadriceps (knee extension)</span></li><li><span style=\"font-size:14.0pt;\">Hip flexors (iliopsoas) — L2-L3</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Sensory:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Anterior thigh</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Reflex affected:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Patellar reflex (L3-L4)</span></li><li><span style=\"font-size:14.0pt;\">L3 lesion causes anterior thigh symptoms, not sciatic distribution or dorsiflexion weakness.</span></li></ul></li></ul><p style=\"margin-left:72.0pt;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. L4 nerve root:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Motor involvement:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Quadriceps (knee extension)</span></li><li><span style=\"font-size:14.0pt;\">Ankle dorsiflexion (tibialis anterior)</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Sensory:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Medial leg and medial foot</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Reflex affected:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Patellar reflex</span></li><li><span style=\"font-size:14.0pt;\">L4 may cause mild dorsiflexion issues but not isolated big toe dorsiflexion weakness. Pain distribution is also more anterior/medial, not down the lateral leg.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. S1 nerve root:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Motor involvement:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Plantarflexion (gastrocnemius, soleus)</span></li><li><span style=\"font-size:14.0pt;\">Gluteus maximus (hip extension)</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Sensory:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Lateral foot and sole</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Reflex affected:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Achilles reflex</span></li><li><span style=\"font-size:14.0pt;\">S1 would cause difficulty standing on tiptoes, not lifting the big toe.</span></li></ul></li></ul><p><br><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_snCArXC.png\" width=\"736\" height=\"392\"></strong></span></p>",
      "correct_choice_id": 314427,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78915/Orthopedics_Q_5Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78915/Orthopedics_Q_5Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78846,
      "choices": [
        {
          "id": 314153,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of sensation over the angle of the mandible on the left side</span></p>"
        },
        {
          "id": 314154,
          "text": "<p><span style=\"font-size:14.0pt;\">Difficulty protruding the tongue</span></p>"
        },
        {
          "id": 314155,
          "text": "<p><span style=\"font-size:14.0pt;\">Inability to close the right eye</span></p>"
        },
        {
          "id": 314156,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of taste from the posterior third of the tongue</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old woman presents with progressive swelling in her right cheek over the past 6 months, accompanied by mild facial asymmetry. She has a history of smoking and reports occasional difficulty moving the right side of her face. On examination, there is a firm, non-tender mass anterior to the ear at the angle of the mandible. Fine needle aspiration confirms a diagnosis of mucoepidermoid carcinoma of the parotid gland. A right-sided total parotidectomy is planned. Following surgery, which of the following is the patient most likely to experience?&nbsp;</span></p>",
      "unique_key": "Q9115596",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inability to close the right eye</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>facial nerve (CN VII)</strong> passes through the <strong>parotid gland</strong> but does <strong>not innervate it</strong>. During a <strong>total parotidectomy</strong>, especially when excising malignant tumors such as <strong>mucoepidermoid carcinoma</strong>, the <strong>facial nerve is at significant risk of injury</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Damage to this nerve, particularly its <strong>temporal and zygomatic branches</strong>, may lead to <strong>inability to close the eye</strong>, loss of <strong>forehead wrinkling</strong>, deviation of angle of mouth, loss of power in lower lip, and <strong>flattening of the nasolabial fold</strong> on the affected side.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Loss of sensation over the angle of the mandible on the left side:&nbsp;</strong>&nbsp;It is mediated by the <strong>great auricular nerve</strong>, not CN VII. While it runs close to the surgical site, it is not the primary concern post-parotidectomy. Injury to the great auricular nerve can lead to Frey’s Syndrome on the ipsilateral side&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Difficulty protruding the tongue:&nbsp;</strong>It<strong>&nbsp;</strong>is seen in <strong>hypoglossal nerve (CN XII)</strong> injury, not facial nerve injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Loss of taste from the posterior third of the tongue</strong>: It is supplied by <strong>CN IX (glossopharyngeal nerve)</strong>. Facial nerve supplies taste from the anterior 2/3.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Injury to the <strong>facial nerve (CN VII)</strong> is the most feared complication of <strong>parotid gland surgery</strong>, leading to <strong>ipsilateral facial muscle weakness</strong>, especially <strong>inability to close the eye</strong> and <strong>wrinkle the forehead</strong>.</span></li></ul>",
      "correct_choice_id": 314155,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78846/Surgery_Q_15_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78846/Surgery_Q_15_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79045,
      "choices": [
        {
          "id": 314941,
          "text": "<p><span style=\"font-size:14.0pt;\">Instruct the patient to skip the next 3 doses of warfarin and discharge home</span></p>"
        },
        {
          "id": 314942,
          "text": "<p><span style=\"font-size:14.0pt;\">Hold warfarin and administer fresh frozen plasma</span></p>"
        },
        {
          "id": 314943,
          "text": "<p><span style=\"font-size:14.0pt;\">Hold warfarin and administer subcutaneous vitamin K</span></p>"
        },
        {
          "id": 314944,
          "text": "<p><span style=\"font-size:14.0pt;\">Hold warfarin and administer oral vitamin K</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 69-year-old woman from Nagpur with atrial fibrillation on chronic warfarin therapy presents for routine anticoagulation monitoring. She reports feeling well, with no history of recent trauma, bleeding gums, hematuria, or melena. She has a known past history of peptic ulcer disease but no active gastrointestinal symptoms currently. She is hemodynamically stable. Her rest of the laboratory results are as follow:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VAh9C5B.png\" width=\"897\" height=\"215\"></span></p>",
      "unique_key": "Q8842616",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hold warfarin and administer oral vitamin K</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients with <strong>INR &gt;10 without active bleeding</strong> are at high risk for spontaneous hemorrhage and require <strong>active reversal</strong> of warfarin effect.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Oral vitamin K (2.5–5 mg)</strong> is the preferred route for safe and effective correction in such asymptomatic cases.</span></li><li><span style=\"font-size:14.0pt;\">Oral administration leads to <strong>predictable absorption</strong>, avoids complications of intravenous (e.g., anaphylaxis), and is faster acting than subcutaneous injection.</span></li><li><span style=\"font-size:14.0pt;\">Fresh frozen plasma (FFP) or prothrombin complex concentrate (PCC) are reserved for <strong>patients with major bleeding</strong> or those requiring urgent invasive procedures.</span></li><li><span style=\"font-size:14.0pt;\">Simply withholding warfarin without administering vitamin K is inadequate when the INR exceeds 10, given the bleeding risk.</span></li><li><span style=\"font-size:14.0pt;\">Subcutaneous vitamin K absorption is <strong>unpredictable and variable</strong>, making it unsuitable for reliable reversal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management Strategy Based on INR and Bleeding Status:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GlksvO5.png\" width=\"1148\" height=\"175\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Instruct the patient to skip the next 3 doses of warfarin and discharge home:</strong> Insufficient for INR &gt;10; requires active reversal with vitamin K.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hold warfarin and administer fresh frozen plasma: </strong>Used only when <strong>active major bleeding</strong> is present or immediate reversal is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hold warfarin and administer subcutaneous vitamin K</strong>: Poor, unpredictable absorption; inferior to oral administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with an INR &gt;10 without active bleeding, warfarin should be withheld and <strong>oral vitamin K administered</strong> to safely and effectively reduce the risk of spontaneous hemorrhage.</span></p>",
      "correct_choice_id": 314944,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79045/Dr._Dilip_Mock_Test_2_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79045/Dr._Dilip_Mock_Test_2_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78898,
      "choices": [
        {
          "id": 314357,
          "text": "<p><span style=\"font-size:14.0pt;\">Hinge joint</span></p>"
        },
        {
          "id": 314358,
          "text": "<p><span style=\"font-size:14.0pt;\">Ball-and-socket joint</span></p>"
        },
        {
          "id": 314359,
          "text": "<p><span style=\"font-size:14.0pt;\">Ellipsoid joint</span></p>"
        },
        {
          "id": 314360,
          "text": "<p><span style=\"font-size:14.0pt;\">Saddle joint</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old patient came to the OPD after a fall on his hand. He is now experiencing pain in the hand region. The X-ray of the patient is given below. Identify the type of joint marked in the X-ray?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JRYaGER.png\" width=\"394\" height=\"576\"></strong></span></p>",
      "unique_key": "Q4559416",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ellipsoid joint</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the provided X-ray, the joint displayed is the <strong>radiocarpal joint</strong> (wrist joint), which is an <strong>ellipsoid joint</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This joint is located between the <strong>radius</strong> and the <strong>proximal carpal bones</strong> (mainly the scaphoid and lunate).</span></li><li><span style=\"font-size:14.0pt;\">Ellipsoid joints are characterized by their oval-shaped articular surfaces, which allow movement in two planes—<strong>flexion/extension</strong> and <strong>abduction/adduction</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This structure is ideal for the wrist, enabling a wide range of motion but limiting rotational movements, which are instead handled by the distal radioulnar joint.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key points from the X-ray:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>radius</strong> can be seen articulating with the <strong>scaphoid</strong> and <strong>lunate</strong> bones of the wrist.</span></li><li><span style=\"font-size:14.0pt;\">This type of joint is classically referred to as an <strong>ellipsoid joint</strong> because of its shape and movement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mnemonic for Carpal Bones</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_G6yxPjQ.png\" width=\"643\" height=\"436\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">To remember the carpal bones seen on the X-ray, you can use the mnemonic: <strong>\"Shyam Lal Tinde Pakao Tumhare Tinde Kacche Hai\"</strong>. These bones, in order, are:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Scaphoid</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Lunate</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Triquetrum</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Pisiform</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Trapezium</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Trapezoid</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Capitate</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hamate</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This mnemonic helps recall the carpal bones in sequence, which are crucial for understanding the anatomy of the wrist joint.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>radiocarpal joint</strong> allows <strong>ellipsoid joint</strong> movements like flexion, extension, abduction, and adduction, but not rotation. Therefore, it fits the criteria of an <strong>ellipsoid joint</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hinge joint:</strong> Hinge joints, like the elbow, permit movement in only one plane (flexion and extension). This type of joint is not seen in the wrist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ball-and-socket joint:</strong> These joints, such as the shoulder and hip, allow movement in multiple planes (flexion, extension, abduction, adduction, and rotation). The wrist joint, however, does not fit this description.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Saddle joint:</strong> The saddle joint is found at the <strong>first carpometacarpal joint</strong> (thumb), where the first metacarpal and trapezium articulate, allowing for a greater range of motion. This joint is not visible in the provided X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>radiocarpal joint</strong> or <strong>wrist joint</strong> is an <strong>ellipsoid joint</strong> that allows movement in two planes—<strong>flexion/extension</strong> and <strong>abduction/adduction</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This joint involves the articulation between the <strong>radius</strong> and the <strong>proximal carpal bones</strong> (scaphoid and lunate).&nbsp;</span></li></ul>",
      "correct_choice_id": 314359,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78898/Anatomy_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78898/Anatomy_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78896,
      "choices": [
        {
          "id": 314349,
          "text": "<p><span style=\"font-size:14.0pt;\">Brain abscess</span></p>"
        },
        {
          "id": 314350,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurocysticercosis</span></p>"
        },
        {
          "id": 314351,
          "text": "<p><span style=\"font-size:14.0pt;\">Glioblastoma multiforme</span></p>"
        },
        {
          "id": 314352,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasmosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man presents with his first generalized tonic-clonic seizure. He recently immigrated from rural Honduras. He has no history of trauma, alcohol use, or chronic medical illness. On examination, he is postictal but arousable. A non-contrast CT scan of the head is shown below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xVtzuXE.png\" width=\"493\" height=\"438\"></span></p>",
      "unique_key": "Q4735301",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Neurocysticercosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The CT image shows a <strong>well-defined cystic lesion</strong> with an <strong>eccentric hyperdense nodule</strong>, known as the <strong>\"dot sign\"</strong> — representing the <strong>scolex</strong> of Taenia solium larva. Surrounding edema is also visible, consistent with the <strong>colloidal-vesicular stage</strong> of <strong>neurocysticercosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Neurocysticercosis is the <strong>most common parasitic infection of the CNS</strong>, especially in individuals from <strong>Latin America, Southeast Asia, and sub-Saharan Africa</strong>. It often presents with <strong>new-onset seizures</strong> in young adults from endemic areas. Imaging is diagnostic, especially when the <strong>scolex is visible</strong>, confirming the presence of the larval cyst.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Brain abscess:&nbsp;</strong>Often larger ring-enhancing but typically lacks a <strong>central scolex</strong>. Patients also present&nbsp;</span></p><p><br><br><span style=\"font-size:14.0pt;\"><strong>Option C. Glioblastoma multiforme:</strong> Usually appears as an <strong>irregular ring-enhancing mass</strong> with necrotic center and significant edema. It is <strong>not cystic with a scolex</strong> and usually presents in older adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Toxoplasmosis:</strong> Seen in <strong>immunocompromised patients</strong>, particularly with HIV/AIDS. Lesions are typically <strong>multiple ring-enhancing</strong> without a scolex and are more commonly located in the <strong>basal ganglia</strong> or <strong>corticomedullary junction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Neurocysticercosis should be suspected in patients from endemic regions presenting with seizures and CT findings of cystic brain lesions with a central scolex (dot sign).</span></p>",
      "correct_choice_id": 314350,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78896/Radiology_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78896/Radiology_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79072,
      "choices": [
        {
          "id": 315049,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and the Reason is the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 315050,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but the Reason is not the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 315051,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but the Reason is false</span></p>"
        },
        {
          "id": 315052,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is false, but the Reason is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> Antigenic drift results in a gradual, sequential change in the antigenic structure of the influenza virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> The new antigens formed by antigenic drift are completely unrelated to the previous viral antigens.<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6481269",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Assertion is true, but the Reason is false</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Antigenic drift</strong> is a <strong>true phenomenon</strong> involving <strong>gradual point mutations</strong> in the genes encoding <strong>hemagglutinin (HA)</strong> and <strong>neuraminidase (NA)</strong> surface proteins of the influenza virus.</span></li><li><span style=\"font-size:14.0pt;\">This leads to <strong>small, sequential antigenic changes</strong>, allowing the virus to partially escape <strong>host immune recognition</strong>, which contributes to <strong>seasonal epidemics</strong> of influenza.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Reason</strong> is <strong>false</strong> because:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The antigens formed via drift are <strong>similar but not identical</strong> to previous strains.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, antibodies to previous strains may <strong>partially neutralize</strong> the new variants, although not completely.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Antigenic drift causes small, gradual changes in viral antigens that contribute to seasonal influenza outbreaks; however, the resulting antigens remain partially related to their predecessors.</span></p>",
      "correct_choice_id": 315051,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79072/Microbiology_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79072/Microbiology_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78804,
      "choices": [
        {
          "id": 313989,
          "text": "<p><span style=\"font-size:14.0pt;\">Shifting from a defined-benefit pension system to a defined-contribution pension system</span></p>"
        },
        {
          "id": 313990,
          "text": "<p><span style=\"font-size:14.0pt;\">Reducing healthcare access for the elderly to lower medical costs</span></p>"
        },
        {
          "id": 313991,
          "text": "<p><span style=\"font-size:14.0pt;\">Implementing tax cuts to encourage higher birth rates</span></p>"
        },
        {
          "id": 313992,
          "text": "<p><span style=\"font-size:14.0pt;\">Increasing investment in AI and automation to replace elderly workers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following interventions would be most effective in mitigating the economic impact of a rising Old Age Dependency Ratio (OADR) in a rapidly aging country?</span></p>",
      "unique_key": "Q6210627",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Shifting from a defined-benefit pension system to a defined-contribution pension system</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A rising Old Age DR (&gt;65 year old) puts strain on government-funded pension systems. Transitioning to a defined-contribution system (where individuals save for their own retirement) reduces the long-term financial burden on the government while still providing retirement security.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> R<strong>educing healthcare access for the elderly to lower medical costs:</strong> Incorrect, reducing healthcare for the elderly is unethical and could increase healthcare costs in the long run.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Implementing tax cuts to encourage higher birth rates:&nbsp;</strong>Incorrect, Higher birth rates provide long-term solutions but do not immediately mitigate rising OADR.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Increasing investment in AI and automation to replace elderly workers:&nbsp;</strong>Incorrect, AI and automation assist productivity but do not directly impact dependency ratios.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Shifting from a defined-benefit to a defined-contribution pension system is an effective strategy to reduce financial strain from a rising Old Age DR.</span></p>",
      "correct_choice_id": 313989,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78804/Psm_Q_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78804/Psm_Q_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79047,
      "choices": [
        {
          "id": 314949,
          "text": "<p><span style=\"font-size:14.0pt;\">High-dose corticosteroids</span></p>"
        },
        {
          "id": 314950,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous immunoglobulin (IVIG)</span></p>"
        },
        {
          "id": 314951,
          "text": "<p><span style=\"font-size:14.0pt;\">Exchange transfusion</span></p>"
        },
        {
          "id": 314952,
          "text": "<p><span style=\"font-size:14.0pt;\">Rituximab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old postpartum woman from Delhi presents to the emergency department with acute-onset confusion and bleeding gums, occurring 7 days after receiving multiple blood transfusions during labor. She is febrile, and her GCS is 12/15. Examination reveals lesions as shown in the image below. Initial labs show hemoglobin 9.8 g/dL and a platelet count of 4,000/μL. CT brain reveals an intracerebral hemorrhage without mass effect. Despite transfusion of 10 units of platelets over the last 24 hours, there has been no improvement in the platelet count. What is the most appropriate next step in management of this condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ijoppnP.png\" width=\"499\" height=\"413\"></span></p>",
      "unique_key": "Q4128496",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Intravenous immunoglobulin (IVIG)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical scenario is highly characteristic of <strong>post-transfusion purpura (PTP)</strong>, an <strong>alloimmune thrombocytopenia</strong> occurring 5–10 days after transfusion, most often in <strong>multiparous women</strong> sensitized to <strong>human platelet antigen (HPA)-1a</strong>.</span></li><li><span style=\"font-size:14.0pt;\">PTP is caused by the formation of <strong>alloantibodies against platelet antigens</strong>, leading to destruction of both transfused and autologous platelets.</span></li><li><span style=\"font-size:14.0pt;\">It presents with <strong>severe thrombocytopenia (&lt;10,000/µL)</strong>, purpura, and often life-threatening bleeding, <strong>typically unresponsive to platelet transfusions</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IVIG</strong> is the treatment of choice and rapidly raises platelet counts by blocking Fc receptors on macrophages, thus reducing immune-mediated clearance.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Corticosteroids and rituximab</strong> may be used in refractory cases, but are not first-line in acute, life-threatening thrombocytopenia.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Exchange transfusion</strong> is not effective and reserved only for extreme or refractory cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnostic Clues for Post-Transfusion Purpura:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rHcdSNw.png\" width=\"1310\" height=\"335\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management Comparison:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jH1PVIL.png\" width=\"1052\" height=\"331\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. High-dose corticosteroids</strong>: May help in chronic immune thrombocytopenia (ITP), but IVIG works faster and is preferred in acute, life-threatening bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Exchange transfusion</strong>: Considered only in rare, refractory PTP with ongoing hemorrhage — not first-line.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rituximab</strong>: Useful for long-term antibody suppression in chronic or refractory cases, not acute management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Post-transfusion purpura presents with severe thrombocytopenia and hemorrhage 5–10 days after transfusion, especially in multiparous women. IVIG is the first-line treatment, as platelet transfusions are typically ineffective due to ongoing alloimmune destruction.</span></p>",
      "correct_choice_id": 314950,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79047/Dr._Dilip_Mock_Test_2_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79047/Dr._Dilip_Mock_Test_2_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79080,
      "choices": [
        {
          "id": 315081,
          "text": "<p><span style=\"font-size:14.0pt;\">Beta Glucocerebrosidase – Von Gierke’s disease</span></p>"
        },
        {
          "id": 315082,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceruloplasmin – Hepatolenticular degeneration</span></p>"
        },
        {
          "id": 315083,
          "text": "<p><span style=\"font-size:14.0pt;\">High LDH1/LDH2 – Myocardial infarction</span></p>"
        },
        {
          "id": 315084,
          "text": "<p><span style=\"font-size:14.0pt;\">Lipase – Pancreatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following enzyme/diagnostic marker pairs is incorrectly matched with its associated disease?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1406301",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Beta Glucocerebrosidase – Von Gierke’s disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Beta-glucocerebrosidase deficiency is seen in <strong>Gaucher's disease</strong>, a lysosomal storage disorder.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Von Gierke’s disease</strong> (Glycogen Storage Disease Type I) is due to <strong>glucose-6-phosphatase deficiency</strong>, not beta-glucocerebrosidase.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ceruloplasmin – Hepatolenticular degeneration:&nbsp;</strong>Correct. Hepatolenticular degeneration is another name for <strong>Wilson's disease</strong>, where <strong>ceruloplasmin levels are decreased</strong> due to defective copper transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. High LDH1/LDH2 – Myocardial infarction:</strong> Correct. An elevated <strong>LDH1/LDH2 ratio</strong> (called a “<strong>flipped ratio</strong>”) is a <strong>classic marker</strong> of <strong>myocardial infarction</strong>, especially in settings where troponin is unavailable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lipase – Pancreatitis:</strong> Correct. <strong>Lipase</strong> is a sensitive and specific enzyme elevated in <strong>acute pancreatitis</strong>, and more reliable than amylase for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Beta-glucocerebrosidase deficiency is seen in Gaucher’s disease, not Von Gierke’s. Von Gierke’s is caused by a deficiency of glucose-6-phosphatase. Recognizing enzyme-disease pairings is key in metabolic and diagnostic pathology.</span></p>",
      "correct_choice_id": 315081,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79080/Biochem_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79080/Biochem_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78901,
      "choices": [
        {
          "id": 314369,
          "text": "<p><span style=\"font-size:14.0pt;\">Nummular</span></p>"
        },
        {
          "id": 314370,
          "text": "<p><span style=\"font-size:14.0pt;\">Target</span></p>"
        },
        {
          "id": 314371,
          "text": "<p><span style=\"font-size:14.0pt;\">Annular</span></p>"
        },
        {
          "id": 314372,
          "text": "<p><span style=\"font-size:14.0pt;\">Discoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male presents with pruritic lesions on his thigh that have progressively enlarged over several weeks. On examination, the lesions are circular with a clear center and an erythematous, raised border. The lesions are as shown in the image. How would you best describe these lesions?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZcLIziZ.png\" width=\"205\" height=\"273\"></span></p>",
      "unique_key": "Q1088095",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Annular&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Annular lesions are characterized by their ring-shaped appearance, with a central area that is often clear and an active erythematous or raised border.</span></li><li><span style=\"font-size:14.0pt;\">This pattern is typical in conditions such as tinea corporis (ringworm), which is consistent with the presentation of this patient.</span></li><li><span style=\"font-size:14.0pt;\">The activity at the edge of the lesion (scaling, inflammation) helps distinguish it from other patterns.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the image clearly shows annular lesions with active edges and central clearing, which is the hallmark of this description.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Annular lesions differ from discoid or nummular lesions because the latter have uniform involvement without central clearing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Nummular:</strong> Nummular (or discoid) lesions are coin-shaped with uniform involvement throughout the lesion. They do not have central clearing and active edges as seen in this case. Nummular eczema or discoid lupus erythematosus often have this presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Target:&nbsp;</strong>Target lesions (as seen in erythema multiforme) are characterized by concentric rings with three zones: a central dusky or necrotic area, an edematous middle ring, and an outer erythematous border. This pattern is distinct and not seen in the provided image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Discoid:&nbsp;</strong>Discoid (a synonym for nummular) describes coin-shaped lesions that lack central clearing or an active border. This term is used interchangeably with nummular but does not describe the annular pattern seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Annular lesions are ring-shaped with active, erythematous borders and central clearing. They are most commonly associated with dermatophyte infections such as tinea corporis. This presentation differs from nummular/discoid lesions, which are uniform without central clearing, and target lesions, which have three distinct concentric zones.</span></p>",
      "correct_choice_id": 314371,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78901/Dermatology_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78901/Dermatology_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78946,
      "choices": [
        {
          "id": 314549,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 3, and 5 are correct</span></p>"
        },
        {
          "id": 314550,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 2, 4, and 5 are correct</span></p>"
        },
        {
          "id": 314551,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 2, 3, 4, and 5 are correct</span></p>"
        },
        {
          "id": 314552,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding genital tuberculosis<strong>&nbsp;</strong>are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Genital tuberculosis typically begins in the fallopian tubes and later spreads to other pelvic organs.</span></li><li><span style=\"font-size:14.0pt;\">Hysterosalpingography in genital TB shows findings such as cornual block and tobacco-pouch appearance.</span></li><li><span style=\"font-size:14.0pt;\">The most common causative agent is Mycobacterium leprae.</span></li><li><span style=\"font-size:14.0pt;\">A doughy abdomen on palpation and menstrual irregularities are common clinical features.</span></li><li><span style=\"font-size:14.0pt;\">A recurrent pelvic inflammatory mass in an unmarried woman is likely to be tubercular in origin.</span></li></ol>",
      "unique_key": "Q2112513",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Statements 1, 2, 4, and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1:</strong> Correct – Genital TB commonly begins in the fallopian tubes and spreads to the endometrium and ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2:</strong> Correct – HSG features include <strong>lead pipe tubes, beading, cornual block, tobacco-pouch appearance</strong>, and calcification.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4:</strong> Correct – <strong>Menstrual irregularities</strong> and a <strong>doughy-feeling abdomen</strong> are classic findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5:</strong> Correct – In an <strong>unmarried woman</strong>, a <strong>chronic recurrent pelvic mass</strong> is strongly suggestive of TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3:</strong> Incorrect – The causative agent is <strong>Mycobacterium tuberculosis</strong>, not M. leprae.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Genital tuberculosis</strong> is a common cause of infertility and chronic pelvic inflammatory disease in developing countries. It classically involves the fallopian tubes and presents with menstrual irregularities, a doughy abdomen, and specific radiological findings like <strong>cornual block</strong> and <strong>tobacco-pouch hydrosalpinx</strong>.</span></p>",
      "correct_choice_id": 314550,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78946/Obg_Q_10_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78946/Obg_Q_10_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78882,
      "choices": [
        {
          "id": 314293,
          "text": "<p><span style=\"font-size:14.0pt;\">Juvenile macular dystrophy</span></p>"
        },
        {
          "id": 314294,
          "text": "<p><span style=\"font-size:14.0pt;\">Best’s Vitelliform Dystrophy</span></p>"
        },
        {
          "id": 314295,
          "text": "<p><span style=\"font-size:14.0pt;\">Retinitis pigmentosa</span></p>"
        },
        {
          "id": 314296,
          "text": "<p><span style=\"font-size:14.0pt;\">Macular cone dystrophy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A child is brought to the ophthalmology clinic with complaints of progressive loss of central vision. Fundus examination is largely normal, and systemic examination is unremarkable. An electro-oculogram (EOG) shows an Arden Index &lt;1.50. What is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q2444010",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Best’s Vitelliform Dystrophy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Best’s Vitelliform Dystrophy</strong> is an <strong>inherited macular dystrophy</strong> typically presenting in childhood with <strong>loss of central vision</strong>. It is <strong>associated with a reduced Arden ratio (&lt;1.50)</strong> on <strong>electro-oculogram (EOG)</strong>, which helps differentiate it from other maculopathies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key diagnostic clues:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Normal early fundus appearance</span></li><li><span style=\"font-size:14.0pt;\">Central vision affected</span></li><li><span style=\"font-size:14.0pt;\"><strong>EOG abnormal (Arden Index &lt;1.50)</strong></span></li><li><span style=\"font-size:14.0pt;\">Family history may be present</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-01%20170512.png\" width=\"1003\" height=\"639\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Juvenile macular dystrophy:&nbsp;</strong>&nbsp;This is a vague, non-specific term and does not refer to a distinct clinical entity. Best’s disease is a more precise diagnosis when EOG shows an Arden ratio &lt;1.50.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Retinitis pigmentosa:&nbsp;</strong>&nbsp;Typically presents with <strong>night blindness and peripheral vision loss</strong>, not isolated central vision loss. Also associated with <strong>bone-spicule pigmentation</strong>, not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Macular cone dystrophy:&nbsp;</strong>&nbsp;Affects central vision and cone function but <strong>EOG is typically normal</strong>, and other findings like <strong>photophobia</strong> and <strong>color vision defects</strong> are usually present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Best’s Vitelliform Dystrophy</strong> is a juvenile-onset macular dystrophy characterized by central vision loss and an abnormal electro-oculogram with an Arden index &lt;1.50. It is an important differential for macular disorders in children.</span></p>",
      "correct_choice_id": 314294,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78882/Ophthalmology_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78882/Ophthalmology_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78916,
      "choices": [
        {
          "id": 314429,
          "text": "<p><span style=\"font-size:14.0pt;\">15 mL/dL</span></p>"
        },
        {
          "id": 314430,
          "text": "<p><span style=\"font-size:14.0pt;\">17 mL/dL</span></p>"
        },
        {
          "id": 314431,
          "text": "<p><span style=\"font-size:14.0pt;\">13 mL/dL</span></p>"
        },
        {
          "id": 314432,
          "text": "<p><span style=\"font-size:14.0pt;\">20 mL/dL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 19-year-old male presents for a routine health check-up. He is asymptomatic and his vitals are within normal limits. His lab reports show a haemoglobin level of 13 g/dL. What is the estimated oxygen-carrying capacity of his blood?&nbsp;</span></p>",
      "unique_key": "Q7163933",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 17 mL/dL</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The oxygen-carrying capacity of blood is directly proportional to the haemoglobin (Hb) concentration. Each gram of haemoglobin binds approximately <strong>1.34 mL of oxygen</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Formula to calculate oxygen-carrying capacity:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Oxygen Carrying Capacity = Hb (g/dL) × 1.34 mL/g</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Substituting the given value:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hb = 13 g/dL</span></li><li><span style=\"font-size:14.0pt;\">Oxygen Carrying Capacity = 13 × 1.34 = 17.42 mL/dL</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the estimated oxygen-carrying capacity of this 19-year-old male is approximately 17 mL/dL</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The oxygen-carrying capacity of blood can be calculated by multiplying haemoglobin concentration (g/dL) by 1.34 mL/g, the approximate amount of oxygen that each gram of haemoglobin can bind. This calculation is crucial for understanding oxygen delivery in clinical settings.</span></p>",
      "correct_choice_id": 314430,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78916/Physiology_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78916/Physiology_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78888,
      "choices": [
        {
          "id": 314317,
          "text": "<p><span style=\"font-size:14.0pt;\">A student who is angry with his teacher starts breaking furniture</span></p>"
        },
        {
          "id": 314318,
          "text": "<p><span style=\"font-size:14.0pt;\">A person who feels anxious starts excessive hand-washing</span></p>"
        },
        {
          "id": 314319,
          "text": "<p><span style=\"font-size:14.0pt;\">A man with aggressive impulses becomes a professional boxer</span></p>"
        },
        {
          "id": 314320,
          "text": "<p><span style=\"font-size:14.0pt;\">A woman who dislikes her mother constantly forgets to call her</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the context of defense mechanisms, which of the following is an example of sublimation?&nbsp;</span></p>",
      "unique_key": "Q4129253",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) A man with aggressive impulses becomes a professional boxer</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sublimation</strong> is a mature defense mechanism in which <strong>unacceptable or socially inappropriate impulses</strong> (e.g., aggression, sexual urges) are <strong>channeled into constructive, acceptable, and often socially valued activities</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the man is transforming his <strong>aggressive impulses</strong> into a <strong>socially acceptable outlet</strong> — professional boxing — making this a classic example of sublimation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A student who is angry with his teacher starts breaking furniture:</strong> This is an example of <strong>acting out</strong>, where emotions are expressed through <strong>destructive or impulsive behavior</strong> instead of being processed adaptively.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. A person who feels anxious starts excessive hand-washing:</strong> It may reflect an attempt to reduce anxiety through <strong>ritualistic behavior</strong>, not sublimation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. A woman who dislikes her mother constantly forgets to call her:</strong> This is an example of <strong>repression</strong> or possibly <strong>avoidance</strong>, where the mind <strong>unconsciously forgets</strong> due to emotional conflict.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sublimation is the transformation of a socially unacceptable impulse into socially acceptable behaviour.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a mature defence mechanism. E.g. Vincent van Gogh transformed his emotional turmoil into expressive paintings, using art as a form of sublimation to cope with his struggles.</span></li></ul>",
      "correct_choice_id": 314319,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78888/Psychiatry_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78888/Psychiatry_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78848,
      "choices": [
        {
          "id": 314161,
          "text": "<p><span style=\"font-size:14.0pt;\">Epigenetic silencing due to methylation error</span></p>"
        },
        {
          "id": 314162,
          "text": "<p><span style=\"font-size:14.0pt;\">Expanded trinucleotide tandem repeat</span></p>"
        },
        {
          "id": 314163,
          "text": "<p><span style=\"font-size:14.0pt;\">Nondisjunction during meiosis</span></p>"
        },
        {
          "id": 314164,
          "text": "<p><span style=\"font-size:14.0pt;\">Large deletion in one gene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old male reports a gradual decline in memory and increasing difficulty with coordination over the past 6 months. His partner has also noticed personality changes and episodes of involuntary limb movements. His medical history is unremarkable, but his father and grandfather developed similar progressive neurologic symptoms at ages 50 and 55, respectively. Genetic testing is planned. Which of the following best describes the underlying genetic mechanism responsible for his condition?&nbsp;</span></p>",
      "unique_key": "Q8618673",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Expanded trinucleotide tandem repeat</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient presents with:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Progressive memory loss</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Personality changes</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Chorea (involuntary limb movements)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Poor coordination</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Family history</strong> with earlier onset in successive generations</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These findings are <strong>highly characteristic of Huntington disease</strong>, a <strong>neurodegenerative disorder</strong> inherited in an <strong>autosomal dominant</strong> pattern. The disease is caused by an:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Expansion of CAG trinucleotide repeats</strong> in the <strong>HTT gene</strong> on chromosome 4</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anticipation</strong> (earlier onset in successive generations) is a hallmark feature, due to expansion of repeats during <strong>paternal transmission</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The phrase “<strong>expanded trinucleotide tandem repeat</strong>” captures this exact mechanism and is the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Epigenetic silencing due to methylation error:&nbsp;</strong>This mechanism is more relevant in disorders such as <strong>fragile X syndrome</strong> or <strong>Prader-Willi/Angelman syndromes</strong>, which involve <strong>imprinting or methylation errors</strong>, not Huntington disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Nondisjunction during meiosis:&nbsp;</strong>Nondisjunction leads to <strong>chromosomal aneuploidy</strong> (e.g., Down syndrome), not trinucleotide repeat expansion. It results in <strong>whole chromosome gains or losses</strong>, not progressive neurodegeneration with anticipation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Large deletion in one gene:&nbsp;</strong>Conditions like <strong>Duchenne muscular dystrophy</strong> or <strong>alpha-thalassemia</strong> involve large gene deletions, not <strong>trinucleotide repeat expansions</strong>, and they don't typically show the pattern of <strong>anticipation</strong> or the <strong>specific neuropsychiatric presentation</strong> seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Huntington disease is caused by an expanded CAG trinucleotide repeat in the HTT gene. It presents with progressive cognitive decline, personality changes, chorea, and shows genetic anticipation due to further expansion of repeats in successive generations.</span></p>",
      "correct_choice_id": 314162,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78848/Pathology_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78848/Pathology_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79044,
      "choices": [
        {
          "id": 314937,
          "text": "<p><span style=\"font-size:14.0pt;\">Cefotaxime and IV albumin</span></p>"
        },
        {
          "id": 314938,
          "text": "<p><span style=\"font-size:14.0pt;\">Ciprofloxacin PO</span></p>"
        },
        {
          "id": 314939,
          "text": "<p><span style=\"font-size:14.0pt;\">Meropenem</span></p>"
        },
        {
          "id": 314940,
          "text": "<p><span style=\"font-size:14.0pt;\">Only fluid resuscitation and lactulose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 59-year-old man from Pune with a known history of alcohol-related cirrhosis presents to the emergency department with increasing confusion, low-grade fever, and abdominal discomfort over the last 2 days. On examination, he is drowsy, oriented only to place, has flapping tremors, and a tense, distended abdomen. There is no history of hematemesis or GI bleeding. Laboratory tests reveal serum bilirubin 6.4 mg/dL and creatinine 1.2 mg/dL. Diagnostic paracentesis is performed, and the fluid appears clear. Ascitic fluid analysis has been performed and the report is shown below:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GB59jyV.png\" width=\"973\" height=\"187\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most appropriate treatment?</span></p>",
      "unique_key": "Q7778085",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cefotaxime and IV albumin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient meets the diagnostic criteria for <strong>spontaneous bacterial peritonitis (SBP)</strong> — defined as an <strong>ascitic neutrophil count ≥250/mm³</strong> without an evident intraabdominal source.</span></li><li><span style=\"font-size:14.0pt;\">He has <strong>tense ascites, fever, hepatic encephalopathy</strong>, and biochemical indicators of <strong>liver dysfunction</strong>, with <strong>bilirubin &gt;4 mg/dL</strong> and <strong>creatinine &gt;1.0 mg/dL</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Third-generation cephalosporins (e.g., cefotaxime)</strong> are the first-line antibiotics in SBP due to their excellent gram-negative coverage and ascitic penetration.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IV albumin (1.5 g/kg on Day 1, 1 g/kg on Day 3)</strong> is added to <strong>prevent hepatorenal syndrome (HRS)</strong>, especially when bilirubin is &gt;4 or creatinine &gt;1.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ciprofloxacin</strong> is used for <strong>SBP prophylaxis</strong>, not for treatment.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Meropenem</strong> is reserved for nosocomial or resistant organisms.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lactulose</strong> is used to manage hepatic encephalopathy but does <strong>not treat SBP</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key Diagnostic &amp; Management Points in SBP:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pBt8Xc6.png\" width=\"1148\" height=\"359\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ciprofloxacin PO</strong>: Used for <strong>secondary prophylaxis</strong> of SBP, not for treatment of active infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Meropenem</strong>: Reserved for <strong>MDR or nosocomial SBP</strong> — not first-line in community-acquired SBP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fluid resuscitation and lactulose</strong>: Treat hepatic encephalopathy but <strong>do not address the underlying infection</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In cirrhotic patients with ascitic neutrophil count ≥250/mm³, spontaneous bacterial peritonitis should be promptly treated with third-generation cephalosporins and IV albumin to prevent renal dysfunction and reduce mortality, especially when bilirubin and creatinine are elevated.</span></p>",
      "correct_choice_id": 314937,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79044/Dr._Dilip_Mock_Test_2_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79044/Dr._Dilip_Mock_Test_2_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78913,
      "choices": [
        {
          "id": 314417,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Brodie’s abscess</span></p>"
        },
        {
          "id": 314418,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Osteoid osteoma</span></p>"
        },
        {
          "id": 314419,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Intra-cortical hemangioma</span></p>"
        },
        {
          "id": 314420,
          "text": "<p><span style=\"font-size:14.0pt;\">Chondromyxoid fibroma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male presents with a complaint of persistent pain in his right tibia for the past 3 weeks. He reports mild swelling but denies fever or chills. The pain is localized and worsens with activity. Physical examination reveals tenderness and mild swelling over the anterior aspect of the tibia. There is no significant medical history, and his vital signs are normal. X-ray is given below, which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LbwefVV.png\" width=\"356\" height=\"409\"></strong></span></p>",
      "unique_key": "Q6976536",
      "difficulty_level": "beginner",
      "solution": "<p style=\"margin-left:0cm;text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Ans. A) Brodie’s abscess</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>BRODIE’S ABSCESS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">It is a long standing <strong>localized pyogenic abscess</strong> in the bone (long standing because of strong defence mechanism of body)&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Seen in <strong>immunocompetent host.</strong></span></li><li><span style=\"font-size:14.0pt;\">This intraosseous abscess is related to subacute or chronic pyogenic osteomyelitis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It usually involves long bones (metaphysis or diaphysis); e.g., Upper end of tibia</span></li><li><span style=\"font-size:14.0pt;\">Classical Brodie’s abscess looks like a <strong>small walled off</strong> <strong>(sclerotic margins)</strong> <strong>cavity in bone with little or no periosteal reaction.</strong></span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_of4M3El.png\" width=\"400\" height=\"280\"></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Usual isolated organism is&nbsp;Staphylococcus aureus&nbsp;(although most cultures are negative)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment:</strong> Trial of injectable antibiotics is given; if it fails, curettage of the cavity is carried out.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Osteoid osteoma:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It is commonest benign true bone tumor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient has pain that is worse at night and is relieved by aspirin or other NSAID medications. When the lesion is in a vertebra, scoliosis may occur.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both Osteoblastic &amp; Osteoclastic cells are seen. The lesion has central lysis with surrounding sclerosis. Growing center is called as Nidus (Seed).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is most common in diaphysis of femur. CT is the best study to identify the nidus and confirm the diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">D/D of osteoid osteoma is bone island.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Radiofrequency ablation is used for osteoid osteoma.&nbsp;Surgical management involves removal of the entire nidus done by burr-down technique.</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Xrxsaml.png\" width=\"444\" height=\"492\"></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intra-cortical hemangioma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:white;font-size:14.0pt;\">The bone hemangioma is a benign tumor that usually involves a vertebra or the skull and commonly is found as an incidental asymptomatic lesion.&nbsp;&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">They are slightly less commonly encountered in men (M:F = 0.7:1) and most commonly seen in the 5<sup>th</sup>&nbsp;decade of life but can occur at any age.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These tumors are slow-growing and are most commonly asymptomatic unless they exert mass effect on sensitive structures, present as a swelling or a palpable mass, especially in the skull.</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">Most commonly, they are located in the thoracic spine, followed by the skull and facial bones, followed by long bones where they preferentially involve metaphysis or diaphysis.</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:#3D3D3D;font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_haZYYPa.jpeg\" alt=\"images_large_10.1177_1066896911415669-fig2\" width=\"268\" height=\"201\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hemangioma of proximal femur</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chondromyxoid fibroma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chondromyxoid fibroma is a rare lesion of cartilaginous origin. Although chondromyxoid fibromas may occur at any age, most commonly occur in patients of 10-30 years old.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Any bone may be involved, but the proximal tibia is the most common location. In contrast to other cartilaginous lesions, radiographic evidence of intralesional calcification usually is absent.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treatment consists of resection or extended curettage.</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vd1D637.png\" width=\"517\" height=\"264\"></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The given image shows Brodie’s abscess, which is a long-standing localized pyogenic abscess in the bone, seen in subacute or chronic pyogenic osteomyelitis.&nbsp;</span></p>",
      "correct_choice_id": 314417,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78913/Orthopedics_Q_4Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78913/Orthopedics_Q_4Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79085,
      "choices": [
        {
          "id": 315101,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B6 deficiency</span></p>"
        },
        {
          "id": 315102,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B1 deficiency</span></p>"
        },
        {
          "id": 315103,
          "text": "<p><span style=\"font-size:14.0pt;\">Niacin deficiency</span></p>"
        },
        {
          "id": 315104,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B2 deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman presents to the clinic with symptoms of irritability, depression, and peripheral neuropathy. She reports fatigue, headaches, and difficulty concentrating. Her medical history includes poor dietary habits and frequent alcohol consumption. On physical examination, she has glossitis (inflamed tongue) and cheilosis (cracks at the corners of her mouth). Blood tests reveal microcytic anemia with a low hemoglobin level. Given the neurological symptoms, her physician orders a urine test to assess the excretion of metabolites. The results show elevated levels of xanthurenic acid in the urine. Further assessment indicates a deficiency of a specific vitamin involved in amino acid metabolism. The physician explains that this deficiency disrupts tryptophan metabolism, resulting in the accumulation of xanthurenic acid. Which of the following nutrient deficiencies is associated with increased urinary excretion of xanthurenic acid?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7926806",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Vitamin B6 deficiency</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vitamin B6 (pyridoxine) is a crucial cofactor for the enzyme <strong>kynureninase</strong> in the tryptophan metabolism pathway. It helps convert tryptophan to niacin and other metabolites.</span></li><li><span style=\"font-size:14.0pt;\">In the absence of adequate vitamin B6, tryptophan metabolism is disrupted, resulting in the accumulation of <strong>xanthurenic acid</strong>, which is excreted in the urine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Elevated xanthurenic acid is a specific marker for vitamin B6 deficiency. This deficiency can also lead to peripheral neuropathy, mood disturbances, and anemia due to impaired heme synthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Chronic alcohol consumption further exacerbates vitamin B6 deficiency by reducing its absorption and utilization.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vitamin B1 deficiency:&nbsp;</strong>Vitamin B1 (thiamine) check RBC transketolase activity. Deficiency leads to <strong>beriberi</strong> and <strong>Wernicke-Korsakoff syndrome</strong>, but it does not result in xanthurenic aciduria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Niacin deficiency:&nbsp;</strong>Niacin deficiency results in <strong>pellagra</strong> — characterized by the \"3 D's\": dermatitis, diarrhea, and dementia. While niacin is synthesized from tryptophan, a vitamin B6 deficiency disrupts this pathway, leading to reduced niacin synthesis. However, increased xanthurenic acid excretion is specifically linked to a lack of vitamin B6.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vitamin B2 deficiency: For&nbsp;</strong>Vitamin B2 (riboflavin) check RBC glutathion reductase activity. Its deficiency causes glossitis, cheilosis, and sore throat but does not elevate xanthurenic acid levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Vitamin B6 deficiency disrupts tryptophan metabolism by impairing kynureninase activity, leading to elevated urinary excretion of xanthurenic acid and causing symptoms like peripheral neuropathy, mood disturbances, and microcytic anemia</span></p>",
      "correct_choice_id": 315101,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79085/Biochem_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79085/Biochem_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79092,
      "choices": [
        {
          "id": 315125,
          "text": "<p><span style=\"font-size:14.0pt;\">Fabry disease</span></p>"
        },
        {
          "id": 315126,
          "text": "<p><span style=\"font-size:14.0pt;\">Farber disease</span></p>"
        },
        {
          "id": 315127,
          "text": "<p><span style=\"font-size:14.0pt;\">Forbes Disease&nbsp;</span></p>"
        },
        {
          "id": 315128,
          "text": "<p><span style=\"font-size:14.0pt;\">Krabbe disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy was evaluated for burning sensations in his feet and clusters of small, red-purple spots on his skin. Laboratory studies revealed protein in his urine. Enzymatic analysis revealed a deficiency of α galactosidase, and enzyme replacement therapy was recommended. The most likely diagnosis is:&nbsp;</span></p>",
      "unique_key": "Q7154565",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Fabry disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fabry disease is caused by a <strong>deficiency of α-galactosidase A</strong>, leading to accumulation of globotriaosylceramide in various tissues. It is the only <strong>X-linked sphingolipidosis</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical features include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Burning pain</strong> in the extremities (acroparesthesias)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Red-purple skin rash</strong> (angiokeratomas)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Renal involvement</strong> (proteinuria, progressive kidney failure)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cardiac complications</strong> (hypertrophy, arrhythmias)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Gastrointestinal symptoms</strong> and <strong>cerebrovascular disease</strong> can also occur.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Early <strong>enzyme replacement therapy</strong> can help prevent irreversible damage to the kidneys, heart, and nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Farber Disease:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by a deficiency of <strong>ceramidase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Presents with <strong>painful swollen joints</strong>, <strong>subcutaneous nodules</strong>, and <strong>hoarseness</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Does <strong>not involve angiokeratomas, α-galactosidase deficiency, or burning foot pain</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Forbes Disease (Glycogen Storage Disease Type III):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by <strong>debranching enzyme deficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Manifests as <strong>hepatomegaly</strong>, <strong>hypoglycemia</strong>, and <strong>muscle weakness</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is a <strong>glycogen storage disorder</strong>, unrelated to sphingolipid metabolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Krabbe Disease:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by <strong>galactocerebrosidase deficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Features <strong>severe neurological deterioration</strong>, <strong>spasticity</strong>, and <strong>optic atrophy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">No <strong>angiokeratomas</strong> or <strong>renal proteinuria</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Fabry disease</strong> results from <strong>α-galactosidase deficiency</strong>, leading to systemic accumulation of globotriaosylceramide. It presents with neuropathic pain, angiokeratomas, renal involvement, and cardiac complications; early enzyme replacement therapy improves outcomes and reduces organ damage</span></p>",
      "correct_choice_id": 315125,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79092/Biochem_Q_10_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79092/Biochem_Q_10_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78823,
      "choices": [
        {
          "id": 314065,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose-6-phosphatase</span></p>"
        },
        {
          "id": 314066,
          "text": "<p><span style=\"font-size:14.0pt;\">Muscle phosphorylase</span></p>"
        },
        {
          "id": 314067,
          "text": "<p><span style=\"font-size:14.0pt;\">Acid maltase</span></p>"
        },
        {
          "id": 314068,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver phosphorylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-month-old infant is brought for evaluation of feeding difficulties and delayed developmental milestones. His presentation, Xray and ECG are as shown in the picture below. Which of the following enzyme deficiencies is most likely responsible for this presentation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xVYxaAI.png\" width=\"940\" height=\"357\"></strong></span></p>",
      "unique_key": "Q4349626",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Acid maltase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical scenario, chest X-ray, and ECG findings are classical for <strong>Pompe disease (Type II glycogen storage disease)</strong>, which is caused by a deficiency of <strong>acid maltase (also called alpha-1,4-glucosidase)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key findings:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypotonia and head lag</strong> → generalized muscle weakness</span></li><li><span style=\"font-size:14.0pt;\"><strong>Frog-leg posture</strong> → due to muscle flaccidity</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cardiomegaly on chest X-ray</strong> → glycogen accumulation in myocardium</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tall QRS with short PR interval on ECG</strong> → due to hypertrophic cardiomyopathy</span></li><li><span style=\"font-size:14.0pt;\"><strong>Infantile-onset Pompe disease</strong> → presents within first few months of life with progressive hypotonia, feeding difficulties, and heart failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Glucose-6-phosphatase</strong> – Deficiency causes Von Gierke disease (Type I), characterized by severe fasting hypoglycemia, hepatomegaly, and lactic acidosis; heart is not primarily involved.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Muscle phosphorylase</strong> – Deficiency causes McArdle disease (Type V); presents in older children/adults with exercise-induced muscle cramps and myoglobinuria.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Liver phosphorylase</strong> – Deficiency causes Hers disease (Type VI); primarily hepatomegaly and mild hypoglycemia without cardiomyopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pompe disease (Type II glycogen storage disorder)</strong> is caused by <strong>acid maltase deficiency</strong>, leading to glycogen accumulation in lysosomes. It presents in infancy with <strong>hypotonia, cardiomegaly, and heart failure</strong>, along with characteristic <strong>ECG changes (short PR, tall QRS)</strong> and is often fatal without enzyme replacement therapy.</span></p>",
      "correct_choice_id": 314067,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78823/Pediatrics_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78823/Pediatrics_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78910,
      "choices": [
        {
          "id": 314405,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-C, 4-A</span></p>"
        },
        {
          "id": 314406,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 314407,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-D, 4-A</span></p>"
        },
        {
          "id": 314408,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-A, 4-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following cerebellar cells with their corresponding characteristics:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Cerebellar Cells)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Purkinje cell</span></li><li><span style=\"font-size:14.0pt;\">Golgi cell</span></li><li><span style=\"font-size:14.0pt;\">Basket cell</span></li><li><span style=\"font-size:14.0pt;\">Granular cell</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (Function/Location)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Excitatory cell located in the granular layer</span></li><li><span style=\"font-size:14.0pt;\">Inhibits deep cerebellar nuclei via GABA; located in Purkinje layer</span></li><li><span style=\"font-size:14.0pt;\">Inhibits Purkinje cells; located in the molecular layer</span></li><li><span style=\"font-size:14.0pt;\">Modulates granule cells; found in the granular layer</span></li></ol>",
      "unique_key": "Q2283989",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1-B, 2-D, 3-C, 4-A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Purkinje cell (1-B):</strong> The only efferent neuron from the cerebellar cortex; releases GABA to inhibit deep cerebellar nuclei.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Golgi cell (2-D):</strong> Inhibitory interneuron in the granular layer that modulates granule cell activity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Basket cell (3-C):</strong> Inhibitory interneuron located in the molecular layer; inhibits Purkinje cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Granular cell (4-A):</strong> Small excitatory neuron found in the granular layer; sends axons to the molecular layer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Purkinje cells are the principal output neurons of the cerebellar cortex and exert inhibitory control over the deep cerebellar nuclei through GABA, playing a key role in motor coordination.</span></li></ul>",
      "correct_choice_id": 314405,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78910/Anatomy_Q_7Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78910/Anatomy_Q_7Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78906,
      "choices": [
        {
          "id": 314389,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal pupillary size and absence of bradycardia</span></p>"
        },
        {
          "id": 314390,
          "text": "<p><span style=\"font-size:14.0pt;\">Excessive salivation and fasciculations</span></p>"
        },
        {
          "id": 314391,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute respiratory distress and wheezing</span></p>"
        },
        {
          "id": 314392,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid improvement after atropine administration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following findings would most strongly suggest pyrethroid toxicity rather than organophosphate poisoning?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4747891",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Normal pupillary size and absence of bradycardia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The correct answer is <strong>Normal pupillary size and absence of bradycardia</strong>, as this finding is <strong>more characteristic of pyrethroid toxicity</strong> and helps differentiate it from <strong>organophosphate poisoning</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pyrethroids</strong> are synthetic insecticides that act primarily on <strong>voltage-gated sodium channels</strong> in nerves. While they can cause <strong>neurotoxic symptoms</strong> like tremors, seizures, and paraesthesia, due to excitation of CNS and PNS. &nbsp;They <strong>do not cause significant cholinergic effects</strong>, so signs like <strong>miosis (pinpoint pupils), bradycardia, and secretions</strong> are generally <strong>absent</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Organophosphates</strong>, on the other hand, <strong>inhibit acetylcholinesterase</strong>, leading to <strong>accumulation of acetylcholine</strong> and a <strong>cholinergic crisis</strong>. This includes <strong>miosis</strong>, <strong>bradycardia</strong>, <strong>bronchorrhea</strong>, <strong>salivation</strong>, and <strong>fasciculations</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, <strong>normal pupils and absence of bradycardia</strong> point <strong>away from organophosphate poisoning</strong> and <strong>suggest pyrethroid exposure</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Excessive salivation and fasciculations:</strong> These are <strong>classic signs of organophosphate poisoning</strong>, due to excessive cholinergic stimulation. This option points <strong>toward organophosphates</strong>, not pyrethroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute respiratory distress and wheezing:</strong> While this can occur in <strong>both</strong> types of poisoning, it is <strong>non-specific</strong>. Organophosphates may cause this through bronchorrhea and bronchospasm, while pyrethroids may irritate airways, but this symptom <strong>does not clearly distinguish</strong> between the two.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rapid improvement after atropine administration:</strong> <strong>Atropine specifically counters cholinergic effects</strong>, so a rapid response suggests <strong>organophosphate poisoning</strong>, where the <strong>toxic mechanism is cholinergic overstimulation</strong>. Pyrethroid poisoning <strong>does not respond significantly to atropine</strong>, as the mechanism is not cholinergic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Normal pupils and absence of bradycardia favor pyrethroid toxicity over organophosphate poisoning, which typically presents with cholinergic signs.</span></p>",
      "correct_choice_id": 314389,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78906/Fmt_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78906/Fmt_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78989,
      "choices": [
        {
          "id": 314721,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1, 2 and 4 are true</span></p>"
        },
        {
          "id": 314722,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2, 3 and 4 are true</span></p>"
        },
        {
          "id": 314723,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2 and 5 are true</span></p>"
        },
        {
          "id": 314724,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman presents with progressive bilateral hearing loss. She reports hearing better in noisy environments, and denies any history of trauma or infections. Otoscopy reveals an intact tympanic membrane. Tuning fork tests show a Rinne negative result on the right and Weber lateralizing to the right. Which of the following statements regarding otosclerosis are true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The most common site of pathology is the cochlear promontory.</span></li><li><span style=\"font-size:14.0pt;\">Paracusis Willisii is a feature seen in these patients.</span></li><li><span style=\"font-size:14.0pt;\">Schwartze’s sign is seen in active lesions and presents as a reddish hue on otoscopy.</span></li><li><span style=\"font-size:14.0pt;\">Audiometry typically shows a dip at 2000 Hz on bone conduction curve (Carhart’s notch).</span></li><li><span style=\"font-size:14.0pt;\">The preferred treatment is cochlear implant in all patients.</span></li></ol>",
      "unique_key": "Q5678779",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Only statements 2, 3 and 4 are true</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Correct: Paracusis Willisii</strong> is a feature of otosclerosis where patients paradoxically hear better in noisy surroundings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Correct:</strong> <strong>Schwartze’s sign</strong> (also called Flamingo pink sign) is seen in <strong>active otosclerotic lesions</strong>, characterized by a reddish hue seen through an intact tympanic membrane due to hypervascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Correct:</strong> On <strong>pure tone audiometry</strong>, a characteristic <strong>dip at 2000 Hz in the bone conduction curve</strong> is seen. This is known as <strong>Carhart’s notch</strong> and is diagnostic of stapes fixation in otosclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Incorrect:</strong> The most common site of pathology in otosclerosis is the <strong>fissula ante fenestram</strong>, located just at anterior part of the oval window. This is where abnormal bone remodeling typically begins—not the cochlear promontory.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Incorrect:</strong> <strong>Cochlear implants</strong> are not the treatment of choice in all patients. The <strong>first-line treatment</strong> is <strong>surgery (Stapedotomy &gt; Stapedectomy)</strong> in operable cases. Cochlear implants are reserved for advanced cochlear otosclerosis with severe sensorineural hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9MosBtu.png\" width=\"1213\" height=\"520\"></strong></span></p>",
      "correct_choice_id": 314722,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78989/Ent_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78989/Ent_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79052,
      "choices": [
        {
          "id": 314969,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated intracranial pressure</span></p>"
        },
        {
          "id": 314970,
          "text": "<p><span style=\"font-size:14.0pt;\">Absence of brainstem reflexes</span></p>"
        },
        {
          "id": 314971,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum phenobarbital level</span></p>"
        },
        {
          "id": 314972,
          "text": "<p><span style=\"font-size:14.0pt;\">Fixed dilated pupils</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 21-year-old man from Delhi is admitted to the ICU after sustaining severe traumatic brain injury following a road traffic accident. He remains unresponsive for over 48 hours despite ventilatory support. Clinical examination reveals absent brain stem reflexes with fixed dilated pupils. He has been receiving intravenous phenobarbital for seizure control, and current serum phenobarbital level is 21 mcg/mL (normal: 10–40 mcg/mL). MRI brain demonstrates diffuse cerebral edema with effacement of basal cisterns. What factor currently prevents the declaration of brain death in this patient?</span></p>",
      "unique_key": "Q3491376",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Serum phenobarbital level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Brain death is defined as the irreversible cessation of all functions of the brain, including the brainstem. Diagnosis is strictly clinical but requires specific preconditions to be fulfilled before testing. The presence of CNS depressant drugs like phenobarbital can mimic brain death by suppressing neurological function. In this patient, the serum phenobarbital level remains within the therapeutic range (10–40 mcg/mL), thereby <strong>confounding the neurological assessment</strong>. Formal declaration of brain death cannot proceed until sedative effects have cleared. Diffuse cerebral edema on imaging supports catastrophic brain injury but is not sufficient alone for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Preconditions that must be fulfilled before brain death examination:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JotG7c8.png\" width=\"1163\" height=\"514\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical examination criteria for brain death:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_avD2jk0.png\" width=\"1293\" height=\"382\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">If clinical testing cannot be completed, investigations are used:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YIjHz4v.png\" width=\"1089\" height=\"292\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology following brain death includes progressive systemic changes:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tNVuA0J.png\" width=\"1358\" height=\"316\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Brain death must also be differentiated from other conditions:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dQWFl86.png\" width=\"1245\" height=\"480\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elevated intracranial pressure:</strong> Supports massive brain injury but does not preclude brain death declaration if other criteria are fulfilled.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Absence of brainstem reflexes:</strong> Required for diagnosis; not a barrier to declaration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fixed dilated pupils:</strong> An expected finding in brain death and not a contraindication.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Before diagnosing brain death, it is mandatory to exclude all reversible confounders such as CNS depressant drug effect, hypothermia, metabolic abnormalities, or neuromuscular blockade. The presence of therapeutic phenobarbital levels mandates delay of brain death testing until drug clearance is confirmed.</span></p>",
      "correct_choice_id": 314971,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79052/Dr._Dilip_Mock_Test_2_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79052/Dr._Dilip_Mock_Test_2_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79077,
      "choices": [
        {
          "id": 315069,
          "text": "<p><span style=\"font-size:14.0pt;\">CD 28 on MHC-1 and B7 on T lymphocytes</span></p>"
        },
        {
          "id": 315070,
          "text": "<p><span style=\"font-size:14.0pt;\">B7 on MHC-1 and CD 28 on T lymphocytes</span></p>"
        },
        {
          "id": 315071,
          "text": "<p><span style=\"font-size:14.0pt;\">B7 on MHC-1 and CTLA-4 on T lymphocytes</span></p>"
        },
        {
          "id": 315072,
          "text": "<p><span style=\"font-size:14.0pt;\">CTLA-4 on MHC-1 and CD 28 on T lymphocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Peptide fragments are found to be presented to CD8+ cytotoxic T lymphocytes via a major histocompatibility complex class I (MHC-I) molecule. What are the co-receptors on MHC-1 and CD8+ cytotoxic T lymphocytes that leads to the activation of the T cells?&nbsp;</span></p>",
      "unique_key": "Q1156823",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B7 on MHC-I and CD28 on T lymphocytes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>T cell activation</strong> requires two essential signals:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Signal 1</strong>: Recognition of the <strong>antigenic peptide</strong> presented by <strong>MHC-I</strong> on an <strong>antigen-presenting cell (APC)</strong> to the <strong>T-cell receptor (TCR)</strong> on <strong>CD8+ T lymphocytes</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Signal 2 (co-stimulation)</strong>: Interaction between <strong>co-stimulatory molecules</strong> — specifically, <strong>B7 (CD80/CD86)</strong> expressed on the <strong>APC</strong> and <strong>CD28</strong> on the <strong>T cell</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Although <strong>MHC-I</strong> primarily presents antigen to <strong>CD8+ T cells</strong>, it is the <strong>APC</strong> that expresses <strong>B7</strong>, not the MHC molecule itself. This B7-CD28 interaction provides the <strong>second signal</strong> necessary for <strong>T cell activation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore, the correct co-receptors are <strong>B7 on the antigen-presenting cell (in context of MHC-I)</strong> and <strong>CD28 on the T lymphocyte</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CD28 on MHC-I and B7 on T lymphocytes: CD28 is not expressed on MHC-I</strong>, and <strong>B7 is not present on T lymphocytes</strong>. The direction of expression is reversed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. B7 on MHC-I and CTLA-4 on T lymphocytes:&nbsp;</strong>While B7 is correctly on the APC, <strong>CTLA-4 is an inhibitory receptor</strong>, not a co-stimulatory one. <strong>CTLA-4 dampens T cell activation</strong> rather than promotes it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CTLA-4 on MHC-I and CD28 on T lymphocytes: CTLA-4 is expressed on T cells</strong>, not on MHC-I. This pairing does not reflect the correct biology of T cell activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Co-stimulatory activation of CD8+ T lymphocytes requires B7 (CD80/86) on antigen-presenting cells and CD28 on T cells, in addition to peptide-MHC-I–TCR interaction.</span></p>",
      "correct_choice_id": 315070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79077/Microbiology_Q_13_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79077/Microbiology_Q_13_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78891,
      "choices": [
        {
          "id": 314329,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 4</span></p>"
        },
        {
          "id": 314330,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 314331,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4</span></p>"
        },
        {
          "id": 314332,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Consider the following statements about obsessive-compulsive disorder (OCD):&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Patients recognize their obsessions as irrational</span></li><li><span style=\"font-size:14.0pt;\">Compulsions reduce anxiety caused by obsessions</span></li><li><span style=\"font-size:14.0pt;\">Insight is always absent in OCD</span></li><li><span style=\"font-size:14.0pt;\">Exposure and response prevention is a first-line therapy</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the above statements are correct?</span></p>",
      "unique_key": "Q8699850",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) 1, 2, and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Patients recognize their obsessions as irrational: Correct. </strong>Most individuals with OCD have <strong>good insight</strong>, meaning they recognize that their obsessions and compulsions are <strong>excessive or unreasonable</strong>, although this insight can vary.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;2. Compulsions reduce anxiety caused by obsessions: Correct. </strong>Compulsions are <strong>repetitive behaviors or mental acts</strong> performed to <strong>neutralize or reduce the distress</strong> caused by obsessions.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;4. Exposure and response prevention is a first-line therapy: Correct.</strong></span><br><span style=\"font-size:14.0pt;\"><strong>Cognitive Behavioral Therapy (CBT)</strong>, specifically <strong>Exposure and Response Prevention (ERP)</strong>, is a <strong>first-line treatment</strong> for OCD, along with SSRIs.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;3. Insight is always absent in OCD</strong>: Insight is <strong>not always absent</strong>. In fact, OCD is typically associated with <strong>preserved insight</strong>, although in some cases (especially in children or severe OCD), insight may be <strong>poor or absent</strong>.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>OCD</strong> is characterized by <strong>obsessions (intrusive thoughts)</strong> and <strong>compulsions (ritualistic behaviors)</strong>, often with <strong>preserved insight</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>ERP-based CBT</strong> and <strong>SSRIs</strong> are the mainstay of treatment. Insight can vary, but it is <strong>not always absent</strong>.</span></li></ul>",
      "correct_choice_id": 314329,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78891/Psychiatry_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78891/Psychiatry_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78797,
      "choices": [
        {
          "id": 313961,
          "text": "<p><span style=\"font-size:14.0pt;\">Highly likely to have colorectal cancer given the test’s high sensitivity.</span></p>"
        },
        {
          "id": 313962,
          "text": "<p><span style=\"font-size:14.0pt;\">Confirm with additional diagnostic tests due to the potential for false positives.</span></p>"
        },
        {
          "id": 313963,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin immediate cancer treatment based on the positive result.</span></p>"
        },
        {
          "id": 313964,
          "text": "<p><span style=\"font-size:14.0pt;\">Dismiss the positive result due to low cancer prevalence.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with no family history of colorectal cancer undergoes a screening colonoscopy due to his age. The test, which has a sensitivity of 95% and a specificity of 90%, shows a positive result. Given the general population prevalence of colorectal cancer at his age is approximately 1.5%, how should the positive result be interpreted?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3099040",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Confirm with additional diagnostic tests due to the potential for false positives</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Despite the high sensitivity and specificity of the screening test, the relatively low prevalence of colorectal cancer significantly impacts the positive predictive value.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This means that while the test is a good initial screening tool, a positive result at this prevalence still carries a considerable chance of being a false positive. Therefore, further confirmatory tests, such as biopsies during a follow-up colonoscopy, are necessary to accurately confirm the diagnosis.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Highly likely to have colorectal cancer given the test’s high sensitivity:</strong> Incorrect, because even a test with high sensitivity can yield false positives, particularly in the context of low disease prevalence.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Begin immediate cancer treatment based on the positive result:</strong> Incorrect, as initiating treatment solely based on a screening test without further confirmation can lead to unnecessary interventions.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Dismiss the positive result due to low cancer prevalence:</strong> Incorrect, because dismissing a positive result outright is not advisable without further investigation given the implications of a cancer diagnosis.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Even when a screening test for a condition like colorectal cancer shows high sensitivity and specificity, the prevalence of the disease significantly affects the interpretation of a positive result.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Given the low prevalence, positive results should be confirmed with additional testing to ensure accuracy and prevent unnecessary treatment. This cautious approach helps in making informed and safe treatment decisions for patients.</span></li></ul>",
      "correct_choice_id": 313962,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78797/Psm_Q_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78797/Psm_Q_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78815,
      "choices": [
        {
          "id": 314033,
          "text": "<p><span style=\"font-size:14.0pt;\">Paired t-test</span></p>"
        },
        {
          "id": 314034,
          "text": "<p><span style=\"font-size:14.0pt;\">Unpaired t-test</span></p>"
        },
        {
          "id": 314035,
          "text": "<p><span style=\"font-size:14.0pt;\">ANOVA</span></p>"
        },
        {
          "id": 314036,
          "text": "<p><span style=\"font-size:14.0pt;\">Fisher’s exact test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A clinical trial is evaluating the effectiveness of a new anticoagulant medication compared to standard therapy in preventing stroke recurrence among patients with atrial fibrillation. The study categorizes patients into two groups (new drug vs. standard therapy) and records the proportion of patients in each group who experience a stroke within one year. Which of the following statistical tests is/are appropriate for comparing these two proportions?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6019484",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Fisher’s exact test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>When comparing two proportions (categorical data), the appropriate statistical tests are the Chi-square test and Fisher’s exact test.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Chi-square test</strong> is used when sample sizes are <strong>large (n &gt; 5 in each cell of the contingency table)</strong> and compares expected vs. observed frequencies.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fisher’s exact test</strong> is preferred when sample sizes are <strong>small (n &lt; 5 in any cell)</strong> since it provides an exact probability calculation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Paired t-test:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The <strong>t-test is used for continuous numerical data, not categorical proportions</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>paired t-test is used for comparing means within the same group (before-and-after studies)</strong>, not between two independent groups.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Unpaired t-test:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The <strong>unpaired (independent) t-test compares means between two independent groups</strong>, which is <strong>not applicable</strong> when comparing proportions.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:14.0pt;\"><strong>Option C. &nbsp;ANOVA:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>ANOVA (Analysis of Variance) is used to compare means across three or more groups</strong> and is not applicable for categorical proportions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When comparing two proportions (categorical data), use the Chi-square test for large sample sizes and Fisher’s exact test for small sample sizes. T-tests and ANOVA are only applicable for continuous numerical data.</span></p>",
      "correct_choice_id": 314036,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78815/Psm_Q_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78815/Psm_Q_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78909,
      "choices": [
        {
          "id": 314401,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Anterior hip dislocation</span></p>"
        },
        {
          "id": 314402,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Posterior hip dislocation</span></p>"
        },
        {
          "id": 314403,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Intertrochanteric fracture of the femur</span></p>"
        },
        {
          "id": 314404,
          "text": "<p><span style=\"font-size:14.0pt;\">Fracture of the femoral neck</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A person fell off a bicycle and developed pain around the hip. On examination, the affected limb is shortened and positioned in flexion, adduction, and internal rotation. What is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q3032998",
      "difficulty_level": "beginner",
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><strong>Ans. B) Posterior dislocation of hip</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">It is more common (90%)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism of injury:&nbsp;</strong></span><ul><li><span style=\"font-size:14.0pt;\"><strong>Dashboard injury:</strong> Occur with axial load applied on a flexed knee placed in adduction - seen as one sits in the front seat of the car.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The typical attitude of the lower limb would be a flexion, adduction and internal rotation (FADIR).</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hbLBe1G.png\" width=\"359\" height=\"259\"></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Complications:</strong> AVN of femoral head, sciatic nerve injury, associated fractures of femoral head and acetabulum and also associated knee injuries.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Imaging Findings:</strong>&nbsp;</span><ul><li><span style=\"font-size:14.0pt;\">Dislocation is usually seen on AP view; in a few cases, lateral view may be needed to establish the diagnosis.</span></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_scC1i9p.png\" width=\"266\" height=\"301\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">CT scan is the best investigation to judge dislocation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:14.0pt;\">More the deformity is a sign that probably there is no associated fracture of acetabulum or femoral head/neck. These cases can undergo closed reduction under some sedation.</span></li><li><span style=\"font-size:14.0pt;\">Reduction under general anesthesia (GA).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anterior Dislocation of Hip:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">It is less common than posterior dislocation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is of 2 types. <strong>Type I:</strong> Pubic (femoral head lies superiorly) and <strong>Type II:</strong> Obturator (femoral head lies inferiorly).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Patient assumes externally rotated, abducted and slightly flexed posture (FABER) at the affected hip, with restriction of movement.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Head of femur is often felt either anteriorly (superior type) or in the groin (inferior type). Dislocation is usually seen on AP view.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treatment is<strong>&nbsp;</strong>reduction under general anesthesia (GA).</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Hno6bRX.png\" width=\"363\" height=\"248\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_SubRQWU.png\" width=\"342\" height=\"279\"></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Inter-trochanteric fracture of femur:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patients suffering from intertrochanteric femoral fractures are mainly of elder age group (&gt; 60 years of age) with poor health condition &amp; comorbidities.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is seen more commonly in males.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient presents with severe pain, swelling &amp; ecchymosis. There is tenderness present over the greater trochanter.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hip is externally rotated to &gt; 45° (lateral border of foot touches the couch). There is &gt; 1 inch of shortening in the affected limb.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Broadening of greater trochanter is seen. The patient is unable to walk and SLR is also not possible.&nbsp;</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_W9mT7bq.jpeg\" alt=\"Intertrochanteric Fractures – Core EM\" width=\"201\" height=\"201\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fracture neck of femur:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:white;font-size:14.0pt;\">Femoral neck fractures are a specific type of&nbsp;intracapsular hip fracture.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">The junctional location makes the femoral neck prone to fracture. They are associated with low energy falls in the elderly.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">In younger patients, the cause is usually secondary to high-energy trauma such as a substantial height or motor vehicle accidents.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">Risk factors include female gender, decreased mobility, and low bone density.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">Displaced fractures put the blood supply at risk, usually tearing the ascending cervical branches. This may compromise the healing of the fracture, inevitably causing non-union or osteonecrosis.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">Non-operative management for these fractures is rarely the treatment course.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">Young patients&nbsp;with femoral neck fractures will require treatment with emergent open reduction internal fixation.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">Non-displaced fractures are treated typically with percutaneous cannulated screws or a sliding hip screw.&nbsp;</span></li><li><span style=\"background-color:white;font-size:14.0pt;\">With displaced fractures in less active elderly patients, the treatment&nbsp;is given by hemiarthroplasty and with&nbsp;more active individuals, total hip arthroplasty is done.</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uC6bjhM.png\" width=\"299\" height=\"343\"></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The limb position of flexion, adduction and internal rotation (FADIR) is specific of posterior dislocation of the hip.&nbsp;</span></p>",
      "correct_choice_id": 314402,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78909/Orthopedics_Q_1Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78909/Orthopedics_Q_1Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78877,
      "choices": [
        {
          "id": 314277,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-b, 4-a</span></p>"
        },
        {
          "id": 314278,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-d, 3-a, 4-b</span></p>"
        },
        {
          "id": 314279,
          "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-c, 4-d</span></p>"
        },
        {
          "id": 314280,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-a, 3-d, 4-c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following: Hypersensitivity Reactions:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_E5vXDfC.png\" width=\"1082\" height=\"522\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the correct matching?</span></p>",
      "unique_key": "Q8654894",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp; A) 1-d, 2-c, 3-b, 4-a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Type I → d</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Involves <strong>IgE</strong> binding to mast cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Subsequent exposure</strong> leads to <strong>degranulation</strong> → histamine release → allergic reaction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Type II → c</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mediated by <strong>IgG or IgM</strong> antibodies binding directly to <strong>cellular antigens</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This activates <strong>complement</strong>, causing <strong>cell lysis or death</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Type III → b</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Involves <strong>immune complex (antigen-antibody)</strong> formation.</span></li><li><span style=\"font-size:14.0pt;\">Complexes deposit in tissues, triggering <strong>complement activation</strong> and <strong>inflammation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Type IV → a</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cell-mediated</strong> immunity involving <strong>T helper cells (TH1)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These secrete <strong>cytokines</strong> that activate <strong>macrophages</strong> and <strong>cytotoxic T cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No antibody</strong> involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hypersensitivity reactions are classified into four types based on immune reactants and mechanisms: Type I (IgE, mast cells), Type II (IgG/IgM, cytotoxicity), Type III (immune complex deposition), and Type IV (T-cell mediated, delayed response).</span></p>",
      "correct_choice_id": 314277,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78877/Pathology_Q_11_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78877/Pathology_Q_11_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78858,
      "choices": [
        {
          "id": 314201,
          "text": "<p><span style=\"font-size:14.0pt;\">Penicillamine</span></p>"
        },
        {
          "id": 314202,
          "text": "<p><span style=\"font-size:14.0pt;\">Dimercaprol</span></p>"
        },
        {
          "id": 314203,
          "text": "<p><span style=\"font-size:14.0pt;\">Deferoxamine</span></p>"
        },
        {
          "id": 314204,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium thiosulfate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old male presents to the emergency department with severe abdominal pain, nausea, and neurological symptoms including wrist drop and fatigue. He works in a battery manufacturing plant. Laboratory studies show microcytic anemia and elevated blood lead levels. He is diagnosed with acute lead poisoning. Which of the following is the most appropriate chelation therapy for this patient?&nbsp;</span></p>",
      "unique_key": "Q8105475",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Dimercaprol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Dimercaprol (British Anti-Lewisite, BAL)</strong> is a <strong>chelating agent</strong> used in the treatment of <strong>heavy metal poisoning</strong>, particularly:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Lead poisoning</strong> (in combination with EDTA)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Arsenic poisoning</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Mercury poisoning</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Gold poisoning</strong></span></li><li><span style=\"font-size:14.0pt;\">In <strong>severe cases of lead poisoning</strong>, particularly with <strong>neurologic involvement</strong>, <strong>Dimercaprol + EDTA</strong> is the <strong>treatment of choice</strong>. It works by binding metal ions through its sulfhydryl groups, forming stable, excretable complexes.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Penicillamine:&nbsp;</strong>Used primarily in <strong>copper poisoning</strong> (e.g., <strong>Wilson disease</strong>) and sometimes in <strong>mild lead poisoning</strong>, but <strong>not first-line</strong> for severe cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Deferoxamine:&nbsp;</strong>Chelates <strong>iron</strong> and is used in <strong>iron overdose</strong> or <strong>transfusion-related iron overload</strong>, not lead.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sodium thiosulfate:&nbsp;</strong>Used in <strong>cyanide poisoning</strong>, not effective for heavy metal toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dimercaprol is a chelating agent used in the treatment of arsenic, mercury, and severe lead poisoning. In lead toxicity with neurologic symptoms, it is typically combined with EDTA for optimal effect.</span></li></ul>",
      "correct_choice_id": 314202,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78858/Pharmacology_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78858/Pharmacology_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78872,
      "choices": [
        {
          "id": 314257,
          "text": "<p><span style=\"font-size:14.0pt;\">Ranolazine</span></p>"
        },
        {
          "id": 314258,
          "text": "<p><span style=\"font-size:14.0pt;\">Ivabradine</span></p>"
        },
        {
          "id": 314259,
          "text": "<p><span style=\"font-size:14.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 314260,
          "text": "<p><span style=\"font-size:14.0pt;\">Isosorbide mononitrate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man with chronic stable angina is started on a medication that helps reduce myocardial oxygen demand without significantly affecting heart rate or blood pressure. He has already been optimized on beta-blockers and nitrates but continues to have exertional chest discomfort. The new medication works by inhibiting the late phase of the inward sodium current in ischemic cardiac myocytes. Which of the following drugs was most likely prescribed?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7075706",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ranolazine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ranolazine is an antianginal agent used as add-on therapy for chronic stable angina.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It works by inhibiting the late phase of the inward sodium current (late INa) in ischemic cardiac myocytes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This action indirectly reduces intracellular calcium, improving diastolic function and reducing myocardial oxygen consumption.</span></li><li><span style=\"font-size:14.0pt;\">Ranolazine is unique because it:</span><ul><li><span style=\"font-size:14.0pt;\">Does <strong>not significantly reduce heart rate or blood pressure</strong></span></li><li><span style=\"font-size:14.0pt;\">Can be used in patients who are <strong>already on beta-blockers and nitrates</strong></span></li><li><span style=\"font-size:14.0pt;\">Is <strong>metabolized by CYP3A4</strong>, so caution is required with strong inhibitors or inducers</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ivabradine:&nbsp;</strong>Selectively inhibits the <strong>funny current (If)</strong> in the SA node, reducing <strong>heart rate</strong> but <strong>not used primarily</strong> for angina in patients without heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Amlodipine:&nbsp;</strong>&nbsp;A <strong>dihydropyridine calcium channel blocker</strong> that reduces <strong>afterload</strong> and <strong>blood pressure</strong>, used in angina but <strong>affects BP</strong>, unlike ranolazine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Isosorbide mononitrate:&nbsp;</strong>A <strong>long-acting nitrate</strong> that reduces <strong>preload</strong> and can cause <strong>reflex tachycardia</strong>; commonly used but not the correct mechanism described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ranolazine is an antianginal drug that inhibits the late inward sodium current in cardiac cells, reducing myocardial oxygen demand without affecting heart rate or blood pressure. It is useful as an add-on therapy for chronic stable angina.</span></li></ul>",
      "correct_choice_id": 314257,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78872/Pharmacology_Q_17_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78872/Pharmacology_Q_17_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78803,
      "choices": [
        {
          "id": 313985,
          "text": "<p><span style=\"font-size:14.0pt;\">Proceed with MTP after obtaining the opinion of two medical practitioners</span></p>"
        },
        {
          "id": 313986,
          "text": "<p><span style=\"font-size:14.0pt;\">Inform her that MTP is mandatory for fetal anomalies beyond 20 weeks</span></p>"
        },
        {
          "id": 313987,
          "text": "<p><span style=\"font-size:14.0pt;\">Respect her autonomy and allow the pregnancy to continue if she wishes</span></p>"
        },
        {
          "id": 313988,
          "text": "<p><span style=\"font-size:14.0pt;\">Seek Medical Board approval and proceed with termination</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A pregnant woman at 22 weeks gestation is diagnosed with a fetal anomaly incompatible with life. However, she wishes to continue her pregnancy. According to the MTP Amendment Act, 2021, what is the most appropriate recommendation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8671645",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Respect her autonomy and allow the pregnancy to continue if she wishes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Under the MTP Act, 2021, while MTP is an option for substantial fetal anomalies, it is not mandatory. A pregnant woman has the right to continue her pregnancy if she wishes, and termination is only offered, not imposed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Proceed with MTP after obtaining the opinion of two medical practitioners:</strong> Incorrect, MTP is not mandatory even if two doctors approve; the decision lies with the woman.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Inform her that MTP is mandatory for fetal anomalies beyond 20 weeks:&nbsp;</strong>Incorrect, MTP is never mandatory; informed consent is essential.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Seek Medical Board approval and proceed with termination:</strong> Incorrect, Medical Board approval is needed beyond 24 weeks, but MTP is still not mandatory.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">MTP for fetal anomalies is an option, not a mandate. A pregnant woman has the right to continue her pregnancy if she wishes, even in cases of fetal malformations.</span></p>",
      "correct_choice_id": 313987,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78803/Psm_Q_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78803/Psm_Q_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78871,
      "choices": [
        {
          "id": 314253,
          "text": "<p><span style=\"font-size:14.0pt;\">Clear cell sarcoma of kidney</span></p>"
        },
        {
          "id": 314254,
          "text": "<p><span style=\"font-size:14.0pt;\">Nephroblastoma</span></p>"
        },
        {
          "id": 314255,
          "text": "<p><span style=\"font-size:14.0pt;\">Angiomyolipoma</span></p>"
        },
        {
          "id": 314256,
          "text": "<p><span style=\"font-size:14.0pt;\">Lymphoma involving the kidney</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 18-month-old child presents with painless hematuria. On physical examination, a firm, non-tender left flank mass is palpated that does not cross the midline. His blood pressure is elevated. Abdominal imaging shows a well-defined mass in the right kidney, and a nephrectomy is planned. The gross specimen from surgery is shown in the image. Based on clinical and gross findings, which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nY3K3x0.png\" width=\"436\" height=\"433\"></p>",
      "unique_key": "Q7087073",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Nephroblastoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nephroblastoma, also known as <strong>Wilms tumor</strong>, is the most <strong>common renal malignancy in children</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key clinical and gross features include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Age under 5 years</strong> (typically 2–5 years old)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Painless abdominal mass</strong> that does <strong>not cross the midline</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hematuria</strong>, <strong>hypertension</strong> (due to renin production)</span></li><li><span style=\"font-size:14.0pt;\">Grossly: <strong>Well-circumscribed</strong>, tan to gray, soft mass, often with areas of hemorrhage or necrosis</span></li><li><span style=\"font-size:14.0pt;\">Microscopy: <strong>Triphasic</strong> (blastemal, stromal, epithelial components)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presentation and gross appearance are classic for Wilms tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Clear cell sarcoma of kidney:&nbsp;</strong>Though a pediatric renal tumor, it often <strong>metastasizes to bone</strong> and does not typically present with hypertension or a mass this large in such a young child. Gross appearance is also less typical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Angiomyolipoma:&nbsp;</strong>Benign tumor composed of <strong>fat, blood vessels, and smooth muscle</strong>. More common in adults and <strong>tuberous sclerosis</strong>. Rare in infants and typically found incidentally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lymphoma involving the kidney:&nbsp;</strong>Uncommon as a primary kidney tumor in children. Kidney may be involved <strong>secondarily</strong> in <strong>systemic lymphoma</strong>, but mass effect is usually bilateral or diffuse, not a well-circumscribed unilateral tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nephroblastoma (Wilms tumor) is the most common renal malignancy in children. It presents with a non-tender abdominal mass that does not cross the midline, hematuria, and hypertension.</span></p>",
      "correct_choice_id": 314254,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78871/Pathology_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78871/Pathology_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78869,
      "choices": [
        {
          "id": 314245,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 314246,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4, 5</span></p>"
        },
        {
          "id": 314247,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 5</span></p>"
        },
        {
          "id": 314248,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Mesangial immune complex deposits are typically found in which of the following renal conditions?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Henoch-Schönlein purpura</span></li><li><span style=\"font-size:14.0pt;\">Rapidly progressive glomerulonephritis</span></li><li><span style=\"font-size:14.0pt;\">Diabetic nephropathy</span></li><li><span style=\"font-size:14.0pt;\">Berger disease (IgA nephropathy)</span></li><li><span style=\"font-size:14.0pt;\">Minimal change disease</span></li></ol>",
      "unique_key": "Q5701279",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 1, 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Henoch-Schönlein Purpura (HSP)</strong> – Involves <strong>IgA immune complex deposition</strong> in the <strong>mesangium</strong>. It shares pathological features with Berger disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Rapidly Progressive Glomerulonephritis (RPGN)</strong> – Certain types (like post-infectious and lupus-associated) involve <strong>mesangial and capillary immune complex deposition</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Berger disease (IgA nephropathy)</strong> –Classic example of <strong>mesangial IgA deposition</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Diabetic nephropathy</strong> – Shows <strong>mesangial matrix expansion</strong>, but <strong>not immune complex deposits</strong>. It's a <strong>non-immune, metabolic/glomerulosclerotic</strong> condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Minimal change disease</strong> – Characterized by <strong>effacement of foot processes</strong> on electron microscopy. There are <strong>no immune deposits</strong> seen on immunofluorescence or light microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mesangial immune complex deposition is seen in IgA nephropathy (Berger disease), Henoch-Schönlein purpura, and certain forms of immune complex–mediated rapidly progressive glomerulonephritis.</span></p>",
      "correct_choice_id": 314248,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78869/Pathology_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78869/Pathology_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78800,
      "choices": [
        {
          "id": 313973,
          "text": "<p><span style=\"font-size:14.0pt;\">300 INR</span></p>"
        },
        {
          "id": 313974,
          "text": "<p><span style=\"font-size:14.0pt;\">200 INR</span></p>"
        },
        {
          "id": 313975,
          "text": "<p><span style=\"font-size:14.0pt;\">400 INR</span></p>"
        },
        {
          "id": 313976,
          "text": "<p><span style=\"font-size:14.0pt;\">500 INR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman from a high-focus state undergoes tubectomy under the RCH program. Her health worker wants to know how much incentive an ASHA worker receives for motivating the patient. According to the Sterilization Incentive Package, how much is given to the ASHA worker for this case?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8583265",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 200 INR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In 11 high-focus states, ASHA workers receive 200 INR for motivating and assisting a patient undergoing tubectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Sterilization Incentive Package (RCH Program):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_bhgO2dp.png\" width=\"735\" height=\"762\"></strong></span></p>",
      "correct_choice_id": 313974,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78800/Psm_Q_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78800/Psm_Q_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78992,
      "choices": [
        {
          "id": 314733,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-A, 4-B</span></p>"
        },
        {
          "id": 314734,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-D, 3-C, 4-B</span></p>"
        },
        {
          "id": 314735,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-A, 3-C, 4-B</span></p>"
        },
        {
          "id": 314736,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-B, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following: Congenital Hearing Disorders and Their Features:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Disorder)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Michel aplasia</span></li><li><span style=\"font-size:14.0pt;\">Alexander dysplasia</span></li><li><span style=\"font-size:14.0pt;\">Mondini dysplasia</span></li><li><span style=\"font-size:14.0pt;\">Bing–Seibenmann dysplasia</span></li></ol><p><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (Feature)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Complete absence of membranous labyrinth</span></li><li><span style=\"font-size:14.0pt;\">Only 1.5 turns of cochlea formed; only basal coil present</span></li><li><span style=\"font-size:14.0pt;\">Basal turn of cochlea affected</span></li><li><span style=\"font-size:14.0pt;\">Complete absence of both bony and membranous labyrinth</span></li></ol>",
      "unique_key": "Q1423039",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 1-D, 2-C, 3-B, 4-A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1-D. Michel aplasia:&nbsp;</strong>Characterized by complete absence of both bony and membranous labyrinth. It is the most severe form of inner ear malformation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2-C. Alexander dysplasia:&nbsp;</strong>Involves the basal turn of the cochlea, leading to high-frequency sensorineural hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3-B. Mondini dysplasia:&nbsp;</strong>Only 1.5 turns of the cochlea are formed (normal is 2.5–2.75 turns), indicating an incomplete cochlear development.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4-A):</strong> <strong>Bing–Seibenmann dysplasia:&nbsp;</strong>There is a complete absence of the membranous labyrinth, while the bony labyrinth may still be present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_v5axLOZ.png\" width=\"1285\" height=\"236\"></strong></span></p>",
      "correct_choice_id": 314736,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78992/Ent_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78992/Ent_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79084,
      "choices": [
        {
          "id": 315097,
          "text": "<p><span style=\"font-size:14.0pt;\">Amino acid activation by attachment to a tRNA</span></p>"
        },
        {
          "id": 315098,
          "text": "<p><span style=\"font-size:14.0pt;\">Correct alignment of the mRNA on the 40S ribosome</span></p>"
        },
        {
          "id": 315099,
          "text": "<p><span style=\"font-size:14.0pt;\">Formation of the 80S initiation complex</span></p>"
        },
        {
          "id": 315100,
          "text": "<p><span style=\"font-size:14.0pt;\">Translocation of the ribosome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During the process of protein synthesis, the factor eEF-2 induces the hydrolysis of GTP. The energy of this hydrolysis is coupled to which of the following?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1144992",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Translocation of the ribosome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The translation factor, <strong>eukaryotic Elongation Factor 2 (eEF-2)</strong>, plays a critical role in the <strong>elongation phase</strong> of protein synthesis.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Specifically, <strong>eEF-2 catalyzes the GTP-dependent translocation</strong> of the ribosomes along the mRNA to the next codon after peptide bond formation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hydrolysis of 1 GTP</strong> by eEF-2 provides the energy required to shift the ribosome:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Moving the newly formed peptidyl-tRNA from the A-site to the P-site.</span></li><li><span style=\"font-size:14.0pt;\">Freeing the A-site for the next aminoacyl-tRNA entry.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Without eEF-2-mediated translocation, the ribosome would stall, halting protein synthesis</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amino acid activation by attachment to a tRNA:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This step is catalyzed by the family of enzymes called aminoacyl-tRNA synthetases.</span></li><li><span style=\"font-size:14.0pt;\">It involves the attachment of an amino acid to its respective tRNA and uses &nbsp;2 ATP, not GTP.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Correct alignment of the mRNA on the 40S ribosome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Facilitated by initiation factor eIF-1 during the scanning process to locate the start codon (AUG).</span></li><li><span style=\"font-size:14.0pt;\">This occurs in the initiation phase, not elongation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Formation of the 80S initiation complex:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Happens after the complete assembly of the 40S preinitiation complex.</span></li><li><span style=\"font-size:14.0pt;\">Requires the action of eIF-5, which helps join the 40S and 60S subunits.</span></li><li><span style=\"font-size:14.0pt;\">Involves GTP but is distinct from the role of eEF-2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Additional Note:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Formation of the peptide bond between amino acids is catalyzed by peptidyltransferase activity of the 60S ribosomal subunit.</span></li><li><span style=\"font-size:14.0pt;\">This process does not require external energy from ATP or GTP.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>eEF-2</strong> drives the <strong>GTP-dependent translocation</strong> of the ribosome along the mRNA during peptide elongation, ensuring proper reading frame progression and continuous protein synthesis.</span></p>",
      "correct_choice_id": 315100,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79084/Biochem_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79084/Biochem_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78911,
      "choices": [
        {
          "id": 314409,
          "text": "<p><span style=\"font-size:14.0pt;\">Prosthetic joint infection</span></p>"
        },
        {
          "id": 314410,
          "text": "<p><span style=\"font-size:14.0pt;\">Aseptic loosening</span></p>"
        },
        {
          "id": 314411,
          "text": "<p><span style=\"font-size:14.0pt;\">Periprosthetic fracture</span></p>"
        },
        {
          "id": 314412,
          "text": "<p><span style=\"font-size:14.0pt;\">Polyethylene liner dislocation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents 2 years after total knee replacement with progressive knee pain and instability. ESR and CRP are normal. X-ray is given below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F6YKnrq.png\" width=\"270\" height=\"313\"></strong></span></p>",
      "unique_key": "Q3846359",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Aseptic loosening</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aseptic loosening is the most common long-term complication of TKR.</span></li><li><span style=\"font-size:14.0pt;\">Caused by chronic micromotion, wear debris, and inflammatory response leading to osteolysis and bone resorption around the implant.</span></li><li><span style=\"font-size:14.0pt;\">Seen radiologically as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Radiolucent lines at implant–bone interface</span></li><li><span style=\"font-size:14.0pt;\">Possible component migration or subsidence</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Clinically:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Gradual onset of pain, instability, difficulty bearing weight</span></li><li><span style=\"font-size:14.0pt;\">No systemic signs of infection</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Labs: ESR/CRP are normal (helps differentiate from infection)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Prosthetic joint infection (PJI):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Infection is a serious complication but less likely here due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Late onset (2 years), unless it's low-grade indolent</span></li><li><span style=\"font-size:14.0pt;\">Normal ESR and CRP</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Typical signs of infection:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Pain, swelling, fever, warmth</span></li><li><span style=\"font-size:14.0pt;\">Elevated ESR/CRP, possibly positive joint aspirate culture</span></li></ul></li><li><span style=\"font-size:14.0pt;\">X-ray may show:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Osteolysis, periosteal reaction, joint effusion</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Diagnosis often requires joint aspiration and synovial fluid analysis</span></li><li><span style=\"font-size:14.0pt;\">Not likely here: no systemic signs, and labs are normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Periprosthetic fracture:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fractures around a prosthetic component (usually femur or tibia).</span></li><li><span style=\"font-size:14.0pt;\">Presents with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Acute pain, often after trauma or fall</span></li><li><span style=\"font-size:14.0pt;\">Inability to bear weight</span></li></ul></li><li><span style=\"font-size:14.0pt;\">X-ray would show:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Clear fracture line around implant</span></li><li><span style=\"font-size:14.0pt;\">Possible displacement</span></li></ul></li><li><p><span style=\"font-size:14.0pt;\">Risk factors: osteoporosis, loosening, trauma</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Option D. Polyethylene liner dislocation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Rare, but can occur in mobile bearing prostheses</span></li><li><span style=\"font-size:14.0pt;\">Symptoms:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Sudden instability, locking, or pain</span></li><li><span style=\"font-size:14.0pt;\">May feel or hear a \"pop\"</span></li></ul></li><li><span style=\"font-size:14.0pt;\">X-ray:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">May show eccentric alignment of tibial component</span></li><li><span style=\"font-size:14.0pt;\">Often needs advanced imaging to detect (CT or MRI with metal artifact reduction)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Not consistent: this case shows progressive, chronic symptoms — not sudden mechanical failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_O89Vjmz.png\" width=\"731\" height=\"456\"></strong></span></p>",
      "correct_choice_id": 314410,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78911/Orthopedics_Q_2Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78911/Orthopedics_Q_2Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79076,
      "choices": [
        {
          "id": 315065,
          "text": "<p><span style=\"font-size:14.0pt;\">Freund’s incomplete adjuvant</span></p>"
        },
        {
          "id": 315066,
          "text": "<p><span style=\"font-size:14.0pt;\">Freund’s complete adjuvant</span></p>"
        },
        {
          "id": 315067,
          "text": "<p><span style=\"font-size:14.0pt;\">Alum-based adjuvant</span></p>"
        },
        {
          "id": 315068,
          "text": "<p><span style=\"font-size:14.0pt;\">Squalene-based adjuvant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A research scientist is designing an experimental vaccine in animal models to enhance the immune response. He chooses an adjuvant composed of an oil emulsion containing killed Mycobacterium tuberculosis. Which of the following best describes this adjuvant?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3600379",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Freund’s complete adjuvant</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Freund’s complete adjuvant</strong> is composed of <strong>Freund’s incomplete adjuvant</strong> (a water-in-oil emulsion) <strong>plus killed Mycobacterium tuberculosis bacilli</strong> in the oil phase.</span></li><li><span style=\"font-size:14.0pt;\">It is used to <strong>stimulate a strong cell-mediated immune response</strong>, particularly in research animals.</span></li><li><span style=\"font-size:14.0pt;\">The inclusion of <strong>killed tubercle bacilli</strong> enhances antigen presentation and immunogenicity via activation of macrophages and dendritic cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Freund’s incomplete adjuvant:</strong> Consists of a water-in-oil emulsion without mycobacterial components.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Alum-based adjuvant:</strong> Commonly used in human vaccines; promotes Th2-type (antibody) responses, not strong cell-mediated immunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Squalene-based adjuvant:</strong> Found in some human vaccine formulations (e.g., MF59), used for its immune-enhancing oil-in-water emulsion properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Freund’s complete adjuvant contains an oil emulsion and killed Mycobacterium tuberculosis bacilli, enhancing cell-mediated immunity and is primarily used in research models.</span></p>",
      "correct_choice_id": 315066,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79076/Microbiology_Q_12_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79076/Microbiology_Q_12_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78814,
      "choices": [
        {
          "id": 314029,
          "text": "<p><span style=\"font-size:14.0pt;\">Regression analysis / Likelihood test</span></p>"
        },
        {
          "id": 314030,
          "text": "<p><span style=\"font-size:14.0pt;\">Correlation analysis / Bland-Altman test</span></p>"
        },
        {
          "id": 314031,
          "text": "<p><span style=\"font-size:14.0pt;\">Baltin and Altimore method</span></p>"
        },
        {
          "id": 314032,
          "text": "<p><span style=\"font-size:14.0pt;\">Kimorov and Samletor technique</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A research team is evaluating the accuracy of a new rapid antigen test for tuberculosis (TB) compared to the existing gold-standard sputum culture test. They aim to assess the agreement between the two tests across multiple patient samples rather than measuring cause-and-effect relationships. Which of the following statistical methods is most appropriate for this type of analysis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3542085",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Correlation analysis / Bland-Altman test</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bland-Altman analysis is a statistical method used to compare a new diagnostic test with a gold-standard test by assessing agreement between them rather than just correlation.</span></li><li><span style=\"font-size:14.0pt;\">Correlation analysis alone is insufficient because it only determines the relationship between two variables, not their agreement.</span></li><li><span style=\"font-size:14.0pt;\">Bland-Altman plots measure bias, agreement limits, and potential systematic differences between the two tests, making it ideal for validating new medical tests against an existing gold standard.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Regression analysis / Likelihood test:</strong> Incorrect,</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Regression analysis is used to assess relationships between dependent and independent variables, not agreement between two diagnostic methods.</span></li><li><span style=\"font-size:14.0pt;\">Likelihood ratios help determine test usefulness (e.g., positive and negative likelihood ratios for ruling in or ruling out disease), but do not compare two tests directly.</span><br>&nbsp;</li></ul><p><span style=\"font-size:14.0pt;\"><strong>Option C. Baltin and Altimore method:</strong> Incorrect,</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">No such statistical method exists in medical research or biostatistics.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:14.0pt;\"><strong>Option D. Kimorov and Samletor technique:</strong> Incorrect,</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">This is not a recognized statistical method for diagnostic test comparison.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Bland-Altman test is the preferred method for comparing a new diagnostic test with a gold-standard test, as it assesses the level of agreement and potential bias between the two tests.</span></p>",
      "correct_choice_id": 314030,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78814/Psm_Q_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78814/Psm_Q_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78830,
      "choices": [
        {
          "id": 314093,
          "text": "<p><span style=\"font-size:14.0pt;\">Abductor pollicis longus</span></p>"
        },
        {
          "id": 314094,
          "text": "<p><span style=\"font-size:14.0pt;\">Adductor pollicis</span></p>"
        },
        {
          "id": 314095,
          "text": "<p><span style=\"font-size:14.0pt;\">Extensor pollicis longus</span></p>"
        },
        {
          "id": 314096,
          "text": "<p><span style=\"font-size:14.0pt;\">Extensor pollicis brevis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male presents with difficulty in pinching objects and a positive Froment’s sign following a deep laceration to the medial aspect of the hand. On examination, thumb adduction is impaired. Which of the following muscles is referred to as the&nbsp;\"graveyard of the ulnar nerve\" due to its vulnerability in ulnar nerve injuries?</span></p>",
      "unique_key": "Q7410755",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Adductor pollicis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The&nbsp;<strong>adductor pollicis</strong> is innervated by the&nbsp;<strong>ulnar nerve</strong> and is considered the&nbsp;<strong>\"graveyard of the ulnar nerve\"</strong> because it is one of the last muscles to be supplied by the ulnar nerve in the hand.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Ulnar nerve injury compromises its function, leading to impaired thumb adduction. This is clinically tested using Froment's sign or the \"book test.\"</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Abductor pollicis longus:</strong> Innervated by the&nbsp;<strong>radial nerve</strong>, responsible for thumb abduction.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Extensor pollicis longus:</strong> Also radial nerve innervated, functions in thumb extension.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Extensor pollicis brevis:</strong> Radial nerve innervation, aids thumb extension—not affected by ulnar nerve injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The&nbsp;<strong>adductor pollicis</strong>, supplied by the ulnar nerve, plays a crucial role in thumb adduction and is notably affected in ulnar nerve palsy, earning it the term&nbsp;<strong>\"graveyard of the ulnar nerve.\"</strong></span></li></ul>",
      "correct_choice_id": 314094,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78830/Anatomy_Q_10Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78830/Anatomy_Q_10Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78840,
      "choices": [
        {
          "id": 314129,
          "text": "<p><span style=\"font-size:14.0pt;\">T1</span></p>"
        },
        {
          "id": 314130,
          "text": "<p><span style=\"font-size:14.0pt;\">T2</span></p>"
        },
        {
          "id": 314131,
          "text": "<p><span style=\"font-size:14.0pt;\">T3</span></p>"
        },
        {
          "id": 314132,
          "text": "<p><span style=\"font-size:14.0pt;\">T4a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with a history of consuming tobacco presents with a lesion on his tongue. It is 3 x 2 cm in size. Biopsy confirms the lesion to be a squamous cell carcinoma. Imaging reveals that the tumor depth is 12 mm, without invasion into the floor of mouth or mandible. What is the T stage of the tumor?&nbsp;</span></p>",
      "unique_key": "Q5424424",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) T3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tumor of size 3 x 2 cm with DOI of 12 mm is T3.</span></li><li><span style=\"font-size:14.0pt;\">Tumors &gt;4 cm in size, or those with DOI &gt;10 mm, are classified as T3.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the tumor has a DOI of 12 mm, which places it in the T3 category, regardless of its size.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. T1:</strong> Tumors that are ≤2 cm in greatest dimension and have a depth of invasion (DOI) ≤5 mm fall under this category. Since the tumor is 3 cm in size and has a DOI of 12 mm, this stage does not apply.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. T2:</strong> Tumors &gt;2 cm but ≤4 cm in size, or those with DOI &gt;5 mm but ≤10 mm are classified as T2. Although the tumor is within the size range for T2 (3 cm), its depth of invasion exceeds the upper limit of 10 mm, so T2 does not apply.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. T4a:</strong> Tumors with invasion into adjacent structures, such as the floor of the mouth, mandible, or skin, fall into this stage. Since the imaging confirms no invasion into surrounding structures, T4a does not apply.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JgtiPqr.png\" width=\"794\" height=\"651\"></p>",
      "correct_choice_id": 314131,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78840/Surgery_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78840/Surgery_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78868,
      "choices": [
        {
          "id": 314241,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated serum albumin</span></p>"
        },
        {
          "id": 314242,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal serum potassium</span></p>"
        },
        {
          "id": 314243,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated serum sodium</span></p>"
        },
        {
          "id": 314244,
          "text": "<p><span style=\"font-size:14.0pt;\">Low serum albumin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-year-old girl is brought to the emergency department with lethargy and generalized edema. Physical examination reveals sparse, easily pluckable hair, skin changes with hyperpigmented patches that appear to be peeling, and a protuberant abdomen. Her weight is 8 kg. Which of the following laboratory findings would you most expect to find?&nbsp;</span></p>",
      "unique_key": "Q2086730",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Low serum albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical scenario describes a <strong>classic case of kwashiorkor</strong>, a form of severe acute malnutrition characterized by edema (due to hypoalbuminemia), skin changes <strong>(\"flaky paint\" dermatosis</strong>), hair changes (sparse, easily pluckable), protuberant abdomen, and growth failure. <strong>Hypoalbuminemia is a hallmark finding in kwashiorkor</strong> due to protein deficiency and is directly responsible for the generalized edema observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Options A. Elevated serum albumin</strong>: This is incorrect because kwashiorkor is characterized by hypoalbuminemia, not hyperalbuminemia. The protein deficiency in kwashiorkor leads to decreased albumin synthesis by the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Normal serum potassium:</strong> This is incorrect because patients with kwashiorkor typically have electrolyte imbalances, particularly hypokalemia. The total body potassium depletion requires supplementation at 3-4 mEq/kg/day during treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Elevated serum sodium:</strong> This is incorrect because hyponatremia rather than hypernatremia is more common in kwashiorkor. This occurs due to fluid shifts and dilutional effects from the edema associated with low oncotic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hypoalbuminemia (&lt;2.5 g/dL) is a cardinal laboratory finding in kwashiorkor and directly causes the edema through decreased oncotic pressure</strong>. This protein-deficiency state differs from marasmus (calorie deficiency) which lacks edema.</span></p>",
      "correct_choice_id": 314244,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78868/Q2086730.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78868/Q2086730.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78854,
      "choices": [
        {
          "id": 314185,
          "text": "<p><span style=\"font-size:14.0pt;\">Protamine sulfate</span></p>"
        },
        {
          "id": 314186,
          "text": "<p><span style=\"font-size:14.0pt;\">Idarucizumab</span></p>"
        },
        {
          "id": 314187,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin K</span></p>"
        },
        {
          "id": 314188,
          "text": "<p><span style=\"font-size:14.0pt;\">Andexanet alfa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man with atrial fibrillation is brought to the emergency department after a fall. He is confused, and CT scan reveals a small intracranial hemorrhage. He has been taking dabigatran for stroke prevention. Which of the following is the most appropriate pharmacologic agent to reverse the anticoagulant effect of this medication?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9918373",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Idarucizumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Dabigatran</strong> is a <strong>direct thrombin inhibitor</strong> (DTI), used as an oral anticoagulant primarily for:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Stroke prevention</strong> in <strong>atrial fibrillation</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment and prevention</strong> of <strong>deep vein thrombosis (DVT)</strong> and <strong>pulmonary embolism (PE)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">In cases of <strong>life-threatening bleeding</strong> or <strong>emergency surgery</strong>, <strong>Idarucizumab</strong> is the <strong>specific reversal agent</strong> for dabigatran. It is a <strong>monoclonal antibody fragment</strong> that binds dabigatran with high affinity, neutralizing its anticoagulant effect <strong>within minutes</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Protamine sulfate:&nbsp;</strong>Used to reverse <strong>heparin and low molecular weight heparin</strong>, not effective for dabigatran.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vitamin K:&nbsp;</strong>Reverses <strong>warfarin</strong> by aiding synthesis of vitamin K–dependent clotting factors. Has <strong>no effect on dabigatran</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Andexanet alfa:&nbsp;</strong>Reversal agent for <strong>factor Xa inhibitors</strong> (e.g., rivaroxaban, apixaban), <strong>not for thrombin inhibitors</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dabigatran is an oral direct thrombin inhibitor used as an anticoagulant. In cases of major bleeding, its effects can be rapidly reversed by idarucizumab, a monoclonal antibody fragment that specifically binds and neutralizes dabigatran.</span></li></ul>",
      "correct_choice_id": 314186,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78854/Pharmacology_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78854/Pharmacology_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78865,
      "choices": [
        {
          "id": 314229,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetazolamide</span></p>"
        },
        {
          "id": 314230,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrochlorothiazide</span></p>"
        },
        {
          "id": 314231,
          "text": "<p><span style=\"font-size:14.0pt;\">Triamterene</span></p>"
        },
        {
          "id": 314232,
          "text": "<p><span style=\"font-size:14.0pt;\">Spironolactone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 49-year-old man with liver cirrhosis and peripheral edema is started on a diuretic. Two weeks later, he presents with laboratory findings of hyperkalemia and non-anion gap metabolic acidosis. Which of the following medications is the most likely cause of these findings?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2534442",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Spironolactone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Spironolactone</strong> is a <strong>potassium-sparing diuretic</strong> and an <strong>aldosterone antagonist</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is commonly used in <strong>cirrhotic patients with ascites and edema</strong>, as it counteracts aldosterone-driven sodium and water retention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, by blocking aldosterone in the <strong>collecting duct</strong>, it <strong>reduces sodium reabsorption</strong> and <strong>decreases potassium and hydrogen ion secretion</strong>, leading to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hyperkalemia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Non-anion gap (normal anion gap) metabolic acidosis</strong></span></li><li><span style=\"font-size:14.0pt;\">These are predictable adverse effects of aldosterone antagonism.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acetazolamide:&nbsp;</strong>&nbsp;A <strong>carbonic anhydrase inhibitor</strong> acting in the <strong>proximal tubule</strong>. It causes <strong>bicarbonate loss</strong>, leading to <strong>metabolic acidosis</strong>, but it does <strong>not cause hyperkalemia</strong> (may cause <strong>hypokalemia</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hydrochlorothiazide:&nbsp;</strong>A <strong>thiazide diuretic</strong> acting on the <strong>distal convoluted tubule</strong>. It causes <strong>hypokalemia</strong> and <strong>metabolic alkalosis</strong>, not hyperkalemia or acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Triamterene:</strong> This is a <strong>potassium-sparing diuretic</strong> like spironolactone, but <strong>does not antagonize aldosterone directly</strong>. It can also cause <strong>hyperkalemia</strong>, but spironolactone is the preferred agent in <strong>cirrhotic edema</strong> due to its aldosterone-blocking effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Spironolactone, a potassium-sparing aldosterone antagonist, is commonly used to treat cirrhotic edema and can cause hyperkalemia and metabolic acidosis by inhibiting sodium reabsorption and reducing potassium and hydrogen ion excretion in the distal nephron.</span></li></ul>",
      "correct_choice_id": 314232,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78865/Pharmacology_Q_12_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78865/Pharmacology_Q_12_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78811,
      "choices": [
        {
          "id": 314017,
          "text": "<p><span style=\"font-size:14.0pt;\">Purely Health Education, as it provides preventive guidance</span></p>"
        },
        {
          "id": 314018,
          "text": "<p><span style=\"font-size:14.0pt;\">Primarily Health Propaganda, as it emotionally influences behaviour</span></p>"
        },
        {
          "id": 314019,
          "text": "<p><span style=\"font-size:14.0pt;\">Neither Health Education nor Health Propaganda, as it lacks clear scientific instruction</span></p>"
        },
        {
          "id": 314020,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Health Education and Health Propaganda, as it combines emotional appeal with preventive measures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During a cholera outbreak, a government-run TV network broadcasts a dramatic re-enactment of a child dying from dehydration, followed by a public service message advising people to boil water and use oral rehydration therapy. Which of the following best describes this intervention?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9335902",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Both Health Education and Health Propaganda, as it combines emotional appeal with preventive measures</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The dramatic re-enactment triggers an emotional response (propaganda), while the preventive message provides actionable knowledge (education).</span></li><li><span style=\"font-size:14.0pt;\">By integrating both methods, the campaign maximizes behavioural impact.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Purely Health Education, as it provides preventive guidance:</strong> Incorrect, Dramatic portrayal introduces propaganda elements.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Primarily Health Propaganda, as it emotionally influences behaviour:&nbsp;</strong>Incorrect, it also provides scientifically sound preventive strategies.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Neither Health Education nor Health Propaganda, as it lacks clear scientific instruction:</strong> Incorrect, despite dramatization, it delivers a clear health message.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Public health campaigns often integrate both propaganda and education to enhance compliance while ensuring informed decision-making.</span></p><p><span style=\"font-size:14.0pt;\"><strong>Health Education vs. Health Propaganda</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_x9VboGf.png\" width=\"688\" height=\"272\"></strong></span></p>",
      "correct_choice_id": 314020,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78811/Psm_Q_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78811/Psm_Q_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79049,
      "choices": [
        {
          "id": 314957,
          "text": "<p><span style=\"font-size:14.0pt;\">Amyotrophic Lateral Sclerosis</span></p>"
        },
        {
          "id": 314958,
          "text": "<p><span style=\"font-size:14.0pt;\">Myasthenia Gravis</span></p>"
        },
        {
          "id": 314959,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral Medullary Syndrome</span></p>"
        },
        {
          "id": 314960,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic inflammatory demyelinating polyradiculoneuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man from Chennai presents with a 9-month history of progressive difficulty in speaking and swallowing. His wife reports that his voice has become increasingly nasal and slurred, and he has frequent choking episodes while eating. On examination, deep tendon reflexes are brisk in all four limbs. Power is reduced symmetrically in the upper extremities without significant sensory loss. MRI brain and cervical spine are unremarkable. A tongue image is shown below.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mWXfqn3.png\" width=\"402\" height=\"307\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most likely diagnosis?</span></p>",
      "unique_key": "Q9018388",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Amyotrophic Lateral Sclerosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with classical <strong>bulbar-onset ALS</strong>, characterized by <strong>progressive dysarthria, dysphagia, nasal speech</strong>, and evidence of <strong>combined upper and lower motor neuron dysfunction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>spastic, small tongue</strong> without fasciculations suggests <strong>predominant upper motor neuron (UMN)</strong> involvement in the bulbar region.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Brisk limb reflexes</strong> (hyperreflexia) further support UMN pathology.</span></li><li><span style=\"font-size:14.0pt;\">ALS uniquely combines <strong>UMN signs</strong> (spasticity, hyperreflexia) and <strong>LMN signs</strong> (atrophy, weakness, later fasciculations).</span></li><li><span style=\"font-size:14.0pt;\">MRI exclusion of other structural lesions strengthens the diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">Myasthenia gravis typically causes <strong>fatigable weakness</strong> without hyperreflexia or spasticity.</span></li><li><span style=\"font-size:14.0pt;\">Medullary strokes can mimic bulbar dysfunction but would present acutely, not over months.</span></li><li><span style=\"font-size:14.0pt;\">CIDP involves demyelination with hyporeflexia, not hyperreflexia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Distinguishing ALS from other causes of bulbar dysfunction:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uc3eCDR.png\" width=\"1188\" height=\"566\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Myasthenia Gravis:</strong> Would cause fatigable weakness without UMN signs like spasticity or brisk reflexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lateral Medullary Syndrome:&nbsp;</strong>Would include sensory deficits, vertigo, nystagmus, Horner's syndrome, and crossed findings (ipsilateral face + contralateral body), which are not present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP):</strong> Typically causes symmetric sensorimotor symptoms with <strong>hyporeflexia</strong>, not hyperreflexia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bulbar-onset ALS should be suspected in patients with progressive dysarthria, dysphagia, spastic small tongue, hyperreflexia, and absence of sensory involvement, especially when imaging rules out alternative structural lesions.</span></p>",
      "correct_choice_id": 314957,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79049/Dr._Dilip_Mock_Test_2_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79049/Dr._Dilip_Mock_Test_2_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79013,
      "choices": [
        {
          "id": 314817,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 4</span></p>"
        },
        {
          "id": 314818,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4</span></p>"
        },
        {
          "id": 314819,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, and 5</span></p>"
        },
        {
          "id": 314820,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4, and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with recurrent epistaxis and AV malformations detected in lungs, GI tract, liver, CNS, nasopharynx as shown below.&nbsp;Which of the following statements regarding the condition are true?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9m5Tgr0.png\" width=\"1008\" height=\"227\"></span><br>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It is inherited in an autosomal recessive pattern.</span></li><li><span style=\"font-size:14.0pt;\">The disease is characterized by mucocutaneous telangiectasias and arteriovenous malformations in organs like the GI tract, lungs, and CNS.</span></li><li><span style=\"font-size:14.0pt;\">A deficiency in elastic tissue within blood vessel walls leads to recurrent epistaxis.</span></li><li><span style=\"font-size:14.0pt;\">Bevacizumab, a VEGF inhibitor, has shown potential in managing this condition.</span></li><li><span style=\"font-size:14.0pt;\">Curative surgical excision of AV malformations is the mainstay of treatment.</span></li></ol>",
      "unique_key": "Q3003358",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2, 3, and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>This is Osler-Weber-Rendu disease/ hereditary hemorrhagic telangiectasia (HHT), is a rare, autosomal dominant genetic disorder that causes abnormal blood vessel formation.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2 – True:</strong> The disease presents with <strong>mucocutaneous telangiectasias</strong> and <strong>AV malformations</strong> involving multiple organs like the <strong>GI tract, lungs, liver, spleen, CNS, and nasopharynx</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3 – True:</strong> Recurrent <strong>epistaxis</strong> is a hallmark feature due to the <strong>deficiency of smooth muscle and elastic tissue</strong> in the vessel walls.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4 – True:</strong> <strong>Bevacizumab</strong>, a VEGF inhibitor, is an emerging therapy being tried in refractory cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1 – False:</strong> Osler-Weber-Rendu is inherited in an <strong>autosomal dominant</strong> pattern, not recessive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5 – False:</strong> <strong>Surgical excision is not curative</strong> and not the mainstay. Management is largely <strong>supportive</strong>, including <strong>propranolol</strong>, <strong>tranexamic acid</strong>, and <strong>laser ablation</strong> in selected cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7AylhtX.png\" width=\"1149\" height=\"248\"></strong></span></p>",
      "correct_choice_id": 314818,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79013/Ent_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79013/Ent_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78807,
      "choices": [
        {
          "id": 314001,
          "text": "<p><span style=\"font-size:14.0pt;\">BOAA-induced neuronal apoptosis leads to late-onset neurodegeneration</span></p>"
        },
        {
          "id": 314002,
          "text": "<p><span style=\"font-size:14.0pt;\">Cumulative axonal dysfunction occurs due to persistent glutamatergic excitotoxicity</span></p>"
        },
        {
          "id": 314003,
          "text": "<p><span style=\"font-size:14.0pt;\">Latent demyelination of descending motor pathways worsens with age-related neurodegeneration</span></p>"
        },
        {
          "id": 314004,
          "text": "<p><span style=\"font-size:14.0pt;\">BOAA remains stored in fatty tissues and is reactivated under metabolic stress</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man from a rural region presents with bilateral leg weakness and difficulty maintaining balance. His history reveals a high intake of Lathyrus sativus during food shortages decades ago. He was previously asymptomatic but now experiences spasticity, hyperreflexia, and gait abnormalities. Which of the following best explains why his symptoms manifested later in life?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2526007",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Latent demyelination of descending motor pathways worsens with age-related neurodegeneration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lathyrism may initially be asymptomatic but can worsen due to age-related neurodegeneration.</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Progressive degeneration of corticospinal tracts causes late onset worsening of motor function despite cessation of toxin exposure.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>BOAA-induced neuronal apoptosis leads to late-onset neurodegeneration:</strong> Incorrect, BOAA does not cause direct apoptosis but excitotoxic injury.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Cumulative axonal dysfunction occurs due to persistent glutamatergic excitotoxicity:</strong> Incorrect, Glutamatergic excitotoxicity occurs early, not decades later.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>BOAA remains stored in fatty tissues and is reactivated under metabolic stress:</strong> Incorrect, BOAA is not stored in fatty tissue and does not get reactivated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lathyrism can remain latent for years, with symptoms worsening due to age-related degeneration of previously damaged corticospinal pathways.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Food Adulteration Diseases</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_N67FtTi.png\" width=\"738\" height=\"412\"></strong></span></p>",
      "correct_choice_id": 314003,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78807/Psm_Q_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78807/Psm_Q_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79028,
      "choices": [
        {
          "id": 314877,
          "text": "<p><span style=\"font-size:14.0pt;\">Retain catheter and start low-molecular-weight heparin</span></p>"
        },
        {
          "id": 314878,
          "text": "<p><span style=\"font-size:14.0pt;\">Retain catheter and start systemic thrombolytics</span></p>"
        },
        {
          "id": 314879,
          "text": "<p><span style=\"font-size:14.0pt;\">Remove catheter and start empiric antibiotics</span></p>"
        },
        {
          "id": 314880,
          "text": "<p><span style=\"font-size:14.0pt;\">Remove catheter and start heparin drip</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man from Lucknow with recently diagnosed small cell lung carcinoma is undergoing chemotherapy via a right subclavian central venous port. He presents with dull ache and swelling of his right upper limb that has gradually worsened over 2 days. He denies fever, chills, or erythema. The catheter site is clean, with good flow of medications. A bedside ultrasound of the right axillary vein is shown. There is no evidence of limb ischemia or phlegmasia. What is the most appropriate next step in management?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QZEV4UC.png\" width=\"265\" height=\"313\"></span></p>",
      "unique_key": "Q7705162",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Retain catheter and start low-molecular-weight heparin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has a <strong>catheter-associated upper extremity deep vein thrombosis (UEDVT)</strong>, confirmed by ultrasound showing a thrombus in the axillary vein at a venous valve.</span></li><li><span style=\"font-size:14.0pt;\">In patients with cancer and central venous catheters, the <strong>risk of thrombosis is elevated due to malignancy-associated hypercoagulability</strong>, vascular trauma, and stasis.</span></li><li><span style=\"font-size:14.0pt;\">If the catheter is <strong>functioning and not infected</strong>, <strong>it should be retained</strong> to preserve venous access for ongoing chemotherapy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Low-molecular-weight heparin (LMWH)</strong> is the <strong>first-line treatment</strong> in hospitalized cancer patients with thrombosis, preferred over vitamin K antagonists or even DOACs in this context.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Systemic thrombolysis</strong> is reserved for <strong>life- or limb-threatening thrombosis</strong>, not stable DVT.</span></li><li><span style=\"font-size:14.0pt;\">There are <strong>no signs of infection</strong> at the catheter site, so antibiotics are not indicated.</span></li><li><span style=\"font-size:14.0pt;\">Unfractionated heparin drips are used less often now for stable outpatient DVT, and catheter removal is not warranted here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management Strategy for Catheter-Associated UEDVT:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wRsUJGj.png\" width=\"1096\" height=\"449\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Retain catheter and start systemic thrombolytics</strong>: Not indicated unless <strong>severe symptoms or impending limb compromise</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Remove catheter and start empiric antibiotics</strong>: No signs of infection (no erythema, pus, or fever).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Remove catheter and start heparin drip</strong>: Catheter removal not needed; LMWH is safer and more effective long-term in malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In catheter-related upper extremity DVT among cancer patients, the catheter should be retained if it is functional and uninfected. Anticoagulation with low-molecular-weight heparin is the preferred first-line therapy.</span></p>",
      "correct_choice_id": 314877,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79028/Dr._Dilip_Mock_Test_2_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79028/Dr._Dilip_Mock_Test_2_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78950,
      "choices": [
        {
          "id": 314565,
          "text": "<p><span style=\"font-size:14.0pt;\">Insertion of a levonorgestrel-releasing intrauterine device (LNG-IUCD)</span></p>"
        },
        {
          "id": 314566,
          "text": "<p><span style=\"font-size:14.0pt;\">Trial of progestin-only pills for 3 more months</span></p>"
        },
        {
          "id": 314567,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 314568,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial sampling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman presents to the outpatient department with complaints of abnormal uterine bleeding (AUB) for the past two months. Her menstrual cycles have been irregular for the last year, and she has not reached menopause. She is obese (BMI: 32), and a recent transvaginal ultrasound revealed an endometrial thickness of 16 mm. She has not responded to a prior 3-month course of progestin therapy. What is the most appropriate next step in management?&nbsp;</span></p>",
      "unique_key": "Q9824902",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Endometrial sampling</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>peri-menopausal woman</strong> with <strong>abnormal uterine bleeding</strong>, the primary concern is to rule out <strong>endometrial hyperplasia or carcinoma</strong>. The presence of risk factors such as <strong>obesity</strong>, <strong>failed medical management</strong>, and <strong>persistent bleeding</strong> increases the likelihood of endometrial pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Indications for endometrial sampling include</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Age &gt;45 years with AUB</span></li><li><span style=\"font-size:14.0pt;\">Perimenopausal state with AUB</span></li><li><span style=\"font-size:14.0pt;\">Risk factors for unopposed estrogen exposure (e.g., obesity, PCOS, tamoxifen use)</span></li><li><span style=\"font-size:14.0pt;\">Failed initial medical therapy</span></li><li><span style=\"font-size:14.0pt;\">Endometrial thickness &gt;5 mm in postmenopausal women or &gt;12 mm in premenopausal women on TVUS</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sampling may be performed via hysteroscopic guided <strong>endometrial biopsy (pipelle or aspiration)</strong> or <strong>dilation and curettage</strong> if required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Insertion of a levonorgestrel-releasing intrauterine device (LNG-IUCD):&nbsp;</strong>While the <strong>LNG-IUCD</strong> is a highly effective treatment for <strong>AUB</strong>, especially when related to <strong>endometrial hyperplasia without atypia</strong>, it should not be the <strong>first-line step</strong> in a patient with:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Persistent AUB</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Significantly thickened endometrium</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Obesity</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Failed prior medical management</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Before initiating this treatment, it is critical to <strong>rule out malignancy</strong>, which can only be done through <strong>endometrial sampling</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Trial of progestin-only pills for 3 more months:&nbsp;</strong>Given the <strong>failure of a previous 3-month course of progestin therapy</strong>, repeating a similar <strong>medical regimen</strong> without first <strong>ruling out endometrial pathology</strong> would be inappropriate. Continued unresponsiveness can delay diagnosis and treatment of <strong>serious underlying conditions</strong>, such as <strong>endometrial cancer</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hysterectomy:&nbsp;</strong>While <strong>hysterectomy</strong> may eventually be indicated for <strong>definitive treatment</strong> in cases of <strong>confirmed endometrial carcinoma or complex atypical hyperplasia</strong>, it is <strong>not appropriate as the immediate next step</strong>. It is an <strong>invasive surgical procedure</strong> and should only be considered <strong>after tissue diagnosis</strong>. Diagnostic evaluation with <strong>endometrial sampling</strong> is necessary before proceeding to such an extensive intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>perimenopausal women with abnormal uterine bleeding</strong>, especially those who are <strong>obese</strong>, have <strong>increased endometrial thickness</strong>, and have <strong>failed prior progestin therapy</strong>, <strong>endometrial sampling</strong> is essential to evaluate for <strong>endometrial hyperplasia or carcinoma</strong>.</span></p>",
      "correct_choice_id": 314568,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78950/Obg_Q_14_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78950/Obg_Q_14_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78895,
      "choices": [
        {
          "id": 314345,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A.</span></p>"
        },
        {
          "id": 314346,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A.</span></p>"
        },
        {
          "id": 314347,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false.</span></p>"
        },
        {
          "id": 314348,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> The silhouette sign helps localize lung pathology on chest X-rays by identifying loss of normal anatomical borders.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> Obscuration of the left heart border on chest X-ray suggests pathology in the lingula, which is part of the left upper lobe and lies adjacent to the heart.</span></p>",
      "unique_key": "Q1596032",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Both A and R are true, and R is the correct explanation of A.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>silhouette sign</strong> is a radiologic concept used to determine the location of lung pathology by observing which normal silhouette (e.g., heart, diaphragm, aorta) is <strong>obscured</strong>. If the <strong>left heart border is not visible</strong>, it indicates that a lesion is present in the <strong>lingula</strong> of the <strong>left upper lobe</strong>, as this segment is in direct contact with the heart border.</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">Therefore, both the <strong>assertion and reason are true</strong>, and the <strong>reason accurately explains</strong> the assertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gZj1GFF.png\" alt=\"A person looking at the camera\r\n\r\nDescription automatically generated\" width=\"305\" height=\"344\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The silhouette sign localizes lung pathology on chest X-ray by identifying obscured anatomical borders; loss of the left heart border indicates lingular involvement.</span></p>",
      "correct_choice_id": 314345,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78895/Radiology_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78895/Radiology_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78827,
      "choices": [
        {
          "id": 314081,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 5 are correct</span></p>"
        },
        {
          "id": 314082,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, and 4 are correct</span></p>"
        },
        {
          "id": 314083,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4, and 5 are correct</span></p>"
        },
        {
          "id": 314084,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 4, and 5 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Automated External Defibrillators (AEDs) are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">An AED delivers a shock only when it detects a shockable rhythm, such as ventricular fibrillation or pulseless ventricular tachycardia.</span></li><li><span style=\"font-size:14.0pt;\">AEDs can be safely used on a person who has a pacemaker, but electrode placement should be adjusted to avoid direct contact with the device.</span></li><li><span style=\"font-size:14.0pt;\">An AED should be used on a person experiencing cardiac arrest even if they have a pulse, as it can restart the heart.</span></li><li><span style=\"font-size:14.0pt;\">It is safe to use an AED on a wet surface or in a puddle, as water does not interfere with the effectiveness of defibrillation.</span></li><li><span style=\"font-size:14.0pt;\">If the first shock from an AED does not restore a normal rhythm, CPR should be resumed immediately before delivering another shock.</span></li></ol>",
      "unique_key": "Q3259081",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>An AED delivers a shock only when it detects a shockable rhythm, such as ventricular fibrillation or pulseless ventricular tachycardia:</strong> AEDs are designed to deliver a shock <strong>only when a shockable rhythm</strong> (ventricular fibrillation or pulseless ventricular tachycardia) is detected. It does <strong>not</strong> deliver shocks in cases of asystole or normal heart rhythms. In such case, continue giving chest compressions and ventilation.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>AEDs can be safely used on a person who has a pacemaker, but electrode placement should be adjusted to avoid direct contact with the device:&nbsp;</strong>An AED can be used on a patient with a pacemaker, but the <strong>electrodes should be placed at least 1 inch away from the pacemaker</strong> to avoid interference.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>If the first shock from an AED does not restore a normal rhythm, CPR should be resumed immediately before delivering another shock:</strong> If the <strong>first AED shock does not restore normal rhythm</strong>, CPR should be <strong>immediately resumed for 2 minutes</strong> before another shock is delivered. Continuous CPR maintains circulation and improves the effectiveness of subsequent shocks. If there is no pulse, and the rhythm is shockable, another shock can be given.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>An AED should be used on a person experiencing cardiac arrest even if they have a pulse, as it can restart the heart:</strong> An AED <strong>should never be used on a person with a pulse</strong>. Defibrillation is <strong>only indicated for cardiac arrest with a shockable rhythm</strong>. If a person has a pulse, other interventions should be performed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>It is safe to use an AED on a wet surface or in a puddle, as water does not interfere with the effectiveness of defibrillation:</strong> AEDs <strong>should not</strong> be used on a wet surface or in a puddle because <strong>water is a conductor of electricity</strong> and may reduce the effectiveness of the shock or put rescuers at risk. If possible, move the patient to a <strong>dry surface</strong> before applying the AED.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">AEDs should <strong>only be used for cardiac arrest with a shockable rhythm</strong>, and CPR should be <strong>immediately resumed</strong> if the first shock fails.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>AED placement should avoid pacemakers, and wet environments should be avoided.</strong>&nbsp;</span></li></ul>",
      "correct_choice_id": 314081,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78827/Q_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78827/Q_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78962,
      "choices": [
        {
          "id": 314613,
          "text": "<p><span style=\"font-size:14.0pt;\">Postmortem reports</span></p>"
        },
        {
          "id": 314614,
          "text": "<p><span style=\"font-size:14.0pt;\">Dying declaration</span></p>"
        },
        {
          "id": 314615,
          "text": "<p><span style=\"font-size:14.0pt;\">Reports of Fingerprint Bureau</span></p>"
        },
        {
          "id": 314616,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemical Examiner's reports</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The following documents are exceptions to oral evidence in court except:</span></p>",
      "unique_key": "Q4584943",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Postmortem reports</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In Indian law, <strong>oral evidence is generally preferred</strong>, especially in medico-legal cases. While there are defined <strong>exceptions to the rule of oral evidence</strong>, <strong>postmortem reports are not one of them</strong>. The <strong>doctor who performed the postmortem must testify in court</strong> to interpret findings and undergo cross-examination. This is because PM reports often involve <strong>subjective assessments</strong> like cause and time of death, which require clarification and professional judgment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Dying declaration:</strong> Incorrect. Dying declarations are an established exception, especially when the declarant is unavailable due to death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Reports of Fingerprint Bureau:</strong> These are prepared by government forensic experts in their <strong>official capacity</strong> and qualify as <strong>documentary evidence</strong>. As such, they are considered <strong>exceptions to oral evidence</strong> and are admissible in court under statutory provisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chemical Examiner's reports:</strong> These are <strong>official reports</strong> produced by chemical examiners (forensic scientists) as part of their official duties. Just like the others, they are <strong>accepted in court as documentary evidence</strong> and are <strong>exempt from oral testimony requirements</strong>, unless questioned specifically.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Exceptions to oral evidences (i.e. Documentary evidences allowed):&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:14.0pt;\">Dying declaration: Accepted in court as legal evidence in event of victim’s death.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Expert opinions expressed in a treatise: Expert opinions printed in books are accepted as evidence without oral evidence of the author.</span></li><li><span style=\"font-size:14.0pt;\">Deposition of a medical witness taken in lower court: Accepted as evidence in a higher court when it has been recorded and attested by a magistrate in presence of the accused who had an opportunity to cross-examine the witness.</span></li><li><span style=\"font-size:14.0pt;\">Report of certain government scientific experts: Admitted as evidence without their oral examination, e.g. reports of Chemical Examiner or Director of Fingerprint Bureau/Haffkeine Institute/CFSL.</span></li><li><span style=\"font-size:14.0pt;\">Evidence given by a witness in a previous judicial proceeding: Admitted in a subsequent judicial proceeding when the witness is dead or cannot be found or is incapable of giving evidence or cannot be called without unreasonable delay or expense to the court.</span></li><li><span style=\"font-size:14.0pt;\">Public records: Birth and death certificates, and certificates of marriage.</span></li><li><span style=\"font-size:14.0pt;\">Hospital records: Routine entries, such as date of admission, discharge, pulse, temperature, etc. are admissible without oral evidence.</span></li></ol>",
      "correct_choice_id": 314613,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78962/Fmt_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78962/Fmt_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79060,
      "choices": [
        {
          "id": 315001,
          "text": "<p><span style=\"font-size:14.0pt;\">Aerobic culture of stool</span></p>"
        },
        {
          "id": 315002,
          "text": "<p><span style=\"font-size:14.0pt;\">Glutamate dehydrogenase and toxin assay</span></p>"
        },
        {
          "id": 315003,
          "text": "<p><span style=\"font-size:14.0pt;\">Glutamate dehydrogenase assay</span></p>"
        },
        {
          "id": 315004,
          "text": "<p><span style=\"font-size:14.0pt;\">Nucleic acid amplification test (NAAT) only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old hospitalized man presents with profuse watery diarrhea that began 5 days after completing a course of clindamycin for pneumonia. He is afebrile, but appears mildly dehydrated. On physical exam, there is mild lower abdominal tenderness without peritonitis. The clinician suspects Clostridium difficile–associated diarrhea (CDAD) and sends a stool sample for evaluation. Which of the following is considered the best initial diagnostic approach for the detection of Clostridium difficile in this patient's stool?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3966110",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Glutamate dehydrogenase and toxin assay</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Clostridium difficile infection (CDI)</strong> often occurs after <strong>antibiotic use</strong>, especially with <strong>clindamycin, cephalosporins</strong>, or <strong>fluoroquinolones</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The preferred diagnostic approach is a <strong>two-step algorithm</strong> that begins with:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glutamate dehydrogenase (GDH)</strong> detection: a <strong>sensitive marker</strong> for C. difficile antigen (but not specific).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Toxin A/B assay</strong> (EIA): provides <strong>specificity</strong>, detecting toxins responsible for disease.</span></li><li><span style=\"font-size:14.0pt;\">If results are discordant (e.g., GDH positive, toxin negative), <strong>NAAT (e.g., PCR)</strong> is used as a <strong>tie-breaker</strong> to confirm active toxigenic infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aerobic culture of stool:</strong> <strong>Incorrect</strong> because <strong>C. difficile is an anaerobic organism</strong>. Aerobic conditions would not support its growth, making this method ineffective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glutamate dehydrogenase assay:&nbsp;</strong>While <strong>highly sensitive</strong>, it <strong>does not differentiate</strong> between toxigenic and non-toxigenic strains; using it <strong>alone</strong> can result in <strong>false positives</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nucleic acid amplification test (NAAT) only:</strong> Although <strong>highly sensitive</strong>, NAAT alone can <strong>detect colonization</strong> in asymptomatic individuals, leading to <strong>overdiagnosis</strong>. Therefore, it's <strong>not recommended</strong> as a standalone test in all clinical settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The most reliable initial diagnostic strategy for Clostridium difficile infection involves a combination of glutamate dehydrogenase screening and toxin detection, with NAAT used as a confirmatory test when needed.</span></p>",
      "correct_choice_id": 315002,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79060/Microbiology_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79060/Microbiology_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78929,
      "choices": [
        {
          "id": 314481,
          "text": "<p><span style=\"font-size:14.0pt;\">Expectant management with close follow-up</span></p>"
        },
        {
          "id": 314482,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate surgical evacuation</span></p>"
        },
        {
          "id": 314483,
          "text": "<p><span style=\"font-size:14.0pt;\">Administration of misoprostol for medical management</span></p>"
        },
        {
          "id": 314484,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiation of antibiotic therapy and observation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman at 11 weeks gestation presents to the outpatient obstetrics clinic with complaints of heavy vaginal bleeding and crampy lower abdominal pain for the past 2 days. She has no fever or chills. On speculum examination, her cervix is dilated and products of conception are visible at the cervical os. A transvaginal ultrasound shows a collapsed gestational sac with no fetal pole in the uterine cavity. Her vitals are stable. What is the most appropriate next step in the management of this patient?&nbsp;</span></p>",
      "unique_key": "Q3385239",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Immediate surgical evacuation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This case represents an <strong>inevitable abortion</strong>, which is defined by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vaginal bleeding</span></li><li><span style=\"font-size:14.0pt;\">Cramping</span></li><li><span style=\"font-size:14.0pt;\"><strong>Open cervical os</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Visible products of conception</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of an open os with visible products confirms that the pregnancy is <strong>nonviable and will not continue</strong>. The most appropriate management in this scenario is <strong>surgical evacuation</strong> (e.g., dilation and curettage or suction evacuation). This is done to prevent complications such as hemorrhage, infection, and retained products.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Expectant management:&nbsp;</strong>Appropriate only when the cervix is <strong>closed</strong>, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Misoprostol:&nbsp;</strong>Used to induce expulsion when the cervix is <strong>closed</strong>. It is ineffective and unnecessary if the os is already open.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Antibiotics and observation:&nbsp;</strong>Not indicated in the absence of infection. Surgical management takes priority here due to the open os and retained tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>inevitable abortion</strong> with an open cervix and visible products of conception, the preferred management is <strong>immediate surgical evacuation</strong> to prevent complications such as bleeding or infection. Misoprostol and expectant management are considered only when the os is closed.</span></p>",
      "correct_choice_id": 314482,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78929/Obg_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78929/Obg_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78806,
      "choices": [
        {
          "id": 313997,
          "text": "<p><span style=\"font-size:14.0pt;\">Tubal sterilization</span></p>"
        },
        {
          "id": 313998,
          "text": "<p><span style=\"font-size:14.0pt;\">Implanon</span></p>"
        },
        {
          "id": 313999,
          "text": "<p><span style=\"font-size:14.0pt;\">IUCD</span></p>"
        },
        {
          "id": 314000,
          "text": "<p><span style=\"font-size:14.0pt;\">LNG IUD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All are long-term and reversible contraceptive except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9649312",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Tubal sterilization</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tubal sterilization</strong> is a <strong>permanent</strong> method of contraception, typically done via laparoscopy or mini laparotomy, involving occlusion, cutting, or removal of the fallopian tubes. Although termed “long-term,” it is <strong>not reversible</strong> under standard practice and is not classified under <strong>long-acting reversible contraception (LARC)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Even though reversal surgery (tuboplasty) exists, it is complex, expensive, and has limited success rates.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hence, it is not intended as a reversible method.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Implanon:</strong> A subdermal implant containing <strong>etonogestrel</strong>, effective for up to <strong>3 years</strong>. It is <strong>reversible</strong>, and fertility resumes quickly after removal. It falls under the <strong>LARC</strong> category and is a preferred method for women seeking long-term but reversible contraception.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. IUCD (Intrauterine Contraceptive Device):</strong> Copper-containing device inserted into the uterus, effective for <strong>5–10 years</strong> depending on the type. It is <strong>reversible</strong> fertility returns immediately after removal. It is one of the most widely used LARC methods in India under national family planning programs.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. LNG IUD (Levonorgestrel-releasing IUD):</strong> A hormonal IUD that releases <strong>levonorgestrel</strong>, provides contraception for <strong>5–7 years</strong>. It is <strong>reversible</strong>, with rapid return of fertility after removal. Also used to treat heavy menstrual bleeding, endometrial hyperplasia, and dysmenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To distinguish between <strong>permanent</strong> contraceptive methods and <strong>long-acting reversible contraceptives (LARCs)</strong>, which are emphasized in reproductive health programs for effective family planning with the option of future fertility.</span></p>",
      "correct_choice_id": 313997,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78806/Psm_Q_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78806/Psm_Q_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78881,
      "choices": [
        {
          "id": 314289,
          "text": "<p><span style=\"font-size:14.0pt;\">Keratome</span></p>"
        },
        {
          "id": 314290,
          "text": "<p><span style=\"font-size:14.0pt;\">Scleral punch</span></p>"
        },
        {
          "id": 314291,
          "text": "<p><span style=\"font-size:14.0pt;\">Simcoe’s cannula</span></p>"
        },
        {
          "id": 314292,
          "text": "<p><span style=\"font-size:14.0pt;\">Wire vectis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the instrument shown in the image:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0NXJw04.png\" width=\"338\" height=\"375\"></span></p>",
      "unique_key": "Q4977841",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Simcoe’s cannula</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The instrument in the image is a <strong>Simcoe’s cannula</strong>, which is used in ophthalmic surgery — most notably for <strong>aspiration and irrigation during cataract extraction</strong>. It has a <strong>dual-port system</strong> connected to a syringe or tubing, allowing <strong>simultaneous irrigation and aspiration</strong> of lens material during extracapsular cataract surgery (ECCE).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Keratome:&nbsp;</strong>&nbsp;A surgical blade used to make incisions in the cornea, especially during cataract surgery (phacoemulsification). It does not resemble the instrument shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XxPkDlJ.png\" width=\"386\" height=\"381\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Scleral punch:&nbsp;</strong>&nbsp;Used in glaucoma surgeries (e.g., trabeculectomy) to create a small hole in the sclera. It has a punch-like appearance, unlike the cannula shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nJB1gKG.png\" width=\"695\" height=\"263\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Wire Vectis:&nbsp;</strong>&nbsp;A loop-shaped instrument used to deliver the lens nucleus in Small Incision Cataract Surgery (SICS) or ECCE. It lacks the tubing and dual-port structure seen in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tCTYLT3.png\" width=\"464\" height=\"448\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Simcoe’s cannula is a dual-function ophthalmic instrument used for irrigation and aspiration during cataract surgery.&nbsp;</span></p>",
      "correct_choice_id": 314291,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78881/Ophthalmology_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78881/Ophthalmology_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78900,
      "choices": [
        {
          "id": 314365,
          "text": "<p><span style=\"font-size:14.0pt;\">Epidermolysis bullosa simplex</span></p>"
        },
        {
          "id": 314366,
          "text": "<p><span style=\"font-size:14.0pt;\">Bullous impetigo</span></p>"
        },
        {
          "id": 314367,
          "text": "<p><span style=\"font-size:14.0pt;\">Herpes zoster</span></p>"
        },
        {
          "id": 314368,
          "text": "<p><span style=\"font-size:14.0pt;\">Pemphigus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with vesiculobullous lesions over body. A Tzanck smear is performed. Which of the following conditions is least likely to be diagnosed using this technique?</span></p>",
      "unique_key": "Q7738027",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Epidermolysis bullosa simplex</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Epidermolysis bullosa simplex (EBS)</strong> is a <strong>genetic disorder</strong> characterized by fragile skin and blister formation due to <strong>defect in structural protein</strong> keratin. It <strong>requires diagnosis via skin biopsy with genetic testing</strong>, not a cytological test like Tzanck smear. Hence, Tzanck smear is <strong>not helpful</strong> in diagnosing EB.</span></li><li><span style=\"font-size:14.0pt;\">Direct Immunofluorescence will be negative</span></li><li><span style=\"font-size:14.0pt;\">They are characterised under mechanobullous disorders. There will be little bit of friction and they will produce bullous lesions.</span></li><li><span style=\"font-size:14.0pt;\">The genetic defect will lie in the keratin</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9m4siF6.png\" width=\"531\" height=\"480\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_f41ASeL.png\" width=\"532\" height=\"395\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bullous impetigo:&nbsp;</strong>Can be diagnosed with a Tzanck smear, which demonstrates <strong>acantholytic cells</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Herpes zoster</strong>: Tzanck smear may show <strong>multinucleated giant cells</strong> and <strong>acantholytic cells</strong>—hallmark findings of viral blistering infections like HSV or VZV.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pemphigus</strong>: An <strong>autoimmune blistering disorder</strong>, pemphigus shows <strong>multiple acantholytic cells</strong> (Tzanck cells) on smear, making the test useful for its initial diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tzanck smear is a cytological tool useful in diagnosing blistering skin disorders such as <strong>herpes zoster</strong>, <strong>pemphigus</strong>, and <strong>bullous impetigo</strong> by identifying characteristic cellular changes. It is <strong>not used</strong> in diagnosing genetic conditions like <strong>epidermolysis bullosa simplex</strong>, where genetic testing is required.</span></p>",
      "correct_choice_id": 314365,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78900/Dermatology_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78900/Dermatology_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78821,
      "choices": [
        {
          "id": 314057,
          "text": "<p><span style=\"font-size:14.0pt;\">Treacher Collins syndrome</span></p>"
        },
        {
          "id": 314058,
          "text": "<p><span style=\"font-size:14.0pt;\">Pierre Robin sequence</span></p>"
        },
        {
          "id": 314059,
          "text": "<p><span style=\"font-size:14.0pt;\">Goldenhar syndrome</span></p>"
        },
        {
          "id": 314060,
          "text": "<p><span style=\"font-size:14.0pt;\">Crouzon syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old child is brought to the clinic for evaluation of facial asymmetry and ear abnormalities. On examination, the child has a preauricular skin tag, limbal dermoids in the eye, and underdevelopment of one side of the face. The external ear is malformed. Based on the clinical features and image shown, which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_L1Bs4Ii.png\" width=\"422\" height=\"415\"></span></p>",
      "unique_key": "Q5761134",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Goldenhar syndrome</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Goldenhar syndrome, also known as oculo-auriculo-vertebral (OAV) spectrum, is a congenital condition involving abnormal development of the eye, ear, and spine. Classic features include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Limbal dermoids</strong> (benign growths at the eye limbus)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preauricular skin tags or appendages</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Ear anomalies</strong> (microtia, anotia)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hemifacial microsomia</strong> – underdevelopment of facial structures on one side</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">It is a result of abnormal development of the <strong>first and second branchial arches</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Treacher Collins syndrome:</strong> Involves mandibular and zygomatic bone hypoplasia, downward slanting eyes, but not limbal dermoids or skin tags.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pierre Robin sequence:</strong> Characterized by micrognathia, glossoptosis, and cleft palate, without ear or eye involvement.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Crouzon syndrome:</strong> Craniosynostosis with proptosis and midface hypoplasia; no skin tags or limbal dermoids.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Goldenhar syndrome presents with limbal dermoids, preauricular skin tags, hemifacial microsomia, and ear anomalies due to abnormal development of the first and second branchial arches.</span><br><br>&nbsp;</p>",
      "correct_choice_id": 314059,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78821/Pediatrics_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78821/Pediatrics_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78960,
      "choices": [
        {
          "id": 314605,
          "text": "<p><span style=\"font-size:14.0pt;\">Remove the patch and use condoms until her next menstrual period</span></p>"
        },
        {
          "id": 314606,
          "text": "<p><span style=\"font-size:14.0pt;\">Reapply the same patch using additional adhesive</span></p>"
        },
        {
          "id": 314607,
          "text": "<p><span style=\"font-size:14.0pt;\">Apply a new patch and use a condom for 1 week</span></p>"
        },
        {
          "id": 314608,
          "text": "<p><span style=\"font-size:14.0pt;\">Apply a new patch without additional contraceptive protection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 23-year-old sexually active female presents with a concern regarding her transdermal contraceptive patch. She reports that the patch had been partially detached for more than 24 hours, and she is unsure about what to do next. She is otherwise healthy and not on any medications. To maintain contraceptive efficacy, what is the most appropriate next step?</span></p>",
      "unique_key": "Q4779899",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Apply a new patch and use a condom for 1 week</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When a <strong>transdermal contraceptive patch</strong> becomes <strong>partially or completely detached for &gt;24 hours</strong>, it compromises the <strong>consistent hormone delivery</strong> required to prevent ovulation.</span></li><li><span style=\"font-size:14.0pt;\">The safest and most <strong>evidence-based recommendation</strong> is to:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>Apply a new patch immediately</strong>, and</span></li><li><span style=\"font-size:14.0pt;\"><strong>Use backup contraception</strong> (e.g., condoms) for the <strong>next 7 days</strong> to ensure continuous protection.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">This strategy maintains contraceptive reliability while reducing the risk of unintended pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Remove the patch and use condoms until her next menstrual period:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This approach unnecessarily <strong>discontinues hormonal contraception</strong> and increases the chance of <strong>ovulatory rebound</strong>, risking pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">There is <strong>no recommendation</strong> to abandon the patch entirely unless contraindicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Reapply the same patch using additional adhesive:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A patch that has been detached for <strong>more than 24 hours</strong> should <strong>not be reused</strong>, as drug delivery may no longer be reliable.</span></li><li><span style=\"font-size:14.0pt;\">Additional adhesive does <strong>not restore contraceptive effectiveness</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Apply a new patch without additional contraceptive protection:&nbsp;</strong>Incorrect. While applying a <strong>new patch</strong> is appropriate, <strong>backup contraception is also essential</strong> because the delay has potentially allowed for hormonal drop, which could trigger ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>If a transdermal contraceptive patch has been off or partially detached for more than 24 hours, a new patch should be applied immediately, and a backup method (such as condoms) should be used for 7 days to maintain contraceptive effectiveness.</strong></span></p>",
      "correct_choice_id": 314607,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78960/20th_question_INI_CET_Mock_Test_-_2_OBG.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78960/20th_question_INI_CET_Mock_Test_-_2_OBG.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78798,
      "choices": [
        {
          "id": 313965,
          "text": "<p><span style=\"font-size:14.0pt;\">Quarantine the entire ship and administer prophylactic antibiotics to all passengers.</span></p>"
        },
        {
          "id": 313966,
          "text": "<p><span style=\"font-size:14.0pt;\">Implement rigorous sanitation measures and isolate symptomatic passengers.</span></p>"
        },
        {
          "id": 313967,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaccinate all passengers and crew against norovirus.</span></p>"
        },
        {
          "id": 313968,
          "text": "<p><span style=\"font-size:14.0pt;\">Conduct environmental testing to identify sources of contamination.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A norovirus outbreak has occurred on a cruise ship, affecting multiple passengers. As the medical officer on board, you are tasked with implementing a public health strategy to manage the outbreak effectively. Considering the modes of transmission and the setting, which of the following would be the most appropriate initial step to control the spread of the virus?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2419182",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Implement rigorous sanitation measures and isolate symptomatic passengers.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most effective strategy given the characteristics of norovirus, which spreads rapidly through contaminated food/water or/&amp; direct contact with infected individuals and contaminated surfaces.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Implementing rigorous sanitation measures addresses the environmental control of the virus, significantly reducing the likelihood of surface-mediated transmission.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Isolating symptomatic passengers minimizes person-to-person spread, effectively reducing the outbreak's impact.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This dual approach is pivotal in managing norovirus outbreaks in enclosed environments like a cruise ship, where the proximity of passengers can facilitate widespread transmission.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Quarantine the entire ship and administer prophylactic antibiotics to all passengers:</strong> Incorrect, because antibiotics have no effect on viruses such as norovirus. Quarantine without targeted isolation and sanitation might not prevent the spread among the passengers, as communal areas may already be contaminated.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Vaccinate all passengers and crew against norovirus:</strong> Incorrect, as there is currently no effective vaccine available for norovirus. Even if available, vaccines generally do not confer immediate immunity and thus would not be effective as an immediate response to an ongoing outbreak.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Conduct environmental testing to identify sources of contamination:</strong> Incorrect, while useful for understanding the spread and potentially improving long-term management, this action does not provide a direct or immediate solution to controlling the outbreak.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Effective sanitation and isolation are key to controlling outbreaks of highly infectious diseases like norovirus in settings such as cruise ships.</span></p>",
      "correct_choice_id": 313966,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78798/Psm_Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78798/Psm_Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78847,
      "choices": [
        {
          "id": 314157,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of classical complement pathway by immune complexes</span></p>"
        },
        {
          "id": 314158,
          "text": "<p><span style=\"font-size:14.0pt;\">Alloreactive antibody-mediated response</span></p>"
        },
        {
          "id": 314159,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate innate immune neutrophilic infiltration</span></p>"
        },
        {
          "id": 314160,
          "text": "<p><span style=\"font-size:14.0pt;\">Graft infiltration by CD8+ cytotoxic T cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 53-year-old man with end-stage renal disease undergoes a deceased donor kidney transplant. Minutes after vascular anastomosis and reperfusion, the transplanted kidney becomes pale and mottled, and no urine output is observed. Emergent evaluation reveals rapid vascular thrombosis within the graft. Which of the following is the most likely underlying cause of this complication?&nbsp;</span></p>",
      "unique_key": "Q6441243",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Alloreactive antibody-mediated response</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient is experiencing <strong>hyperacute rejection</strong>, a rare but severe complication that occurs <strong>within minutes to hours after transplantation</strong>, typically during or immediately after <strong>graft reperfusion</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It is caused by <strong>preformed antibodies</strong> (most commonly <strong>anti-HLA</strong> or <strong>anti-ABO</strong>) present in the recipient.</span></li><li><span style=\"font-size:14.0pt;\">These <strong>preformed antibodies</strong> bind to donor endothelial antigens, activating <strong>complement</strong> and leading to <strong>widespread thrombosis</strong>, <strong>ischemia</strong>, and <strong>graft failure</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The kidney becomes <strong>pale, mottled</strong>, and <strong>anuric</strong>, as described in the case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This mechanism aligns with the phrase in the original: <strong>“Preformed antibodies”</strong> → <strong>vascular thrombosis</strong> → <strong>no urine output</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Activation of classical complement pathway by immune complexes: </strong>This mechanism is characteristic of <strong>Type III hypersensitivity reactions</strong> and is involved in <strong>immune complex–mediated glomerulonephritis</strong> or <strong>serum sickness</strong>, not hyperacute transplant rejection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Immediate innate immune neutrophilic infiltration:&nbsp;</strong>While <strong>innate immunity</strong> contributes to general inflammation, <strong>neutrophils are not the initiating factor</strong> in hyperacute rejection. The primary event is <strong>preformed antibody binding</strong>, not neutrophil infiltration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Graft infiltration by CD8+ cytotoxic T cells:&nbsp;</strong>This describes <strong>acute cellular rejection</strong>, which occurs <strong>days to weeks</strong> post-transplant. It is a <strong>T cell–mediated</strong> process, not immediate thrombosis from <strong>antibody-mediated damage</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hyperacute transplant rejection occurs within minutes due to preformed recipient antibodies against donor antigens, leading to rapid thrombosis, ischemia, and graft loss.</span></p>",
      "correct_choice_id": 314158,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78847/Pathology_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78847/Pathology_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78850,
      "choices": [
        {
          "id": 314169,
          "text": "<p><span style=\"font-size:14.0pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 314170,
          "text": "<p><span style=\"font-size:14.0pt;\">Rimegepant</span></p>"
        },
        {
          "id": 314171,
          "text": "<p><span style=\"font-size:14.0pt;\">Lasmiditan</span></p>"
        },
        {
          "id": 314172,
          "text": "<p><span style=\"font-size:14.0pt;\">Eptinezumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 37-year-old woman with a long-standing history of migraine headaches presents to the clinic for medication adjustment. She experiences moderate to severe migraines 2–3 times per month, often associated with nausea, photophobia, and phonophobia. She has a history of coronary artery disease and was advised to avoid vasoconstrictive medications. A new abortive therapy is prescribed that acts as a 5-HT1F receptor agonist without causing vasoconstriction. Which of the following medications was most likely prescribed?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6152635",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Lasmiditan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Lasmiditan</strong> is a <strong>selective serotonin 5-HT<sub>1F&nbsp;</sub>receptor agonist</strong> used for the <strong>acute treatment of migraine</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike triptans (which act on <strong>5-HT <sub>1B/1D</sub> receptors</strong> and cause vasoconstriction), lasmiditan <strong>does not cause vasoconstriction</strong>, making it a suitable choice for patients with <strong>cardiovascular disease</strong>, such as coronary artery disease.</span></li><li><span style=\"font-size:14.0pt;\">Its primary mechanism involves <strong>inhibition of pain pathways</strong> in the trigeminal system, without the vascular effects seen with older agents.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sumatriptan:</strong> &nbsp;A <strong>5-HT1B/1D receptor agonist</strong> and traditional <strong>triptan</strong>. While effective for abortive migraine treatment, it causes <strong>vasoconstriction</strong> and is <strong>contraindicated in patients with coronary artery disease</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Rimegepant:</strong> Rimegepant is a <strong>CGRP receptor antagonist</strong> (a gepant). It is also used for <strong>abortive migraine treatment</strong> and <strong>does not cause vasoconstriction</strong>, but it <strong>does not act on the 5-HT1F receptor</strong>. Therefore, it does not match the mechanism described in the question.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Eptinezumab:</strong> This is a <strong>CGRP monoclonal antibody</strong> used for <strong>migraine prevention</strong>, not abortive treatment. Also, it does <strong>not act on 5-HT receptors</strong>, and its <strong>indication is prophylactic</strong>, not abortive therapy.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lasmiditan is a 5-HT1F receptor agonist used for the acute treatment of migraine. Unlike triptans and ergots, it does not cause vasoconstriction, making it safer for patients with cardiovascular disease.</span></li></ul>",
      "correct_choice_id": 314171,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78850/Pharmacology_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78850/Pharmacology_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79031,
      "choices": [
        {
          "id": 314889,
          "text": "<p><span style=\"font-size:14.0pt;\">Load with IV phenytoin</span></p>"
        },
        {
          "id": 314890,
          "text": "<p><span style=\"font-size:14.0pt;\">Start oral carbamazepine</span></p>"
        },
        {
          "id": 314891,
          "text": "<p><span style=\"font-size:14.0pt;\">Obtain an EEG</span></p>"
        },
        {
          "id": 314892,
          "text": "<p><span style=\"font-size:14.0pt;\">Observe and treat only if seizures recur</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man from Jaipur with a history of poorly controlled hypertension presents with sudden-onset right-sided weakness and altered sensorium. CT brain is taken and it is shown On day 2, he develops a generalized tonic-clonic seizure lasting 90 seconds, followed by a postictal state. His airway is secure, vitals stable, and there is no ongoing seizure activity at present. What is the most appropriate next step in management?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EG2N9sn.png\" width=\"334\" height=\"308\"></span></p>",
      "unique_key": "Q2067398",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Load with IV phenytoin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Patients with acute intracerebral hemorrhage are at risk of <strong>early seizures</strong> (typically within 1–2 weeks of the hemorrhage), particularly in <strong>lobar bleeds with mass effect or cortical involvement</strong>. In this case, the patient has already had a <strong>generalized seizure</strong>, and immediate initiation of <strong>IV antiepileptic drug (AED)</strong> therapy is warranted to prevent recurrence and rising <strong>intracranial pressure (ICP)</strong>, which could precipitate herniation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key Management Principles in Post-ICH Seizures:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_n6h2e3e.png\" width=\"1274\" height=\"689\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Studies have shown that <strong>AED prophylaxis does not improve long-term outcomes</strong> and may even worsen prognosis if used indiscriminately. However, once a seizure occurs, especially in a setting of <strong>ICH with midline shift</strong>, treatment is necessary to minimize secondary brain injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start oral carbamazepine:</strong> Inappropriate due to <strong>delayed onset</strong> and unreliable absorption in acute ICH with altered consciousness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Obtain an EEG:</strong> May be useful for detecting <strong>nonconvulsive status epilepticus (NCSE)</strong> but should <strong>not delay</strong> the initiation of AEDs post-seizure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Observe and treat only if seizures recur:</strong> Observation alone is inappropriate after a seizure in ICH, especially with mass effect, as further seizures risk worsening ICP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with acute ICH who experience an early seizure, prompt administration of IV antiseizure medication is essential to reduce the risk of recurrent seizures and secondary brain injury. EEG and long-term AED therapy may be considered based on seizure recurrence, but treatment must not be delayed after the initial event.</span></p>",
      "correct_choice_id": 314889,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79031/Dr._Dilip_Mock_Test_2_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79031/Dr._Dilip_Mock_Test_2_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78887,
      "choices": [
        {
          "id": 314313,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A</span></p>"
        },
        {
          "id": 314314,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A</span></p>"
        },
        {
          "id": 314315,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false</span></p>"
        },
        {
          "id": 314316,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion-Reason Question:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> Engulfment of pathogens by phagocytes requires pseudopod extension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> Actin polymerization is associated with pseudopod extension during phagocytosis.</span></p>",
      "unique_key": "Q4007205",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Both A and R are true, and R is the correct explanation of A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Engulfment</strong> is a critical step in phagocytosis where phagocytes like neutrophils and macrophages extend membrane <strong>pseudopods</strong> to surround and internalize a pathogen or particle.</span></li><li><span style=\"font-size:14.0pt;\">This process is powered by <strong>actin cytoskeleton remodeling</strong>, specifically <strong>actin polymerization</strong>, which drives the membrane outward to form the pseudopods.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>actin polymerization is not only associated with pseudopod extension</strong>, but is <strong>required for successful engulfment</strong>, making the reason directly explain the assertion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Phagocytic engulfment of pathogens involves actin polymerization, which facilitates pseudopod extension necessary to internalize the target.</span></p>",
      "correct_choice_id": 314313,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78887/Pathology_Q_15_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78887/Pathology_Q_15_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79053,
      "choices": [
        {
          "id": 314973,
          "text": "<p><span style=\"font-size:14.0pt;\">IV labetalol bolus and infusion</span></p>"
        },
        {
          "id": 314974,
          "text": "<p><span style=\"font-size:14.0pt;\">Start nitroglycerin infusion</span></p>"
        },
        {
          "id": 314975,
          "text": "<p><span style=\"font-size:14.0pt;\">Proceed to surgery</span></p>"
        },
        {
          "id": 314976,
          "text": "<p><span style=\"font-size:14.0pt;\">Give aspirin and clopidogrel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man from Chennai with long-standing hypertension presents with sudden onset severe chest pain and he also complains of back pain between scapulae. BP is 210/105 mmHg, HR 94/min. Chest X ray and ECG are shown He is diaphoretic but alert, and physical examination reveals symmetrical peripheral pulses. What is the most appropriate next step?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tUGbRdC.png\" width=\"594\" height=\"333\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eT8ew8F.png\" width=\"548\" height=\"447\"></span></p>",
      "unique_key": "Q3342940",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) IV labetalol bolus and infusion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The combination of tearing chest pain, hypertension, widened mediastinum, and inferior STEMI on ECG raises suspicion for aortic dissection involving the coronary arteries.</span></li><li><span style=\"font-size:14.0pt;\">Inferior MI pattern may occur if dissection involves the right coronary artery ostium.</span></li><li><span style=\"font-size:14.0pt;\">Administering antiplatelets in dissection can cause catastrophic bleeding into the aortic wall.</span></li><li><span style=\"font-size:14.0pt;\">Priority management is to reduce shear stress by controlling heart rate (target HR &lt;60 bpm) and blood pressure (SBP 100–120 mmHg) with IV beta-blockers.</span></li><li><span style=\"font-size:14.0pt;\">Labetalol, having both alpha- and beta-blocking properties, is preferred over pure beta-blockers.</span></li><li><span style=\"font-size:14.0pt;\">After stabilization, urgent imaging with CT angiography should confirm diagnosis prior to surgery.</span></li><li><span style=\"font-size:14.0pt;\">Surgery is definitive for Stanford type A dissection but must follow hemodynamic stabilization.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Dissection vs True STEMI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZfHZZZ9.png\" width=\"1503\" height=\"454\"></strong></span></p>",
      "correct_choice_id": 314973,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79053/Dr._Dilip_Mock_Test_2_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79053/Dr._Dilip_Mock_Test_2_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78860,
      "choices": [
        {
          "id": 314209,
          "text": "<p><span style=\"font-size:14.0pt;\">Gp Ia/IIa complex deficiency</span></p>"
        },
        {
          "id": 314210,
          "text": "<p><span style=\"font-size:14.0pt;\">von Willebrand factor deficiency</span></p>"
        },
        {
          "id": 314211,
          "text": "<p><span style=\"font-size:14.0pt;\">Gp Ib/IX complex deficiency</span></p>"
        },
        {
          "id": 314212,
          "text": "<p><span style=\"font-size:14.0pt;\">Factor VIII deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 23-year-old male presents with a lifelong history of easy bruising and mucosal bleeding. He reports frequent nosebleeds and prolonged bleeding after minor cuts. Platelet count is normal, but peripheral smear shows giant platelets. Platelet aggregation studies demonstrate defective response to ristocetin, which does not correct with addition of normal plasma. What is the most likely underlying defect responsible for this condition?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tQvF5Fc.png\" width=\"469\" height=\"353\"></span></p>",
      "unique_key": "Q9129262",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Gp Ib/IX complex deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has <strong>Bernard-Soulier disease</strong>, a <strong>rare autosomal recessive bleeding disorder</strong> caused by <strong>deficiency or dysfunction of the Gp Ib/IX complex</strong>, which is a critical <strong>platelet membrane receptor</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Gp Ib/IX is the receptor for <strong>von Willebrand factor (vWF)</strong> and is required for <strong>platelet adhesion</strong> to the damaged endothelium.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency results in <strong>impaired platelet adhesion</strong>, leading to mucocutaneous bleeding.</span></li><li><span style=\"font-size:14.0pt;\">Peripheral smear characteristically shows <strong>large (giant) platelets</strong> and mild <strong>thrombocytopenia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IyRpbf7.png\" width=\"518\" height=\"400\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Platelet aggregation studies show an <strong>abnormal response to ristocetin</strong>, and unlike vWF deficiency, the defect <strong>does not correct</strong> when mixed with normal plasma (since the defect is in the platelet, not in plasma vWF).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gp Ia/IIa complex deficiency:&nbsp;</strong>Gp Ia/IIa is a <strong>collagen receptor</strong> and is <strong>not</strong> involved in ristocetin-induced aggregation. Deficiency in this integrin does not cause Bernard-Soulier phenotype or giant platelets.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. von Willebrand factor deficiency:&nbsp;</strong>vWF deficiency (von Willebrand disease) also causes <strong>abnormal ristocetin-induced aggregation</strong>, but the defect <strong>corrects with normal plasma</strong> because vWF is a <strong>plasma protein</strong>, not a platelet membrane component.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Factor VIII deficiency:&nbsp;</strong>This describes <strong>Hemophilia A</strong>, which presents with <strong>deep tissue and joint bleeding</strong>, <strong>not</strong> mucosal bleeding or platelet function abnormalities. Factor VIII plays a role in the <strong>coagulation cascade</strong>, not platelet adhesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bernard-Soulier disease is caused by Gp Ib/IX complex deficiency, resulting in impaired platelet adhesion, mucosal bleeding, giant platelets, and a characteristic non-correctable defect in ristocetin-induced platelet aggregation.</span></p>",
      "correct_choice_id": 314211,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78860/Pathology_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78860/Pathology_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78813,
      "choices": [
        {
          "id": 314025,
          "text": "<p><span style=\"font-size:14.0pt;\">Autoclave and discard in general municipal waste</span></p>"
        },
        {
          "id": 314026,
          "text": "<p><span style=\"font-size:14.0pt;\">Dispose of in a yellow biohazard bag and send for immediate incineration</span></p>"
        },
        {
          "id": 314027,
          "text": "<p><span style=\"font-size:14.0pt;\">Store in a shielded lead-lined container until radiation levels decay, then discard as biohazard waste</span></p>"
        },
        {
          "id": 314028,
          "text": "<p><span style=\"font-size:14.0pt;\">Place in a red container for chemical disinfection and recycling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A pathology laboratory technician in a tertiary hospital collects nasopharyngeal swabs for a patient undergoing radioiodine therapy for thyroid cancer. After collection, the technician asks about proper disposal. Which of the following is the most appropriate disposal method for these swabs?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4742760",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Store in a shielded lead-lined container until radiation levels decay, then discard as biohazard waste</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Radioactive waste cannot be directly incinerated or autoclaved due to radiation hazards.</span></li><li><span style=\"font-size:14.0pt;\">Swabs from radioiodine patients must be stored in radiation-shielded lead containers until the isotope decays before being treated as standard biohazard waste.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Autoclave and discard in general municipal waste: </strong>Incorrect, Radioactive waste cannot be mixed with general waste.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Dispose of in a yellow biohazard bag and send for immediate incineration:&nbsp;</strong>Incorrect, Incineration without prior radioactive decay can lead to environmental radiation contamination.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Place in a red container for chemical disinfection and recycling:&nbsp;</strong>Incorrect, Red containers are for recyclable plastics, not radioactive biomedical waste.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Swabs contaminated with radioactive material must be stored in lead-lined containers until decay before biohazard disposal.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-04-29%20105100.png\" width=\"982\" height=\"945\"></p>",
      "correct_choice_id": 314027,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78813/Psm_Q_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78813/Psm_Q_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78855,
      "choices": [
        {
          "id": 314189,
          "text": "<p><span style=\"font-size:14.0pt;\">Sacubitril functions as an angiotensin-converting enzyme (ACE) inhibitor to reduce preload and afterload.</span></p>"
        },
        {
          "id": 314190,
          "text": "<p><span style=\"font-size:14.0pt;\">Sacubitril is co-administered with valsartan as part of heart failure management with reduced ejection fraction.</span></p>"
        },
        {
          "id": 314191,
          "text": "<p><span style=\"font-size:14.0pt;\">Sacubitril frequently leads to hypercalcemia as a dose-limiting side effect.</span></p>"
        },
        {
          "id": 314192,
          "text": "<p><span style=\"font-size:14.0pt;\">Sacubitril is routinely prescribed in combination with lisinopril for treatment-resistant hypertension.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Sacubitril is true?</span></p>",
      "unique_key": "Q6189215",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Sacubitril is co-administered with valsartan as part of heart failure management with reduced ejection fraction.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sacubitril</strong> is a <strong>neprilysin inhibitor</strong> used in combination with <strong>valsartan</strong> (an angiotensin receptor blocker) to form an <strong>angiotensin receptor–neprilysin inhibitor (ARNI)</strong>. This combination is indicated in <strong>chronic heart failure with reduced ejection fraction (HFrEF)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Neprilysin inhibition increases <strong>natriuretic peptides</strong>, <strong>bradykinin</strong>, and <strong>substance P</strong>, resulting in <strong>vasodilation</strong>, <strong>natriuresis</strong>, and <strong>reduced sympathetic tone</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Sacubitril is <strong>never combined with ACE inhibitors</strong> due to increased risk of <strong>angioedema</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sacubitril functions as an angiotensin-converting enzyme (ACE) inhibitor to reduce preload and afterload:&nbsp;</strong>Sacubitril is <strong>not</strong> an ACE inhibitor; it is a <strong>neprilysin inhibitor</strong>. Combining it with an ACE inhibitor increases the risk of <strong>angioedema</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sacubitril frequently leads to hypercalcemia as a dose-limiting side effect: Hypercalcemia</strong> is not a recognized adverse effect. Possible adverse effects include <strong>hypotension</strong>, <strong>hyperkalemia</strong>, and <strong>renal dysfunction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sacubitril is routinely prescribed in combination with lisinopril for treatment-resistant hypertension:&nbsp;</strong>Sacubitril is <strong>contraindicated with ACE inhibitors</strong> like <strong>lisinopril</strong> due to <strong>angioedema risk</strong> and is not used for routine <strong>hypertension management</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sacubitril is a neprilysin inhibitor used in combination with valsartan (as an ARNI) for the treatment of heart failure with reduced ejection fraction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is not combined with ACE inhibitors due to the risk of angioedema.</span></li></ul>",
      "correct_choice_id": 314190,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78855/Pharmacology_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78855/Pharmacology_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79056,
      "choices": [
        {
          "id": 314985,
          "text": "<p><span style=\"font-size:14.0pt;\">C1 esterase</span></p>"
        },
        {
          "id": 314986,
          "text": "<p><span style=\"font-size:14.0pt;\">ADAMTS13</span></p>"
        },
        {
          "id": 314987,
          "text": "<p><span style=\"font-size:14.0pt;\">vWF multimers</span></p>"
        },
        {
          "id": 314988,
          "text": "<p><span style=\"font-size:14.0pt;\">Fibrinogen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old woman presents to the emergency department with complaints of progressive fatigue, easy bruising over her limbs, and episodes of confusion over the last three days. She has no fever, joint pains, or bleeding from any orifices. Examination reveals scattered petechiae on her lower extremities and mild disorientation to time. No organomegaly is noted. Laboratory investigations reveal:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-02%20155955.png\" width=\"574\" height=\"170\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Peripheral smear shown below&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sFu9z0I.png\" width=\"417\" height=\"293\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which laboratory value is most likely to be decreased in this patient?</span></p>",
      "unique_key": "Q4301066",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) ADAMTS13</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The combination of anemia, severe thrombocytopenia, schistocytes on smear, renal impairment, and neurological symptoms points toward <strong>thrombotic thrombocytopenic purpura (TTP)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">TTP is caused by a <strong>severe deficiency of ADAMTS13</strong>, a protease that normally cleaves large von Willebrand factor multimers; activity is typically &lt;10%.</span></li><li><span style=\"font-size:14.0pt;\">The uncontrolled accumulation of vWF multimers leads to widespread microvascular platelet-rich thrombi, causing tissue ischemia.</span></li><li><span style=\"font-size:14.0pt;\">Normal PT/INR and fibrinogen levels help differentiate TTP from disseminated intravascular coagulation (DIC), where fibrinogen is decreased and coagulation parameters are deranged.</span></li><li><span style=\"font-size:14.0pt;\">Plasma exchange is the first-line treatment and dramatically improves survival.</span></li><li><span style=\"font-size:14.0pt;\">Compared to DIC, where coagulation abnormalities dominate, TTP is primarily a platelet-vWF mediated process.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>HUS-TTP vs DIC:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9XFyRqy.png\" width=\"1497\" height=\"336\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. C1 esterase:</strong> Decreased in hereditary angioedema presenting with episodic edema, not with microangiopathic hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. vWF multimers:</strong> Increased or normal in TTP due to deficient cleavage, not decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fibrinogen:</strong> Typically remains normal in TTP; decreased fibrinogen suggests DIC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Thrombotic thrombocytopenic purpura is characterized by severe ADAMTS13 deficiency leading to microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction; diagnosis must be suspected clinically and treated urgently with plasma exchange.</span></p>",
      "correct_choice_id": 314986,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79056/Dr._Dilip_Mock_Test_2_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79056/Dr._Dilip_Mock_Test_2_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78883,
      "choices": [
        {
          "id": 314297,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1, 2, and 5 are correct</span></p>"
        },
        {
          "id": 314298,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2, 3, and 4 are correct</span></p>"
        },
        {
          "id": 314299,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1, 4, and 5 are correct</span></p>"
        },
        {
          "id": 314300,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Nd:YAG laser posterior capsulotomy is/are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Nd:YAG laser posterior capsulotomy is routinely performed in cases of posterior capsular opacification (PCO).</span></li><li><span style=\"font-size:14.0pt;\">The procedure creates an opening in the posterior capsule to improve visual axis clarity.</span></li><li><span style=\"font-size:14.0pt;\">This technique is rarely used in pediatric cataract patients due to the higher risk of inflammation and recurrence.</span></li><li><span style=\"font-size:14.0pt;\">Nd:YAG posterior capsulotomy is commonly used as a preventive measure during primary cataract surgery.</span></li><li><span style=\"font-size:14.0pt;\">Nd:YAG laser works via photodisruption, producing plasma and shock waves to create a capsular opening.</span></li></ol>",
      "unique_key": "Q2464501",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only statements 1, 2, and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1 - Correct:&nbsp;</strong>This is the <strong>primary indication</strong> for Nd:YAG capsulotomy. <strong>PCO</strong> is the most common delayed complication after cataract surgery. It results from <strong>residual lens epithelial cell proliferation</strong> on the posterior capsule, leading to decreased visual acuity. Nd:YAG laser (1064 nm) is used to create an opening in the opacified capsule to <strong>restore vision</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2 - Correct:&nbsp;</strong>The goal of Nd:YAG capsulotomy is to <strong>restore a clear visual axis</strong> by creating a central opening in the posterior capsule. This helps remove the obstructive opacification caused by PCO and improves <strong>visual acuity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5 – Correct:</strong> Nd:YAG laser creates capsular openings via <strong>photodisruption</strong>, generating <strong>plasma and shock waves</strong> that precisely cut tissue <strong>without mechanical contact</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3 –&nbsp;</strong>Incorrect, in <strong>pediatric patients</strong>, PCO is usually managed <strong>intraoperatively</strong> via <strong>surgical posterior capsulotomy with anterior vitrectomy</strong>, because children are less cooperative for laser treatment, and recurrence is high. So, <strong>Nd:YAG laser is not first-line</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4 –&nbsp;</strong>Incorrect, Nd: YAG capsulotomy is <strong>not used as a preventive</strong> step during primary cataract surgery. It is performed <strong>postoperatively</strong>, when PCO has already occurred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nd:YAG laser capsulotomy treats posterior capsular opacification using photodisruption. It is not a preventive measure nor commonly used in children, who typically undergo surgical posterior capsulotomy and anterior vitrectomy.</span></p>",
      "correct_choice_id": 314297,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78883/Ophthalmology_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78883/Ophthalmology_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78834,
      "choices": [
        {
          "id": 314109,
          "text": "<p><span style=\"font-size:14.0pt;\">Class I&nbsp;</span></p>"
        },
        {
          "id": 314110,
          "text": "<p><span style=\"font-size:14.0pt;\">Class II&nbsp;</span></p>"
        },
        {
          "id": 314111,
          "text": "<p><span style=\"font-size:14.0pt;\">Class III&nbsp;</span></p>"
        },
        {
          "id": 314112,
          "text": "<p><span style=\"font-size:14.0pt;\">Class IV&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old female with a history of gallstones undergoes an elective laparoscopic cholecystectomy. During the procedure, the gallbladder is carefully dissected, and there is controlled entry into the biliary tract without spillage of bile or pus. The surgical field remains clean throughout the procedure, and the wound is primarily closed without signs of infection. On postoperative day 2, the patient remains afebrile with no signs of wound infection. Which of the following best classifies the surgical wound in this case?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1158227",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Class II&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This classification applies when <strong>controlled entry into the respiratory, alimentary, biliary, or genitourinary tract</strong> occurs without <strong>unusual contamination</strong> or major breaches in sterile technique.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, <strong>laparoscopic cholecystectomy involves entry into the biliary tract, but there was no gross contamination or bile spillage, making it a clean-contaminated wound</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Class I (Clean):</strong> Clean wounds <strong>do not involve entry into the respiratory, gastrointestinal, or genitourinary tract.</strong> Since this procedure <strong>involves the biliary tract</strong>, it is <strong>not a clean wound</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Class III (Contaminated):</strong> Wounds in this category involve <strong>major sterile technique breaks, open traumatic wounds, or gross spillage from the gastrointestinal tract.</strong> Since there was <strong>no bile spillage or infection in this case</strong>, this is <strong>incorrect</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Class IV (Dirty):</strong> These wounds involve <strong>existing infection, abscess, or perforated viscera.</strong> Since this was an <strong>elective surgery with no infection</strong>, it does <strong>not qualify as a dirty wound</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Clean-contaminated surgical wounds (Class II)</strong> occur when there is <strong>controlled entry into hollow organs such as the gastrointestinal, biliary, respiratory, or genitourinary tract</strong> without significant contamination.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Understanding surgical wound classification</strong> helps in predicting <strong>postoperative infection risk and the need for prophylactic antibiotics.</strong></span></li></ul>",
      "correct_choice_id": 314110,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78834/Surgery_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78834/Surgery_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78873,
      "choices": [
        {
          "id": 314261,
          "text": "<p><span style=\"font-size:14.0pt;\">Lobular carcinoma in situ</span></p>"
        },
        {
          "id": 314262,
          "text": "<p><span style=\"font-size:14.0pt;\">Colloid carcinoma</span></p>"
        },
        {
          "id": 314263,
          "text": "<p><span style=\"font-size:14.0pt;\">Cribriform subtype of ductal carcinoma in situ</span></p>"
        },
        {
          "id": 314264,
          "text": "<p><span style=\"font-size:14.0pt;\">Comedo subtype of ductal carcinoma in situ</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 49-year-old woman undergoes screening mammography, which reveals suspicious linear and branching calcifications in the upper outer quadrant of the breast. A core needle biopsy is performed, and histopathologic examination demonstrates ductal epithelial proliferation with central necrosis and calcification. Which of the following is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q5303109",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Comedo subtype of ductal carcinoma in situ</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Comedo subtype of ductal carcinoma in situ (DCIS)</strong> is characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>High-grade malignant cells</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Central necrosis</strong>, which leads to <strong>dystrophic calcification</strong></span></li><li><span style=\"font-size:14.0pt;\">Often detected via <strong>screening mammogram</strong> due to <strong>microcalcifications</strong></span></li><li><span style=\"font-size:14.0pt;\">Represents an aggressive form of <strong>in situ breast carcinoma</strong> confined to ducts</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>presence of both necrosis and calcification</strong> is a classic feature of <strong>Comedo DCIS</strong>, making it the most likely diagnosis in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cKikaNg.png\" width=\"351\" height=\"420\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lobular carcinoma in situ (LCIS):&nbsp;</strong>LCIS typically does <strong>not show necrosis or calcification</strong>. It is usually an <strong>incidental microscopic finding</strong> and does not form masses or calcifications visible on mammography.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Colloid carcinoma:&nbsp;</strong>Also known as <strong>mucinous carcinoma</strong>, this is a rare <strong>invasive breast carcinoma</strong> subtype composed of <strong>extracellular mucin pools</strong>. It does not feature <strong>central necrosis or calcification</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cribriform subtype of DCIS:&nbsp;</strong>While this DCIS subtype shows <strong>uniform cribriform (sieve-like) spaces</strong>, it typically <strong>lacks central necrosis and calcification</strong>. It is a <strong>low-grade</strong> form of DCIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Comedo subtype of ductal carcinoma in situ is characterized by central necrosis and calcification, making it detectable on mammography as suspicious microcalcifications.</span></p>",
      "correct_choice_id": 314264,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78873/Pathology_Q_10_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78873/Pathology_Q_10_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78878,
      "choices": [
        {
          "id": 314281,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased choroidal visibility due to reduced pigmentation in the outer retina</span></p>"
        },
        {
          "id": 314282,
          "text": "<p><span style=\"font-size:14.0pt;\">Structural indentation of the sclera near the optic disc</span></p>"
        },
        {
          "id": 314283,
          "text": "<p><span style=\"font-size:14.0pt;\">Localized vitreoretinal traction in the peripheral retina</span></p>"
        },
        {
          "id": 314284,
          "text": "<p><span style=\"font-size:14.0pt;\">Dislocation of the lens due to defective zonular fibers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old woman presents for a routine eye exam. She has a long-standing history of progressive high myopia since adolescence. On dilated fundus examination, the ophthalmologist notes a tigroid or tessellated appearance of the fundus, particularly in the posterior pole. Which of the following best explains this fundoscopic finding?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7939923",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Increased choroidal visibility due to reduced pigmentation in the outer retina</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>tigroid or tessellated fundus pattern</strong> seen in <strong>high myopia</strong> results from <strong>thinning of the retinal pigment epithelium (RPE)</strong> and <strong>choroid</strong>, making the underlying <strong>choroidal vessels more visible</strong>. This creates a characteristic \"tigroid\" or \"leopard-skin\" appearance, most prominent in the posterior pole. It is a hallmark of long-standing axial myopia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Structural indentation of the sclera near the optic disc:&nbsp;</strong>&nbsp;Describes <strong>posterior staphyloma</strong>, which is another finding in high myopia but not the cause of the <strong>tigroid pattern</strong>. It is a bulging of the weakened sclera, not thinning of the RPE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Localized vitreoretinal traction in the peripheral retina:&nbsp;</strong>&nbsp;Refers to <strong>lattice degeneration</strong>, which is a peripheral retinal condition associated with risk of retinal tears or detachment — <strong>not responsible for the posterior pole tigroid appearance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dislocation of the lens due to defective zonular fibers:&nbsp;</strong>&nbsp;Seen in <strong>ectopia lentis</strong>, as in Marfan or homocystinuria, unrelated to the fundus pigmentation or tigroid pattern seen in myopia.</span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The tigroid or tessellated appearance of the fundus in high myopia results from thinning of the retinal pigment epithelium and choroid, making choroidal vessels more visible. This is a characteristic finding in longstanding axial myopia.</span></p>",
      "correct_choice_id": 314281,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78878/Ophthalmology_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78878/Ophthalmology_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78902,
      "choices": [
        {
          "id": 314373,
          "text": "<p><span style=\"font-size:14.0pt;\">The median nerve of the right hand is injured.</span></p>"
        },
        {
          "id": 314374,
          "text": "<p><span style=\"font-size:14.0pt;\">There is weakness of thenar muscles on the right side.</span></p>"
        },
        {
          "id": 314375,
          "text": "<p><span style=\"font-size:14.0pt;\">The adductor pollicis of the right side is weak.</span></p>"
        },
        {
          "id": 314376,
          "text": "<p><span style=\"font-size:14.0pt;\">The flexor muscles of the thumb of the right hand are weak.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old patient presents to the orthopedic clinic with complaints of progressive weakness in his right hand. The patient reports difficulty in fine movements of the hand. The doctor performed a test over the patient, as shown in the image. Which of the following statements is true about the given image?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_44IsS1h.png\" width=\"500\" height=\"374\"></strong></span></p>",
      "unique_key": "Q8527065",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) The adductor pollicis of the right side is weak</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The test shown in the image is called the <strong>Froment's sign</strong>, also known as the <strong>book test</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This test is used to assess the function of the <strong>ulnar nerve</strong>, specifically the function of the <strong>adductor pollicis</strong> muscle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In the normal hand, the patient should be able to hold a book (or paper) using adduction of the thumb. The <strong>ulnar nerve</strong> is responsible for this movement through the <strong>adductor pollicis</strong> muscle.</span></li><li><span style=\"font-size:14.0pt;\">In this patient, the <strong>ulnar nerve</strong> is damaged, leading to weakness of the <strong>adductor pollicis</strong> muscle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Adductor pollicis is graveyard of the ulnar nerve.</span></li><li><span style=\"font-size:14.0pt;\">As a result, the patient compensates by using the <strong>flexor pollicis longus</strong> (supplied by the <strong>median nerve</strong>) to flex the thumb while holding the paper, as seen in the image.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is why the thumb flexes rather than adducts.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The median nerve of the right hand is injured:</strong> This is incorrect because the <strong>median nerve</strong> is not responsible for the adduction of the thumb. It innervates the <strong>flexor pollicis longus</strong>, which is compensating in this test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. There is weakness of the thenar muscles on the right side:</strong> This is incorrect because the thenar muscles (which are innervated by the <strong>median nerve</strong>) are not affected. The issue is with the <strong>adductor pollicis</strong> (innervated by the <strong>ulnar nerve</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The flexor muscles of the thumb of the right hand are weak:</strong> This is incorrect because the flexor muscles of the thumb (innervated by the <strong>median nerve</strong>) are functioning and are compensating for the weakened <strong>adductor pollicis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Froment’s sign</strong> is a test for <strong>ulnar nerve damage</strong>, specifically testing the <strong>adductor pollicis</strong> muscle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When the ulnar nerve is damaged, the patient compensates by using the <strong>flexor pollicis longus</strong>, resulting in flexion of the thumb instead of adduction.</span></li></ul>",
      "correct_choice_id": 314375,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78902/Anatomy_Q_3Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78902/Anatomy_Q_3Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79091,
      "choices": [
        {
          "id": 315121,
          "text": "<p><span style=\"font-size:14.0pt;\">Hexose monophosphate shunt dehydrogenase</span></p>"
        },
        {
          "id": 315122,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytoplasmic malate dehydrogenase</span></p>"
        },
        {
          "id": 315123,
          "text": "<p><span style=\"font-size:14.0pt;\">6-phosphogluconate dehydrogenase</span></p>"
        },
        {
          "id": 315124,
          "text": "<p><span style=\"font-size:14.0pt;\">Malic enzyme</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman undergoing metabolic evaluation for a suspected lipid metabolism disorder is found to have impaired fatty acid synthesis. Further biochemical analysis reveals a deficiency in NADPH production. Which of the following enzymes is least likely to contribute to the NADPH pool required for fatty acid biosynthesis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5651642",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cytoplasmic malate dehydrogenase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fatty acid synthesis requires a continuous supply of <strong>NADPH</strong>, which acts as a reducing agent. Major sources of NADPH include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Glucose-6-phosphate dehydrogenase</strong> (now rephrased as Hexose monophosphate shunt dehydrogenase in option a): catalyzes the first step in the <strong>pentose phosphate pathway (PPP)</strong> and produces NADPH.</span></li><li><span style=\"font-size:14.0pt;\"><strong>6-phosphogluconate dehydrogenase</strong>: catalyzes a later step in PPP and also generates NADPH.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Malic enzyme</strong>: catalyzes the decarboxylation of malate to pyruvate in the cytoplasm and generates NADPH.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cytoplasmic malate dehydrogenase</strong>, however, is involved in the interconversion of <strong>malate and oxaloacetate</strong>, and <strong>does not produce NADPH</strong>. It is part of the <strong>malate-aspartate shuttle</strong>, which transfers NADH, not NADPH, across mitochondrial membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>main sources of NADPH</strong> for anabolic reactions like fatty acid synthesis are the <strong>pentose phosphate pathway</strong> and the <strong>malic enzyme reaction</strong>. <strong>Cytoplasmic malate dehydrogenase does not produce NADPH</strong> and is not involved in fatty acid biosynthesis.</span></p>",
      "correct_choice_id": 315122,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79091/Biochem_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79091/Biochem_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78842,
      "choices": [
        {
          "id": 314137,
          "text": "<p><span style=\"font-size:14.0pt;\">Ureteric calculi&nbsp;</span></p>"
        },
        {
          "id": 314138,
          "text": "<p><span style=\"font-size:14.0pt;\">Bone lesions</span></p>"
        },
        {
          "id": 314139,
          "text": "<p><span style=\"font-size:14.0pt;\">Mental confusion</span></p>"
        },
        {
          "id": 314140,
          "text": "<p><span style=\"font-size:14.0pt;\">Skin rash&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are seen in symptomatic primary hyperparathyroidism except?</span></p>",
      "unique_key": "Q5238916",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Skin rash&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Skin rash is not typically associated with PHPT.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The classical symptoms are related to the effects of high calcium levels on bones, kidneys, gastrointestinal tract, and the central nervous system.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ureteric calculi:&nbsp;</strong>Renal and ureteric calculi are a common manifestation of primary hyperparathyroidism (PHPT). The condition can lead to hypercalcemia, which in turn can cause calcium to precipitate in kidneys leading to calcium oxalate stones.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bone lesions:&nbsp;</strong>Patients with PHPT can experience bone pain and skeletal fragility. This is due to excess PTH stimulating bone resorption, which can lead to osteitis fibrosa cystica, a condition where bones become weak and deformed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mental confusion:&nbsp; </strong>Elevated calcium levels associated with PHPT can result in neuropsychiatric manifestations, including mental confusion, fatigue, depression, and memory impairment, often referred to as \"psychiatric moans\"</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Skin rash is not a typical manifestation of symptomatic primary hyperparathyroidism, which is classically characterized by symptoms involving the bones, kidneys, gastrointestinal tract, and central nervous system, summarized by the phrase ‘painful bones, renal stones, abdominal groans, fatigue overtones and psychiatric moans’.</span></li></ul>",
      "correct_choice_id": 314140,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78842/Surgery_Q_11_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78842/Surgery_Q_11_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78937,
      "choices": [
        {
          "id": 314513,
          "text": "<p><span style=\"font-size:14.0pt;\">Trisomy 13</span></p>"
        },
        {
          "id": 314514,
          "text": "<p><span style=\"font-size:14.0pt;\">Trisomy 18</span></p>"
        },
        {
          "id": 314515,
          "text": "<p><span style=\"font-size:14.0pt;\">Trisomy 21</span></p>"
        },
        {
          "id": 314516,
          "text": "<p><span style=\"font-size:14.0pt;\">Neural tube defect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old pregnant woman at 17 weeks gestation undergoes a second-trimester quadruple screening test. The results show the following:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">β-hCG: ↑</span></li><li><span style=\"font-size:14.0pt;\">Alpha-fetoprotein (AFP): ↓</span></li><li><span style=\"font-size:14.0pt;\">Unconjugated estriol (uE3): ↓</span></li><li><span style=\"font-size:14.0pt;\">Inhibin A: ↑</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following chromosomal abnormalities is most consistent with this pattern?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8643230",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Trisomy 21</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>quadruple test</strong> includes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>β-hCG</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Alpha-fetoprotein (AFP)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Unconjugated estriol (uE3)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Inhibin A</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The typical pattern of results seen in <strong>Trisomy 21 (Down syndrome)</strong> is:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>↑ β-hCG</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>↓ AFP</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>↓ uE3</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>↑ Inhibin A</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This pattern reflects the <strong>placental dysfunction</strong> associated with Down syndrome and is a classic profile detected in second-trimester screening.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Trisomy 13 (Patau syndrome):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">β-hCG: Normal or ↓</span></li><li><span style=\"font-size:14.0pt;\">AFP: ↑</span></li><li><span style=\"font-size:14.0pt;\">uE3: ↓</span></li><li><span style=\"font-size:14.0pt;\">Inhibin A: Not diagnostic</span><br><span style=\"font-size:14.0pt;\">→ AFP is increased, but β-hCG is not elevated, making this unlikely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Trisomy 18 (Edwards syndrome):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">All three (β-hCG, AFP, uE3) ↓</span></li><li><span style=\"font-size:14.0pt;\">Inhibin A: not useful</span><br><span style=\"font-size:14.0pt;\">→ Doesn’t match the elevated β-hCG and Inhibin A.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Neural tube defect:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>↑ AFP</strong>, normal β-hCG, uE3, and Inhibin A</span><br><span style=\"font-size:14.0pt;\">→ Isolated elevation of AFP only.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>Trisomy 21</strong>, the quadruple screen shows <strong>↑ β-hCG and Inhibin A</strong>, and <strong>↓ AFP and uE3</strong>. This distinct pattern helps in early risk stratification for Down syndrome in the second trimester.</span></p>",
      "correct_choice_id": 314515,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78937/Obg_Q_9_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78937/Obg_Q_9_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79050,
      "choices": [
        {
          "id": 314961,
          "text": "<p><span style=\"font-size:14.0pt;\">Trimethoprim-sulfamethoxazole</span></p>"
        },
        {
          "id": 314962,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhaled pentamidine</span></p>"
        },
        {
          "id": 314963,
          "text": "<p><span style=\"font-size:14.0pt;\">Oseltamivir</span></p>"
        },
        {
          "id": 314964,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone and azithromycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-week pregnant woman from Hyderabad, known to be HIV-positive, presents with a 2-week history of worsening dry cough, low-grade fever, and progressive breathlessness. She denies hemoptysis, chest pain, or purulent sputum. Her last CD4 count, six weeks ago, was 180 cells/µL, and she reports irregular adherence to antiretroviral therapy. On examination, her temperature is 37.8°C, respiratory rate is 22/min, and oxygen saturation is 91% on room air. Chest auscultation is clear. Chest X-ray shows no focal infiltrates or consolidation. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q3737433",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Trimethoprim-sulfamethoxazole</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical picture is strongly suggestive of <strong>Pneumocystis jirovecii pneumonia (PCP)</strong>, a common opportunistic infection in HIV-positive individuals with CD4 &lt;200 cells/μL.</span></li><li><span style=\"font-size:14.0pt;\">PCP often presents with <strong>progressive dyspnea, dry cough, low-grade fever, and hypoxia</strong>, despite a <strong>normal or near-normal chest X-ray</strong> early in the disease course.</span></li><li><span style=\"font-size:14.0pt;\">Chest radiographic findings may be normal in 5-30% of patients with a diagnosis of PCP. The literature reports a false-negative rate of 35- 40% when chest radiography is used for diagnosis of PCP.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Trimethoprim-sulfamethoxazole (TMP-SMX)</strong> remains the <strong>first-line treatment</strong> for PCP, including during pregnancy after the first trimester.</span></li><li><span style=\"font-size:14.0pt;\">Adjunctive corticosteroids (e.g., prednisone) should be added if PaO₂ &lt;70 mmHg or if the alveolar-arterial (A–a) gradient exceeds 35 mmHg.</span></li><li><span style=\"font-size:14.0pt;\">Oseltamivir treats influenza, and ceftriaxone plus azithromycin is reserved for typical <strong>bacterial community-acquired pneumonia</strong>, which presents differently.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">PCP vs Bacterial Pneumonia vs Influenza:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5DcibOz.png\" width=\"1388\" height=\"449\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inhaled pentamidine:</strong> Used for prophylaxis, not effective for treating active PCP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oseltamivir:</strong> Appropriate for influenza, which presents with acute high-grade fever, myalgias, and systemic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ceftriaxone and azithromycin:</strong> Standard empiric therapy for bacterial pneumonia but ineffective against Pneumocystis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In HIV-positive patients presenting with possible Pneumocystis jirovecii pneumonia one should treat with trimethoprim-sulfamethoxazole, even during pregnancy.</span></p>",
      "correct_choice_id": 314961,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79050/Dr._Dilip_Mock_Test_2_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79050/Dr._Dilip_Mock_Test_2_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78836,
      "choices": [
        {
          "id": 314117,
          "text": "<p><span style=\"font-size:14.0pt;\">Deep vein thrombosis (DVT)</span></p>"
        },
        {
          "id": 314118,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic venous insufficiency&nbsp;</span></p>"
        },
        {
          "id": 314119,
          "text": "<p><span style=\"font-size:14.0pt;\">Lymphedema</span></p>"
        },
        {
          "id": 314120,
          "text": "<p><span style=\"font-size:14.0pt;\">Peripheral arterial disease (PAD)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient undergoes the procedure shown in the image. What is the most likely underlying pathology?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NMiLF58.png\" width=\"528\" height=\"285\"></span></p>",
      "unique_key": "Q3342505",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Chronic venous insufficiency</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The images depict <strong>Endovenous Laser Ablation (EVLA)</strong>, a <strong>minimally invasive procedure</strong> used for treating <strong>chronic venous insufficiency (CVI) and varicose veins</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this condition, <strong>venous valve dysfunction leads to reflux</strong>, causing <strong>venous stasis, edema, and venous hypertension</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">EVLT works by using <strong>laser energy</strong> to cause <strong>thermal ablation</strong> of the affected vein, leading to fibrosis and closure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Deep vein thrombosis (DVT):&nbsp;</strong>DVT presents with <strong>unilateral limb swelling, tenderness, and warmth</strong>, and is diagnosed with <strong>compression ultrasound</strong>. It is managed with <strong>anticoagulation</strong>, not <strong>EVLT</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lymphedema:</strong> Lymphedema results from <strong>lymphatic obstruction</strong>, leading to <strong>painless, non-pitting edema</strong>. It does not improve with leg elevation and is not treated with EVLT. It is treated with limb reductive surgeries.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Peripheral arterial disease (PAD):&nbsp;</strong>PAD is due to <strong>atherosclerosis</strong> causing <strong>claudication and ischemic symptoms</strong>. It is diagnosed with <strong>Ankle-Brachial Index (ABI)</strong> and treated with <strong>revascularization</strong>, not EVLT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">EVLT (Endovenous Laser Therapy) is a <strong>first-line minimally invasive treatment</strong> for <strong>chronic venous insufficiency and varicose veins</strong>, caused by <strong>venous valve incompetence</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Patients present with <strong>leg pain, edema, and visible varicosities</strong>, which worsen with prolonged standing and improve with leg elevation.</span></li></ul>",
      "correct_choice_id": 314118,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78836/Surgery_Q_6_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78836/Surgery_Q_6_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78907,
      "choices": [
        {
          "id": 314393,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-4, C-3, D-1</span></p>"
        },
        {
          "id": 314394,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-1, C-4, D-3</span></p>"
        },
        {
          "id": 314395,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-3, C-4, D-1</span></p>"
        },
        {
          "id": 314396,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-3, C-1, D-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_B2PzX1r.png\" width=\"843\" height=\"194\"></p>",
      "unique_key": "Q9540894",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A-2, B-3, C-4, D-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A. Lingual artery is a branch of the external carotid artery (ECA), responsible for supplying the tongue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">B. Vertebral artery is a branch of the subclavian artery, providing blood supply to the brain and forming part of the Circle of Willis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">C. Anterior cerebral artery is a branch of the internal carotid artery (ICA), forming part of the Circle of Willis and supplying the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">D. Iliolumbar artery is a branch of the internal iliac artery, supplying the pelvic region and lower back.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qsfO0ma.png\" width=\"1001\" height=\"311\"></strong></span></p>",
      "correct_choice_id": 314395,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78907/Anatomy_Q_5Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78907/Anatomy_Q_5Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78844,
      "choices": [
        {
          "id": 314145,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate surgical excision of the cyst</span></p>"
        },
        {
          "id": 314146,
          "text": "<p><span style=\"font-size:14.0pt;\">PAIR<strong>&nbsp;</strong>procedure with prior albendazole treatment</span></p>"
        },
        {
          "id": 314147,
          "text": "<p><span style=\"font-size:14.0pt;\">Observation and repeat imaging after 6 months</span></p>"
        },
        {
          "id": 314148,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiation of high-dose praziquantel therapy alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old shepherd from a rural region presents with dull right upper quadrant pain and intermittent fever for 2 months. He reports weight loss but no jaundice or vomiting. On abdominal examination, a vague mass is palpable in the right hypochondrium. An ultrasound is shown in the image. Which of the following is the next best step in management?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_yDql0hq.png\" width=\"432\" height=\"245\"></span></p>",
      "unique_key": "Q6198211",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) PAIR procedure with prior albendazole treatment</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hydatid disease caused by Echinococcus granulosus presents with cysts in the liver or lungs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of the classic \"floating membrane\" on ultrasound confirms the diagnosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PAIR with albendazole is the preferred first-line treatment for symptomatic uncomplicated or uncalcified hydatid cysts.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is minimally invasive and avoids the risks of open surgery.</span></li><li><span style=\"font-size:14.0pt;\">If the cyst is calcified and symptomatic, wait and watch.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Immediate surgical excision:</strong> It is generally reserved for complicated cysts (e.g., those that are large, ruptured, infected, or exerting pressure on nearby structures). Surgery carries a higher risk and is not the initial management in uncomplicated cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Observation and repeat imaging after 6 months</strong>: It is not appropriate given the symptoms and imaging confirmation. Delaying treatment may increase the risk of rupture or secondary infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Initiation of high-dose praziquantel therapy alone:</strong> Albendazole is the anti-parasitic drug of choice; praziquantel is not first-line for Echinococcus. Monotherapy with praziquantel is not effective in hydatid disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aTvPXlq.png\" width=\"734\" height=\"269\"></strong></span></p>",
      "correct_choice_id": 314146,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78844/Surgery_Q_13_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78844/Surgery_Q_13_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78893,
      "choices": [
        {
          "id": 314337,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior urethral injury involving the membranous urethra</span></p>"
        },
        {
          "id": 314338,
          "text": "<p><span style=\"font-size:14.0pt;\">Bladder neck rupture</span></p>"
        },
        {
          "id": 314339,
          "text": "<p><span style=\"font-size:14.0pt;\">Bulbar urethral injury</span></p>"
        },
        {
          "id": 314340,
          "text": "<p><span style=\"font-size:14.0pt;\">Penile urethral transection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male presents to the emergency department after a bicycle accident during which he struck his perineum against the crossbar. He now has difficulty urinating, a perineal hematoma, and blood at the urethral meatus. A retrograde urethrogram (RUG) is performed, as shown in the image. Based on this finding, what is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_UAIxM8u.png\" width=\"410\" height=\"301\"></strong></span></p>",
      "unique_key": "Q1480592",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Bulbar urethral injury</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>bulbar urethra</strong>, part of the <strong>anterior urethra</strong>, is the most common site of injury in <strong>straddle-type trauma</strong> (e.g., perineal impact from falling on a bicycle).&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>retrograde urethrogram</strong> image shows <strong>contrast extravasation</strong> localized to the bulbar region without reaching the membranous or prostatic urethra, confirming a <strong>partial tear or contusion</strong> in the bulbar urethra.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This injury typically presents with:</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Blood at the meatus</span></li><li><span style=\"font-size:14.0pt;\">Difficulty or inability to void</span></li><li><span style=\"font-size:14.0pt;\">Perineal bruising or “butterfly” hematoma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In such cases, <strong>catheterization should be avoided</strong> until imaging confirms urethral integrity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Posterior urethral injury involving the membranous urethra:&nbsp;</strong>Usually due to <strong>pelvic fractures</strong>, not straddle injuries. Involves the membranous or prostatic urethra and often causes <strong>urinary retention</strong> with a high-riding prostate on exam.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bladder neck rupture:</strong> Associated with <strong>pelvic trauma</strong> and may lead to <strong>extraperitoneal or intraperitoneal urinary leakage</strong> but would not show localized contrast extravasation at the bulbar urethra.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Penile urethral transection:</strong> Typically presents with <strong>complete disruption</strong>, often associated with penile trauma or instrumentation, and contrast would extravasate more distally, near the penile shaft.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bulbar urethral injury is the most common type of anterior urethral injury, typically caused by straddle trauma and confirmed via retrograde urethrogram showing localized contrast extravasation.</span></p>",
      "correct_choice_id": 314339,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78893/Radiology_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78893/Radiology_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79063,
      "choices": [
        {
          "id": 315013,
          "text": "<p><span style=\"font-size:14.0pt;\">Naked double-stranded RNA</span></p>"
        },
        {
          "id": 315014,
          "text": "<p><span style=\"font-size:14.0pt;\">Enveloped double-stranded RNA</span></p>"
        },
        {
          "id": 315015,
          "text": "<p><span style=\"font-size:14.0pt;\">Enveloped single-stranded RNA</span></p>"
        },
        {
          "id": 315016,
          "text": "<p><span style=\"font-size:14.0pt;\">Naked single-stranded RNA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-year-old boy who has not received routine immunizations presents with conjunctival injection, runny nose, and bluish-white lesions on the buccal mucosa adjacent to the lower molars. The next day, he develops a maculopapular rash that begins on the face and neck and gradually spreads downward. Based on clinical findings, a viral exanthem is suspected. Which of the following best describes the genomic and structural characteristics of the causative virus?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2918380",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Enveloped single-stranded RNA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation is <strong>classic for measles (rubeola)</strong>: <strong>Koplik spots</strong>, <strong>coryza</strong>, <strong>conjunctivitis</strong>, and a <strong>maculopapular rash</strong> starting on the face.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Measles virus</strong> is a member of the <strong>Paramyxoviridae</strong> family.</span></li><li><span style=\"font-size:14.0pt;\">It is an <strong>enveloped virus</strong> containing <strong>single-stranded, negative-sense RNA (ssRNA)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Koplik spots</strong> are pathognomonic and usually precede the rash.</span></li><li><span style=\"font-size:14.0pt;\">Measles can be prevented with the <strong>MMR vaccine</strong>, which the child did not receive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Naked double-stranded RNA:</strong> Describes <strong>reoviruses</strong>, such as <strong>rotavirus</strong>, which cause <strong>gastroenteritis</strong>, not a maculopapular rash with Koplik spots.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Enveloped double-stranded RNA:</strong> No known human pathogen fits this profile; <strong>double-stranded RNA viruses are not enveloped</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Naked single-stranded RNA:</strong> Includes viruses like <strong>enteroviruses</strong>, which may cause <strong>hand-foot-mouth disease</strong> or <strong>aseptic meningitis</strong>, but <strong>not measles</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Measles virus is an enveloped, single-stranded, negative-sense RNA virus that presents with coryza, conjunctivitis, Koplik spots, and a descending maculopapular rash, especially in unimmunized children.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note: Mnemonic for Non-enveloped Virus:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">P – Picorna virus</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">R – Reo virus</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A – Hep. A virus</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">C – Calcivirus</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HE – Hep. E virus</span></p>",
      "correct_choice_id": 315015,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79063/Microbiology_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79063/Microbiology_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79048,
      "choices": [
        {
          "id": 314953,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer rasburicase</span></p>"
        },
        {
          "id": 314954,
          "text": "<p><span style=\"font-size:14.0pt;\">Start allopurinol</span></p>"
        },
        {
          "id": 314955,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin sodium bicarbonate infusion</span></p>"
        },
        {
          "id": 314956,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate hemodialysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man from Mumbai undergoing induction chemotherapy for Burkitt lymphoma becomes lethargic and oliguric within 24 hours of treatment initiation. He reports flank discomfort and nausea. On exam, his BP is 128/76 mmHg, HR 102/min, and respiratory rate is 20/min. He is afebrile. Laboratory findings are as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RFrRYCd.png\" width=\"659\" height=\"234\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Urine microscopy image is shown below.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2BGR07c.png\" width=\"338\" height=\"333\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most appropriate next step?</span></p>",
      "unique_key": "Q6734936",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Administer rasburicase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient presents with <strong>clinical tumor lysis syndrome (TLS)</strong> — a life-threatening oncologic emergency due to rapid lysis of tumor cells after chemotherapy, especially in high-burden malignancies like <strong>Burkitt lymphoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia</strong>, and <strong>acute kidney injury</strong> form the hallmark of TLS.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>rhomboids/rosettes</strong> seen in urine are classic for uric acid crystalluria – suggesting urate nephropathy due to intrarenal deposition and tubular injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rasburicase</strong> is the <strong>treatment of choice</strong> because it enzymatically converts uric acid to <strong>allantoin</strong>, a highly soluble and non-toxic metabolite.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Allopurinol</strong> is useful for prophylaxis but does <strong>not eliminate existing uric acid</strong> or dissolve crystals.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sodium bicarbonate</strong> may exacerbate calcium phosphate precipitation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hemodialysis</strong> is reserved for <strong>severe, refractory TLS</strong> with uncontrolled electrolyte abnormalities or volume overload.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Biochemical and Clinical Features of Tumor Lysis Syndrome:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1Gv3TtG.png\" width=\"911\" height=\"288\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start allopurinol</strong>: Prevents TLS but <strong>ineffective in reducing existing uric acid or crystals</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Begin sodium bicarbonate infusion</strong>: Raises urine pH, increasing <strong>calcium phosphate precipitation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Immediate hemodialysis</strong>: Indicated in <strong>life-threatening or refractory TLS</strong>, not initial management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with laboratory and clinical tumor lysis syndrome, <strong>rasburicase is the first-line therapy</strong> for rapidly reducing uric acid and preventing further renal injury. Allopurinol is prophylactic and not effective once TLS has developed.</span></p>",
      "correct_choice_id": 314953,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79048/Dr._Dilip_Mock_Test_2_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79048/Dr._Dilip_Mock_Test_2_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78841,
      "choices": [
        {
          "id": 314133,
          "text": "<p><span style=\"font-size:14.0pt;\">Portal vein</span></p>"
        },
        {
          "id": 314134,
          "text": "<p><span style=\"font-size:14.0pt;\">Superior mesenteric artery</span></p>"
        },
        {
          "id": 314135,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastroduodenal artery</span></p>"
        },
        {
          "id": 314136,
          "text": "<p><span style=\"font-size:14.0pt;\">Superior mesenteric vein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During retro-pancreatic dissection of the neck of the pancreas in Whipple’s procedure, which of the following structures is the least likely to be injured?&nbsp;</span></p>",
      "unique_key": "Q4630384",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C</strong></span><strong>)</strong><span style=\"font-size:14.0pt;\"><strong> Gastroduodenal artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The GDA is a branch of the common hepatic artery and supplies blood to the stomach and the duodenum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It courses anterior to the pancreas rather than posteriorly, making it less likely to be injured during retro-pancreatic dissection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Typically, it is ligated earlier in the surgery to prevent bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Portal vein:</strong> The portal vein runs posterior to the neck of the pancreas and is in close proximity during retro-pancreatic dissection. Therefore, it is highly prone to injury during this step of the Whipple’s procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Superior mesenteric artery (SMA):</strong> The SMA lies posterior to the pancreas and to the left of the superior mesenteric vein. Although protected to some extent, the SMA is in the surgical field and could be at risk of injury during retro-pancreatic dissection if care is not taken.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Superior mesenteric vein (SMV):</strong> The SMV is located posterior to the neck of the pancreas and runs alongside the portal vein. It is vulnerable during retro-pancreatic dissection and thus more likely to be injured compared to the GDA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Gastroduodenal artery</strong> is the least likely to be injured because it lies anterior to the pancreas and is ligated during earlier phases of the procedure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The other structures—portal vein, SMA, and SMV—are located posterior to the pancreas and are within the surgical field during this dissection, increasing their risk of injury.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sIBzbCl.png\" width=\"400\" height=\"370\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/B9781416024170500292_f28-40-9781416024170.jpg\" width=\"522\" height=\"542\"></p>",
      "correct_choice_id": 314135,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78841/Surgery_Q_10_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78841/Surgery_Q_10_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79090,
      "choices": [
        {
          "id": 315117,
          "text": "<p><span style=\"font-size:14.0pt;\">Apo A</span></p>"
        },
        {
          "id": 315118,
          "text": "<p><span style=\"font-size:14.0pt;\">Apo B48</span></p>"
        },
        {
          "id": 315119,
          "text": "<p><span style=\"font-size:14.0pt;\">Apo B100</span></p>"
        },
        {
          "id": 315120,
          "text": "<p><span style=\"font-size:14.0pt;\">Apo CII</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old child is brought to the clinic for evaluation of recurrent episodes of abdominal pain and eruptive skin lesions. Physical examination reveals multiple small yellowish papules over the extensor surfaces of the arms and buttocks. Laboratory testing shows markedly elevated triglyceride levels. Genetic testing reveals a defect in the apolipoprotein required to activate lipoprotein lipase (LPL), resulting in impaired clearance of chylomicrons. Which of the following apolipoproteins is most likely deficient in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3953354",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Apo CII</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Apolipoprotein CII (Apo CII)</strong> is essential for the activation of <strong>lipoprotein lipase (LPL)</strong>, an enzyme responsible for hydrolyzing triglycerides present in <strong>chylomicrons and VLDL</strong> into <strong>free fatty acids</strong> and glycerol, allowing their uptake by peripheral tissues.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In the absence of Apo CII, LPL cannot be activated, leading to accumulation of triglyceride-rich lipoproteins such as <strong>chylomicrons</strong> in the plasma.</span></li><li><span style=\"font-size:14.0pt;\">This condition, often seen in <strong>familial hyperchylomicronemia syndrome (Type I hyperlipoproteinemia)</strong>, presents with <strong>severe hypertriglyceridemia</strong>, acute <strong>pancreatitis</strong>, <strong>eruptive xanthomas</strong>, and sometimes <strong>lipemia retinalis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The elevated triglycerides are a direct result of impaired chylomicron breakdown due to the <strong>lack of Apo CII</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Apo A:&nbsp;</strong>Apo A (especially Apo A-I) is the main apolipoprotein in <strong>HDL particles</strong> and plays a role in <strong>reverse cholesterol transport</strong>. It does not activate LPL and is not involved in chylomicron metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Apo B48:&nbsp;</strong>Apo B48 is essential for the <strong>assembly and secretion of chylomicrons</strong> in the intestine, but it <strong>does not activate LPL</strong>. While important for chylomicron formation, its role is structural, not enzymatic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Apo B100:&nbsp;</strong>Apo B100 is found in <strong>VLDL, IDL, and LDL</strong>, and is necessary for <strong>LDL receptor binding and hepatic uptake</strong> of LDL particles. It is <strong>not involved in LPL activation</strong> or chylomicron metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Apolipoprotein CII is required to activate lipoprotein lipase, enabling the hydrolysis of triglycerides from chylomicrons and VLDL into free fatty acids for tissue uptake.</span></p>",
      "correct_choice_id": 315120,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79090/Biochem_Q_8_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79090/Biochem_Q_8_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78953,
      "choices": [
        {
          "id": 314577,
          "text": "<p><span style=\"font-size:14.0pt;\">Marginal cord insertion</span></p>"
        },
        {
          "id": 314578,
          "text": "<p><span style=\"font-size:14.0pt;\">Battledore placenta</span></p>"
        },
        {
          "id": 314579,
          "text": "<p><span style=\"font-size:14.0pt;\">Velamentous cord insertion</span></p>"
        },
        {
          "id": 314580,
          "text": "<p><span style=\"font-size:14.0pt;\">Circumvallate placenta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old primigravida at 32 weeks gestation undergoes a routine obstetric ultrasound. Which of the following best describes this abnormal placental finding?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gr42ykY.png\" width=\"581\" height=\"392\"></span></p>",
      "unique_key": "Q2583835",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Velamentous cord insertion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Velamentous cord insertion</strong> occurs when the umbilical cord inserts into the fetal membranes (amnion and chorion) rather than directly into the placenta. The fetal vessels then travel within the membranes, unprotected by Wharton’s jelly, before reaching the placental disc. This exposes the vessels to risk of <strong>rupture</strong>, especially during labor or membrane rupture, and is associated with <strong>vasa previa</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Marginal cord insertion:</strong> Also known as <strong>battledore placenta</strong>, where the cord inserts at the edge of the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Battledore placenta:</strong> Another name for marginal insertion; the cord is attached at the periphery of the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Circumvallate placenta:</strong> Involves a thickened, raised placental margin due to folding of the chorion; associated with placental insufficiency and abruption, not with cord insertion anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Velamentous cord insertion</strong> is a placental abnormality where fetal vessels traverse the membranes before inserting into the placenta, increasing the risk of <strong>vessel rupture</strong>, <strong>vasa previa</strong>, and <strong>fetal hemorrhage</strong>. It is diagnosed by prenatal ultrasound and requires careful monitoring.</span></p>",
      "correct_choice_id": 314579,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78953/Obg_Q_17_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78953/Obg_Q_17_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79066,
      "choices": [
        {
          "id": 315025,
          "text": "<p><span style=\"font-size:14.0pt;\">Albert stain</span></p>"
        },
        {
          "id": 315026,
          "text": "<p><span style=\"font-size:14.0pt;\">Modified acid-fast stain</span></p>"
        },
        {
          "id": 315027,
          "text": "<p><span style=\"font-size:14.0pt;\">Ziehl-Neelsen stain</span></p>"
        },
        {
          "id": 315028,
          "text": "<p><span style=\"font-size:14.0pt;\">Silver impregnation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following staining techniques is most appropriate to confirm the presence of Nocardia species?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9037955",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Modified acid-fast stain</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nocardia species</strong> are <strong>aerobic, branching filamentous, weakly acid-fast bacteria</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They contain <strong>mycolic acid</strong> in their cell wall but in smaller amounts than Mycobacterium.</span></li><li><span style=\"font-size:14.0pt;\">As a result, they <strong>do not retain stain with classic Ziehl-Neelsen stain</strong>, but they do stain <strong>positive with modified acid-fast techniques</strong> such as the <strong>Kinyoun method</strong>, which uses a <strong>weaker acid (1% sulfuric acid)</strong> during decolorization.</span></li><li><span style=\"font-size:14.0pt;\">This helps <strong>differentiate Nocardia</strong> from similar-appearing organisms like <strong>Actinomyces</strong> (non–acid-fast).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_kesn07b.png\" width=\"524\" height=\"388\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Albert stain:&nbsp;</strong>Used to detect <strong>metachromatic granules</strong> in <strong>Corynebacterium diphtheriae</strong>, not Nocardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ziehl-Neelsen stain:</strong> Designed for <strong>strong acid-fast organisms</strong> like <strong>Mycobacterium tuberculosis</strong>. Nocardia often fails to retain stain with this method due to its <strong>partial acid-fastness</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Silver impregnation:</strong> Useful for <strong>fungi</strong> and certain <strong>spirochetes</strong> (e.g., Treponema), not typically used to confirm Nocardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Nocardia species are weakly acid-fast, and their presence is best confirmed using a modified acid-fast stain, such as the Kinyoun technique.</span></p>",
      "correct_choice_id": 315026,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79066/Microbiology_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79066/Microbiology_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78805,
      "choices": [
        {
          "id": 313993,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased risk of ovarian cancer.​</span></p>"
        },
        {
          "id": 313994,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased bone mineral density.​</span></p>"
        },
        {
          "id": 313995,
          "text": "<p><span style=\"font-size:14.0pt;\">Protection against pelvic inflammatory disease.​</span></p>"
        },
        {
          "id": 313996,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced risk of endometrial cancer.​</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old nulliparous woman desires long-term contraception and is interested in any additional health benefits the method may provide. Which of the following non-contraceptive benefits is associated with CuT 380A use?​<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1247728",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Reduced risk of endometrial cancer.​</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The use of non-hormonal IUDs, such as CuT 380A, has been associated with a reduced risk of endometrial cancer.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The exact mechanism is not fully understood but is thought to involve the local inflammatory response induced by the IUD, which may have protective effects against the development of endometrial malignancies. ​</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Decreased risk of ovarian cancer:&nbsp;</strong>Incorrect, there is no significant evidence linking CuT 380A use to a decreased risk of ovarian cancer.​</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Increased bone mineral density:&nbsp;</strong>Incorrect, CuT 380A does not impact bone mineral density; this benefit is more associated with hormonal contraceptives.​</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Protection against pelvic inflammatory disease:&nbsp;</strong>Incorrect, While IUDs do not increase the risk of pelvic inflammatory disease after the initial insertion period, they do not provide protection against it.​</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">CuT 380A use is associated with a reduced risk of endometrial cancer, likely due to the local inflammatory response it induces in the endometrium.</span></p>",
      "correct_choice_id": 313996,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78805/Psm_Q_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78805/Psm_Q_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78965,
      "choices": [
        {
          "id": 314625,
          "text": "<p><span style=\"font-size:14.0pt;\">Toluidine dye should be used to detect recent microinjuries on genitalia before taking the swab for sperm detection</span></p>"
        },
        {
          "id": 314626,
          "text": "<p><span style=\"font-size:14.0pt;\">History should not be taken from the victim if her age &lt; 12 years</span></p>"
        },
        {
          "id": 314627,
          "text": "<p><span style=\"font-size:14.0pt;\">Radiological confirmation of age of victim should be done in every case of rape victim examination</span></p>"
        },
        {
          "id": 314628,
          "text": "<p><span style=\"font-size:14.0pt;\">Per speculum examination may not be needed in young victim if there is no history of penetration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is true with respect to examination of a female victim of sexual assault?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1803375",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Per speculum examination may not be needed in young victim if there is no history of penetration</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The correct answer is <strong>Per speculum examination may not be needed in young victim if there is no history of penetration</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In cases of sexual assault involving young female victims, the examination approach must be <strong>child-sensitive, minimally invasive</strong>, and based strictly on the <strong>history provided</strong>. A <strong>per speculum examination</strong> is an invasive procedure typically used to inspect the vagina and cervix.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, if the victim is <strong>young</strong> and there is <strong>no history or signs of vaginal penetration</strong>, performing such an examination is <strong>not mandatory</strong> and may even be <strong>discouraged to prevent further trauma</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The medico-legal examination should always prioritize <strong>comfort, dignity, and consent</strong>, especially in minors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Toluidine dye should be used to detect recent microinjuries on genitalia before taking the swab for sperm detection:</strong>&nbsp; <strong>Incorrect</strong>, while <strong>toluidine blue dye</strong> is used for identifying microtrauma in genital examination, <strong>applying it before collecting swabs</strong> can interfere with <strong>sperm detection and other forensic evidence collection</strong>. Forensic swabs for sperm, semen, or DNA must be taken <strong>prior to using any dyes or reagents</strong> to avoid contamination or loss of evidence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. History should not be taken from the victim if her age &lt; 12 years: Incorrect,</strong> and misleading. The <strong>history is an essential part</strong> of any sexual assault examination. If the child is capable of providing a coherent account, <strong>history should be taken in a sensitive and age-appropriate manner</strong>. If needed, a <strong>guardian or trained counselor</strong> may assist, but the victim’s own version should not be ignored solely due to age.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Radiological confirmation of age of victim should be done in every case of rape victim examination:</strong> <strong>Not true,</strong> for <strong>every case</strong>. <strong>Radiological age estimation</strong> is usually performed <strong>only if there is a dispute or legal requirement regarding the age</strong> of the victim (e.g., in child sexual abuse cases where age affects the legal charge). It is <strong>not mandated in all rape victim examinations</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Per speculum examination may not be needed in a young female victim of sexual assault if there is no history of penetration.</strong></span><br><span style=\"font-size:14.0pt;\">Invasive procedures must be guided by the history and clinical findings, especially in children.</span></p>",
      "correct_choice_id": 314628,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78965/Fmt_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78965/Fmt_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78853,
      "choices": [
        {
          "id": 314181,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1 and 3 are correct</span></p>"
        },
        {
          "id": 314182,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2 and 4 are correct</span></p>"
        },
        {
          "id": 314183,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1 and 4 are correct</span></p>"
        },
        {
          "id": 314184,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 37-year-old obese woman reports worsening heartburn after meals for the past 5 years. She undergoes upper endoscopy and biopsy of the distal esophagus, shown in the histology image below. Based on these findings, which of the following statements regarding this condition are true?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The biopsy reveals a transformation of normal squamous epithelium into columnar epithelium with intestinal features.</span></li><li><span style=\"font-size:14.0pt;\">Goblet cell hyperplasia is the hallmark of esophageal squamous cell carcinoma.</span></li><li><span style=\"font-size:14.0pt;\">This metaplastic process is typically a response to chronic acid reflux and can predispose to adenocarcinoma.</span></li><li><span style=\"font-size:14.0pt;\">The lamina propria shows atrophy as a result of repeated mucosal injury.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XECvfBg.png\" width=\"430\" height=\"281\"></span></p>",
      "unique_key": "Q1003261",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only statements 1 and 3 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1 – True:&nbsp;</strong>This describes <strong>Barrett esophagus</strong>, where <strong>non-keratinized stratified squamous epithelium</strong> of the distal esophagus is replaced by <strong>non-ciliated, mucin-secreting columnar epithelium with goblet cells</strong> — a <strong>metaplastic adaptation</strong> to chronic acid exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3 – True:&nbsp;</strong>Chronic <strong>gastroesophageal reflux disease (GERD)</strong> leads to this metaplasia. Over time, this change may progress to <strong>dysplasia</strong> and eventually <strong>esophageal adenocarcinoma</strong>, especially in obese individuals with chronic reflux.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2 – False: Goblet cells</strong> are <strong>not</strong> a feature of <strong>squamous cell carcinoma</strong>. Instead, goblet cells are found in <strong>Barrett esophagus</strong>, and their presence confirms <strong>intestinal metaplasia</strong>, not carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4 – False:&nbsp;</strong>The <strong>lamina propria</strong> is <strong>not atrophic</strong> in Barrett esophagus. The key histologic feature is <strong>replacement of squamous cells</strong> with <strong>columnar epithelium</strong>, not thinning of the lamina propria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Barrett esophagus is characterized by columnar metaplasia with goblet cells in the distal esophagus, secondary to chronic GERD. This metaplasia increases the risk of developing esophageal adenocarcinoma.</span></p>",
      "correct_choice_id": 314181,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78853/Pathology_Q_5_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78853/Pathology_Q_5_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78876,
      "choices": [
        {
          "id": 314273,
          "text": "<p><span style=\"font-size:14.0pt;\">Milnacipran</span></p>"
        },
        {
          "id": 314274,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregabalin</span></p>"
        },
        {
          "id": 314275,
          "text": "<p><span style=\"font-size:14.0pt;\">Fluoxetine</span></p>"
        },
        {
          "id": 314276,
          "text": "<p><span style=\"font-size:14.0pt;\">Amitriptyline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman reports widespread musculoskeletal pain, fatigue, and unrefreshing sleep for the past several months. Physical examination reveals tenderness in multiple soft tissue areas without joint swelling or redness. Laboratory tests, including inflammatory markers, are within normal limits. She is diagnosed with fibromyalgia and started on a medication that works by inhibiting the reuptake of both serotonin and norepinephrine. Which of the following drugs was most likely prescribed?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9094767",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Milnacipran</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Milnacipran</strong> is a <strong>serotonin-norepinephrine reuptake inhibitor (SNRI)</strong> specifically approved for the <strong>management of fibromyalgia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It <strong>inhibits the reuptake of serotonin and norepinephrine</strong>, leading to increased levels of these neurotransmitters in the CNS, which helps modulate <strong>pain perception</strong> and improves <strong>energy and mood</strong> in patients with fibromyalgia.</span><ul><li><span style=\"font-size:14.0pt;\">It does <strong>not treat depression</strong> in the U.S., although it is an SNRI.</span></li><li><span style=\"font-size:14.0pt;\">Its role in fibromyalgia is <strong>FDA-approved</strong> and clinically effective in reducing <strong>pain and fatigue</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pregabalin:&nbsp;</strong>While also FDA-approved for fibromyalgia, it works by binding to <strong>alpha-2-delta subunits of voltage-gated calcium channels</strong>, <strong>not by serotonin-norepinephrine reuptake inhibition</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fluoxetine:&nbsp;</strong>A <strong>selective serotonin reuptake inhibitor (SSRI)</strong>. It may be helpful in some fibromyalgia patients but <strong>does not affect norepinephrine reuptake</strong>, which is believed to be important in pain modulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amitriptyline:&nbsp;</strong>A <strong>tricyclic antidepressant (TCA)</strong> sometimes used off-label for fibromyalgia, but it <strong>blocks multiple receptors</strong> (muscarinic, alpha-adrenergic, H1) and has a broader side effect profile compared to milnacipran.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Milnacipran is an SNRI that treats fibromyalgia by inhibiting the reuptake of serotonin and norepinephrine, helping to modulate pain and fatigue in patients with this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note - 3 main SNRI – Venlafaxine, Duloxetine and Milnacipran</strong></span></p>",
      "correct_choice_id": 314273,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78876/Pharmacology_Q_20_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78876/Pharmacology_Q_20_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78808,
      "choices": [
        {
          "id": 314005,
          "text": "<p><span style=\"font-size:14.0pt;\">Fluoride toxicity from prolonged water consumption</span></p>"
        },
        {
          "id": 314006,
          "text": "<p><span style=\"font-size:14.0pt;\">Lead leaching from corroded pipes due to acidic water</span></p>"
        },
        {
          "id": 314007,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic arsenic poisoning from groundwater contamination</span></p>"
        },
        {
          "id": 314008,
          "text": "<p><span style=\"font-size:14.0pt;\">Methemoglobinemia due to excessive nitrate levels in well water</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A rural elementary school has reported a sharp decline in cognitive performance among children, along with fatigue, irritability, and attention difficulties over the past year. A public health team investigates possible environmental exposures and finds that the school’s drinking water has a pH of 6.2, total dissolved solids (TDS) of 480 mg/L, and fluoride levels of 1.8 ppm. Other parameters, including turbidity and bacterial counts, are within normal limits. Which of the following is the most likely cause of these students’ symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4718305",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Lead leaching from corroded pipes due to acidic water</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Water with a pH below 6.5 is corrosive and can leach heavy metals, particularly lead, from old plumbing systems.</span></li><li><span style=\"font-size:14.0pt;\">Lead toxicity in children causes cognitive decline, behavioral issues, anemia, and neurological impairment, which matches the symptoms seen in the students.</span></li><li><span style=\"font-size:14.0pt;\">Fluoride at 1.8 ppm is slightly above the recommended limit (&lt;1 ppm) but is unlikely to cause neurotoxicity at this level.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Fluoride toxicity from prolonged water consumption:</strong> Incorrect, Fluoride toxicity typically causes dental fluorosis, not cognitive decline.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Chronic arsenic poisoning from groundwater contamination:</strong> Incorrect, Arsenic poisoning causes skin changes, peripheral neuropathy, and carcinogenic effects, not immediate cognitive impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Methemoglobinemia due to excessive nitrate levels in well water:</strong> Incorrect, Methemoglobinemia presents with cyanosis and dyspnea rather than cognitive dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Water with low pH (&lt;6.5) increases the risk of lead leaching from old pipes, contributing to chronic neurotoxicity and cognitive impairment in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Water Quality Guidelines:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PXi0Y2Y.png\" width=\"528\" height=\"400\"></strong></span></p>",
      "correct_choice_id": 314006,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78808/Psm_Q_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78808/Psm_Q_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78832,
      "choices": [
        {
          "id": 314101,
          "text": "<p><span style=\"font-size:14.0pt;\">Extracorporeal Shock Wave Lithotripsy (ESWL)</span></p>"
        },
        {
          "id": 314102,
          "text": "<p><span style=\"font-size:14.0pt;\">Uretero-renoscopic removal (URS)</span></p>"
        },
        {
          "id": 314103,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait and watch</span></p>"
        },
        {
          "id": 314104,
          "text": "<p><span style=\"font-size:14.0pt;\">Plain CT KUB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old male presents to the emergency department with acute left flank pain radiating to the groin. The pain is colicky in nature and associated with mild nausea. On examination, there is tenderness over the left costovertebral angle (CVA). His urine dipstick shows microscopic hematuria. After controlling his colic, the following imaging is done. What is the next step in the management of this patient?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AkexLdT.png\" width=\"261\" height=\"274\"></strong></span></p>",
      "unique_key": "Q3273649",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Plain CT KUB</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a patient presenting with <strong>acute flank pain suggestive of ureteric colic</strong>, the <strong>gold standard</strong> for evaluation is <strong>non-contrast CT KUB (Kidneys, Ureters, Bladder)</strong>, which is the most sensitive imaging modality for detecting urinary calculi.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Plain X-ray KUB</strong>, while useful for detecting <strong>radio-opaque stones</strong>, does <strong>not visualize uric acid stones</strong> or <strong>small stones</strong> and cannot assess obstruction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>CT KUB is preferred because it identifies even radiolucent stones and determines the exact location, size, and degree of obstruction.</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Extracorporeal Shock Wave Lithotripsy (ESWL):&nbsp;</strong>ESWL is a <strong>treatment modality</strong>, not a diagnostic step. It is used <strong>only after confirming the stone's location and size</strong>, typically for stones &lt;2 cm in the kidney or proximal ureter. <strong>Without confirming stone characteristics on CT, proceeding directly to ESWL is inappropriate.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Uretero-renoscopic removal (URS):&nbsp;</strong>URS is indicated <strong>if the stone is &lt; 10 mm, causing obstruction, or if ESWL fails.&nbsp;</strong>Since the <strong>diagnosis is not yet confirmed</strong>, <strong>immediate intervention is not appropriate.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Wait and Watch:&nbsp;</strong>Observation is considered for <strong>small (&lt;5 mm) non-obstructing stones</strong> that are likely to pass spontaneously. <strong>Before deciding on conservative management, imaging confirmation with CT KUB is necessary.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients with <strong>suspected renal colic</strong>, <strong>non-contrast CT KUB</strong> is the <strong>gold standard</strong> for diagnosing urinary stones.</span></li><li><span style=\"font-size:14.0pt;\">It <strong>identifies stone size, location, and degree of obstruction</strong>, guiding further management. <strong>X-ray KUB alone is inadequate</strong>, as it may miss radiolucent stones.</span></li><li><span style=\"font-size:14.0pt;\"><strong>ESWL, URS, or conservative management should only be considered after confirming stone characteristics on imaging.</strong></span></li></ul>",
      "correct_choice_id": 314104,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78832/Surgery_Q_2__Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78832/Surgery_Q_2__Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78892,
      "choices": [
        {
          "id": 314333,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 314334,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 314335,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
        },
        {
          "id": 314336,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the incorrect pair:&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Talocalcaneonavicular joint – Saddle joint</span></li><li><span style=\"font-size:14.0pt;\">Malleo-incudal joint – Ball and socket joint</span></li><li><span style=\"font-size:14.0pt;\">Atlanto-axial joint – Pivot joint</span></li><li><span style=\"font-size:14.0pt;\">Acromio-clavicular joint – Plane joint</span></li></ol>",
      "unique_key": "Q2781063",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Talocalcaneonavicular joint – Saddle joint</strong>: The talocalcaneonavicular joint is a <strong>ball and socket type of synovial joint</strong>, not a saddle joint. It contributes significantly to inversion and eversion movements of the foot.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Malleo-incudal joint – Ball and socket joint</strong>: The malleus and incus form the <strong>incudomalleolar joint</strong>, which is a <strong>saddle type of synovial joint</strong>, not a ball and socket joint. The joint allows limited movement necessary for sound conduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Atlanto-axial joint – Pivot joint</strong>: The median atlanto-axial joint is a <strong>pivot joint</strong>, allowing rotation of the head side to side (as in saying \"no\").</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Acromio-clavicular joint – Plane joint</strong>: The acromioclavicular joint is a <strong>plane type synovial joint</strong>, allowing gliding movements between the clavicle and the acromion of the scapula.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JLJ5zLR.png\" width=\"1463\" height=\"513\"></strong></span></p>",
      "correct_choice_id": 314335,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78892/Anatomy_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78892/Anatomy_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78912,
      "choices": [
        {
          "id": 314413,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexor digitorum superficialis tendon</span></p>"
        },
        {
          "id": 314414,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexor digitorum profundus tendon</span></p>"
        },
        {
          "id": 314415,
          "text": "<p><span style=\"font-size:14.0pt;\">Extensor digitorum tendon</span></p>"
        },
        {
          "id": 314416,
          "text": "<p><span style=\"font-size:14.0pt;\">Lumbrical muscle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old carpenter presents after accidentally cutting his hand with a saw. On examination, he is unable to flex the distal phalanx of his index finger. Sensation is intact. There is no active bleeding, but a deep laceration is noted over the volar aspect of the proximal phalanx. What structure is most likely injured?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9985232",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Flexor digitorum profundus tendon</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inserts on the distal phalanx</span></li><li><span style=\"font-size:14.0pt;\">Responsible for flexion of the DIP joint</span></li><li><span style=\"font-size:14.0pt;\">Injury → inability to flex DIP, especially isolated if only one tendon is cut</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Flexor digitorum superficialis (FDS):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inserts on the middle phalanx</span></li><li><span style=\"font-size:14.0pt;\">Flexes the PIP joint, not the DIP</span></li><li><span style=\"font-size:14.0pt;\">Injury to FDS would not prevent distal phalanx flexion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Extensor digitorum tendon:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Located on the dorsal side of the hand</span></li><li><span style=\"font-size:14.0pt;\">Responsible for extension, not flexion</span></li><li><span style=\"font-size:14.0pt;\">Injury wouldn’t cause loss of flexion — wrong surface and function.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lumbrical muscle:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Intrinsic muscle originating from FDP tendons</span></li><li><span style=\"font-size:14.0pt;\">Functions: MCP flexion and IP extension</span></li><li><span style=\"font-size:14.0pt;\">Does not directly flex the DIP — injury here wouldn’t cause isolated DIP weakness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The tendon runs through Zone II, where both FDS and FDP lie together</span></p>",
      "correct_choice_id": 314414,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78912/Orthopedics_Q_3Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78912/Orthopedics_Q_3Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78897,
      "choices": [
        {
          "id": 314353,
          "text": "<p><span style=\"font-size:14.0pt;\">Bullous pemphigoid</span></p>"
        },
        {
          "id": 314354,
          "text": "<p><span style=\"font-size:14.0pt;\">Pemphigus vulgaris</span></p>"
        },
        {
          "id": 314355,
          "text": "<p><span style=\"font-size:14.0pt;\">Dermatitis herpetiformis</span></p>"
        },
        {
          "id": 314356,
          "text": "<p><span style=\"font-size:14.0pt;\">Linear IgA disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man presents with multiple flaccid bullae on his trunk and oral mucosa. A skin biopsy followed by direct immunofluorescence is as shown in the image below. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Z8VyzEg.png\" width=\"453\" height=\"340\"></strong></span></p>",
      "unique_key": "Q4415148",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Pemphigus vulgaris</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows <strong>intercellular IgG deposition</strong> in a <strong>\"chicken wire/fish net\" pattern</strong>, which is <strong>pathognomonic of pemphigus vulgaris</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Pemphigus vulgaris is an autoimmune blistering disease where autoantibodies are directed against <strong>desmoglein-3</strong> &gt; desmoglein-1, components of desmosomes in the epidermis.</span></li><li><span style=\"font-size:14.0pt;\">The condition presents with <strong>flaccid bullae</strong>, <strong>oral mucosal involvement</strong>, and a <strong>positive Nikolsky sign</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eiAa7Df.png\" width=\"764\" height=\"550\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bullous pemphigoid:</strong> Subepidermal blisters with <strong>linear IgG deposition along the basement membrane</strong>, not intercellular staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dermatitis herpetiformis:</strong> IgA deposition in dermal papillae in granular pattern; intensely pruritic grouped vesicles, often on extensor surfaces.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Linear IgA disease:</strong> Shows <strong>linear IgA deposition</strong> at the basement membrane as annular lesions with characteristic crown of jewel/ string of jewel appearance, not fish net appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Zgtn3vU.png\" width=\"747\" height=\"369\"></strong></span></p>",
      "correct_choice_id": 314354,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78897/Dermatology_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78897/Dermatology_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78921,
      "choices": [
        {
          "id": 314449,
          "text": "<p><span style=\"font-size:14.0pt;\">45%</span></p>"
        },
        {
          "id": 314450,
          "text": "<p><span style=\"font-size:14.0pt;\">55%</span></p>"
        },
        {
          "id": 314451,
          "text": "<p><span style=\"font-size:14.0pt;\">60%</span></p>"
        },
        {
          "id": 314452,
          "text": "<p><span style=\"font-size:14.0pt;\">70%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with well-controlled hypertension undergoes echocardiographic evaluation. His left ventricular pressure-volume loop is as shown below. Based on this, what is the estimated ejection fraction (EF)?&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Image%201%20(3).jpg\" width=\"1500\" height=\"1684\"></p>",
      "unique_key": "Q2707831",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 60%</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Ejection fraction (EF)</strong> is the percentage of the <strong>end-diastolic volume</strong> that is ejected during systole. It is a key indicator of ventricular function.</span><br><br>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IyIkTIz.png\" width=\"331\" height=\"331\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>ejection fraction</strong> is a critical measure of systolic function and is calculated as the ratio of stroke volume to end-diastolic volume. A normal EF typically ranges from <strong>50% to 70%</strong>, with <strong>60%</strong> considered a healthy midpoint. Values below this range may suggest varying degrees of heart failure. ​</span></p>",
      "correct_choice_id": 314451,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78921/Physiology_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78921/Physiology_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78828,
      "choices": [
        {
          "id": 314085,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4 are correct</span></p>"
        },
        {
          "id": 314086,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 5 are correct</span></p>"
        },
        {
          "id": 314087,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 4, and 5 are correct</span></p>"
        },
        {
          "id": 314088,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, and 4 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Laryngeal Mask Airways (LMAs) are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">LMA placement requires neuromuscular blockade for successful insertion.</span></li><li><span style=\"font-size:14.0pt;\">LMAs provide a secure airway and can be used for both spontaneous and controlled ventilation.</span></li><li><span style=\"font-size:14.0pt;\">LMAs do not completely protect against aspiration, as they do not seal off the esophagus completely.</span></li><li><span style=\"font-size:14.0pt;\">LMAs are contraindicated in patients with an increased risk of regurgitation, such as pregnant women or those with bowel obstruction.</span></li><li><span style=\"font-size:14.0pt;\">LMAs should always be removed while the patient is deeply anesthetized to prevent airway complications.</span></li></ol>",
      "unique_key": "Q9374015",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 2, 3, and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>LMAs provide a secure airway and can be used for both spontaneous and controlled ventilation:&nbsp;</strong>LMAs can be used for both <strong>spontaneous and controlled ventilation</strong>. They are commonly used in <strong>short surgeries</strong> and <strong>difficult airway management</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>LMAs do not completely protect against aspiration, as they do not seal off the esophagus completely:</strong> LMAs <strong>do not provide complete airway protection</strong> against <strong>aspiration</strong> since they do <strong>not fully seal off the esophagus</strong>, unlike endotracheal tubes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>LMAs are contraindicated in patients with an increased risk of regurgitation, such as pregnant women or those with bowel obstruction:</strong> LMAs are <strong>contraindicated in patients with a high risk of aspiration</strong>, such as those with <strong>gastroesophageal reflux, pregnancy, or bowel obstruction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. LMA placement requires neuromuscular blockade for successful insertion:</strong> <strong>Neuromuscular blockade is not required</strong> for LMA insertion. Unlike endotracheal intubation, LMAs can be inserted <strong>without muscle relaxation</strong> and with just sedation or deep state of anesthesia with propofol or inhalational agents.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>LMAs should always be removed while the patient is deeply anesthetized to prevent airway complications:</strong> LMAs should be removed <strong>when the patient is awake and protecting their airway</strong>. Removing an LMA while the patient is still deeply anesthetized increases the risk of <strong>airway obstruction, aspiration, or laryngospasm</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">LMAs are useful airway devices that <strong>do not require muscle relaxation</strong>, allow for <strong>spontaneous and controlled ventilation</strong>, but <strong>do not fully protect against aspiration</strong>. They should be <strong>removed when the patient is awake</strong> to avoid complications.</span></p>",
      "correct_choice_id": 314085,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78828/Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78828/Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78796,
      "choices": [
        {
          "id": 313957,
          "text": "<p><span style=\"font-size:14.0pt;\">Conditional logistic regression to match cases and controls on exposure duration</span></p>"
        },
        {
          "id": 313958,
          "text": "<p><span style=\"font-size:14.0pt;\">Cross-sectional analysis at the point of case identification</span></p>"
        },
        {
          "id": 313959,
          "text": "<p><span style=\"font-size:14.0pt;\">Prospective cohort analysis excluding the nested case-control component</span></p>"
        },
        {
          "id": 313960,
          "text": "<p><span style=\"font-size:14.0pt;\">Multivariate regression adjusting for potential confounders like age, job type, and baseline stress levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a nested case-control study investigating the association between long-term exposure to occupational stress and the development of chronic anxiety disorders, researchers use baseline data for exposure assessment. What analytical approach should be prioritized to enhance the interpretability of the results concerning the development of new cases?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5220627",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Conditional logistic regression to match cases and controls on exposure duration</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Conditional logistic regression is particularly effective in nested case-control studies for analyzing data where cases and controls are matched on several criteria, including the duration of exposure.</span></li><li><span style=\"font-size:14.0pt;\">This approach allows for the adjustment of matched pairs, enhancing the accuracy of the analysis by directly comparing similar individuals, thus increasing the reliability of conclusions drawn about the impact of occupational stress on anxiety disorders.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Cross-sectional analysis at the point of case identification:&nbsp;</strong>Incorrect, as cross-sectional analysis does not effectively utilize the longitudinal data available in a nested case-control study.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Prospective cohort analysis excluding the nested case-control component:&nbsp;</strong>Incorrect, because excluding the nested case-control component overlooks the benefits of this efficient and targeted analysis method.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Multivariate regression adjusting for potential confounders like age, job type, and baseline stress levels:&nbsp;</strong>Incorrect, while multivariate regression is useful, conditional logistic regression specifically leverages the matched study design for more precise results.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In nested case-control studies assessing the relationship between chronic exposures (such as occupational stress) and health outcomes (like anxiety disorders), conditional logistic regression is crucial.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This method effectively matches cases and controls on exposure duration and adjusts for potential confounders, providing a robust analytical approach that enhances the interpretability of the causal relationships investigated.</span></li></ul>",
      "correct_choice_id": 313957,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78796/Psm_Q_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78796/Psm_Q_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79070,
      "choices": [
        {
          "id": 315041,
          "text": "<p><span style=\"font-size:14.0pt;\">2-Mercaptoethanol test</span></p>"
        },
        {
          "id": 315042,
          "text": "<p><span style=\"font-size:14.0pt;\">Complement fixation test</span></p>"
        },
        {
          "id": 315043,
          "text": "<p><span style=\"font-size:14.0pt;\">Standard agglutination test</span></p>"
        },
        {
          "id": 315044,
          "text": "<p><span style=\"font-size:14.0pt;\">Coombs' test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old cattle farmer presents with complaints of intermittent fever, malaise, and joint pain persisting for several years. He reports occupational exposure to livestock and unpasteurized dairy products. Chronic brucellosis is suspected based on clinical history and confirmatory exposure risk. Which of the following serological tests is least useful in diagnosing chronic brucellosis in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5412075",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Standard agglutination test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Standard Agglutination Test (SAT)</strong> detects <strong>IgM antibodies</strong>, which are more prominent in <strong>acute brucellosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>chronic brucellosis</strong>, antibody levels often shift to <strong>non-agglutinating IgG</strong>, which SAT may not detect reliably.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, SAT has <strong>limited sensitivity</strong> in the <strong>chronic phase</strong>, making it less useful for long-standing disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 2-Mercaptoethanol test:&nbsp;</strong>This test breaks down IgM antibodies and allows detection of <strong>IgG antibodies</strong>, making it <strong>useful in chronic brucellosis</strong>, where IgG predominates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Complement fixation test:&nbsp;</strong>Detects <strong>non-agglutinating IgG antibodies</strong>, making it more appropriate in <strong>chronic brucellosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Coombs' test:</strong> The <strong>Coombs' anti-human globulin test</strong> detects <strong>incomplete IgG antibodies</strong>, which are common in <strong>chronic brucellosis</strong> and not easily picked up by SAT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>chronic brucellosis</strong>, diagnostic tests should focus on detecting <strong>non-agglutinating IgG antibodies</strong>; hence, <strong>Standard Agglutination Test is less useful</strong>, while <strong>2-Mercaptoethanol</strong>, <strong>complement fixation</strong>, and <strong>Coombs' test</strong> are more appropriate.</span></p>",
      "correct_choice_id": 315043,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79070/Microbiology_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79070/Microbiology_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78954,
      "choices": [
        {
          "id": 314581,
          "text": "<p><span style=\"font-size:14.0pt;\">Vesicovaginal fistula</span></p>"
        },
        {
          "id": 314582,
          "text": "<p><span style=\"font-size:14.0pt;\">Urethrovaginal fistula</span></p>"
        },
        {
          "id": 314583,
          "text": "<p><span style=\"font-size:14.0pt;\">Ureterovaginal fistula</span></p>"
        },
        {
          "id": 314584,
          "text": "<p><span style=\"font-size:14.0pt;\">Urethral diverticulum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman presents with continuous urinary leakage following a total abdominal hysterectomy performed 2 weeks ago. Physical examination reveals a moist vaginal vault. A methylene blue 3-swab test is performed, during which methylene blue dye is instilled into the bladder, and three sterile swabs are placed in the vaginal canal. After 30 minutes, the uppermost swab is found to be wet but not stained, while the other two swabs remain dry and unstained. Which of the following is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q2807278",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ureterovaginal fistula</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the <strong>methylene blue 3-swab test</strong>, methylene blue dye is instilled into the bladder. Swabs are placed in the vaginal canal to localize the origin of urinary leakage:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If the <strong>upper swab</strong> is wet but <strong>not stained</strong>, this suggests <strong>clear urine leaking from the ureter</strong>, indicating a <strong>ureterovaginal fistula</strong>.</span></li><li><span style=\"font-size:14.0pt;\">If the <strong>middle swab</strong> is <strong>stained blue</strong>, it suggests dye-stained urine from the bladder leaking into the vagina — a <strong>vesicovaginal fistula</strong>.</span></li><li><span style=\"font-size:14.0pt;\">If the <strong>lower swab</strong> is stained, it indicates leakage from the urethra — a <strong>urethrovaginal fistula</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In this case, the <strong>upper swab is wet but not stained</strong>, indicating <strong>ureteral leakage</strong> and thus a <strong>ureterovaginal fistula</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vesicovaginal fistula:</strong> Would show blue-stained fluid on the <strong>middle swab</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Urethrovaginal fistula:</strong> Would stain the <strong>lower swab</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Urethral diverticulum:</strong> Presents as post-void dribbling or a tender anterior vaginal wall mass, not identified by this test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>methylene blue 3-swab test</strong> helps localize urinary fistulas. A <strong>wet, unstained upper swab</strong> suggests a <strong>ureterovaginal fistula</strong>, while <strong>blue-stained middle or lower swabs</strong> suggest vesicovaginal or urethrovaginal fistulas, respectively.</span></p>",
      "correct_choice_id": 314583,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78954/Obg_Q_18_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78954/Obg_Q_18_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78925,
      "choices": [
        {
          "id": 314465,
          "text": "<p><span style=\"font-size:14.0pt;\">Amniocentesis performed at 16 weeks gestation</span></p>"
        },
        {
          "id": 314466,
          "text": "<p><span style=\"font-size:14.0pt;\">Manual removal of placenta following vaginal delivery</span></p>"
        },
        {
          "id": 314467,
          "text": "<p><span style=\"font-size:14.0pt;\">Intrauterine transfusion at 28 weeks for fetal anemia</span></p>"
        },
        {
          "id": 314468,
          "text": "<p><span style=\"font-size:14.0pt;\">Medical termination of pregnancy at 63 days gestation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old Rh-negative pregnant woman at 28 weeks of gestation is undergoing evaluation for Rh immunoprophylaxis. She has no prior alloimmunization and her indirect Coombs test is negative. Which of the following clinical situations does not require administration of anti-D immunoglobulin?&nbsp;</span></p>",
      "unique_key": "Q3559745",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Intrauterine transfusion at 28 weeks for fetal anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Anti-D immunoglobulin</strong> is administered to Rh-negative pregnant women to prevent alloimmunization in situations where <strong>feto-maternal hemorrhage</strong> (FMH) is likely. Common indications include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Abortion, MTP, ectopic pregnancy</span></li><li><span style=\"font-size:14.0pt;\">Amniocentesis, chorionic villus sampling</span></li><li><span style=\"font-size:14.0pt;\">External cephalic version</span></li><li><span style=\"font-size:14.0pt;\">Placental abruption, abdominal trauma</span></li><li><span style=\"font-size:14.0pt;\">Manual removal of placenta</span></li><li><span style=\"font-size:14.0pt;\">Delivery of Rh-positive infant</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">However, in the case of <strong>intrauterine transfusion</strong>, especially beyond <strong>28 weeks</strong>, there is <strong>no maternal exposure to fetal red cells</strong> due to the nature of the sterile intrauterine procedure. Thus, <strong>anti-D prophylaxis is not required</strong> post-intrauterine transfusion alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amniocentesis performed at 16 weeks gestation:&nbsp;</strong>Invasive procedures involving the uterus can cause FMH, so anti-D should be given.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Manual removal of placenta following vaginal delivery:&nbsp;</strong>This increases the risk of significant FMH and necessitates anti-D administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Medical termination of pregnancy at 63 days gestation:&nbsp;</strong>Even early gestational interventions require anti-D prophylaxis due to FMH risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Anti-D immunoglobulin is indicated for Rh-negative women in situations where feto-maternal hemorrhage can occur, except in <strong>procedures like intrauterine transfusion</strong> beyond 28 weeks, where fetal red cells are not introduced into maternal circulation.</span></p>",
      "correct_choice_id": 314467,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78925/Obg_Q_3_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78925/Obg_Q_3_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79083,
      "choices": [
        {
          "id": 315093,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyruvate to oxaloacetate</span></p>"
        },
        {
          "id": 315094,
          "text": "<p><span style=\"font-size:14.0pt;\">Gamma-carboxylation of glutamate residues</span></p>"
        },
        {
          "id": 315095,
          "text": "<p><span style=\"font-size:14.0pt;\">Conversion of propionyl-CoA to methylmalonyl-CoA</span></p>"
        },
        {
          "id": 315096,
          "text": "<p><span style=\"font-size:14.0pt;\">Formation of malonyl-CoA from acetyl-CoA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following biochemical conversions is not dependent on biotin?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4121511",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Gamma-carboxylation of glutamate residues</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Biotin (vitamin B7)</strong> functions as a <strong>coenzyme for carboxylation reactions</strong>, where <strong>CO₂ is added</strong> to a substrate. Key biotin-dependent enzymes include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Pyruvate carboxylase</strong> (Pyruvate → Oxaloacetate)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Propionyl-CoA carboxylase</strong> (Propionyl-CoA → Methylmalonyl-CoA)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Acetyl-CoA carboxylase</strong> (Acetyl-CoA → Malonyl-CoA)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These enzymes <strong>require biotin</strong> to function properly. In contrast, <strong>gamma-carboxylation of glutamate residues</strong> is a <strong>vitamin K-dependent</strong> reaction, not a biotin-dependent one. It plays a role in modifying <strong>clotting factors II, VII, IX, X</strong>, and proteins C and S.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Biotin (vitamin B7) is a coenzyme required for carboxylation reactions such as in gluconeogenesis, fatty acid synthesis, and amino acid metabolism. Gamma-carboxylation of glutamate residues, however, is a vitamin K–dependent process, not involving biotin.</span></p>",
      "correct_choice_id": 315094,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79083/Biochem_Q_2_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79083/Biochem_Q_2_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78927,
      "choices": [
        {
          "id": 314473,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal head compression</span></p>"
        },
        {
          "id": 314474,
          "text": "<p><span style=\"font-size:14.0pt;\">Uteroplacental insufficiency</span></p>"
        },
        {
          "id": 314475,
          "text": "<p><span style=\"font-size:14.0pt;\">Umbilical cord compression</span></p>"
        },
        {
          "id": 314476,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal fetal response during active labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old primigravida at 39 weeks gestation is undergoing continuous electronic fetal monitoring during labor. The fetal heart rate tracing pattern is shown below. Which of the following conditions is most commonly associated with the pattern seen in this tracing?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wXbvUtq.png\" width=\"697\" height=\"392\"></span></p>",
      "unique_key": "Q5157267",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Umbilical cord compression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The tracing shows <strong>variable decelerations</strong>, characterized by <strong>abrupt decreases in fetal heart rate</strong> that vary in onset, duration, and intensity relative to uterine contractions. These are <strong>not uniform</strong> in appearance and typically have a rapid drop and recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Variable decelerations are most commonly caused by umbilical cord compression like in oligohydramnios</strong>, which can lead to transient reductions in fetal blood flow and oxygenation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fetal head compression:&nbsp;</strong>Causes <strong>early decelerations</strong>, which are uniform and mirror contractions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Uteroplacental insufficiency:</strong>&nbsp;Causes <strong>late decelerations</strong>, which begin after the contraction starts and resolve after it ends.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Normal fetal response:&nbsp;</strong>Baseline variability and accelerations are considered reassuring, not variable decelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Variable decelerations</strong> on fetal heart rate monitoring are most commonly due to <strong>umbilical cord compression</strong> and are identified by their abrupt onset, variable shape, and inconsistent relationship with contractions.</span></p>",
      "correct_choice_id": 314475,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78927/Obg_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78927/Obg_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78919,
      "choices": [
        {
          "id": 314441,
          "text": "<p><span style=\"font-size:14.0pt;\">III A</span></p>"
        },
        {
          "id": 314442,
          "text": "<p><span style=\"font-size:14.0pt;\">III B</span></p>"
        },
        {
          "id": 314443,
          "text": "<p><span style=\"font-size:14.0pt;\">III C1</span></p>"
        },
        {
          "id": 314444,
          "text": "<p><span style=\"font-size:14.0pt;\">III C2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old postmenopausal woman presents with abnormal vaginal bleeding for the past 2 months. MRI of the pelvis reveals a mass in the endometrial cavity invading more than 50% of the myometrium. The tumor extends to involve the upper vagina. However, there is no radiological evidence of lymph node involvement (pelvic or para-aortic). What is the most appropriate FIGO 2023 stage of her endometrial carcinoma?&nbsp;</span></p>",
      "unique_key": "Q7514534",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) III B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to the <strong>Revised FIGO 2023 staging for endometrial cancer</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Stage 1:</strong> It is confined to uterus</span><ul><li><span style=\"font-size:14.0pt;\">1A: &lt;50 % of Myometrial invasion</span></li><li><span style=\"font-size:14.0pt;\">1B: &gt;50 % of Myometrial invasion</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Stage 2:</strong> Cervical invasion</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stage IlI</strong> indicates <strong>local or regional spread</strong> of the tumor beyond the uterus</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stage 4:</strong> Distant metastasis</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stage III B</strong> includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Direct extension or metastasis to the vagina</strong>, <strong>parametrium</strong>, or <strong>pelvic peritoneum</strong>, <strong>without lymph node involvement</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In this case:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The tumor <strong>extends to the upper vagina</strong>, which qualifies for <strong>Stage IIIB</strong>.</span></li><li><span style=\"font-size:14.0pt;\">There is <strong>no involvement of pelvic or para-aortic lymph nodes</strong>, thus excluding Stage IIIC1 or IIIC2.</span></li><li><span style=\"font-size:14.0pt;\">Myometrial invasion alone (even &gt;50%) does not qualify for Stage III unless it extends to adjacent structures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. III A:&nbsp;</strong>This stage refers to <strong>serosal</strong> or <strong>adnexal involvement</strong>, which is not mentioned in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. III C1:&nbsp;</strong>Refers to <strong>metastasis to pelvic lymph nodes</strong>, which this patient does not have.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. III C2:&nbsp;</strong>Refers to <strong>para-aortic lymph node involvement</strong>, possibly with or without pelvic lymph node metastasis—also not present here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Endometrial carcinoma extending to the <strong>vagina</strong> but without <strong>nodal involvement</strong> is staged as <strong>FIGO Stage IIIB</strong>, reflecting <strong>direct extension to vaginal or parametrial structures</strong> without regional lymph node metastasis.</span></p>",
      "correct_choice_id": 314442,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78919/Obg_Q_1_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78919/Obg_Q_1_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78859,
      "choices": [
        {
          "id": 314205,
          "text": "<p><span style=\"font-size:14.0pt;\">Aliskiren</span></p>"
        },
        {
          "id": 314206,
          "text": "<p><span style=\"font-size:14.0pt;\">Valsartan</span></p>"
        },
        {
          "id": 314207,
          "text": "<p><span style=\"font-size:14.0pt;\">Ivabradine</span></p>"
        },
        {
          "id": 314208,
          "text": "<p><span style=\"font-size:14.0pt;\">Fasudil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with stable angina is started on a newly prescribed medication. Shortly after initiation, he reports transient visual disturbances, describing luminous phenomena (e.g., bright halos or flashing lights). Which of the following medications was most likely started?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9612598",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ivabradine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ivabradine</strong> is a <strong>selective inhibitor of the funny current (If) in the sinoatrial node</strong>, leading to <strong>heart rate reduction</strong> without affecting contractility or blood pressure. It is used for:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stable angina</strong> in patients who cannot tolerate beta-blockers</span></li><li><span style=\"font-size:14.0pt;\"><strong>Heart failure with reduced ejection fraction (HFrEF)</strong></span></li><li><span style=\"font-size:14.0pt;\">A notable side effect of Ivabradine is <strong>visual disturbances</strong>, particularly photopsia/ <strong>phosphenes</strong> (brief moments of enhanced brightness in vision) or <strong>luminous phenomena</strong>, due to its effect on <strong>retinal ion channels</strong> (similar to those in the SA node).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aliskiren:&nbsp; </strong>A <strong>direct renin inhibitor</strong>, used in hypertension. Not associated with visual side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Valsartan:&nbsp;</strong>&nbsp;An <strong>angiotensin II receptor blocker (ARB)</strong>, also used for hypertension and heart failure. Visual disturbances are <strong>not typical</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fasudil:&nbsp;</strong>A <strong>Rho-kinase inhibitor</strong> used experimentally in some vascular conditions (e.g., cerebral vasospasm), but <strong>not standard</strong> in angina management and <strong>not linked to visual disturbances</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ivabradine is an anti-anginal drug that reduces heart rate via inhibition of the funny current in the SA node and is associated with visual side effects, such as phosphenes or luminous visual phenomena.</span></li></ul>",
      "correct_choice_id": 314207,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78859/Pharmacology_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78859/Pharmacology_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78799,
      "choices": [
        {
          "id": 313969,
          "text": "<p><span style=\"font-size:14.0pt;\">Conduct annual mass drug administration in the region.</span></p>"
        },
        {
          "id": 313970,
          "text": "<p><span style=\"font-size:14.0pt;\">Establish permanent vector control measures.</span></p>"
        },
        {
          "id": 313971,
          "text": "<p><span style=\"font-size:14.0pt;\">Provide ongoing public education about filariasis transmission and prevention.</span></p>"
        },
        {
          "id": 313972,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate genetic modification programs for mosquito populations.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health consultant is assessing strategies to sustain the elimination of lymphatic filariasis in a previously endemic area. Which intervention would be most effective in preventing the re-establishment of the disease?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9877958",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Establish permanent vector control measures.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For diseases like lymphatic filariasis, where transmission depends on vector mosquitoes, establishing permanent vector control measures is crucial.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These measures (e.g., use of insecticide-treated bed nets, environmental management to eliminate breeding sites) directly reduce the mosquito population, thereby decreasing the risk of disease resurgence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This approach addresses the root cause of transmission and provides a sustainable solution to maintain disease elimination.</span></li></ul><p><br><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Conduct annual mass drug administration in the region:</strong> Incorrect, because while mass drug administration is effective in reducing infection levels, it does not provide a long-term solution to prevent transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Provide ongoing public education about filariasis transmission and prevention:</strong> Incorrect, as public education is important but must be complemented by direct interventions that reduce transmission risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Initiate genetic modification programs for mosquito populations:</strong> Incorrect, because genetic modification of mosquitoes, while promising, is still experimental and not widely implemented.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Permanent vector control measures are essential for maintaining disease elimination, particularly for vector-borne diseases, by directly limiting the potential for disease transmission.</span></p>",
      "correct_choice_id": 313970,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78799/Psm_Q_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78799/Psm_Q_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78932,
      "choices": [
        {
          "id": 314493,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 3, and 5 are correct</span></p>"
        },
        {
          "id": 314494,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 2, 3, and 4 are correct</span></p>"
        },
        {
          "id": 314495,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 2, and 5 are correct</span></p>"
        },
        {
          "id": 314496,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 2, 4 and 5 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding common causes of vaginal discharge are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Bacterial vaginosis is characterized by a positive whiff test and the presence of clue cells on wet mount.</span></li><li><span style=\"font-size:14.0pt;\">Trichomoniasis presents with thin, frothy, greenish-yellow discharge and is associated with motile flagellates on wet mount.</span></li><li><span style=\"font-size:14.0pt;\">Vulvovaginal candidiasis typically presents with curdy white discharge and vaginal pH &gt;5.</span></li><li><span style=\"font-size:14.0pt;\">Bacterial vaginosis is usually non-irritating and is treated with oral metronidazole.</span></li><li><span style=\"font-size:14.0pt;\">The first-line treatment for candidiasis includes fluconazole or intravaginal clotrimazole.</span></li></ol>",
      "unique_key": "Q2807290",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Statements 1, 2, 4 and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1: Bacterial vaginosis is characterized by a positive whiff test and the presence of clue cells on wet mount:&nbsp;</strong>Correct. Bacterial vaginosis (BV) typically presents with a <strong>thin, grayish-white discharge</strong> and a characteristic <strong>fishy odor</strong>, especially after adding <strong>10% potassium hydroxide (KOH)</strong> to the sample (positive <strong>whiff test</strong>). <strong>Clue cells</strong>, which are <strong>vaginal epithelial cells coated with adherent bacteria</strong>, are seen on <strong>saline wet mount</strong> and are a hallmark of BV.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2: Trichomoniasis presents with thin, frothy, greenish-yellow discharge and is associated with motile flagellates on wet mount:&nbsp;</strong>Correct. <strong>Trichomoniasis</strong>, caused by Trichomonas vaginalis, presents with a <strong>thin, frothy, greenish-yellow vaginal discharge</strong>, often with <strong>vaginal irritation</strong>, and may show a <strong>\"strawberry cervix\"</strong>. Diagnosis is confirmed by observing <strong>motile flagellated protozoa</strong> on a <strong>saline wet mount</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4: Bacterial vaginosis is usually non-irritating and is treated with oral metronidazole: </strong>Correct. Bacterial vaginosis often lacks significant irritation or inflammation, unlike candidiasis or trichomoniasis. Oral metronidazole is the recommended first-line treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5: The first-line treatment for candidiasis includes fluconazole or intravaginal clotrimazole:&nbsp;</strong>Correct. <strong>Vulvovaginal candidiasis</strong>, commonly caused by Candida albicans, presents with <strong>thick, curdy white (\"cottage cheese-like\") discharge</strong> and intense <strong>itching or irritation</strong>. First-line treatments include <strong>oral fluconazole</strong> or <strong>intravaginal antifungals</strong> such as <strong>clotrimazole</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3: Vulvovaginal candidiasis typically presents with curdy white discharge and vaginal pH &gt;5:&nbsp;</strong>Incorrect. While it is true that <strong>vulvovaginal candidiasis</strong> presents with <strong>curdy white discharge</strong>, the <strong>vaginal pH typically remains normal (≤4.5)</strong>. A pH <strong>&gt;5</strong> is more consistent with <strong>bacterial vaginosis or trichomoniasis</strong>, not candidiasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BIN25Mn.png\" width=\"858\" height=\"668\"></strong></span></p>",
      "correct_choice_id": 314496,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78932/Obg_Q_7_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78932/Obg_Q_7_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 78819,
      "choices": [
        {
          "id": 314049,
          "text": "<p><span style=\"font-size:14.0pt;\">5,000 IU</span></p>"
        },
        {
          "id": 314050,
          "text": "<p><span style=\"font-size:14.0pt;\">100,000 IU</span></p>"
        },
        {
          "id": 314051,
          "text": "<p><span style=\"font-size:14.0pt;\">150,000 IU</span></p>"
        },
        {
          "id": 314052,
          "text": "<p><span style=\"font-size:14.0pt;\">200,000 IU</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-year-old child weighing 10 kg is brought to the clinic with signs of xerophthalmia and night blindness. The physician suspects vitamin A deficiency. What is the most appropriate therapeutic dose of vitamin A for treating this child?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2648079",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 200,000 IU</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>WHO-recommended treatment regimen</strong> for <strong>vitamin A deficiency</strong> in children is based on age:</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>&lt;6 months:</strong> 50,000 IU</span></li><li><span style=\"font-size:14.0pt;\"><strong>6–12 months:</strong> 100,000 IU</span></li><li><span style=\"font-size:14.0pt;\"><strong>&gt;12 months (including 2-year-olds):</strong> <strong>200,000 IU</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This dose is usually given <strong>on day 1, day 2, and repeated on day 14</strong> to ensure resolution and prevent recurrence. Since this child is <strong>2 years old and weighs 10 kg</strong>, the correct therapeutic dose is <strong>200,000 IU</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Children older than 12 months with vitamin A deficiency should be treated with <strong>200,000 IU</strong> of vitamin A to reverse ocular symptoms and prevent long-term visual impairment.</span></p>",
      "correct_choice_id": 314052,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78819/Pediatrics_Q_4_Test_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/78819/Pediatrics_Q_4_Test_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 79033,
      "choices": [
        {
          "id": 314897,
          "text": "<p><span style=\"font-size:14.0pt;\">Leukapheresis</span></p>"
        },
        {
          "id": 314898,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous fluids</span></p>"
        },
        {
          "id": 314899,
          "text": "<p><span style=\"font-size:14.0pt;\">Dexamethasone 10 mg</span></p>"
        },
        {
          "id": 314900,
          "text": "<p><span style=\"font-size:14.0pt;\">Packed RBC transfusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 76-year-old man, recently diagnosed with acute myeloid leukemia (AML), presents to the emergency department with worsening breathlessness and lethargy. He has no fever or chest pain. On examination, he is tachypneic with an SpO₂ of 90% on room air, RR 24/min, and bilateral coarse crackles on auscultation. Chest X-ray is done and it is shown.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_umQ5UBz.png\" width=\"455\" height=\"390\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Laboratory values are:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uJ6SAcq.png\" width=\"581\" height=\"316\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most appropriate immediate intervention?</span></p>",
      "unique_key": "Q4519376",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Leukapheresis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>hyperleukocytosis</strong> (WBC &gt;100,000/μL) with <strong>respiratory symptoms</strong> and bilateral infiltrates on imaging, suggesting <strong>leukostasis</strong>, a hematologic emergency.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Leukostasis</strong> is characterized by decreased tissue perfusion due to high blast burden, primarily affecting the <strong>lungs and CNS</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Symptoms include <strong>dyspnea, confusion, coma, or retinal hemorrhages</strong>, even if oxygen saturation appears deceptively normal (due to artifactual hypoxia).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Leukapheresis</strong>, in combination with <strong>hydroxyurea</strong>, is recommended as <strong>urgent cytoreductive therapy</strong> when <strong>intensive chemotherapy cannot be started immediately</strong> (as in this case).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chemotherapy alone</strong> (e.g., cytarabine + anthracycline) is preferred when feasible, but <strong>leukapheresis is life-saving</strong> when there's symptomatic leukostasis and chemotherapy delay.</span></li><li><span style=\"font-size:14.0pt;\">Supportive care includes <strong>aggressive hydration</strong>, <strong>TLS prophylaxis</strong>, and <strong>transfusion restriction</strong>, as excessive RBC transfusion may increase viscosity and worsen leukostasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hyperleukocytosis and Leukostasis in AML – Clinical Approach:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YD8Q2Le.png\" width=\"1486\" height=\"542\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Intravenous fluids</strong>: Supportive only; does not reduce blast burden rapidly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dexamethasone 10 mg</strong>: Not indicated in AML; used in ALL for CNS involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Packed RBC transfusion</strong>: May worsen viscosity unless the patient is severely anemic; used cautiously.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">AML patients with hyperleukocytosis and symptoms of leukostasis require urgent cytoreduction. When induction chemotherapy cannot be immediately administered, <strong>leukapheresis combined with hydroxyurea</strong> is the preferred temporizing strategy to prevent respiratory failure, CNS deterioration, and death.</span></p>",
      "correct_choice_id": 314897,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79033/Dr._Dilip_Mock_Test_2_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/79033/Dr._Dilip_Mock_Test_2_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}